data_2mov_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mov _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 99.99 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.32 71.67 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.094 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -93.11 135.6 34.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.939 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.37 120.97 27.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.859 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.2 mm -125.95 121.94 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 99.99 111.15 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.83 138.62 33.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.142 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.33 166.98 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.118 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.06 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.849 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.98 121.64 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.117 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.27 3.96 78.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.513 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -101.43 139.76 20.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 99.99 110.898 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.38 50.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 99.99 112.335 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.7 tp -144.57 142.15 29.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.894 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.87 146.9 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.163 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -132.22 148.37 52.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -112.04 148.88 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.908 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.12 100.82 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.832 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.37 102.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.92 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 99.99 112.483 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.803 0.335 . . . . 99.99 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.31 146.77 46.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 99.99 110.873 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.2 132.36 48.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.949 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -135.55 142.62 45.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 tp -138.42 134.41 34.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.933 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -115.16 121.92 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.874 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -138.3 176.27 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.118 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.26 -131.15 13.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.51 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.66 -37.75 4.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 99.99 110.856 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 t -179.31 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 99.99 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -102.25 33.26 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.833 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.22 -6.74 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.169 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -61.92 131.32 49.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.934 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.45 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.903 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.2 t -100.62 120.66 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.151 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.56 146.95 24.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.961 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.32 163.46 36.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 99.99 110.877 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 0.48 5.61 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.661 2.241 . . . . 99.99 112.32 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.931 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.776 0.322 . . . . 99.99 111.089 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.48 164.83 18.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.877 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.66 132.01 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.114 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.63 158.76 84.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 99.99 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -25.11 28.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 99.99 112.313 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -83.57 2.06 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.905 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.33 32.46 8.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 99.99 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -179.53 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 99.99 110.851 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.0 tp -130.47 129.59 43.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.965 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -124.37 129.62 51.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.859 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mp -116.57 130.74 24.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 99.99 110.934 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -32.61 18.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 99.99 112.352 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.63 101.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 99.99 111.084 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.69 118.59 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.169 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.07 163.99 30.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 99.99 112.473 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -30.84 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 99.99 111.152 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -75.83 -23.26 55.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.93 -4.67 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.883 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.53 140.83 58.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.913 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.74 -138.55 5.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.482 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.64 135.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 99.99 111.132 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -103.27 135.24 45.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.857 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -131.36 131.47 43.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.866 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 t -125.95 156.12 40.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.87 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.16 142.73 34.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 99.99 110.886 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.17 162.53 33.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.087 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.0 ttm -130.43 124.72 32.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.888 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.04 172.25 8.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.833 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -71.44 -19.35 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.871 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -74.08 -20.17 60.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.85 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.43 37.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 99.99 112.438 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.1 147.47 26.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 99.99 110.935 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.69 144.7 31.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 99.99 110.901 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 131.72 50.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.111 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.53 142.91 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.896 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.91 121.81 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 99.99 110.854 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 123.02 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -125.86 120.11 29.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.926 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.0 130.55 34.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.875 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -121.12 137.32 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.29 131.88 45.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.902 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 m -95.81 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.51 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.928 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 143.6 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.925 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.65 159.58 50.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.652 0.739 . . . . 99.99 111.146 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 99.99 112.34 179.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.963 0.411 . . . . 99.99 110.797 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.61 72.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.087 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 133.18 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.931 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.37 120.44 26.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.939 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mm -125.91 121.61 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.085 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.93 137.7 34.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 99.99 111.142 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.42 166.78 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 99.99 111.085 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.59 148.72 44.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.946 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -52.08 121.57 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.145 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 6.67 75.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 99.99 112.538 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -101.83 140.13 20.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.709 0.766 . . . . 99.99 110.846 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 143.88 52.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.745 2.297 . . . . 99.99 112.33 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 tp -144.23 142.0 30.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.898 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 t -122.81 147.91 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.088 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 mt -131.58 149.05 52.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.951 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.48 152.53 27.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.916 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.74 101.33 10.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.826 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 113.09 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.918 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 99.99 112.579 -180.0 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.776 0.322 . . . . 99.99 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.2 147.79 44.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.943 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -129.41 138.93 51.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.958 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -144.11 136.04 26.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 99.99 110.933 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.98 139.83 38.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 99.99 110.931 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -112.07 127.97 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.895 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -137.55 178.29 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.102 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.17 -130.44 19.08 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.476 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -112.67 -37.39 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.903 0.382 . . . . 99.99 110.888 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -178.42 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.055 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -102.26 33.89 2.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.9 -5.54 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.14 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -59.22 132.29 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.857 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 153.59 46.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.91 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.87 121.7 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.433 . . . . 99.99 111.109 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.51 145.34 25.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 163.74 36.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.639 0.733 . . . . 99.99 110.854 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 2.36 3.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.7 2.267 . . . . 99.99 112.275 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.937 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.695 0.284 . . . . 99.99 111.152 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.67 160.21 37.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.931 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -109.5 128.82 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.102 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.63 158.25 87.49 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.528 0.68 . . . . 99.99 110.957 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -21.38 33.41 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.24 . . . . 99.99 112.338 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -82.87 0.9 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.914 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.01 16.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 m -112.28 179.89 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 99.99 110.938 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 tp -129.73 126.25 37.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -126.46 135.46 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.892 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.06 129.59 25.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 99.99 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -33.03 17.17 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 99.99 112.301 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.2 102.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.432 . . . . 99.99 111.134 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.91 117.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.423 . . . . 99.99 111.183 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.05 162.2 30.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.805 -0.712 . . . . 99.99 112.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -30.26 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.72 0.295 . . . . 99.99 111.084 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -75.58 -22.74 56.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.927 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.59 -4.95 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.856 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.84 141.0 58.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.922 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.76 -137.96 5.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 99.99 112.465 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.6 mm -124.13 127.55 73.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 99.99 111.161 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.77 134.73 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.876 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.28 144.97 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.928 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 155.45 43.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.875 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.89 130.25 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.908 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.57 161.93 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.154 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -130.14 125.28 34.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.49 173.16 9.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -70.64 -19.23 62.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.824 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -74.53 -20.56 59.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.11 -8.0 38.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 99.99 112.508 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.96 147.05 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.698 0.285 . . . . 99.99 110.948 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.94 140.32 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 129.64 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.14 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.87 144.23 33.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -145.08 125.95 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 99.99 110.85 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.7 124.12 45.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 99.99 110.891 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.87 120.62 28.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.953 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 131.34 35.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.94 137.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.1 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.49 129.05 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.865 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.58 -176.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.058 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -63.53 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 99.99 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.37 144.01 54.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.947 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.23 159.57 49.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 99.99 111.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 C-N-CA 122.718 2.278 . . . . 99.99 112.376 179.867 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.813 0.339 . . . . 99.99 110.84 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.35 73.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.496 . . . . 99.99 111.126 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -91.4 139.1 31.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.906 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -84.11 121.02 26.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.916 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -125.68 121.62 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.065 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -95.35 139.72 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 99.99 111.126 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.83 166.33 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.058 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -124.03 149.2 46.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.823 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.6 mt -53.88 120.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.168 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.35 6.94 77.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 99.99 112.452 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -102.37 140.7 21.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 99.99 110.902 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 145.06 56.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 99.99 112.35 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 tp -142.51 142.72 32.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.967 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.12 147.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.072 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.8 mt -131.18 148.21 52.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -113.01 153.13 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.97 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.95 100.68 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.905 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.18 118.39 6.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.562 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.734 0.302 . . . . 99.99 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.63 148.09 41.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 99.99 110.848 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -122.96 138.25 54.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.14 142.56 34.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.877 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 tp -137.94 135.79 36.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.852 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -115.23 121.94 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.94 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.17 176.72 8.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.199 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.83 -131.58 12.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 99.99 112.543 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -112.88 -37.89 4.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.369 . . . . 99.99 110.852 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -179.18 -30.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 99.99 111.142 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.1 33.63 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 -6.1 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.122 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -59.88 132.16 53.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 153.93 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.818 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.18 121.26 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.144 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.55 145.24 25.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.853 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.82 162.12 49.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.697 0.76 . . . . 99.99 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.92 11.01 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.706 2.271 . . . . 99.99 112.327 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.942 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.845 0.355 . . . . 99.99 111.061 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 159.41 20.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 99.99 110.83 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.51 125.06 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.0 mt -68.21 156.99 88.77 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.641 0.734 . . . . 99.99 110.919 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.1 Cg_endo -69.74 -20.71 34.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.673 2.249 . . . . 99.99 112.33 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -82.48 0.89 40.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.885 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.97 28.7 14.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.501 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -112.53 173.67 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 99.99 110.807 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.9 tp -129.29 130.42 46.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.871 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -124.29 136.03 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.874 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.05 130.75 23.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.656 0.741 . . . . 99.99 110.93 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -37.81 8.68 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 99.99 112.332 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.73 104.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.093 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 m -73.06 117.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.139 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.97 162.67 24.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 99.99 112.476 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -29.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 99.99 111.107 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.94 -24.17 58.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.933 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.89 -4.54 56.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.839 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.59 141.38 58.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.6 -139.81 7.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.76 130.25 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 99.99 111.103 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.2 144.3 31.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 99.99 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 146.35 52.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.823 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.7 t -126.98 151.44 48.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.899 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.84 131.76 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.907 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.75 161.91 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 99.99 111.054 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.8 mtp -130.17 124.4 32.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.817 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.42 172.87 9.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.911 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -70.53 -19.42 62.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 99.99 110.893 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.74 -20.34 59.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.861 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.02 39.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 99.99 112.463 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.91 147.7 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 99.99 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -104.3 142.66 34.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.813 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.74 132.55 50.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.14 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 144.1 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.954 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -145.06 126.09 14.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 99.99 110.889 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -118.69 122.56 42.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.901 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -128.72 120.79 27.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.955 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -83.14 133.18 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.912 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.85 138.34 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 99.99 111.125 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -129.25 143.91 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.82 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.47 -176.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 99.99 111.151 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.41 -79.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.933 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.76 144.79 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.952 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.4 159.66 49.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 99.99 111.163 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.254 . . . . 99.99 112.352 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.351 . . . . 99.99 110.865 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.49 94.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.12 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.22 133.08 36.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.949 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -89.68 119.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.935 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.77 122.59 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.127 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -95.79 139.95 31.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.176 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.54 167.65 24.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.24 148.46 43.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.818 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.9 mt -52.42 121.25 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.128 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.42 8.02 71.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.498 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -101.94 140.3 21.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 99.99 110.952 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 144.09 52.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.707 2.271 . . . . 99.99 112.341 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.08 142.23 30.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.936 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 t -121.84 145.93 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.133 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.9 mt -131.43 148.56 52.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.926 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -112.82 152.77 28.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.893 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.0 t -105.66 99.99 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 99.99 110.851 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 120.09 7.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.899 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 99.99 112.503 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.77 0.319 . . . . 99.99 110.875 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -120.88 148.07 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.899 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -127.39 136.17 51.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.863 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.4 136.83 28.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.874 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.4 138.99 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.929 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -112.29 126.55 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.907 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -138.14 179.22 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.155 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.08 -130.83 19.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 99.99 112.472 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -114.9 -38.07 4.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 99.99 110.837 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -176.28 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.154 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -99.09 34.02 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.848 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.15 -4.56 7.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.075 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -58.12 131.13 49.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.961 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 154.06 47.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 99.99 110.903 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.06 118.39 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.163 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.54 145.33 24.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.13 163.19 43.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 99.99 110.925 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -3.73 12.66 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.648 2.232 . . . . 99.99 112.351 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.837 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.833 0.349 . . . . 99.99 111.065 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.32 163.01 26.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.924 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.76 130.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.91 157.8 87.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.626 0.727 . . . . 99.99 110.886 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -21.71 33.32 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 99.99 112.338 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.29 1.12 42.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.1 29.91 11.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 99.99 112.569 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 m -113.19 179.15 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.411 . . . . 99.99 110.827 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 tp -130.01 129.31 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 99.99 110.971 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -124.6 133.94 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.838 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mp -114.97 131.04 23.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.549 0.69 . . . . 99.99 110.95 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -33.64 15.94 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.673 2.249 . . . . 99.99 112.365 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.95 104.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.099 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -73.43 113.12 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.137 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.98 162.0 33.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.718 -0.753 . . . . 99.99 112.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -30.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 99.99 111.206 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.9 -23.71 55.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 99.99 110.889 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -4.07 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.68 140.62 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.884 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.49 -137.63 5.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.478 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.54 133.39 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 99.99 111.052 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -103.81 143.56 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.895 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -138.67 137.99 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.886 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.8 t -126.51 155.29 42.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.84 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.11 135.11 32.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.963 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.02 162.66 30.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.079 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ttm -130.11 124.81 33.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -89.94 172.4 8.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.874 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -71.29 -18.65 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.952 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -73.85 -20.43 60.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -15.58 33.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.734 -0.746 . . . . 99.99 112.407 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -85.16 146.17 27.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 99.99 110.881 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.15 144.61 32.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.919 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 133.32 49.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.14 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.47 145.25 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.934 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -144.91 126.92 15.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 99.99 110.888 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.18 122.71 42.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -124.28 119.37 29.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.891 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 133.86 34.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.895 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.36 137.25 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.078 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -130.33 132.7 45.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.873 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.67 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.128 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -65.39 -80.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.941 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -65.49 142.98 57.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.912 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.13 159.54 49.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 99.99 111.184 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.134 0 C-N-CA 122.695 2.263 . . . . 99.99 112.355 179.878 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 99.99 110.873 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.162 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.883 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.111 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.145 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.074 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.877 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.071 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.568 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 99.99 110.919 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 99.99 112.424 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.861 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.107 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.869 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.877 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.829 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.865 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.476 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.816 0.341 . . . . 99.99 110.911 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.83 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.94 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.912 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.884 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.897 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.105 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.484 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 99.99 110.906 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.159 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.815 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.088 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.834 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.082 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.961 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 99.99 110.839 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 99.99 112.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.944 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.893 0.378 . . . . 99.99 111.073 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.858 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.103 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 99.99 110.91 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 99.99 112.336 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.886 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.487 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 99.99 110.849 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.839 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 99.99 110.959 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 99.99 112.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.079 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 99.99 112.497 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 99.99 111.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.937 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.872 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.504 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 99.99 111.112 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.843 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.872 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.942 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.116 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.847 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 99.99 110.829 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.527 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 99.99 110.919 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.913 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.133 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.879 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 99.99 110.835 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.913 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.878 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.906 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.127 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.893 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.119 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.898 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 99.99 111.184 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 99.99 112.339 179.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.914 0.388 . . . . 99.99 110.857 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.46 100.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 99.99 111.099 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.04 133.27 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.944 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 6.5 m-80 -84.26 120.31 26.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 99.99 110.932 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 mm -126.17 121.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.162 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 p -96.89 138.31 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.24 165.64 30.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.142 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -124.25 149.05 46.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -53.98 121.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.206 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.73 84.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.444 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.09 139.63 20.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 99.99 110.902 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 143.09 49.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.671 2.248 . . . . 99.99 112.358 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -144.72 141.79 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -122.97 148.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 99.99 111.056 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -131.58 149.03 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.95 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -106.29 148.96 27.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.895 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 t -112.26 101.83 10.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.927 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -55.88 95.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.903 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 99.99 112.488 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.775 0.321 . . . . 99.99 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -120.37 147.4 45.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -134.49 138.8 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.931 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -136.46 142.01 43.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.923 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -134.98 135.06 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.933 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -116.64 120.62 39.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.892 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -139.17 177.59 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 99.99 111.167 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.75 -128.91 9.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.36 -36.98 5.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 99.99 110.848 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.9 -30.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.166 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -103.13 33.46 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.874 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.65 -6.69 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.134 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 133.24 55.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.937 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 157.99 40.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.872 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.98 120.46 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.14 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.43 145.75 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.889 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.62 163.06 41.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.729 . . . . 99.99 110.89 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 0.11 6.12 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.714 2.276 . . . . 99.99 112.316 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.919 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.825 0.345 . . . . 99.99 111.081 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 161.73 23.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.896 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.73 129.88 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.145 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 6.5 mp -69.61 158.26 87.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.61 0.719 . . . . 99.99 110.898 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.78 -23.12 31.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 99.99 112.303 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.03 3.48 34.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.818 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.14 24.84 28.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.457 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -105.97 179.73 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 99.99 110.869 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.86 127.91 39.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 99.99 110.943 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -126.1 129.41 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.896 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -117.77 131.24 24.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.612 0.72 . . . . 99.99 110.975 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.63 -32.47 19.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.763 2.309 . . . . 99.99 112.364 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.59 101.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.6 m -73.55 119.41 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.092 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.39 161.48 28.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.705 -0.759 . . . . 99.99 112.514 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -29.39 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.728 0.299 . . . . 99.99 111.124 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -74.47 -23.2 58.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 99.99 110.893 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -5.14 57.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 99.99 110.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.66 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.912 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.49 -139.11 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.483 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.28 128.14 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 99.99 111.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -104.5 136.72 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.839 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.45 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.881 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.4 t -127.14 152.31 47.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.909 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 131.03 24.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.63 163.06 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.07 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ttm -130.06 124.9 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.88 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -88.42 172.36 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.913 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.53 -18.91 62.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.926 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -73.89 -20.26 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.919 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.93 -13.53 34.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 99.99 112.548 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -84.87 147.27 26.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 99.99 110.909 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.58 143.85 32.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.925 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.76 126.89 51.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 99.99 111.12 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 144.23 34.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.867 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 m -145.8 127.74 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 99.99 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.82 122.52 41.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.827 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.72 119.04 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 99.99 110.906 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.02 131.45 34.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 99.99 110.87 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.75 139.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.143 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 128.57 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.866 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 m -92.48 -176.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.099 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -64.69 -78.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.948 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -68.2 145.89 53.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.9 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.62 0.724 . . . . 99.99 111.072 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.166 0 C-N-CA 122.751 2.301 . . . . 99.99 112.312 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.883 0.373 . . . . 99.99 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 97.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 99.99 111.111 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -93.24 133.65 36.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.836 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -89.83 121.43 31.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 mm -125.33 121.44 60.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.08 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -96.01 141.19 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 99.99 111.115 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 167.46 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.051 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -122.63 148.22 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.861 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mt -53.12 121.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.122 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.9 5.76 76.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 99.99 112.47 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -102.04 140.11 20.89 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 99.99 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 144.01 52.47 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.608 2.205 . . . . 99.99 112.286 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 142.01 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.919 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.84 144.6 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.139 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.03 146.26 52.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.939 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -114.5 151.2 33.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.952 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 m -108.05 101.83 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.57 126.71 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 99.99 112.53 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.825 0.345 . . . . 99.99 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.74 129.12 53.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.925 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -111.93 144.53 41.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.911 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -136.96 141.23 42.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.982 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 tp -136.05 135.29 39.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.942 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -116.13 121.47 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.2 p -138.35 179.27 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 99.99 111.139 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.95 -130.24 11.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.49 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -112.5 -37.95 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 99.99 110.933 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 t -179.83 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 99.99 111.134 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -102.6 34.03 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.862 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.57 -6.76 8.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.147 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -61.82 131.34 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.873 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 158.46 38.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.854 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.91 123.1 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.16 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.52 143.5 26.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.919 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 163.02 43.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.647 0.736 . . . . 99.99 110.856 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.694 2.263 . . . . 99.99 112.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.94 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 99.99 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.92 163.0 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.851 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -107.45 127.5 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.063 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 5.6 mp -68.27 157.58 87.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.586 0.707 . . . . 99.99 110.919 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.81 -20.83 34.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 99.99 112.335 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.6 1.62 41.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 28.53 20.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.827 -0.702 . . . . 99.99 112.486 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -112.57 178.01 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 99.99 110.896 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.01 127.93 44.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.912 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -125.81 135.04 51.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.903 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mp -113.43 128.59 25.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 99.99 110.901 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -32.5 18.34 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 99.99 112.368 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.04 102.65 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.098 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.36 118.42 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.151 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.37 158.79 26.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.494 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -31.43 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.787 0.327 . . . . 99.99 111.102 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.79 -22.8 53.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.908 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.55 -5.27 44.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.881 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 142.49 55.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.831 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.16 -147.16 15.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.724 . . . . 99.99 112.511 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.82 129.91 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 99.99 111.144 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.87 135.28 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.853 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.0 146.72 50.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 99.99 110.799 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.59 152.72 46.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.867 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.7 128.13 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.902 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.08 31.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 99.99 111.078 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 ttm -130.11 124.71 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.873 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -87.71 171.9 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.943 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -71.76 -18.18 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -73.28 -26.06 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.86 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.92 -18.22 12.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -84.18 147.16 27.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 99.99 110.892 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.26 144.86 31.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.873 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 128.12 50.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 99.99 111.154 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 145.31 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 99.99 110.919 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -144.67 126.96 15.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.85 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 122.1 40.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.874 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.69 120.04 28.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.953 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.91 132.12 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.886 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.89 136.37 58.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.115 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -130.76 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.879 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.7 -175.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 99.99 111.142 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -66.37 -78.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.927 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -66.53 146.03 54.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.914 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.4 159.48 49.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 99.99 111.133 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.275 . . . . 99.99 112.338 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.849 0.357 . . . . 99.99 110.913 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.49 63.64 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.146 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -92.72 137.87 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.95 120.99 31.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 99.99 110.871 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.24 122.3 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -95.49 142.09 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.11 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.77 168.34 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.111 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.41 148.19 41.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.871 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.03 122.08 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.064 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.4 3.85 86.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 99.99 112.555 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -101.39 142.7 25.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.736 . . . . 99.99 110.93 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 144.03 53.35 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.703 2.269 . . . . 99.99 112.378 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.2 tp -143.93 143.26 31.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.4 t -121.07 147.71 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.148 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -131.48 149.12 52.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.893 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -107.18 151.63 25.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.896 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.6 t -107.63 100.11 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.854 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -59.71 120.53 9.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.898 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.466 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.772 0.32 . . . . 99.99 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -120.51 148.21 44.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.867 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -124.79 143.28 50.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.879 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 143.94 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 134.63 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -116.45 121.18 41.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 p -139.39 179.38 6.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 99.99 111.104 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.56 -133.35 15.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 99.99 112.552 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -112.56 -37.57 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 99.99 110.817 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.7 t -179.31 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.158 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -102.08 33.71 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.85 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.92 -6.81 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.129 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -60.38 128.95 39.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.918 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.34 156.34 44.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 99.99 110.938 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 t -93.49 123.35 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.188 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.66 143.65 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.915 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.73 162.52 50.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.693 0.758 . . . . 99.99 110.854 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -4.0 13.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.767 2.311 . . . . 99.99 112.34 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.9 -179.941 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.796 0.331 . . . . 99.99 111.088 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 161.53 17.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 99.99 110.849 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.43 130.24 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.172 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.82 157.83 87.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.592 0.71 . . . . 99.99 110.926 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.51 33.47 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 99.99 112.344 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.44 1.65 47.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.894 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.58 31.11 9.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 99.99 112.53 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -113.34 -179.05 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 99.99 110.839 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.2 tp -129.84 128.71 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.95 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -126.36 135.85 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.91 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.56 128.86 25.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.626 0.727 . . . . 99.99 110.903 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -32.42 19.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.724 2.283 . . . . 99.99 112.4 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.86 100.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.073 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 m -72.75 113.45 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.093 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.54 158.76 30.1 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.531 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.477 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.74 -31.09 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 99.99 111.049 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -76.23 -20.96 56.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.906 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -3.08 27.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.918 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HG3' HG21 ' A' ' 97' ' ' VAL . 23.8 mt-10 -57.57 142.81 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.39 -149.95 21.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 99.99 112.406 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.58 133.03 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 99.99 111.105 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -103.28 139.08 39.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.873 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 141.16 51.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.883 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -125.95 153.82 43.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -139.74 130.3 25.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 163.18 28.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.093 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.8 ttm -128.42 124.78 37.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.835 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -87.23 173.4 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -69.53 -19.07 63.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.842 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -74.42 -20.34 60.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.75 -9.06 43.79 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 99.99 112.457 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -85.05 148.64 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 99.99 110.916 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.21 140.31 37.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.35 132.77 51.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 99.99 111.179 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.32 145.0 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.881 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -144.7 126.94 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.872 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -119.22 124.23 46.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.877 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.8 119.25 24.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.47 134.45 34.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 99.99 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.8 t -122.63 135.98 60.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.158 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.26 148.18 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -110.74 -175.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.114 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -67.06 -78.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.9 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -63.17 146.45 53.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.918 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 99.99 111.151 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 99.99 112.36 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 99.99 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 96.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.093 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -93.03 132.84 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.996 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.7 p-10 -86.33 119.51 26.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.881 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.2 123.2 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 99.99 111.18 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -95.58 138.66 32.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.153 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.12 166.14 27.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 99.99 111.117 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.45 149.21 44.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.804 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mt -52.58 121.34 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.139 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 6.96 76.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 99.99 112.471 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -102.09 139.65 20.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.718 0.771 . . . . 99.99 110.886 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 144.51 54.7 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.711 2.274 . . . . 99.99 112.345 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.5 tp -143.86 141.91 30.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.947 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.39 144.72 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 99.99 111.202 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.14 146.88 52.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.981 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -114.34 151.75 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.933 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.21 99.67 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.9 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -56.39 124.53 18.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.471 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.799 0.333 . . . . 99.99 110.926 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.15 149.56 47.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.911 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -117.84 135.27 54.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.951 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -145.87 136.58 24.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.88 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.54 140.83 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.873 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -111.7 129.0 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.914 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.6 p -135.83 179.89 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.148 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.27 -129.36 17.4 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -112.7 -37.51 4.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 99.99 110.874 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 t -178.96 -30.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.29 33.95 2.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.878 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.87 -5.14 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.05 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.05 132.19 53.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.941 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 157.56 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.886 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 t -102.56 120.35 52.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 99.99 111.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mt -92.38 146.05 23.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.908 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 163.5 39.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.636 0.732 . . . . 99.99 110.849 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -0.6 7.14 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.704 2.269 . . . . 99.99 112.321 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.914 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.796 0.332 . . . . 99.99 111.084 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 161.4 17.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.871 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.9 t -108.47 129.57 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.141 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.9 mt -69.11 157.47 89.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 99.99 110.937 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -22.56 31.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.726 2.284 . . . . 99.99 112.364 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -83.46 0.61 45.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.849 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.14 29.38 11.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 99.99 112.506 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -111.7 -179.68 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 99.99 110.927 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -128.97 129.58 45.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 99.99 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -125.37 131.03 53.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.915 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.97 130.92 23.43 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.646 0.736 . . . . 99.99 110.911 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -38.3 7.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 99.99 112.334 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.74 101.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.072 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -73.63 116.92 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.103 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.71 164.73 31.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.505 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -29.4 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.7 0.286 . . . . 99.99 111.096 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -75.11 -23.96 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.95 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -3.86 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.915 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.57 141.24 52.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.902 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.66 -140.5 7.59 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.697 -0.763 . . . . 99.99 112.452 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.18 132.99 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 99.99 111.108 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -101.34 143.91 30.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.887 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.86 147.22 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.837 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.15 150.62 49.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.93 128.47 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.884 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.31 162.69 29.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.082 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -130.12 125.09 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.85 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -89.9 172.91 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.9 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -71.07 -19.24 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.868 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -73.81 -20.25 60.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.927 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.73 -15.17 34.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 99.99 112.454 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -84.88 146.64 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 99.99 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -105.81 144.72 32.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.896 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.98 50.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.175 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.37 144.95 32.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.908 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.2 m -145.03 127.49 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.854 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -118.74 127.47 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.872 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.87 118.1 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.957 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.75 127.29 34.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 99.99 110.85 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.13 139.94 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -128.04 129.15 46.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.846 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 m -88.68 -175.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 99.99 111.085 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -65.28 -80.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.952 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -65.76 144.48 56.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.918 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.4 159.99 47.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.698 0.761 . . . . 99.99 111.116 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 99.99 112.339 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.861 0.363 . . . . 99.99 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.95 72.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.072 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -93.11 132.69 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.881 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -84.29 120.71 26.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.43 126.03 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -93.59 141.95 27.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.21 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.13 168.24 22.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.088 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.08 147.95 47.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.865 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -54.62 122.39 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 99.99 111.127 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 3.94 80.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.509 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.1 139.56 20.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 99.99 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 143.0 49.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 99.99 112.42 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 tp -144.35 141.01 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 99.99 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.15 148.35 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.134 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -131.61 148.67 52.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.882 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.49 149.48 27.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.876 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.5 t -112.49 101.69 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -53.65 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.84 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 99.99 112.464 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.709 0.29 . . . . 99.99 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.38 142.36 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.891 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -126.09 143.29 51.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.919 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -141.98 142.55 32.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.915 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 tp -137.87 135.99 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.878 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -114.99 123.33 48.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.893 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -138.87 -179.76 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.132 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.45 -126.83 8.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.468 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -37.45 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 99.99 110.832 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.13 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.148 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.67 32.92 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.88 -7.79 8.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.102 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -60.14 129.6 42.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.956 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 158.57 39.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.874 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.63 121.02 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.077 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.33 144.46 25.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.96 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.53 45.72 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.734 0.778 . . . . 99.99 110.868 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 0.47 5.5 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.263 . . . . 99.99 112.361 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.923 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.821 0.343 . . . . 99.99 111.037 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.51 160.91 17.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.863 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.73 130.46 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.153 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 45.8 mt -69.1 158.78 85.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 99.99 110.885 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.77 -22.66 31.7 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.672 2.248 . . . . 99.99 112.35 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -85.33 1.99 46.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.898 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.78 23.91 24.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.529 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 1.4 m -104.4 -179.0 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 99.99 110.852 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -130.14 130.04 44.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.487 . . . . 99.99 110.906 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.45 129.68 50.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.926 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -118.14 129.77 25.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.605 0.717 . . . . 99.99 110.884 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -32.74 18.01 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 99.99 112.421 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.27 101.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 99.99 111.088 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.03 119.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.119 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.36 160.71 32.03 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.501 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -31.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 99.99 111.117 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -76.46 -22.07 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.934 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -4.75 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.908 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.23 142.35 52.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.926 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.74 -145.89 13.44 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.452 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.33 133.82 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 99.99 111.16 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -101.37 139.24 37.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.883 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.77 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.872 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 149.98 50.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -140.22 126.5 19.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.07 163.12 29.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.064 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 66.7 mmm -129.41 124.64 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.86 172.52 9.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.893 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -71.23 -22.48 61.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.926 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -74.23 -20.14 60.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.863 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.92 -2.99 35.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.729 . . . . 99.99 112.568 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.7 149.07 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 99.99 110.949 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -102.87 141.77 35.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 123.45 47.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.149 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.93 141.61 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.877 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -147.26 125.87 12.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.935 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -119.25 125.08 48.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 99.99 110.879 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.86 119.74 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.885 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 131.84 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.61 137.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.112 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.35 152.93 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.831 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.86 -175.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 99.99 111.148 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -65.86 -78.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.932 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.83 144.78 56.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 159.6 49.36 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.634 0.731 . . . . 99.99 111.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 99.99 112.357 179.903 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.916 0.389 . . . . 99.99 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.44 80.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.091 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.42 138.6 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.918 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.43 119.92 25.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.876 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -126.26 123.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.159 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.1 p -93.72 140.47 29.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.171 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.03 165.07 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.091 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.78 149.44 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.36 120.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.114 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.17 5.48 89.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.516 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.69 141.5 22.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.703 0.763 . . . . 99.99 110.905 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.9 144.06 52.1 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.665 2.243 . . . . 99.99 112.343 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.5 tp -144.2 143.29 30.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.906 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -121.47 147.23 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.1 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.85 150.64 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.966 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -111.79 152.79 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -106.45 101.63 11.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.884 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -61.42 115.94 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.942 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 99.99 112.516 179.896 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.814 0.34 . . . . 99.99 110.877 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -120.29 148.36 43.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.868 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -127.05 134.39 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.965 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 136.41 25.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.912 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 140.54 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.903 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.87 127.95 55.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.868 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -136.75 179.32 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.166 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.0 -129.98 12.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.654 -0.784 . . . . 99.99 112.517 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -112.62 -37.75 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 99.99 110.897 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 t -179.44 -30.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.19 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -102.7 33.68 3.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.888 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.44 -6.54 8.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.084 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -59.23 130.29 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.923 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.53 153.52 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.88 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.21 120.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.138 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.9 145.13 25.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.61 163.25 39.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.656 0.741 . . . . 99.99 110.82 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -2.37 10.06 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 99.99 112.368 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.903 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 99.99 111.048 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.15 160.67 24.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.882 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 t -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.079 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.27 157.53 89.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 99.99 110.886 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -22.08 32.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.679 2.253 . . . . 99.99 112.395 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -83.25 0.63 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 99.99 110.894 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.7 30.71 10.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.715 -0.755 . . . . 99.99 112.432 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 m -113.49 179.04 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 99.99 110.896 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.2 128.37 43.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -126.39 133.5 51.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.914 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.42 130.8 24.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 99.99 110.856 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -33.06 17.01 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.68 2.253 . . . . 99.99 112.333 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.97 100.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.11 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.57 114.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.136 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.77 164.25 39.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 99.99 112.568 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.56 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.749 0.309 . . . . 99.99 111.102 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -75.72 -22.71 56.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.871 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -5.0 41.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -66.37 140.85 58.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.91 -137.32 5.25 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.711 -0.757 . . . . 99.99 112.456 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mp -124.19 132.68 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 99.99 111.133 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -104.79 133.52 49.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.938 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -128.0 137.57 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.883 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.36 153.7 42.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.869 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.66 131.64 27.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.918 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.8 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.028 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 tpp -130.02 124.77 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.17 172.61 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -71.15 -18.44 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.46 -20.37 60.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.856 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.16 -16.4 32.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 99.99 112.487 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -85.21 146.81 26.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.686 0.279 . . . . 99.99 110.926 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.31 143.93 32.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.44 132.54 50.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.135 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 145.73 31.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.934 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -143.73 125.34 14.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.876 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.12 122.66 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.814 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.3 125.11 40.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.938 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -83.25 134.02 34.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.861 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -121.16 136.08 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 99.99 111.099 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -131.18 127.95 39.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.837 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.1 m -93.09 -177.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.6 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.974 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -61.62 141.83 57.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.94 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.468 ' H ' ' NE2' ' A' ' 99' ' ' GLN . 0.6 OUTLIER -121.45 159.7 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.719 . . . . 99.99 111.119 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 99.99 112.31 179.916 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.907 0.384 . . . . 99.99 110.884 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.47 94.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 99.99 111.084 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.81 131.16 38.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.896 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -89.88 121.94 32.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.866 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.96 122.42 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.117 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.09 136.9 35.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.187 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.57 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.108 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 147.91 43.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.878 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -52.94 121.76 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.11 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.93 6.93 71.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.656 -0.783 . . . . 99.99 112.45 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -101.37 139.4 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.592 0.71 . . . . 99.99 110.968 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.39 50.82 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 99.99 112.381 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 39.2 tp -144.65 141.74 29.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.957 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.55 143.62 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.107 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.6 mt -132.16 148.01 52.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.969 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -112.98 153.13 28.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.94 101.94 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.852 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.77 122.93 13.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.423 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.738 0.304 . . . . 99.99 110.935 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.58 149.26 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.899 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -111.82 140.77 46.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.884 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -137.63 142.43 41.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.865 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.8 134.62 33.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.89 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -116.23 126.98 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.861 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -139.86 178.01 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.097 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.61 -131.65 19.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 99.99 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -37.29 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 99.99 110.862 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 t -178.48 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.133 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -101.09 33.19 2.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.87 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.99 -4.51 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.124 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -62.73 132.2 51.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.03 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 158.75 38.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.19 122.42 52.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.065 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.81 143.63 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.942 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.27 163.17 41.83 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.695 0.759 . . . . 99.99 110.805 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -1.01 7.7 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 99.99 112.308 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.922 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.749 0.309 . . . . 99.99 111.115 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 160.68 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.76 128.79 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.179 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.16 157.83 88.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.562 0.696 . . . . 99.99 110.928 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -22.72 31.58 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 99.99 112.345 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -83.01 0.25 45.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.65 29.43 10.86 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.483 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -111.68 179.85 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 99.99 110.869 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.93 129.72 44.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.912 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -125.34 131.2 53.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.814 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.33 129.42 24.89 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 99.99 110.946 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -33.01 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 99.99 112.375 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.32 102.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 99.99 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -72.88 116.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.063 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.7 33.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.48 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -29.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 99.99 111.087 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -75.11 -23.37 57.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.912 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.06 -5.41 57.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.7 140.33 58.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.906 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 -135.37 4.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.472 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.4 135.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 99.99 111.093 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -101.71 138.5 38.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.906 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -138.83 128.12 24.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.899 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.3 t -125.26 157.33 36.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.831 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -138.0 140.08 39.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.891 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.09 162.71 30.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 99.99 111.082 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ttm -129.56 124.99 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.864 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -90.88 172.81 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.894 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -71.1 -18.77 62.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.81 -20.33 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.946 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.58 35.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -85.06 146.04 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 99.99 110.877 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.51 143.26 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.864 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -105.72 130.4 53.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.173 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -107.1 145.69 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.957 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 124.55 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.847 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.5 128.79 52.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.912 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -131.19 122.23 26.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.906 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 124.5 30.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.872 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.7 139.45 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.126 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 129.05 42.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.919 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -88.41 -175.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.168 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.32 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.92 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -66.31 142.35 57.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.9 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.35 159.75 48.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 99.99 111.161 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 99.99 112.277 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.916 0.388 . . . . 99.99 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.39 71.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.06 139.39 30.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 99.99 110.849 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.4 m-80 -82.4 121.09 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mm -125.11 122.05 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.201 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.64 142.13 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 99.99 111.11 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.96 166.25 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.116 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.96 148.57 48.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.866 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.29 121.25 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.198 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.0 5.01 90.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.532 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.96 141.87 23.5 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 99.99 110.892 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.87 52.36 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.783 2.322 . . . . 99.99 112.284 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.2 tp -144.6 143.16 30.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.881 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.13 146.73 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.172 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.3 mt -131.48 149.94 52.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.953 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -111.91 150.55 30.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 99.99 110.872 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.9 t -108.73 101.2 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -57.1 124.99 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.913 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 99.99 112.497 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.03 0 CA-C-O 120.8 0.334 . . . . 99.99 110.92 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.62 148.58 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 99.99 110.887 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -122.79 137.03 55.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.969 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 139.79 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.874 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.99 136.08 36.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.889 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -114.63 127.43 55.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -138.85 176.79 8.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.42 -130.81 16.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 99.99 112.445 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.53 -37.35 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 99.99 110.873 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t -178.76 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.18 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.99 32.8 3.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.931 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.79 -5.88 6.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.503 . . . . 99.99 111.115 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -59.4 132.27 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.893 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.51 153.33 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.871 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.0 t -100.17 122.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.195 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.29 143.6 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.884 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.33 42.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 99.99 110.9 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -1.76 9.08 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 99.99 112.294 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.931 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.782 0.325 . . . . 99.99 111.113 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.35 160.58 18.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.836 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 t -109.54 129.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.154 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.55 158.51 85.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.678 . . . . 99.99 110.942 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.88 32.91 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.712 2.275 . . . . 99.99 112.387 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.32 1.33 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.77 9.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.726 . . . . 99.99 112.531 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 m -112.22 -179.66 3.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 99.99 110.901 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.9 tp -128.9 128.27 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.857 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -126.22 136.93 53.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.891 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.61 132.22 22.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.646 0.736 . . . . 99.99 110.871 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.8 15.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 99.99 112.272 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.19 100.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.29 -0.414 . . . . 99.99 111.17 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.13 112.98 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.129 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.97 163.08 37.71 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.47 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -30.74 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.745 0.307 . . . . 99.99 111.146 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.15 -22.72 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.972 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -5.05 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.917 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.95 142.08 57.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.905 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.95 -142.88 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 99.99 112.476 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.95 133.22 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 99.99 111.108 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -104.75 140.14 38.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.849 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -135.23 142.39 45.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.868 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 155.81 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.862 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -140.7 129.28 22.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 99.99 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 162.19 31.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.115 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 ttm -130.65 125.08 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.889 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -89.59 172.28 9.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.865 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -71.68 -18.52 62.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.812 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -73.45 -20.01 60.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.922 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.54 31.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 99.99 112.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -84.98 146.83 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 99.99 110.936 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.09 143.87 32.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 126.64 51.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 99.99 111.171 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 145.11 32.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.83 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -144.58 124.52 13.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.852 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.88 121.45 40.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.827 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -128.89 120.42 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.957 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.75 134.28 34.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.914 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.29 139.36 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.172 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -129.14 148.44 51.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.851 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.67 -177.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.11 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -66.35 -81.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.933 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -59.24 146.25 39.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.907 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.41 159.7 49.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.611 0.72 . . . . 99.99 111.154 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 99.99 112.345 179.835 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.885 0.374 . . . . 99.99 110.79 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.39 96.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.058 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.85 133.79 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.896 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -84.29 119.62 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 99.99 110.862 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.52 123.54 63.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.096 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -94.78 140.83 29.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.116 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.72 167.27 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.113 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -124.25 148.32 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.909 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.9 mt -53.83 121.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.125 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.72 3.97 79.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.45 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -101.1 140.33 21.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 99.99 110.867 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 142.28 47.59 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.676 2.251 . . . . 99.99 112.339 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.43 141.97 29.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.912 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.34 147.97 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.116 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.5 148.6 52.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 99.99 110.983 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -110.49 149.0 30.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.923 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 101.19 9.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.85 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.19 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 99.99 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.497 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.777 0.322 . . . . 99.99 110.928 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.13 148.62 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.861 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -127.67 132.76 49.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.856 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -137.6 135.41 36.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 99.99 110.871 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.93 138.84 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.881 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -112.95 127.63 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.848 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.1 p -137.22 179.77 6.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.149 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 -127.71 13.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.48 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -114.33 -37.49 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 99.99 110.823 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.09 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.158 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -99.98 32.91 2.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.895 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.76 -6.24 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.139 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -60.71 131.25 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.93 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 158.77 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 99.99 110.877 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.06 118.73 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 99.99 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mt -90.25 145.78 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.03 162.74 43.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 99.99 110.881 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 0.16 6.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.237 . . . . 99.99 112.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.884 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.805 0.336 . . . . 99.99 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 162.06 23.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.881 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.27 130.15 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.18 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.54 158.86 85.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 99.99 110.869 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -23.41 30.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 99.99 112.37 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -83.79 0.48 47.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.2 25.24 19.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 99.99 112.497 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 m -105.84 -179.43 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 99.99 110.911 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.7 tp -130.03 129.97 44.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.931 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -125.37 128.83 48.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.817 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.26 130.02 25.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.647 0.737 . . . . 99.99 110.946 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.36 18.95 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 99.99 112.343 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.24 101.71 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 99.99 111.057 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 m -73.09 119.33 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.03 161.91 33.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.533 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -31.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.779 0.323 . . . . 99.99 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -75.05 -23.16 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.843 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.44 -5.48 45.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 99.99 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 140.48 58.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.868 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.36 -141.72 8.19 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.547 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.5 133.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 99.99 111.173 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -104.48 139.95 38.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 99.99 110.876 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -135.41 142.01 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 41.8 t -128.91 150.43 50.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.3 126.75 21.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.925 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.97 163.06 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.124 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.7 ttm -129.35 125.02 35.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.25 172.55 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.905 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -70.96 -18.54 62.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.839 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -73.83 -25.83 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.85 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.78 -14.24 19.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 99.99 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.35 147.88 26.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.717 0.294 . . . . 99.99 110.882 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.12 142.49 34.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.911 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.69 126.29 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.137 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 144.2 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.901 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.1 m -146.9 126.7 13.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.91 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.22 126.91 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.919 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -124.1 120.96 33.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.974 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -83.53 130.07 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 99.99 110.799 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.02 134.2 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.121 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -131.45 127.92 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.885 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.66 -177.67 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.068 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -66.76 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.898 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -62.48 143.83 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.882 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 159.72 48.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 99.99 111.124 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 99.99 112.311 179.864 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.896 0.379 . . . . 99.99 110.886 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.32 93.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.09 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -93.39 131.46 38.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.925 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 1.8 m120 -88.34 120.54 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.881 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.87 128.37 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.112 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -89.3 141.09 28.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.13 165.95 26.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.134 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 150.06 43.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 99.99 110.829 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.7 mt -68.76 120.61 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.152 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.75 -6.34 60.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 99.99 112.49 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -102.09 141.09 21.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 99.99 110.842 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 145.69 58.03 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 99.99 112.347 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 tp -137.95 143.07 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.914 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.09 145.0 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.133 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.4 mt -131.3 149.48 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.927 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.16 152.75 27.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 99.99 110.972 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -106.31 101.78 11.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.861 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -58.76 120.38 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.864 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.451 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.777 0.322 . . . . 99.99 110.931 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.6 144.81 47.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 99.99 110.96 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -126.22 136.88 53.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.948 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -144.36 136.4 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.82 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 tp -138.95 136.81 35.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.887 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.45 127.13 56.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.868 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -137.99 179.39 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.108 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.39 -131.18 16.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.528 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.5 -37.29 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 99.99 110.89 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -179.4 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.133 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.09 33.32 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.21 7.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.101 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -60.36 130.59 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.904 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 153.46 47.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.846 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.04 121.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 99.99 111.101 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.82 145.84 24.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.946 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.56 163.13 40.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.723 . . . . 99.99 110.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 2.82 3.19 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.675 2.25 . . . . 99.99 112.366 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.914 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.784 0.326 . . . . 99.99 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.54 160.18 37.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.9 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.0 t -109.0 129.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.113 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.28 158.82 86.65 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 99.99 110.934 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -21.87 33.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 99.99 112.339 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -83.16 1.83 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.884 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.21 29.69 14.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 99.99 112.472 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -113.9 -178.9 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 99.99 110.88 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.8 tp -129.47 127.62 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -125.9 136.05 52.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.879 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 mp -119.29 130.22 24.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.636 0.732 . . . . 99.99 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.93 17.37 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.28 . . . . 99.99 112.308 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.77 102.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.105 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.74 119.2 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.039 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.16 161.55 27.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.53 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -32.26 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 99.99 111.079 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -76.01 -22.51 55.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.918 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -4.98 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 99.99 110.84 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.32 141.3 57.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.913 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.08 -138.95 5.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.743 . . . . 99.99 112.48 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.95 130.35 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 99.99 111.132 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -105.49 134.17 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.84 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.56 139.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.817 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.5 t -125.5 156.3 39.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.896 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -140.75 134.67 30.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.908 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 162.36 32.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.143 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.8 mtp -130.16 125.24 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.908 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -91.51 172.43 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.827 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -18.87 62.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.864 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -73.94 -20.43 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.907 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.99 -15.33 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 99.99 112.414 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 146.18 27.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 99.99 110.88 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -106.16 143.63 34.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.87 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 129.46 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.16 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 145.11 35.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.858 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.21 121.53 10.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.9 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.37 124.37 47.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.832 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -129.82 117.93 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.827 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -84.24 130.6 34.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.873 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.08 140.32 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 99.99 111.118 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.23 127.73 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.859 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -88.69 -176.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.107 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.6 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.937 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 140.74 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.885 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.71 159.63 50.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.654 0.74 . . . . 99.99 111.074 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.68 2.254 . . . . 99.99 112.274 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.826 0.346 . . . . 99.99 110.856 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.33 66.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.108 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.57 133.55 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.934 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -84.01 121.03 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.888 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mm -125.4 121.78 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.157 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.98 138.77 33.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.093 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 166.88 26.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.122 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -120.93 148.35 44.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.841 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mt -52.61 121.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.058 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.61 7.19 72.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.515 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -101.37 139.43 20.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 99.99 110.939 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 143.15 49.62 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 99.99 112.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.1 tp -145.44 142.04 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.859 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.13 148.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mt -131.14 147.21 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.906 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -113.26 154.89 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.902 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 t -104.06 100.57 10.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.893 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.64 116.56 4.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.901 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.504 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.767 0.318 . . . . 99.99 110.932 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -145.55 148.54 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.855 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -120.64 132.07 54.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.897 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -139.97 135.9 33.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.952 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.1 140.05 24.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.945 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.95 128.74 55.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.927 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 p -136.33 -179.73 5.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.68 -129.14 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 99.99 112.549 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.51 -37.45 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 99.99 110.906 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 t -179.32 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.156 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -102.26 33.93 2.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.841 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.63 -6.32 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.148 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.73 130.2 45.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.942 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.8 152.97 49.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.882 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.85 120.66 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.189 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.88 146.71 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.44 46.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 99.99 110.93 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -1.92 9.26 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 99.99 112.322 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.974 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.796 0.331 . . . . 99.99 111.137 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.64 161.18 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.937 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -109.0 129.93 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.042 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.45 158.98 86.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.7 . . . . 99.99 110.899 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -20.98 33.91 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.608 2.205 . . . . 99.99 112.294 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -83.12 1.59 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.39 25.17 26.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.505 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -110.84 -178.72 3.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 99.99 110.823 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.7 tp -129.72 127.57 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.917 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -126.12 132.51 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.904 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.54 129.61 25.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.663 0.744 . . . . 99.99 110.935 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.74 17.86 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.739 2.293 . . . . 99.99 112.313 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.76 101.29 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.044 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 m -73.35 116.71 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.1 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.4 165.35 33.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.512 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -30.17 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 99.99 111.111 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.853 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -5.0 56.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.821 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.69 140.94 58.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.76 -141.56 7.87 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 99.99 112.528 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mm -124.41 127.72 73.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 99.99 111.115 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -104.66 134.18 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.897 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -127.92 146.5 50.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.837 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.4 t -126.25 153.87 44.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.922 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.04 130.82 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.887 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.55 162.58 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 99.99 111.105 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.4 ttm -130.32 125.01 33.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.919 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -89.14 172.23 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.836 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.53 -18.61 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.853 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -73.57 -20.23 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.829 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.91 -17.44 29.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.49 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -84.81 147.9 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 99.99 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -104.01 149.18 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.875 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.14 133.5 48.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.131 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 143.41 33.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.921 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.5 m -145.23 122.74 11.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.831 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.66 124.36 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.925 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -128.37 119.83 25.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.89 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.9 132.15 34.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.823 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.88 136.26 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.118 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.58 44.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.849 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 m -95.87 -175.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 99.99 111.171 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -66.39 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.867 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -62.85 146.33 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.943 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.56 49.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.688 0.756 . . . . 99.99 111.081 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 99.99 112.329 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.949 0.404 . . . . 99.99 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.9 71.11 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.082 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 133.28 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.946 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.45 119.13 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.887 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 124.64 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.136 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -93.51 142.25 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.115 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.43 166.57 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.029 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.61 148.28 46.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.92 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mt -54.9 121.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.173 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.41 76.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -101.91 140.7 21.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.689 0.757 . . . . 99.99 110.899 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 144.03 52.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.664 2.242 . . . . 99.99 112.331 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 tp -143.54 141.31 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.907 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.44 147.19 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.131 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -130.97 148.28 52.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.899 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -112.07 151.82 28.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.807 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 t -107.18 100.76 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.853 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.1 120.22 8.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.892 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.515 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.707 0.289 . . . . 99.99 110.951 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -121.51 148.62 44.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.878 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -123.11 138.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 99.99 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -150.97 135.76 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.94 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.25 145.94 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.889 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.99 129.43 56.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.943 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -138.42 -179.58 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.157 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.89 -132.78 16.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 99.99 112.53 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.79 -37.69 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 99.99 110.882 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 t -179.12 -29.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.098 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -101.53 34.81 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.874 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.09 -4.23 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 99.99 111.06 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -57.32 128.05 35.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 156.64 47.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.873 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.7 t -105.5 122.24 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.125 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.91 147.14 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.864 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.77 162.21 46.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.73 0.776 . . . . 99.99 110.846 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -2.62 10.52 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.687 2.258 . . . . 99.99 112.319 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.899 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.811 0.339 . . . . 99.99 111.137 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 162.8 25.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.916 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.75 130.95 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.167 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.1 mt -68.7 157.69 87.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 99.99 110.914 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -22.16 32.65 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.669 2.246 . . . . 99.99 112.365 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.7 1.2 43.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.46 29.83 11.65 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 99.99 112.438 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -112.86 -179.6 3.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 99.99 110.87 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 tp -129.51 129.24 44.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.873 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -124.63 136.72 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.881 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.41 124.79 29.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 99.99 110.913 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.71 19.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 99.99 112.375 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.49 103.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.076 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.62 118.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.124 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.58 157.44 23.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 99.99 112.506 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -32.02 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 99.99 111.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -75.6 -23.4 56.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.858 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -5.26 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 99.99 110.823 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 142.01 56.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.918 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.22 -138.17 5.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.798 -0.715 . . . . 99.99 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.68 127.32 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 99.99 111.195 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 14.6 m-85 -104.78 144.49 31.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.853 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -138.27 143.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 99.99 110.865 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.8 t -127.21 155.66 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.891 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.14 133.8 30.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.926 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.5 162.71 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 99.99 111.089 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 mtp -129.94 125.12 34.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -91.39 172.51 8.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.876 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.45 -18.81 62.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 99.99 110.852 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.06 -20.57 60.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 99.99 110.872 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.02 -15.21 33.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.83 -0.7 . . . . 99.99 112.515 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -85.02 146.35 27.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.742 0.306 . . . . 99.99 110.893 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 144.26 33.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.89 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 132.15 50.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 99.99 111.189 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 145.14 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.937 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -145.34 127.9 16.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.825 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' ND2' ' HE ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -116.97 124.93 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 99.99 110.849 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -125.41 121.6 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.944 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HE ' ' ND2' ' A' ' 92' ' ' ASN . 16.9 mmt85 -83.07 133.03 35.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.874 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -120.95 134.82 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.219 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 128.79 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.872 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 m -98.33 -177.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.198 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.55 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.954 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.89 144.53 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.4 159.61 49.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 99.99 111.125 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.34 0.117 0 C-N-CA 122.686 2.258 . . . . 99.99 112.319 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.81 0.338 . . . . 99.99 110.894 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.69 66.91 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.084 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -93.23 131.94 37.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.916 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.439 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.3 p-10 -90.83 121.85 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.887 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.58 127.42 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.137 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -94.52 142.52 27.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 99.99 111.179 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.35 168.44 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.061 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.43 148.06 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -67.28 121.99 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.06 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.17 -9.96 54.58 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.429 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -101.71 142.66 25.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.723 . . . . 99.99 110.862 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 145.07 56.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 99.99 112.334 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.0 tp -139.71 144.44 37.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.909 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.46 145.03 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.104 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.3 mt -131.28 147.78 52.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -113.62 150.87 32.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 99.99 110.924 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.11 100.26 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.894 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -54.27 128.41 31.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.939 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.727 . . . . 99.99 112.472 179.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.526 0.041 0 CA-C-O 120.81 0.338 . . . . 99.99 110.888 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.71 148.44 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.895 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -134.47 144.11 47.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.982 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -136.21 142.05 44.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 99.99 110.924 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.4 139.03 42.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.936 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -112.12 127.29 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.901 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.7 p -138.16 -179.8 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.141 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.44 -129.97 23.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.852 -0.689 . . . . 99.99 112.435 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -112.61 -37.4 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 99.99 110.897 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -178.69 -29.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.174 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -101.73 34.07 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.887 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.23 -5.54 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.123 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -59.62 131.82 52.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 99.99 110.929 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 155.07 45.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.935 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.48 121.75 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.137 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 143.13 27.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.911 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.93 164.09 39.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 99.99 110.808 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 0.85 5.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.707 2.271 . . . . 99.99 112.277 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.899 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.819 0.342 . . . . 99.99 111.116 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.52 160.2 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.85 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.9 129.25 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.158 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 86.4 mt -69.29 157.19 90.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 99.99 110.929 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.5 Cg_endo -69.77 -20.41 34.81 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.75 2.3 . . . . 99.99 112.278 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -82.41 0.57 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.863 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 27.39 17.37 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 99.99 112.443 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.4 m -111.77 175.73 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.852 0.358 . . . . 99.99 110.896 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -129.34 130.11 45.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.865 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -124.42 135.39 53.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 99.99 110.852 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.56 129.51 24.87 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 99.99 110.917 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.62 -31.68 20.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.285 . . . . 99.99 112.414 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.55 104.36 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 99.99 111.145 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 119.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 99.99 111.163 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.93 153.49 20.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 99.99 112.447 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.464 ' HA ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.02 -31.18 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 99.99 111.151 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.28 -22.01 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.35 -3.53 34.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.839 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HG3' HG22 ' A' ' 97' ' ' VAL . 16.8 mt-10 -58.43 142.17 49.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.46 -151.74 22.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 99.99 112.561 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.29 133.98 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 99.99 111.107 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -103.04 139.38 38.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.87 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.52 141.04 51.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 m -126.82 150.24 49.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.891 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.07 125.51 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.881 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.43 163.97 28.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.091 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.8 ttm -128.34 124.88 37.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.907 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -86.91 173.15 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 99.99 110.871 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -70.22 -17.97 63.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.87 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -73.23 -19.74 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.36 -18.78 32.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.43 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -85.16 148.2 26.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 99.99 110.916 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.5 143.61 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.895 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.55 131.6 51.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.127 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 145.34 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.93 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -146.32 124.41 12.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 99.99 110.846 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -118.82 124.6 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.24 117.02 20.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.927 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -90.9 136.11 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.928 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.18 138.57 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.134 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.21 128.14 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.855 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -92.2 -175.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.11 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -65.98 -80.62 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -58.67 146.67 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.847 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.31 159.49 49.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.693 0.759 . . . . 99.99 111.132 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 99.99 112.368 179.849 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.835 0.35 . . . . 99.99 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.47 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 99.99 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -93.44 132.42 37.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.863 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 7.0 p30 -87.13 119.96 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.898 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.78 127.47 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.117 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -92.11 141.88 28.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 99.99 111.102 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.54 167.58 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.073 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.78 149.68 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.885 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.47 120.7 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.122 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.69 -8.29 59.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.691 -0.766 . . . . 99.99 112.468 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -102.08 140.81 21.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.701 . . . . 99.99 110.911 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 145.11 55.98 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.704 2.269 . . . . 99.99 112.33 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -142.35 143.4 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.917 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 13.7 t -122.49 148.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 99.99 111.146 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.6 mt -129.85 149.1 51.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.934 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -108.8 149.56 28.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.878 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.3 t -112.12 100.69 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' N ' ' HG ' ' A' ' 91' ' ' SER . 0.1 OUTLIER -52.12 100.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.842 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.799 -0.715 . . . . 99.99 112.51 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.805 0.336 . . . . 99.99 110.937 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 148.33 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.912 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -127.59 137.92 52.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.923 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -135.72 138.57 42.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.957 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -137.3 131.53 32.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.948 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -116.53 120.68 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.939 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.8 p -138.36 179.39 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.191 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.61 -132.16 12.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 99.99 112.462 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 99.99 110.83 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 t -179.67 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.141 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -102.19 33.73 2.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.917 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 -6.01 7.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.118 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -69.24 130.59 43.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 159.32 42.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.875 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.73 121.48 43.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.071 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -89.63 146.12 24.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.94 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.96 162.7 43.99 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.614 0.721 . . . . 99.99 110.852 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 0.51 5.48 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.743 2.295 . . . . 99.99 112.335 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.899 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.829 0.347 . . . . 99.99 111.101 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -112.01 161.04 16.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.932 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.36 128.16 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.139 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 26.3 mt -69.05 157.32 89.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.596 0.712 . . . . 99.99 110.925 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.3 Cg_endo -69.63 -22.96 31.95 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.638 2.225 . . . . 99.99 112.363 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -83.45 1.12 43.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.86 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.13 13.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.455 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 2.0 m -109.67 177.19 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 99.99 110.79 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 7.4 tp -130.28 129.34 43.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.908 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -124.16 129.43 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.859 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -117.29 131.22 24.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 99.99 110.892 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -32.22 18.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 99.99 112.274 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 100.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 119.88 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.143 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.6 166.92 30.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 99.99 112.508 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -30.83 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 99.99 111.156 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -74.8 -21.25 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.858 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.32 -3.08 31.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.804 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 139.71 58.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.869 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.98 -147.23 14.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.745 . . . . 99.99 112.516 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.91 133.78 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 99.99 111.118 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -104.94 128.29 53.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.877 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.13 138.13 53.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 156.67 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.913 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -141.26 127.92 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.929 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.21 162.95 29.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 99.99 111.139 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.01 124.43 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.905 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -88.65 172.52 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.899 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -71.09 -18.39 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.823 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -73.62 -19.77 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 99.99 110.915 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.78 -16.88 33.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 99.99 112.417 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -84.96 147.61 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 99.99 110.937 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.31 143.79 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.46 125.6 50.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.15 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 144.76 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.888 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' A' ' 19' ' ' LYS . 1.3 m -145.55 121.27 10.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.834 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 123.54 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 99.99 110.92 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -129.16 118.27 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.877 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.58 132.38 33.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.86 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.79 139.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.134 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 127.94 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.892 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.83 -177.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 99.99 111.138 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.943 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.1 142.52 51.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.93 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.29 159.59 49.27 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.555 0.693 . . . . 99.99 111.159 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.188 0 C-N-CA 122.666 2.244 . . . . 99.99 112.338 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 99.99 110.873 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.162 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.883 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.859 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.111 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.145 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.074 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.877 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.071 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.568 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 99.99 110.919 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 99.99 112.424 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.861 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.869 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.877 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.829 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.476 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.816 0.341 . . . . 99.99 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.83 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.94 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.912 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.884 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.897 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.105 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.484 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 99.99 110.906 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.159 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.815 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.088 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.902 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.082 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.961 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 99.99 110.839 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 99.99 112.38 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.944 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.893 0.378 . . . . 99.99 111.073 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.858 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.103 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 99.99 110.91 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 99.99 112.336 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.886 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.487 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 99.99 110.849 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.839 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 99.99 110.959 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 99.99 112.363 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.079 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.1 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 99.99 112.497 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 99.99 111.119 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.874 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.937 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.504 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 99.99 111.112 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.843 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.889 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.872 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.847 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.886 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 99.99 110.829 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.527 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 99.99 110.919 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.913 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.133 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.879 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 99.99 110.835 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.878 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.906 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.127 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.119 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.898 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.902 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 99.99 111.184 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 99.99 112.339 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.501 -0.24 . . . . 99.99 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.69 107.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.388 . . . . 99.99 110.898 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.32 71.67 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.094 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -93.11 135.6 34.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.939 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.37 120.97 27.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.859 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.2 mm -125.95 121.94 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 99.99 111.15 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.83 138.62 33.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.142 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.33 166.98 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.118 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.06 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.849 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.98 121.64 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.117 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.27 3.96 78.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.513 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -101.43 139.76 20.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 99.99 110.898 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.38 50.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 99.99 112.335 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.7 tp -144.57 142.15 29.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.894 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.87 146.9 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.163 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.1 mt -132.22 148.37 52.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.897 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -112.04 148.88 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.908 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.12 100.82 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.832 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.37 102.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.92 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 149.48 -46.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 99.99 112.483 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.15 102.24 10.38 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.541 0.686 . . . . 99.99 111.099 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.2 Cg_endo -69.75 -162.96 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.689 2.259 . . . . 99.99 112.363 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.46 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.911 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.463 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -45.92 168.68 0.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.627 0.727 . . . . 99.99 110.91 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.7 Cg_endo -69.73 172.93 11.7 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 99.99 112.351 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.9 Cg_endo -69.75 97.25 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.688 2.259 . . . . 99.99 112.354 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.28 -174.29 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.934 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 ttm-85 -63.15 132.77 52.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 pp -177.47 162.16 1.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.903 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.31 146.77 46.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 99.99 110.873 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.2 132.36 48.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.949 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -135.55 142.62 45.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 tp -138.42 134.41 34.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.933 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -115.16 121.92 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.874 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -138.3 176.27 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.118 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.26 -131.15 13.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.51 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.66 -37.75 4.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 99.99 110.856 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 t -179.31 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 99.99 111.172 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -102.25 33.26 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.833 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.22 -6.74 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.169 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -61.92 131.32 49.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.934 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.45 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.903 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.2 t -100.62 120.66 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.151 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.56 146.95 24.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.961 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.32 163.46 36.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 99.99 110.877 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 0.48 5.61 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.661 2.241 . . . . 99.99 112.32 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -118.8 71.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.931 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.24 3.11 79.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.479 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 106.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 99.99 112.494 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.07 -72.76 0.46 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.729 -0.748 . . . . 99.99 112.504 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -0.14 6.46 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 99.99 112.359 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.409 ' HB2' ' HG3' ' A' ' 57' ' ' ARG . 17.8 p-90 -51.65 -35.1 40.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.945 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -69.59 -25.16 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.913 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -42.96 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.883 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.27 -97.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 99.99 111.118 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -158.63 173.63 16.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.089 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -124.48 164.83 18.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.877 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.66 132.01 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.114 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -68.63 158.76 84.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 99.99 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -25.11 28.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 99.99 112.313 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -83.57 2.06 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.905 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.33 32.46 8.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 99.99 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -179.53 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 99.99 110.851 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.0 tp -130.47 129.59 43.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.965 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -124.37 129.62 51.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.859 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mp -116.57 130.74 24.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 99.99 110.934 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -32.61 18.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 99.99 112.352 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.63 101.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 99.99 111.084 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.69 118.59 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.169 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.07 163.99 30.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 99.99 112.473 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -30.84 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 99.99 111.152 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -75.83 -23.26 55.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.93 -4.67 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.883 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.53 140.83 58.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.913 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.74 -138.55 5.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.482 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.64 135.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 99.99 111.132 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -103.27 135.24 45.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.857 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -131.36 131.47 43.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.866 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 t -125.95 156.12 40.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.87 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' HB3' ' C6 ' ' A' ' 201' ' ' IOR . 13.8 pt20 -141.16 142.73 34.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 99.99 110.886 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.17 162.53 33.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.087 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.0 ttm -130.43 124.72 32.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.888 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.04 172.25 8.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.833 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -71.44 -19.35 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.871 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -74.08 -20.17 60.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.85 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.43 37.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 99.99 112.438 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.1 147.47 26.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 99.99 110.935 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.69 144.7 31.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 99.99 110.901 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 131.72 50.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.111 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.53 142.91 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.896 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.91 121.81 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 99.99 110.854 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 123.02 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -125.86 120.11 29.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.926 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.0 130.55 34.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.875 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -121.12 137.32 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.29 131.88 45.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.902 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 m -95.81 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.51 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.928 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 143.6 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.925 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.65 159.58 50.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.652 0.739 . . . . 99.99 111.146 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -31.64 20.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 99.99 112.34 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.21 -77.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.738 . . . . 99.99 112.461 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -86.66 137.71 33.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 99.99 110.901 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 166.16 28.53 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 99.99 112.305 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.9 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.437 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.445 -0.262 . . . . 99.99 112.445 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m 58.73 96.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 99.99 110.797 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.61 72.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.087 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 133.18 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.931 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.37 120.44 26.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.939 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mm -125.91 121.61 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.085 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.93 137.7 34.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 99.99 111.142 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.42 166.78 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 99.99 111.085 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.59 148.72 44.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.946 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -52.08 121.57 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.145 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 6.67 75.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 99.99 112.538 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -101.83 140.13 20.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.709 0.766 . . . . 99.99 110.846 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 143.88 52.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.745 2.297 . . . . 99.99 112.33 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 tp -144.23 142.0 30.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.898 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 t -122.81 147.91 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.088 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 mt -131.58 149.05 52.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.951 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.48 152.53 27.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.916 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.74 101.33 10.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.826 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 113.09 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.918 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.19 -39.15 1.89 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 99.99 112.579 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.19 129.17 44.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.605 0.717 . . . . 99.99 111.05 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -167.28 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 99.99 112.33 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.02 -51.52 41.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.8 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 133.97 21.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.508 0.671 . . . . 99.99 110.927 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.689 2.259 . . . . 99.99 112.361 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -58.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 99.99 112.344 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -107.16 -179.2 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.922 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.64 152.68 44.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.71 153.11 39.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.925 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.2 147.79 44.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.943 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -129.41 138.93 51.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.958 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -144.11 136.04 26.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 99.99 110.933 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.98 139.83 38.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 99.99 110.931 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -112.07 127.97 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.895 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -137.55 178.29 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.102 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.17 -130.44 19.08 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.476 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -112.67 -37.39 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.903 0.382 . . . . 99.99 110.888 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -178.42 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.055 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -102.26 33.89 2.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.872 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.9 -5.54 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.14 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -59.22 132.29 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.857 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 153.59 46.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.91 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.87 121.7 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.433 . . . . 99.99 111.109 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.51 145.34 25.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.929 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 163.74 36.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.639 0.733 . . . . 99.99 110.854 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 2.36 3.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.7 2.267 . . . . 99.99 112.275 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -116.64 101.68 8.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.937 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.33 72.44 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.528 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.18 133.53 5.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.552 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.22 -113.46 4.68 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 99.99 112.476 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.21 34.39 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.747 2.298 . . . . 99.99 112.338 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 7.7 m-90 -64.75 -33.81 76.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.908 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -24.17 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.842 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.48 -33.95 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.828 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.82 -73.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' H ' HG21 ' A' ' 55' ' ' VAL . . . -150.57 156.5 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.152 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' HG3' ' HB3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -132.67 160.21 37.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.931 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -109.5 128.82 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.102 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.63 158.25 87.49 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.528 0.68 . . . . 99.99 110.957 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -21.38 33.41 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.24 . . . . 99.99 112.338 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -82.87 0.9 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.914 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.01 16.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 m -112.28 179.89 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 99.99 110.938 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 tp -129.73 126.25 37.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -126.46 135.46 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.892 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.06 129.59 25.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 99.99 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -33.03 17.17 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 99.99 112.301 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.2 102.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.432 . . . . 99.99 111.134 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.91 117.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.423 . . . . 99.99 111.183 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.05 162.2 30.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.805 -0.712 . . . . 99.99 112.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -30.26 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.72 0.295 . . . . 99.99 111.084 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -75.58 -22.74 56.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.927 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.59 -4.95 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.856 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.84 141.0 58.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.922 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.76 -137.96 5.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 99.99 112.465 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.6 mm -124.13 127.55 73.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 99.99 111.161 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.77 134.73 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.876 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.28 144.97 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.928 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 155.45 43.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.875 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.89 130.25 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.908 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.57 161.93 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.154 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -130.14 125.28 34.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.49 173.16 9.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -70.64 -19.23 62.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.824 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -74.53 -20.56 59.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.11 -8.0 38.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 99.99 112.508 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.96 147.05 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.698 0.285 . . . . 99.99 110.948 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.94 140.32 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 129.64 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.14 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.87 144.23 33.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -145.08 125.95 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 99.99 110.85 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.7 124.12 45.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 99.99 110.891 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.87 120.62 28.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.953 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 131.34 35.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.94 137.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.1 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.49 129.05 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.865 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.58 -176.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.058 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -63.53 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 99.99 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.37 144.01 54.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.947 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.23 159.57 49.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 99.99 111.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 176.4 6.79 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.718 2.278 . . . . 99.99 112.376 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.94 82.41 0.14 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.469 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -155.67 137.77 9.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.603 0.716 . . . . 99.99 110.888 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.64 147.88 64.6 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.701 2.267 . . . . 99.99 112.346 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.862 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.42 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.497 -0.241 . . . . 99.99 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t -179.33 97.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 99.99 110.84 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.35 73.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.496 . . . . 99.99 111.126 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -91.4 139.1 31.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.906 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -84.11 121.02 26.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.916 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -125.68 121.62 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.065 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -95.35 139.72 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 99.99 111.126 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.83 166.33 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.058 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -124.03 149.2 46.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.823 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.6 mt -53.88 120.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.168 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.35 6.94 77.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 99.99 112.452 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -102.37 140.7 21.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 99.99 110.902 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 145.06 56.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 99.99 112.35 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 tp -142.51 142.72 32.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.967 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.12 147.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.072 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.8 mt -131.18 148.21 52.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.96 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -113.01 153.13 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.97 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.95 100.68 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.905 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.18 118.39 6.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.39 -40.71 1.81 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.562 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.51 129.43 42.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.551 0.691 . . . . 99.99 111.098 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -165.62 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.766 2.31 . . . . 99.99 112.341 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.36 -52.14 30.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.908 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -112.21 128.59 25.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.52 0.676 . . . . 99.99 110.965 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 110.22 2.49 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.693 2.262 . . . . 99.99 112.362 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -53.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 99.99 112.373 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -106.05 -178.86 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.915 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -70.27 159.24 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.891 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.27 174.48 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.88 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.63 148.09 41.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 99.99 110.848 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -122.96 138.25 54.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.14 142.56 34.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.877 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 tp -137.94 135.79 36.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.852 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -115.23 121.94 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.94 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.17 176.72 8.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.199 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.83 -131.58 12.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 99.99 112.543 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -112.88 -37.89 4.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.369 . . . . 99.99 110.852 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -179.18 -30.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 99.99 111.142 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.1 33.63 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 -6.1 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.122 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -59.88 132.16 53.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 153.93 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.818 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.18 121.26 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.144 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.55 145.24 25.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.853 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.82 162.12 49.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.697 0.76 . . . . 99.99 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.92 11.01 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.706 2.271 . . . . 99.99 112.327 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -122.33 81.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.942 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.34 13.43 64.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.708 -0.758 . . . . 99.99 112.503 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 92.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.681 -0.771 . . . . 99.99 112.478 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.59 -64.8 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.736 -0.745 . . . . 99.99 112.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.81 3.32 2.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.645 2.23 . . . . 99.99 112.361 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -49.69 -34.59 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.912 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.82 -24.94 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 -43.91 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.833 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.68 -99.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.114 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.98 176.28 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 99.99 111.061 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.23 159.41 20.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 99.99 110.83 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.51 125.06 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.0 mt -68.21 156.99 88.77 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.641 0.734 . . . . 99.99 110.919 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.1 Cg_endo -69.74 -20.71 34.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.673 2.249 . . . . 99.99 112.33 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -82.48 0.89 40.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.885 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.97 28.7 14.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.501 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -112.53 173.67 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 99.99 110.807 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.9 tp -129.29 130.42 46.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.871 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -124.29 136.03 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.874 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.05 130.75 23.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.656 0.741 . . . . 99.99 110.93 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -37.81 8.68 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 99.99 112.332 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.73 104.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.093 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 m -73.06 117.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.139 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.97 162.67 24.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 99.99 112.476 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -29.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 99.99 111.107 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.94 -24.17 58.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.933 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.89 -4.54 56.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.839 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.59 141.38 58.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.6 -139.81 7.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.76 130.25 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 99.99 111.103 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.2 144.3 31.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 99.99 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 146.35 52.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.823 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.7 t -126.98 151.44 48.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.899 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.84 131.76 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.907 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.75 161.91 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 99.99 111.054 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.8 mtp -130.17 124.4 32.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.817 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.42 172.87 9.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.911 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -70.53 -19.42 62.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 99.99 110.893 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.74 -20.34 59.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.861 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.02 39.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 99.99 112.463 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.91 147.7 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 99.99 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -104.3 142.66 34.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.813 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.74 132.55 50.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.14 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 144.1 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.954 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -145.06 126.09 14.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 99.99 110.889 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HB2' ' C ' ' A' ' 201' ' ' IOR . 6.2 t-20 -118.69 122.56 42.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.901 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -128.72 120.79 27.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.955 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -83.14 133.18 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.912 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.85 138.34 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 99.99 111.125 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -129.25 143.91 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.82 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.47 -176.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 99.99 111.151 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.41 -79.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.933 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.76 144.79 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.952 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.4 159.66 49.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 99.99 111.163 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 161.85 44.35 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.254 . . . . 99.99 112.352 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.58 -56.09 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 99.99 112.404 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -113.99 72.72 2.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.515 0.674 . . . . 99.99 110.886 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 -177.65 2.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 99.99 112.287 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.886 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.429 ' C ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.51 -0.236 . . . . 99.99 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.53 154.17 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 99.99 110.865 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.49 94.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.12 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.22 133.08 36.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.949 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -89.68 119.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.935 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.77 122.59 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.127 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -95.79 139.95 31.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.176 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.54 167.65 24.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.24 148.46 43.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.818 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.9 mt -52.42 121.25 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.128 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.42 8.02 71.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.498 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -101.94 140.3 21.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 99.99 110.952 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 144.09 52.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.707 2.271 . . . . 99.99 112.341 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.08 142.23 30.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.936 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 t -121.84 145.93 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.133 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.9 mt -131.43 148.56 52.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.926 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -112.82 152.77 28.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.893 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.0 t -105.66 99.99 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 99.99 110.851 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 120.09 7.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.899 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -42.19 1.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 99.99 112.503 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.5 129.31 51.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 99.99 111.077 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.263 . . . . 99.99 112.338 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.56 -51.59 35.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.883 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.51 134.18 21.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.609 0.719 . . . . 99.99 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 109.98 2.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.638 2.225 . . . . 99.99 112.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -58.42 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.693 2.262 . . . . 99.99 112.408 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -107.22 -179.21 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.948 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -67.98 155.79 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.898 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.84 154.64 41.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.875 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -120.88 148.07 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.899 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -127.39 136.17 51.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.863 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.4 136.83 28.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.874 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.4 138.99 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.929 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -112.29 126.55 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.907 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -138.14 179.22 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.155 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.08 -130.83 19.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 99.99 112.472 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -114.9 -38.07 4.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 99.99 110.837 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -176.28 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.154 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -99.09 34.02 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.848 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.15 -4.56 7.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.075 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -58.12 131.13 49.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.961 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 154.06 47.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 99.99 110.903 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.06 118.39 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.163 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.54 145.33 24.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.13 163.19 43.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 99.99 110.925 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -3.73 12.66 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.648 2.232 . . . . 99.99 112.351 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.91 86.41 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.837 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.12 2.15 63.4 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.752 -0.737 . . . . 99.99 112.497 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.44 105.4 0.41 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.74 -73.6 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.511 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -2.07 9.53 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.661 2.241 . . . . 99.99 112.351 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -35.29 48.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.917 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.07 -24.41 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.858 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.98 -43.81 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.9 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.53 -97.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 99.99 111.142 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -151.35 173.73 14.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.065 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.32 163.01 26.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.924 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.76 130.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.91 157.8 87.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.626 0.727 . . . . 99.99 110.886 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -21.71 33.32 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 99.99 112.338 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.29 1.12 42.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.1 29.91 11.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 99.99 112.569 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 m -113.19 179.15 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.411 . . . . 99.99 110.827 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 tp -130.01 129.31 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 99.99 110.971 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -124.6 133.94 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.838 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mp -114.97 131.04 23.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.549 0.69 . . . . 99.99 110.95 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -33.64 15.94 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.673 2.249 . . . . 99.99 112.365 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.95 104.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.099 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -73.43 113.12 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.137 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.98 162.0 33.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.718 -0.753 . . . . 99.99 112.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -30.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 99.99 111.206 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.9 -23.71 55.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 99.99 110.889 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -4.07 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.68 140.62 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.884 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.49 -137.63 5.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.478 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.54 133.39 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 99.99 111.052 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -103.81 143.56 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.895 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -138.67 137.99 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.886 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.8 t -126.51 155.29 42.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.84 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.11 135.11 32.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.963 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.02 162.66 30.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.079 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ttm -130.11 124.81 33.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -89.94 172.4 8.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.874 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -71.29 -18.65 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.952 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -73.85 -20.43 60.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -15.58 33.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.734 -0.746 . . . . 99.99 112.407 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -85.16 146.17 27.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 99.99 110.881 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.15 144.61 32.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.919 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 133.32 49.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.14 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.47 145.25 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.934 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -144.91 126.92 15.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 99.99 110.888 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.18 122.71 42.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -124.28 119.37 29.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.891 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 133.86 34.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.895 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.36 137.25 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.078 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -130.33 132.7 45.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.873 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 m -95.67 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.128 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -65.39 -80.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.941 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -65.49 142.98 57.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.912 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.13 159.54 49.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 99.99 111.184 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -47.08 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.695 2.263 . . . . 99.99 112.355 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.66 96.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 99.99 112.565 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -51.7 156.88 2.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 99.99 110.863 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 100.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 99.99 112.327 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.879 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.404 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.471 -0.252 . . . . 99.99 112.471 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.74 111.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 99.99 110.873 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.162 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.883 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.111 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.145 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.074 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.877 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.071 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.568 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 99.99 110.919 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 99.99 112.424 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.861 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.107 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.869 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.877 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.829 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.865 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.41 -44.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.476 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 130.52 58.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 99.99 111.07 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.258 . . . . 99.99 112.306 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -48.34 -50.51 30.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.925 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 51.5 mmtt -110.07 153.47 43.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.644 0.735 . . . . 99.99 110.842 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.67 109.52 2.31 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 99.99 112.412 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.2 Cg_endo -69.66 -84.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.768 2.312 . . . . 99.99 112.386 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -98.81 -176.24 3.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.902 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -62.73 149.01 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.873 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 155.43 42.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.911 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.83 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.94 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.912 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.884 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.897 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.105 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.484 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 99.99 110.906 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.159 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.815 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.088 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.834 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.082 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.961 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 99.99 110.839 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 99.99 112.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -120.32 74.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.944 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 57' ' ' ARG . . . -77.46 -1.45 76.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 99.99 112.501 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.82 103.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.471 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.75 -74.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.482 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -4.15 13.44 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.598 2.198 . . . . 99.99 112.406 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -34.64 57.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.951 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.81 -24.76 62.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.826 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.18 -42.96 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.803 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.16 -97.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.097 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.63 173.65 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.073 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.858 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.103 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 99.99 110.91 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 99.99 112.336 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.886 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.487 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 99.99 110.849 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.839 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 99.99 110.959 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 99.99 112.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.079 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 99.99 112.497 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 99.99 111.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.937 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.872 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.504 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 99.99 111.112 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.843 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.872 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.942 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.116 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.847 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 99.99 110.829 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.527 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 99.99 110.919 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.913 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.133 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.879 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 99.99 110.835 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.913 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.878 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.906 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.127 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.893 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.119 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.898 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 99.99 111.184 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 156.76 62.44 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 99.99 112.339 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.72 -76.19 1.03 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 99.99 112.526 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -153.36 157.53 32.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 99.99 110.858 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.625 2.216 . . . . 99.99 112.411 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.919 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.538 -0.225 . . . . 99.99 112.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.58 153.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.914 0.388 . . . . 99.99 110.857 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.46 100.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 99.99 111.099 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.04 133.27 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.944 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 6.5 m-80 -84.26 120.31 26.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 99.99 110.932 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 mm -126.17 121.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.162 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 p -96.89 138.31 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.24 165.64 30.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.142 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -124.25 149.05 46.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -53.98 121.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.206 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.73 84.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.444 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.09 139.63 20.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 99.99 110.902 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 143.09 49.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.671 2.248 . . . . 99.99 112.358 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -144.72 141.79 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.896 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -122.97 148.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 99.99 111.056 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -131.58 149.03 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.95 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -106.29 148.96 27.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.895 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 t -112.26 101.83 10.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.927 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -55.88 95.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.903 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.61 -46.25 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 99.99 112.488 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.08 103.89 13.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.65 0.738 . . . . 99.99 111.107 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 99.99 112.354 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -62.72 -8.95 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.915 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -44.86 168.07 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 99.99 110.903 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 54.5 Cg_endo -69.74 172.08 13.27 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.726 2.284 . . . . 99.99 112.402 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.79 97.26 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 99.99 112.352 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.61 -175.64 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.85 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -64.87 133.17 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.839 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 pp -176.16 162.34 2.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.872 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -120.37 147.4 45.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -134.49 138.8 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.931 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -136.46 142.01 43.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.923 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -134.98 135.06 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.933 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -116.64 120.62 39.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.892 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -139.17 177.59 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 99.99 111.167 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.75 -128.91 9.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.36 -36.98 5.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 99.99 110.848 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.9 -30.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.166 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -103.13 33.46 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.874 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.65 -6.69 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.134 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 133.24 55.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.937 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 157.99 40.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.872 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.98 120.46 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.14 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.43 145.75 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.889 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.62 163.06 41.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.729 . . . . 99.99 110.89 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 0.11 6.12 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.714 2.276 . . . . 99.99 112.316 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 -119.78 71.9 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.919 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 11.19 70.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.522 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.22 102.35 0.65 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.812 -0.709 . . . . 99.99 112.495 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 132.55 -67.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 99.99 112.495 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.64 8.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.639 2.226 . . . . 99.99 112.359 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -34.13 38.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.917 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.63 -27.72 67.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 99.99 110.849 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -42.39 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.805 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.1 -95.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.145 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.408 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -159.96 174.44 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 161.73 23.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.896 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.73 129.88 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.145 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 6.5 mp -69.61 158.26 87.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.61 0.719 . . . . 99.99 110.898 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.78 -23.12 31.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 99.99 112.303 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.03 3.48 34.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.818 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.14 24.84 28.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.457 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 m -105.97 179.73 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 99.99 110.869 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tp -130.86 127.91 39.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 99.99 110.943 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -126.1 129.41 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.896 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -117.77 131.24 24.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.612 0.72 . . . . 99.99 110.975 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.63 -32.47 19.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.763 2.309 . . . . 99.99 112.364 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.59 101.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.6 m -73.55 119.41 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.092 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.39 161.48 28.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.705 -0.759 . . . . 99.99 112.514 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -29.39 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.728 0.299 . . . . 99.99 111.124 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -74.47 -23.2 58.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 99.99 110.893 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -5.14 57.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 99.99 110.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.66 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.912 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.49 -139.11 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.483 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.28 128.14 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 99.99 111.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -104.5 136.72 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.839 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.45 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.881 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.4 t -127.14 152.31 47.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.909 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 131.03 24.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.63 163.06 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.07 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ttm -130.06 124.9 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.88 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -88.42 172.36 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.913 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.53 -18.91 62.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.926 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -73.89 -20.26 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.919 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.93 -13.53 34.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 99.99 112.548 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -84.87 147.27 26.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 99.99 110.909 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.58 143.85 32.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.925 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.76 126.89 51.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 99.99 111.12 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 144.23 34.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.867 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 m -145.8 127.74 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 99.99 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.82 122.52 41.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.827 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.72 119.04 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 99.99 110.906 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.02 131.45 34.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 99.99 110.87 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.75 139.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.143 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 128.57 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.866 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.4 m -92.48 -176.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.099 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -64.69 -78.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.948 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -68.2 145.89 53.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.9 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.62 0.724 . . . . 99.99 111.072 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -38.12 8.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.751 2.301 . . . . 99.99 112.312 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.3 93.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 99.99 112.456 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -142.94 159.34 56.82 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.531 0.681 . . . . 99.99 110.924 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -175.51 1.2 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.713 2.275 . . . . 99.99 112.266 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.884 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.42 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 112.479 -0.249 . . . . 99.99 112.479 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -173.55 148.07 1.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 99.99 110.806 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 97.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 99.99 111.111 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -93.24 133.65 36.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.836 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -89.83 121.43 31.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 mm -125.33 121.44 60.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.08 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -96.01 141.19 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 99.99 111.115 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 167.46 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.051 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -122.63 148.22 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.861 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mt -53.12 121.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.122 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.9 5.76 76.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 99.99 112.47 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -102.04 140.11 20.89 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 99.99 110.866 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 144.01 52.47 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.608 2.205 . . . . 99.99 112.286 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 142.01 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.919 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.84 144.6 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.139 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.03 146.26 52.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.939 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -114.5 151.2 33.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.952 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 m -108.05 101.83 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.57 126.71 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.89 -38.8 2.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 99.99 112.53 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.19 131.6 36.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.576 0.703 . . . . 99.99 111.09 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -164.84 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 99.99 112.379 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -48.16 -50.52 28.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.874 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -109.48 152.23 42.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.59 0.71 . . . . 99.99 110.889 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.81 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.595 2.197 . . . . 99.99 112.402 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 53.9 Cg_endo -69.73 -83.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.693 2.262 . . . . 99.99 112.334 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 73.2 mt-30 -103.46 -176.86 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.941 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -63.01 147.59 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.842 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pp -145.79 151.62 38.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.921 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.74 129.12 53.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.925 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -111.93 144.53 41.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.911 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -136.96 141.23 42.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.982 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.6 tp -136.05 135.29 39.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.942 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -116.13 121.47 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.2 p -138.35 179.27 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 99.99 111.139 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.95 -130.24 11.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.49 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -112.5 -37.95 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 99.99 110.933 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 t -179.83 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 99.99 111.134 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -102.6 34.03 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.862 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.57 -6.76 8.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.147 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -61.82 131.34 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.873 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 158.46 38.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.854 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.91 123.1 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.16 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.52 143.5 26.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.919 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 163.02 43.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.647 0.736 . . . . 99.99 110.856 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.694 2.263 . . . . 99.99 112.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -125.66 73.36 1.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.94 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.73 7.72 79.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 99.99 112.459 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 112.02 4.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 99.99 112.446 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.44 -70.6 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 99.99 112.484 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -0.05 6.3 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.682 2.255 . . . . 99.99 112.398 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -51.7 -34.69 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.925 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.56 -25.2 62.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 99.99 110.83 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -44.56 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.863 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.41 -95.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.066 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.52 174.15 12.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.11 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.92 163.0 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.851 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -107.45 127.5 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.063 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 5.6 mp -68.27 157.58 87.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.586 0.707 . . . . 99.99 110.919 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.81 -20.83 34.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 99.99 112.335 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.6 1.62 41.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 28.53 20.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.827 -0.702 . . . . 99.99 112.486 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -112.57 178.01 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 99.99 110.896 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.01 127.93 44.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.912 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -125.81 135.04 51.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.903 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mp -113.43 128.59 25.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 99.99 110.901 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -32.5 18.34 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 99.99 112.368 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.04 102.65 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.098 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.36 118.42 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.151 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.37 158.79 26.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.494 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -31.43 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.787 0.327 . . . . 99.99 111.102 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.79 -22.8 53.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.908 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.55 -5.27 44.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.881 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 142.49 55.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.831 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.16 -147.16 15.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.724 . . . . 99.99 112.511 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.82 129.91 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 99.99 111.144 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.87 135.28 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.853 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.0 146.72 50.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 99.99 110.799 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.59 152.72 46.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.867 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.7 128.13 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.902 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.08 31.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 99.99 111.078 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 ttm -130.11 124.71 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.873 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -87.71 171.9 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.943 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -71.76 -18.18 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -73.28 -26.06 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.86 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.92 -18.22 12.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -84.18 147.16 27.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 99.99 110.892 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.26 144.86 31.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.873 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 128.12 50.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 99.99 111.154 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 145.31 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 99.99 110.919 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -144.67 126.96 15.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.85 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 122.1 40.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.874 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.69 120.04 28.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.953 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.91 132.12 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.886 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.89 136.37 58.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.115 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -130.76 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.879 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.7 -175.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 99.99 111.142 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -66.37 -78.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.927 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -66.53 146.03 54.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.914 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.4 159.48 49.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 99.99 111.133 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.275 . . . . 99.99 112.338 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.03 -37.54 1.51 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.772 -0.727 . . . . 99.99 112.488 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -119.55 73.89 16.53 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 99.99 110.872 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -171.08 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 99.99 112.377 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.927 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.424 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.481 -0.248 . . . . 99.99 112.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -178.93 128.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 99.99 110.913 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.49 63.64 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.146 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -92.72 137.87 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.95 120.99 31.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 99.99 110.871 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.24 122.3 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.16 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -95.49 142.09 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.11 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.77 168.34 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.111 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.41 148.19 41.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.871 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.03 122.08 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.064 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.4 3.85 86.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 99.99 112.555 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -101.39 142.7 25.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.736 . . . . 99.99 110.93 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 144.03 53.35 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.703 2.269 . . . . 99.99 112.378 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.2 tp -143.93 143.26 31.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.4 t -121.07 147.71 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.148 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -131.48 149.12 52.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.893 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -107.18 151.63 25.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.896 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.6 t -107.63 100.11 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.854 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -59.71 120.53 9.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.898 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.11 -39.95 1.98 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.466 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.57 132.27 33.83 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.563 0.697 . . . . 99.99 111.056 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.248 . . . . 99.99 112.385 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -48.38 -52.2 22.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.963 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 144.45 30.64 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.605 0.716 . . . . 99.99 110.898 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 110.58 2.57 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.619 2.213 . . . . 99.99 112.364 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 53.3 Cg_endo -69.76 -83.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.681 2.254 . . . . 99.99 112.319 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 3.3 mp0 -91.15 -177.27 4.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.926 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -63.46 148.28 49.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.97 154.62 42.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.902 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -120.51 148.21 44.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.867 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -124.79 143.28 50.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.879 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 143.94 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 134.63 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -116.45 121.18 41.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 p -139.39 179.38 6.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 99.99 111.104 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.56 -133.35 15.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 99.99 112.552 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -112.56 -37.57 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 99.99 110.817 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.7 t -179.31 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.158 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -102.08 33.71 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.85 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.92 -6.81 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.129 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -60.38 128.95 39.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.918 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.34 156.34 44.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 99.99 110.938 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 t -93.49 123.35 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.188 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.66 143.65 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.915 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.73 162.52 50.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.693 0.758 . . . . 99.99 110.854 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -4.0 13.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.767 2.311 . . . . 99.99 112.34 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -124.48 83.16 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.63 0.43 81.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -52.06 101.05 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.424 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.65 -73.97 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.464 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.67 0.81 5.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.693 2.262 . . . . 99.99 112.341 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -51.43 -35.73 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 99.99 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.55 -23.8 61.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.833 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.43 -43.01 11.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.845 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -98.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.109 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.09 175.76 12.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.088 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 161.53 17.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 99.99 110.849 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.43 130.24 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.172 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.82 157.83 87.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.592 0.71 . . . . 99.99 110.926 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.51 33.47 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 99.99 112.344 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.44 1.65 47.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.894 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.58 31.11 9.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 99.99 112.53 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -113.34 -179.05 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 99.99 110.839 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.2 tp -129.84 128.71 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.95 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -126.36 135.85 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.91 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.56 128.86 25.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.626 0.727 . . . . 99.99 110.903 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -32.42 19.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.724 2.283 . . . . 99.99 112.4 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.86 100.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.073 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 m -72.75 113.45 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.093 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.54 158.76 30.1 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.531 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.477 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.74 -31.09 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 99.99 111.049 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -76.23 -20.96 56.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.906 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -3.08 27.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.918 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HG3' HG21 ' A' ' 97' ' ' VAL . 23.8 mt-10 -57.57 142.81 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.39 -149.95 21.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 99.99 112.406 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.58 133.03 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 99.99 111.105 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -103.28 139.08 39.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.873 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 141.16 51.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.883 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -125.95 153.82 43.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -139.74 130.3 25.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 163.18 28.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.093 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.8 ttm -128.42 124.78 37.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.835 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -87.23 173.4 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -69.53 -19.07 63.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.842 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -74.42 -20.34 60.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.75 -9.06 43.79 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 99.99 112.457 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -85.05 148.64 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 99.99 110.916 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.21 140.31 37.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.35 132.77 51.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 99.99 111.179 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.32 145.0 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.881 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -144.7 126.94 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.872 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.402 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 7.7 t-20 -119.22 124.23 46.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.877 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.8 119.25 24.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.47 134.45 34.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 99.99 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.8 t -122.63 135.98 60.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.158 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.26 148.18 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -110.74 -175.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.114 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -67.06 -78.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.9 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -63.17 146.45 53.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.918 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 99.99 111.151 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -26.17 27.89 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 99.99 112.36 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.23 -102.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.52 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp 57.91 73.38 0.76 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 99.99 110.856 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 137.46 35.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.268 . . . . 99.99 112.376 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 99.99 110.881 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.423 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.469 -0.252 . . . . 99.99 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.05 155.82 6.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 99.99 110.856 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 96.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.093 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -93.03 132.84 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.996 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.7 p-10 -86.33 119.51 26.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.881 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.2 123.2 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 99.99 111.18 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -95.58 138.66 32.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.153 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.12 166.14 27.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 99.99 111.117 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.45 149.21 44.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.804 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mt -52.58 121.34 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.139 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 6.96 76.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 99.99 112.471 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -102.09 139.65 20.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.718 0.771 . . . . 99.99 110.886 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 144.51 54.7 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.711 2.274 . . . . 99.99 112.345 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.5 tp -143.86 141.91 30.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.947 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.39 144.72 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 99.99 111.202 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.14 146.88 52.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.981 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -114.34 151.75 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.933 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.21 99.67 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.9 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -56.39 124.53 18.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.94 -40.28 1.92 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.471 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 128.99 45.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 99.99 111.134 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -164.68 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 99.99 112.34 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -48.17 -51.44 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.914 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -113.35 141.33 25.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 99.99 110.885 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 108.71 2.13 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 99.99 112.321 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.2 Cg_endo -69.79 -57.27 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.697 2.265 . . . . 99.99 112.314 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -107.21 -177.33 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.848 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.9 mtm-85 -64.54 151.4 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 99.99 110.927 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.31 160.5 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 99.99 110.926 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.15 149.56 47.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.911 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -117.84 135.27 54.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.951 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -145.87 136.58 24.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.88 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.54 140.83 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.873 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -111.7 129.0 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.914 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.6 p -135.83 179.89 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.148 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.27 -129.36 17.4 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -112.7 -37.51 4.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 99.99 110.874 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 t -178.96 -30.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.29 33.95 2.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.878 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.87 -5.14 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.05 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.05 132.19 53.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.941 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 157.56 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.886 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 t -102.56 120.35 52.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 99.99 111.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mt -92.38 146.05 23.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.908 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 163.5 39.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.636 0.732 . . . . 99.99 110.849 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -0.6 7.14 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.704 2.269 . . . . 99.99 112.321 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -122.67 71.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.914 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.13 12.39 64.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 99.99 112.431 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 92.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 99.99 112.521 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.46 -65.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 99.99 112.457 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 2.88 3.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.228 . . . . 99.99 112.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -34.13 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.924 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.98 -24.82 62.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.9 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -44.7 9.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.893 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -127.33 -98.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.518 . . . . 99.99 111.153 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.407 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -161.97 176.01 11.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.084 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 161.4 17.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.871 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.9 t -108.47 129.57 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.141 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.9 mt -69.11 157.47 89.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 99.99 110.937 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -22.56 31.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.726 2.284 . . . . 99.99 112.364 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -83.46 0.61 45.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.849 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.14 29.38 11.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 99.99 112.506 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -111.7 -179.68 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 99.99 110.927 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -128.97 129.58 45.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 99.99 110.928 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -125.37 131.03 53.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.915 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.97 130.92 23.43 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.646 0.736 . . . . 99.99 110.911 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -38.3 7.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 99.99 112.334 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.74 101.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.072 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -73.63 116.92 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.103 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.71 164.73 31.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.505 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -29.4 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.7 0.286 . . . . 99.99 111.096 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -75.11 -23.96 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.95 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -3.86 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.915 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.57 141.24 52.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.902 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.66 -140.5 7.59 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.697 -0.763 . . . . 99.99 112.452 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.18 132.99 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 99.99 111.108 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -101.34 143.91 30.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.887 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.86 147.22 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.837 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.15 150.62 49.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.93 128.47 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.884 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.31 162.69 29.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.082 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -130.12 125.09 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.85 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -89.9 172.91 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.9 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -71.07 -19.24 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.868 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -73.81 -20.25 60.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.927 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.73 -15.17 34.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 99.99 112.454 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -84.88 146.64 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 99.99 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -105.81 144.72 32.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.896 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.98 50.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.175 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.37 144.95 32.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.908 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.2 m -145.03 127.49 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.854 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.436 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 17.0 t-20 -118.74 127.47 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.872 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.87 118.1 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.957 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.75 127.29 34.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 99.99 110.85 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.13 139.94 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -128.04 129.15 46.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.846 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 m -88.68 -175.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 99.99 111.085 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -65.28 -80.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.952 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -65.76 144.48 56.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.918 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.4 159.99 47.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.698 0.761 . . . . 99.99 111.116 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 160.62 49.0 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 99.99 112.339 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -89.18 -120.96 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 99.99 112.469 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -169.37 73.35 0.71 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.658 0.742 . . . . 99.99 110.922 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 170.06 17.48 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.675 2.25 . . . . 99.99 112.274 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.874 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.436 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.435 -0.266 . . . . 99.99 112.435 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t 61.85 87.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 99.99 110.867 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.95 72.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.072 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -93.11 132.69 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.881 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -84.29 120.71 26.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.43 126.03 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -93.59 141.95 27.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.21 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.13 168.24 22.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.088 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.08 147.95 47.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.865 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -54.62 122.39 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 99.99 111.127 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.69 3.94 80.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.509 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.1 139.56 20.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 99.99 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 143.0 49.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 99.99 112.42 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 tp -144.35 141.01 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 99.99 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.15 148.35 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.134 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -131.61 148.67 52.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.882 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.49 149.48 27.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.876 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.5 t -112.49 101.69 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -53.65 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.84 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.52 -46.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 99.99 112.464 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.42 103.05 11.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.585 0.707 . . . . 99.99 111.156 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 52.9 Cg_endo -69.75 -163.33 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.704 2.269 . . . . 99.99 112.269 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -10.21 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.857 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.1 mptt -45.72 167.82 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 99.99 110.916 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.4 Cg_endo -69.77 172.4 12.73 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 99.99 112.363 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.8 Cg_endo -69.85 96.05 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.243 . . . . 99.99 112.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.5 -174.94 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.927 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -62.99 132.35 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.831 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -178.22 159.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.963 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.38 142.36 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.891 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -126.09 143.29 51.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.919 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -141.98 142.55 32.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.915 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 tp -137.87 135.99 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.878 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -114.99 123.33 48.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.893 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -138.87 -179.76 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.132 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.45 -126.83 8.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.468 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.39 -37.45 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 99.99 110.832 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.13 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.148 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.67 32.92 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.88 -7.79 8.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.102 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -60.14 129.6 42.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.956 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 158.57 39.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.874 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.63 121.02 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.077 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.33 144.46 25.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.96 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.53 45.72 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.734 0.778 . . . . 99.99 110.868 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 0.47 5.5 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.263 . . . . 99.99 112.361 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -118.93 92.72 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.923 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.67 -5.0 56.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.645 -0.788 . . . . 99.99 112.506 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.46 105.32 0.2 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 99.99 112.486 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 123.48 -75.74 0.37 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.489 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 1.09 4.68 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.716 2.277 . . . . 99.99 112.37 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -51.26 -35.37 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.952 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -24.94 63.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.894 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.16 -42.24 11.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.852 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -122.91 -97.91 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.131 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.401 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -166.03 176.61 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.037 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.51 160.91 17.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.863 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.73 130.46 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.153 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 45.8 mt -69.1 158.78 85.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 99.99 110.885 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.77 -22.66 31.7 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.672 2.248 . . . . 99.99 112.35 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -85.33 1.99 46.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.898 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.78 23.91 24.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.529 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 1.4 m -104.4 -179.0 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 99.99 110.852 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -130.14 130.04 44.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.487 . . . . 99.99 110.906 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.45 129.68 50.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.926 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mp -118.14 129.77 25.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.605 0.717 . . . . 99.99 110.884 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -32.74 18.01 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 99.99 112.421 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.27 101.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 99.99 111.088 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.03 119.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.119 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.36 160.71 32.03 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.501 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -31.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 99.99 111.117 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -76.46 -22.07 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.934 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -4.75 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.908 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.23 142.35 52.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.926 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.74 -145.89 13.44 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.452 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.33 133.82 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 99.99 111.16 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -101.37 139.24 37.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.883 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.77 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.872 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 149.98 50.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' HB2' ' C6 ' ' A' ' 201' ' ' IOR . 7.4 tt0 -140.22 126.5 19.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.89 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.07 163.12 29.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.064 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 66.7 mmm -129.41 124.64 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.86 172.52 9.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.893 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -71.23 -22.48 61.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.926 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -74.23 -20.14 60.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.863 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.92 -2.99 35.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.729 . . . . 99.99 112.568 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.7 149.07 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 99.99 110.949 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -102.87 141.77 35.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 123.45 47.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.149 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.93 141.61 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.877 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -147.26 125.87 12.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.935 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' HB2' ' C ' ' A' ' 201' ' ' IOR . 6.8 t-20 -119.25 125.08 48.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 99.99 110.879 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.86 119.74 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.885 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 131.84 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.61 137.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.112 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.35 152.93 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.831 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.0 m -113.86 -175.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 99.99 111.148 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -65.86 -78.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.932 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.83 144.78 56.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 159.6 49.36 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.634 0.731 . . . . 99.99 111.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 168.56 21.16 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 99.99 112.357 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.8 108.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 99.99 112.479 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? 51.92 71.21 1.56 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 99.99 110.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -171.68 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 99.99 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.931 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.429 ' C6 ' ' HB2' ' A' ' 80' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.52 -0.232 . . . . 99.99 112.52 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -77.93 65.69 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 99.99 110.87 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.44 80.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.091 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.42 138.6 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.918 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.43 119.92 25.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.876 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -126.26 123.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.159 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.1 p -93.72 140.47 29.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.171 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.03 165.07 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.091 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.78 149.44 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.36 120.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.114 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.17 5.48 89.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.516 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.69 141.5 22.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.703 0.763 . . . . 99.99 110.905 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.9 144.06 52.1 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.665 2.243 . . . . 99.99 112.343 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.5 tp -144.2 143.29 30.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.906 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -121.47 147.23 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.1 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.85 150.64 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.966 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -111.79 152.79 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -106.45 101.63 11.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.884 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -61.42 115.94 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.942 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.61 -40.28 1.88 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 99.99 112.516 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.75 128.37 54.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 99.99 111.065 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -166.52 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 99.99 112.334 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -49.94 -51.78 38.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.862 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.82 135.41 21.19 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.573 0.702 . . . . 99.99 110.865 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 109.84 2.4 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.722 2.281 . . . . 99.99 112.36 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -58.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.641 2.227 . . . . 99.99 112.354 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -107.27 -179.08 3.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 99.99 110.898 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -67.85 154.01 42.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.7 152.37 38.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.877 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -120.29 148.36 43.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.868 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -127.05 134.39 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.965 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 136.41 25.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.912 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 140.54 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.903 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.87 127.95 55.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.868 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -136.75 179.32 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.166 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.0 -129.98 12.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.654 -0.784 . . . . 99.99 112.517 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -112.62 -37.75 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 99.99 110.897 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 t -179.44 -30.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.19 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -102.7 33.68 3.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.888 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.44 -6.54 8.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.084 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -59.23 130.29 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.923 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.53 153.52 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.88 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.5 t -100.21 120.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.138 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.9 145.13 25.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.61 163.25 39.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.656 0.741 . . . . 99.99 110.82 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -2.37 10.06 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 99.99 112.368 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -123.36 71.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.45 10.17 67.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.485 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.22 95.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.506 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.8 -67.89 0.56 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 99.99 112.433 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.55 10.37 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.599 2.199 . . . . 99.99 112.379 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -34.59 43.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -66.64 -26.57 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.907 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 -42.13 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -125.18 -96.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.116 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -160.55 174.79 13.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.048 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.15 160.67 24.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.882 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 t -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.079 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.27 157.53 89.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 99.99 110.886 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -22.08 32.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.679 2.253 . . . . 99.99 112.395 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -83.25 0.63 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 99.99 110.894 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.7 30.71 10.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.715 -0.755 . . . . 99.99 112.432 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 m -113.49 179.04 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 99.99 110.896 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.2 128.37 43.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.926 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -126.39 133.5 51.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.914 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.42 130.8 24.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 99.99 110.856 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -33.06 17.01 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.68 2.253 . . . . 99.99 112.333 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.97 100.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.11 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.57 114.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.136 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.77 164.25 39.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 99.99 112.568 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.56 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.749 0.309 . . . . 99.99 111.102 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -75.72 -22.71 56.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.871 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -5.0 41.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -66.37 140.85 58.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.91 -137.32 5.25 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.711 -0.757 . . . . 99.99 112.456 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mp -124.19 132.68 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 99.99 111.133 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -104.79 133.52 49.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.938 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -128.0 137.57 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.883 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.36 153.7 42.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.869 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.66 131.64 27.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.918 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.8 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.028 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 tpp -130.02 124.77 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.17 172.61 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -71.15 -18.44 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.46 -20.37 60.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.856 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.16 -16.4 32.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 99.99 112.487 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -85.21 146.81 26.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.686 0.279 . . . . 99.99 110.926 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.31 143.93 32.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.44 132.54 50.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.135 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 145.73 31.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.934 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -143.73 125.34 14.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.876 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.12 122.66 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.814 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.3 125.11 40.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.938 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -83.25 134.02 34.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.861 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -121.16 136.08 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 99.99 111.099 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -131.18 127.95 39.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.837 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.1 m -93.09 -177.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.6 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.974 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -61.62 141.83 57.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.94 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' H ' ' NE2' ' A' ' 99' ' ' GLN . 0.6 OUTLIER -121.45 159.7 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.719 . . . . 99.99 111.119 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -34.31 14.8 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 99.99 112.31 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.63 114.71 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.751 -0.738 . . . . 99.99 112.471 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.36 137.61 81.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.551 0.691 . . . . 99.99 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 167.16 25.16 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.631 2.221 . . . . 99.99 112.357 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.923 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.443 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.466 -0.254 . . . . 99.99 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t -154.32 -169.02 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 99.99 110.884 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.47 94.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 99.99 111.084 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.81 131.16 38.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.896 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -89.88 121.94 32.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.866 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.96 122.42 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.117 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.09 136.9 35.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.187 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.57 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.108 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 147.91 43.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.878 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -52.94 121.76 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.11 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.93 6.93 71.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.656 -0.783 . . . . 99.99 112.45 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -101.37 139.4 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.592 0.71 . . . . 99.99 110.968 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.39 50.82 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 99.99 112.381 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 39.2 tp -144.65 141.74 29.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.957 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.55 143.62 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.107 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.6 mt -132.16 148.01 52.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.969 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -112.98 153.13 28.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.94 101.94 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.852 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.77 122.93 13.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.29 -39.0 2.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.423 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.33 128.71 45.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.636 0.731 . . . . 99.99 111.056 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.85 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.636 2.224 . . . . 99.99 112.315 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -48.7 -48.82 40.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.896 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.14 150.88 40.44 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 99.99 110.879 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 108.93 2.19 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.757 2.305 . . . . 99.99 112.341 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.6 Cg_endo -69.84 -85.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.256 . . . . 99.99 112.342 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -96.83 -176.02 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.967 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -63.07 142.85 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.802 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.21 160.89 41.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.935 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.58 149.26 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.899 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -111.82 140.77 46.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.884 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -137.63 142.43 41.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.865 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.8 134.62 33.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.89 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -116.23 126.98 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.861 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -139.86 178.01 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.097 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.61 -131.65 19.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 99.99 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -37.29 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 99.99 110.862 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 t -178.48 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.133 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -101.09 33.19 2.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.87 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.99 -4.51 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.124 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -62.73 132.2 51.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.03 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 158.75 38.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.19 122.42 52.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.065 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.81 143.63 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.942 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.27 163.17 41.83 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.695 0.759 . . . . 99.99 110.805 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -1.01 7.7 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 99.99 112.308 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -122.27 88.54 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.922 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.18 67.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 99.99 112.484 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.3 101.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.46 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 123.89 -74.76 0.39 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.488 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 1.12 4.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.726 2.284 . . . . 99.99 112.348 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -51.1 -35.35 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.75 -24.79 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.806 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.98 -42.3 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.851 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -122.96 -98.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.145 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -165.76 176.15 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.115 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 160.68 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.76 128.79 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.179 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.16 157.83 88.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.562 0.696 . . . . 99.99 110.928 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -22.72 31.58 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 99.99 112.345 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -83.01 0.25 45.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.65 29.43 10.86 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.483 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -111.68 179.85 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 99.99 110.869 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.93 129.72 44.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.912 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -125.34 131.2 53.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.814 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.33 129.42 24.89 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 99.99 110.946 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -33.01 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 99.99 112.375 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.32 102.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 99.99 111.101 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 m -72.88 116.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.063 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.7 33.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.48 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -29.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 99.99 111.087 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -75.11 -23.37 57.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.912 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.06 -5.41 57.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.7 140.33 58.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.906 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 -135.37 4.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.472 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.4 135.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 99.99 111.093 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -101.71 138.5 38.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.906 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -138.83 128.12 24.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.899 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.3 t -125.26 157.33 36.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.831 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' HB3' ' C6 ' ' A' ' 201' ' ' IOR . 6.6 pt20 -138.0 140.08 39.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.891 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.09 162.71 30.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 99.99 111.082 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ttm -129.56 124.99 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.864 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -90.88 172.81 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.894 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -71.1 -18.77 62.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.81 -20.33 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.946 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.58 35.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -85.06 146.04 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 99.99 110.877 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.51 143.26 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.864 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -105.72 130.4 53.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.173 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -107.1 145.69 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.957 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 124.55 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.847 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 201' ' ' IOR . 0.1 OUTLIER -121.5 128.79 52.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.912 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -131.19 122.23 26.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.906 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 124.5 30.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.872 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.7 139.45 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.126 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 129.05 42.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.919 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -88.41 -175.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.168 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.32 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.92 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -66.31 142.35 57.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.9 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.35 159.75 48.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 99.99 111.161 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 162.02 43.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 99.99 112.277 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.24 82.49 0.1 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 99.99 112.419 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.4 tttt 52.19 73.46 0.95 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 99.99 110.955 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -179.17 2.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.691 2.261 . . . . 99.99 112.347 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.842 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.442 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.511 -0.236 . . . . 99.99 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 t 63.01 105.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.388 . . . . 99.99 110.866 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.39 71.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.06 139.39 30.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 99.99 110.849 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.4 m-80 -82.4 121.09 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mm -125.11 122.05 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.201 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.64 142.13 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 99.99 111.11 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.96 166.25 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.116 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.96 148.57 48.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.866 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.29 121.25 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.198 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.0 5.01 90.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.532 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.96 141.87 23.5 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 99.99 110.892 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.87 52.36 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.783 2.322 . . . . 99.99 112.284 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.2 tp -144.6 143.16 30.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.881 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.13 146.73 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.172 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.3 mt -131.48 149.94 52.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.953 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -111.91 150.55 30.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 99.99 110.872 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.9 t -108.73 101.2 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -57.1 124.99 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.913 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.74 -39.33 2.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 99.99 112.497 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.18 132.03 35.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.571 0.7 . . . . 99.99 111.089 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -164.96 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.649 2.232 . . . . 99.99 112.309 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -47.83 -51.84 21.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.882 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -111.22 147.48 36.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 99.99 110.961 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 109.7 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.704 2.269 . . . . 99.99 112.364 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.486 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.5 Cg_endo -69.74 -73.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.622 2.214 . . . . 99.99 112.389 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.486 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 3.2 mp0 -102.36 -177.24 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.864 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 mtm-85 -63.63 148.07 49.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.925 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.27 151.15 37.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.92 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.62 148.58 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 99.99 110.887 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -122.79 137.03 55.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.969 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 139.79 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.874 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.99 136.08 36.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.889 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -114.63 127.43 55.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -138.85 176.79 8.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.42 -130.81 16.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 99.99 112.445 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.53 -37.35 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 99.99 110.873 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t -178.76 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.18 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.99 32.8 3.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.931 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.79 -5.88 6.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.503 . . . . 99.99 111.115 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -59.4 132.27 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.893 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.51 153.33 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.871 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.0 t -100.17 122.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.195 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.29 143.6 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.884 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.33 42.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 99.99 110.9 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -1.76 9.08 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 99.99 112.294 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -127.34 81.11 2.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.931 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -0.7 85.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.654 -0.784 . . . . 99.99 112.457 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.78 100.13 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 99.99 112.48 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.36 -75.05 0.36 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 99.99 112.547 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.55 4.32 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.642 2.228 . . . . 99.99 112.374 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 23.9 p-90 -50.65 -35.48 30.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.8 -24.18 62.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.834 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.76 -42.71 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.879 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -121.71 -98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.117 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.401 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -164.82 176.17 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.113 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.35 160.58 18.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.836 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 t -109.54 129.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.154 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.55 158.51 85.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.678 . . . . 99.99 110.942 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.88 32.91 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.712 2.275 . . . . 99.99 112.387 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.32 1.33 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.77 9.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.726 . . . . 99.99 112.531 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.2 m -112.22 -179.66 3.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 99.99 110.901 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.9 tp -128.9 128.27 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.857 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -126.22 136.93 53.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.891 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.61 132.22 22.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.646 0.736 . . . . 99.99 110.871 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.8 15.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 99.99 112.272 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.19 100.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.29 -0.414 . . . . 99.99 111.17 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.13 112.98 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.129 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.97 163.08 37.71 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.47 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -30.74 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.745 0.307 . . . . 99.99 111.146 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.15 -22.72 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.972 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -5.05 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.917 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.95 142.08 57.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.905 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.95 -142.88 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 99.99 112.476 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.95 133.22 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 99.99 111.108 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -104.75 140.14 38.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.849 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -135.23 142.39 45.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.868 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 155.81 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.862 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -140.7 129.28 22.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 99.99 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 162.19 31.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.115 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 ttm -130.65 125.08 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.889 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -89.59 172.28 9.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.865 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -71.68 -18.52 62.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.812 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -73.45 -20.01 60.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.922 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.54 31.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 99.99 112.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -84.98 146.83 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 99.99 110.936 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.09 143.87 32.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 126.64 51.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 99.99 111.171 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 145.11 32.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.83 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -144.58 124.52 13.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.852 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.88 121.45 40.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.827 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -128.89 120.42 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.957 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.75 134.28 34.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.914 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.29 139.36 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.172 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -129.14 148.44 51.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.851 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.67 -177.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.11 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -66.35 -81.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.933 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -59.24 146.25 39.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.907 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.41 159.7 49.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.611 0.72 . . . . 99.99 111.154 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -38.76 7.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 99.99 112.345 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.72 54.53 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 99.99 112.543 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -142.93 160.58 52.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 99.99 110.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 177.82 5.23 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.233 . . . . 99.99 112.357 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.947 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.44 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.423 -0.271 . . . . 99.99 112.423 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.9 p -166.9 147.42 5.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 99.99 110.79 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.39 96.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.058 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.85 133.79 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.896 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -84.29 119.62 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 99.99 110.862 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.52 123.54 63.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.096 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -94.78 140.83 29.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.116 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.72 167.27 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.113 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -124.25 148.32 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.909 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.9 mt -53.83 121.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.125 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.72 3.97 79.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.45 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -101.1 140.33 21.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 99.99 110.867 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 142.28 47.59 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.676 2.251 . . . . 99.99 112.339 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.43 141.97 29.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.912 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.34 147.97 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.116 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.5 148.6 52.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 99.99 110.983 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -110.49 149.0 30.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.923 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 101.19 9.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.85 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.19 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 99.99 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.45 -46.62 0.68 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.497 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.0 103.7 12.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.603 0.716 . . . . 99.99 111.148 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.6 Cg_endo -69.68 -163.25 0.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 99.99 112.366 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.6 -9.48 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.914 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -45.47 168.34 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.583 0.706 . . . . 99.99 110.878 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.5 Cg_endo -69.69 172.85 11.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.756 2.304 . . . . 99.99 112.305 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.76 95.1 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 99.99 112.327 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.92 -174.3 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.902 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -63.62 131.77 49.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.855 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 pp -179.41 157.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.928 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.13 148.62 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.861 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -127.67 132.76 49.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.856 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -137.6 135.41 36.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 99.99 110.871 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.93 138.84 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.881 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -112.95 127.63 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.848 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.1 p -137.22 179.77 6.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.149 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 -127.71 13.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.48 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -114.33 -37.49 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 99.99 110.823 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.09 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.158 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -99.98 32.91 2.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.895 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.76 -6.24 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.139 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -60.71 131.25 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.93 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 158.77 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 99.99 110.877 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.06 118.73 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 99.99 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mt -90.25 145.78 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.03 162.74 43.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 99.99 110.881 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 0.16 6.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.237 . . . . 99.99 112.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -119.46 72.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.74 10.0 62.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.388 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.93 102.26 0.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.787 -0.721 . . . . 99.99 112.487 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 132.33 -67.46 0.56 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.73 -0.748 . . . . 99.99 112.434 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -1.28 8.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.609 2.206 . . . . 99.99 112.371 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -34.08 34.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.856 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.45 -28.05 68.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.855 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.31 -42.29 10.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.83 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.71 -96.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 99.99 111.028 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.52 174.44 12.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.112 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 162.06 23.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.881 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.27 130.15 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.18 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.54 158.86 85.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 99.99 110.869 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -23.41 30.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 99.99 112.37 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -83.79 0.48 47.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.2 25.24 19.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 99.99 112.497 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 m -105.84 -179.43 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 99.99 110.911 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.7 tp -130.03 129.97 44.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.931 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -125.37 128.83 48.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.817 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.26 130.02 25.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.647 0.737 . . . . 99.99 110.946 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.36 18.95 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 99.99 112.343 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.24 101.71 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 99.99 111.057 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 m -73.09 119.33 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.03 161.91 33.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.533 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -31.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.779 0.323 . . . . 99.99 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -75.05 -23.16 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.843 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.44 -5.48 45.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 99.99 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 140.48 58.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.868 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.36 -141.72 8.19 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.547 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.5 133.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 99.99 111.173 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -104.48 139.95 38.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 99.99 110.876 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -135.41 142.01 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 41.8 t -128.91 150.43 50.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.3 126.75 21.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.925 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.97 163.06 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.124 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.7 ttm -129.35 125.02 35.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.25 172.55 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.905 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -70.96 -18.54 62.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.839 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -73.83 -25.83 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.85 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.78 -14.24 19.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 99.99 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.35 147.88 26.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.717 0.294 . . . . 99.99 110.882 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.12 142.49 34.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.911 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.69 126.29 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.137 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 144.2 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.901 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.1 m -146.9 126.7 13.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.91 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.444 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.6 OUTLIER -119.22 126.91 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.919 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -124.1 120.96 33.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.974 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -83.53 130.07 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 99.99 110.799 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.02 134.2 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.121 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -131.45 127.92 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.885 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.66 -177.67 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.068 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -66.76 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.898 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -62.48 143.83 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.882 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.37 159.72 48.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 99.99 111.124 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 123.92 10.59 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 99.99 112.311 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.33 -115.94 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 99.99 112.486 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 160.59 1.16 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 99.99 110.864 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 172.88 11.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.644 2.229 . . . . 99.99 112.321 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.889 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.444 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.528 -0.229 . . . . 99.99 112.528 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -178.25 158.99 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 99.99 110.886 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.32 93.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.09 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -93.39 131.46 38.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.925 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.417 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 1.8 m120 -88.34 120.54 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.881 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.87 128.37 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.112 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -89.3 141.09 28.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.13 165.95 26.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.134 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 150.06 43.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 99.99 110.829 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.7 mt -68.76 120.61 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.152 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.75 -6.34 60.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 99.99 112.49 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -102.09 141.09 21.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 99.99 110.842 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 145.69 58.03 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 99.99 112.347 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 tp -137.95 143.07 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.914 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.09 145.0 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.133 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.4 mt -131.3 149.48 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.927 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.16 152.75 27.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 99.99 110.972 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -106.31 101.78 11.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.861 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -58.76 120.38 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.864 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.22 -42.79 1.46 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.451 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.32 128.6 46.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 99.99 111.083 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -165.14 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 99.99 112.36 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.12 -52.22 27.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 99.99 110.88 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -112.44 129.27 24.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 99.99 110.879 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 109.72 2.38 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.254 . . . . 99.99 112.309 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -54.83 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.67 2.247 . . . . 99.99 112.351 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -105.91 -179.32 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.921 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -71.38 162.47 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.24 157.85 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.931 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.6 144.81 47.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 99.99 110.96 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -126.22 136.88 53.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.948 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -144.36 136.4 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.82 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 tp -138.95 136.81 35.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.887 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.45 127.13 56.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.868 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -137.99 179.39 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.108 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.39 -131.18 16.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.528 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.5 -37.29 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 99.99 110.89 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -179.4 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.133 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.09 33.32 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.21 7.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.101 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -60.36 130.59 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.904 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 153.46 47.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.846 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.04 121.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 99.99 111.101 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.82 145.84 24.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.946 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.56 163.13 40.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.723 . . . . 99.99 110.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 2.82 3.19 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.675 2.25 . . . . 99.99 112.366 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -115.46 101.63 9.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.914 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 69.4 0.53 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.77 . . . . 99.99 112.479 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.77 138.56 9.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 99.99 112.423 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.31 -115.43 5.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 99.99 112.469 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -14.26 35.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.717 2.278 . . . . 99.99 112.374 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 4.8 m-90 -62.95 -34.56 77.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.914 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.39 -24.27 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 99.99 110.825 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -33.76 68.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG21 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.26 -73.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.091 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.401 ' H ' HG21 ' A' ' 55' ' ' VAL . . . -150.85 154.7 37.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 99.99 111.135 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HG3' ' HB3' ' A' ' 52' ' ' TRP . 0.5 OUTLIER -132.54 160.18 37.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.9 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.0 t -109.0 129.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.113 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.0 mt -70.28 158.82 86.65 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 99.99 110.934 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -21.87 33.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 99.99 112.339 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -83.16 1.83 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.884 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.21 29.69 14.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 99.99 112.472 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -113.9 -178.9 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 99.99 110.88 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.8 tp -129.47 127.62 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.901 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -125.9 136.05 52.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.879 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 mp -119.29 130.22 24.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.636 0.732 . . . . 99.99 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.93 17.37 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.28 . . . . 99.99 112.308 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.77 102.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.105 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.74 119.2 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.039 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.16 161.55 27.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.53 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -32.26 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 99.99 111.079 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -76.01 -22.51 55.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.918 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -4.98 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 99.99 110.84 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.32 141.3 57.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.913 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.08 -138.95 5.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.743 . . . . 99.99 112.48 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.95 130.35 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 99.99 111.132 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -105.49 134.17 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.84 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.56 139.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.817 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.5 t -125.5 156.3 39.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.896 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -140.75 134.67 30.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.908 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 162.36 32.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.143 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.8 mtp -130.16 125.24 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.908 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -91.51 172.43 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.827 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -18.87 62.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.864 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -73.94 -20.43 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.907 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.99 -15.33 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 99.99 112.414 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 146.18 27.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 99.99 110.88 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -106.16 143.63 34.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.87 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 129.46 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.16 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 145.11 35.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.858 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.21 121.53 10.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.9 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.8 OUTLIER -118.37 124.37 47.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.832 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -129.82 117.93 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.827 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -84.24 130.6 34.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.873 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.08 140.32 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 99.99 111.118 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.23 127.73 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.859 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -88.69 -176.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.107 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.6 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.937 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 140.74 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.885 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.71 159.63 50.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.654 0.74 . . . . 99.99 111.074 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 100.04 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.68 2.254 . . . . 99.99 112.274 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.08 -37.64 2.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 99.99 112.488 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -51.83 137.51 34.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.532 0.682 . . . . 99.99 110.946 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.64 0.49 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.647 2.231 . . . . 99.99 112.342 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.893 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.41 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.516 -0.234 . . . . 99.99 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -179.71 112.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 99.99 110.856 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.33 66.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.108 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.57 133.55 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.934 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -84.01 121.03 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.888 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mm -125.4 121.78 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.157 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.98 138.77 33.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.093 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 166.88 26.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.122 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -120.93 148.35 44.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.841 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mt -52.61 121.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.058 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.61 7.19 72.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.515 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -101.37 139.43 20.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 99.99 110.939 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 143.15 49.62 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 99.99 112.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.1 tp -145.44 142.04 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.859 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.13 148.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mt -131.14 147.21 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.906 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -113.26 154.89 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.902 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 t -104.06 100.57 10.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.893 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.64 116.56 4.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.901 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.76 -42.81 1.47 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.504 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.02 40.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.545 0.688 . . . . 99.99 111.14 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.9 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 99.99 112.25 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -48.98 -52.58 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.908 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -111.95 129.7 23.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 99.99 110.863 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.13 2.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.594 2.196 . . . . 99.99 112.346 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 -51.16 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.696 2.264 . . . . 99.99 112.406 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -104.36 -178.74 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.897 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.0 mmm-85 -65.55 158.89 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.81 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.49 166.85 32.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.932 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -145.55 148.54 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.855 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -120.64 132.07 54.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.897 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -139.97 135.9 33.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.952 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.1 140.05 24.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.945 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.95 128.74 55.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.927 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 p -136.33 -179.73 5.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.68 -129.14 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 99.99 112.549 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.51 -37.45 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 99.99 110.906 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 t -179.32 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.156 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -102.26 33.93 2.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.841 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.63 -6.32 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.148 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.73 130.2 45.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.942 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.8 152.97 49.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.882 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.85 120.66 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.189 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.88 146.71 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.44 46.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 99.99 110.93 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -1.92 9.26 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 99.99 112.322 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -128.17 71.77 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.974 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -91.85 -33.59 7.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 99.99 112.453 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . -21.67 120.92 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.527 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.11 -124.32 4.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 99.99 112.512 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.82 -6.0 17.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.734 2.289 . . . . 99.99 112.343 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.531 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 1.2 m-90 -62.88 -14.18 43.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 99.99 110.915 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 6.3 p-10 -68.44 -23.13 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.832 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -33.79 76.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.937 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG21 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -123.1 -71.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 99.99 111.133 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' H ' HG21 ' A' ' 55' ' ' VAL . . . -155.86 156.4 34.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.137 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HG3' ' HB3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -131.64 161.18 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.937 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.9 t -109.0 129.93 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.042 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.45 158.98 86.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.7 . . . . 99.99 110.899 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -20.98 33.91 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.608 2.205 . . . . 99.99 112.294 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -83.12 1.59 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 99.99 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.39 25.17 26.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.505 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -110.84 -178.72 3.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 99.99 110.823 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.7 tp -129.72 127.57 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.917 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -126.12 132.51 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.904 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.54 129.61 25.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.663 0.744 . . . . 99.99 110.935 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.74 17.86 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.739 2.293 . . . . 99.99 112.313 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.76 101.29 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.044 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 m -73.35 116.71 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.1 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.4 165.35 33.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.512 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -30.17 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 99.99 111.111 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.853 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -5.0 56.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.821 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.69 140.94 58.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.76 -141.56 7.87 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 99.99 112.528 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mm -124.41 127.72 73.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 99.99 111.115 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -104.66 134.18 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.897 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -127.92 146.5 50.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.837 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.4 t -126.25 153.87 44.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.922 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.04 130.82 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.887 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.55 162.58 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 99.99 111.105 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.4 ttm -130.32 125.01 33.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.919 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -89.14 172.23 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.836 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.53 -18.61 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.853 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -73.57 -20.23 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.829 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.91 -17.44 29.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.49 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -84.81 147.9 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 99.99 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -104.01 149.18 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.875 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.14 133.5 48.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.131 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 143.41 33.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.921 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.5 m -145.23 122.74 11.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.831 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.7 OUTLIER -119.66 124.36 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.925 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -128.37 119.83 25.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.89 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.9 132.15 34.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.823 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.88 136.26 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.118 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.58 44.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.849 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.8 m -95.87 -175.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 99.99 111.171 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -66.39 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.867 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -62.85 146.33 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.943 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.56 49.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.688 0.756 . . . . 99.99 111.081 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -177.19 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 99.99 112.329 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.3 66.43 3.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.761 . . . . 99.99 112.463 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -142.92 137.66 15.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 99.99 110.918 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.48 48.19 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.723 2.282 . . . . 99.99 112.345 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.81 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.447 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.502 -0.239 . . . . 99.99 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 57.53 83.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.949 0.404 . . . . 99.99 110.903 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.9 71.11 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.082 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 133.28 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.946 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.45 119.13 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.887 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 124.64 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.136 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -93.51 142.25 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.115 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.43 166.57 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.029 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.61 148.28 46.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.92 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mt -54.9 121.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.173 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.41 76.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -101.91 140.7 21.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.689 0.757 . . . . 99.99 110.899 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 144.03 52.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.664 2.242 . . . . 99.99 112.331 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 tp -143.54 141.31 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.907 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.44 147.19 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.131 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -130.97 148.28 52.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.899 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -112.07 151.82 28.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.807 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 t -107.18 100.76 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.853 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.1 120.22 8.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.892 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.49 -39.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.515 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 128.64 54.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.709 . . . . 99.99 111.077 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -165.13 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.686 2.257 . . . . 99.99 112.352 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -48.2 46.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.915 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -109.69 150.35 41.15 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.596 0.713 . . . . 99.99 110.891 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 109.59 2.37 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 99.99 112.359 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.8 Cg_endo -69.73 -80.68 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.743 2.295 . . . . 99.99 112.353 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.466 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 21.6 mm100 -103.24 -176.46 3.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.837 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -62.9 148.26 47.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.887 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.58 150.79 37.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.951 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -121.51 148.62 44.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.878 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -123.11 138.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 99.99 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -150.97 135.76 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.94 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.25 145.94 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.889 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.99 129.43 56.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.943 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -138.42 -179.58 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.157 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.89 -132.78 16.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 99.99 112.53 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.79 -37.69 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 99.99 110.882 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 t -179.12 -29.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.098 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -101.53 34.81 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.874 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.09 -4.23 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 99.99 111.06 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -57.32 128.05 35.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 156.64 47.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.873 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.7 t -105.5 122.24 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.125 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mt -89.91 147.14 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.864 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.77 162.21 46.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.73 0.776 . . . . 99.99 110.846 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -2.62 10.52 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.687 2.258 . . . . 99.99 112.319 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -119.96 72.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.899 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.64 -2.53 85.47 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 99.99 112.389 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.42 109.84 0.89 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.76 . . . . 99.99 112.488 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.76 -76.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.504 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -0.65 7.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.725 2.283 . . . . 99.99 112.332 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -52.38 -35.74 52.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.835 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -24.27 61.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.866 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -43.37 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.869 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.24 -97.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.174 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -151.28 173.49 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.137 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 162.8 25.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.916 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 t -106.75 130.95 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.167 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.1 mt -68.7 157.69 87.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 99.99 110.914 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -22.16 32.65 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.669 2.246 . . . . 99.99 112.365 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.7 1.2 43.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.46 29.83 11.65 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 99.99 112.438 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -112.86 -179.6 3.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 99.99 110.87 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.3 tp -129.51 129.24 44.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.873 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -124.63 136.72 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.881 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.41 124.79 29.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 99.99 110.913 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.71 19.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 99.99 112.375 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.49 103.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.076 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.62 118.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.124 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.58 157.44 23.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 99.99 112.506 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -32.02 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 99.99 111.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -75.6 -23.4 56.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.858 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -5.26 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 99.99 110.823 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 142.01 56.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.918 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.22 -138.17 5.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.798 -0.715 . . . . 99.99 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.68 127.32 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 99.99 111.195 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 14.6 m-85 -104.78 144.49 31.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.853 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -138.27 143.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 99.99 110.865 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.8 t -127.21 155.66 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.891 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.14 133.8 30.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.926 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.5 162.71 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 99.99 111.089 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 mtp -129.94 125.12 34.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -91.39 172.51 8.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.876 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.45 -18.81 62.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 99.99 110.852 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.06 -20.57 60.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 99.99 110.872 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.02 -15.21 33.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.83 -0.7 . . . . 99.99 112.515 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -85.02 146.35 27.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.742 0.306 . . . . 99.99 110.893 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 144.26 33.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.89 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 132.15 50.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 99.99 111.189 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 145.14 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.937 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -145.34 127.9 16.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.825 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.448 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.7 OUTLIER -116.97 124.93 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 99.99 110.849 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -125.41 121.6 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.944 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HE ' ' ND2' ' A' ' 92' ' ' ASN . 16.9 mmt85 -83.07 133.03 35.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.874 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -120.95 134.82 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.219 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 128.79 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.872 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 m -98.33 -177.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.198 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.55 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.954 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.89 144.53 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.4 159.61 49.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 99.99 111.125 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 -38.59 7.46 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.686 2.258 . . . . 99.99 112.319 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.99 97.8 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 99.99 112.451 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -178.96 157.75 0.94 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 99.99 110.802 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 168.13 22.53 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.681 2.254 . . . . 99.99 112.294 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.87 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.448 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.465 -0.254 . . . . 99.99 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 179.84 109.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 99.99 110.894 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.69 66.91 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.084 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -93.23 131.94 37.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.916 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.439 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.3 p-10 -90.83 121.85 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.887 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.58 127.42 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.137 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -94.52 142.52 27.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 99.99 111.179 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.35 168.44 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.061 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.43 148.06 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -67.28 121.99 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.06 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.17 -9.96 54.58 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.429 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -101.71 142.66 25.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.723 . . . . 99.99 110.862 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 145.07 56.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 99.99 112.334 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.0 tp -139.71 144.44 37.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.909 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.46 145.03 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.104 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.3 mt -131.28 147.78 52.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -113.62 150.87 32.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 99.99 110.924 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.11 100.26 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.894 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -54.27 128.41 31.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.939 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.81 -42.1 1.59 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.727 . . . . 99.99 112.472 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.99 130.87 36.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.522 0.677 . . . . 99.99 111.13 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -168.47 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.703 2.268 . . . . 99.99 112.358 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -49.99 -54.57 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.905 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -113.91 128.12 26.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 99.99 110.876 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.88 109.77 2.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 99.99 112.271 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -54.32 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.628 2.218 . . . . 99.99 112.312 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -178.4 3.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 99.99 110.893 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -65.49 162.28 18.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.823 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.13 147.04 10.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.888 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.71 148.44 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.895 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -134.47 144.11 47.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.982 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -136.21 142.05 44.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 99.99 110.924 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.4 139.03 42.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.936 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -112.12 127.29 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.901 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.7 p -138.16 -179.8 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.141 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.44 -129.97 23.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.852 -0.689 . . . . 99.99 112.435 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -112.61 -37.4 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 99.99 110.897 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -178.69 -29.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.174 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -101.73 34.07 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.887 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.23 -5.54 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.123 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -59.62 131.82 52.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 99.99 110.929 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 155.07 45.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.935 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.48 121.75 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.137 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 143.13 27.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.911 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.93 164.09 39.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 99.99 110.808 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 0.85 5.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.707 2.271 . . . . 99.99 112.277 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -131.07 75.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.899 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -0.81 86.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 99.99 112.494 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.86 112.03 4.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.523 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.67 -72.65 0.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 99.99 112.462 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -3.21 11.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.693 2.262 . . . . 99.99 112.327 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -34.63 49.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.949 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.61 -25.55 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.39 -43.67 10.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.829 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.58 -96.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.134 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.18 174.56 12.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.116 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.52 160.2 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.85 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.9 129.25 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.158 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 86.4 mt -69.29 157.19 90.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 99.99 110.929 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.5 Cg_endo -69.77 -20.41 34.81 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.75 2.3 . . . . 99.99 112.278 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -82.41 0.57 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.863 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 27.39 17.37 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 99.99 112.443 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.4 m -111.77 175.73 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.852 0.358 . . . . 99.99 110.896 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -129.34 130.11 45.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.865 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -124.42 135.39 53.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 99.99 110.852 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.56 129.51 24.87 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 99.99 110.917 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.62 -31.68 20.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.285 . . . . 99.99 112.414 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.55 104.36 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 99.99 111.145 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 119.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 99.99 111.163 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.93 153.49 20.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 99.99 112.447 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.464 ' HA ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.02 -31.18 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 99.99 111.151 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.28 -22.01 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.35 -3.53 34.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.839 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HG3' HG22 ' A' ' 97' ' ' VAL . 16.8 mt-10 -58.43 142.17 49.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.46 -151.74 22.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 99.99 112.561 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.29 133.98 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 99.99 111.107 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -103.04 139.38 38.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.87 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.52 141.04 51.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 m -126.82 150.24 49.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.891 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.07 125.51 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.881 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.43 163.97 28.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.091 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.8 ttm -128.34 124.88 37.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.907 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -86.91 173.15 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 99.99 110.871 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -70.22 -17.97 63.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.87 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -73.23 -19.74 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.36 -18.78 32.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.43 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -85.16 148.2 26.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 99.99 110.916 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.5 143.61 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.895 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.55 131.6 51.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.127 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 145.34 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.93 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -146.32 124.41 12.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 99.99 110.846 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.455 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 14.4 t-20 -118.82 124.6 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.857 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.24 117.02 20.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.927 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -90.9 136.11 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.928 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.18 138.57 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.134 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.21 128.14 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.855 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -92.2 -175.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.11 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -65.98 -80.62 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -58.67 146.67 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.847 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.31 159.49 49.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.693 0.759 . . . . 99.99 111.132 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -33.6 16.19 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 99.99 112.368 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.4 75.37 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.458 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 tttp 57.29 72.72 0.88 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 99.99 110.898 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 128.63 16.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.25 . . . . 99.99 112.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.895 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.455 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.426 -0.27 . . . . 99.99 112.426 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -168.11 171.34 9.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 99.99 110.87 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.47 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 99.99 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -93.44 132.42 37.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.863 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 7.0 p30 -87.13 119.96 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.898 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.78 127.47 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.117 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -92.11 141.88 28.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 99.99 111.102 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.54 167.58 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.073 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.78 149.68 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.885 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.47 120.7 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.122 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.69 -8.29 59.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.691 -0.766 . . . . 99.99 112.468 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -102.08 140.81 21.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.701 . . . . 99.99 110.911 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 145.11 55.98 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.704 2.269 . . . . 99.99 112.33 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -142.35 143.4 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.917 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 13.7 t -122.49 148.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 99.99 111.146 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.6 mt -129.85 149.1 51.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.934 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -108.8 149.56 28.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.878 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.3 t -112.12 100.69 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' N ' ' HG ' ' A' ' 91' ' ' SER . 0.1 OUTLIER -52.12 100.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.842 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 147.08 -46.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.799 -0.715 . . . . 99.99 112.51 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.6 102.75 10.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.538 0.685 . . . . 99.99 111.075 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.9 Cg_endo -69.73 -163.21 0.1 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.705 2.27 . . . . 99.99 112.341 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -61.58 -9.4 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.932 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -45.37 168.04 0.1 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.704 . . . . 99.99 110.891 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.1 Cg_endo -69.79 172.57 12.42 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.655 2.237 . . . . 99.99 112.377 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.4 Cg_endo -69.77 97.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 99.99 112.355 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -100.29 -175.01 2.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.893 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -63.55 132.06 50.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.819 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -179.43 158.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.937 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 148.33 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.912 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -127.59 137.92 52.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.923 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -135.72 138.57 42.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.957 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -137.3 131.53 32.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.948 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -116.53 120.68 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.939 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.8 p -138.36 179.39 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.191 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.61 -132.16 12.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 99.99 112.462 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 99.99 110.83 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 t -179.67 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.141 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -102.19 33.73 2.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.917 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.35 -6.01 7.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.118 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -69.24 130.59 43.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 159.32 42.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.875 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.73 121.48 43.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.071 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -89.63 146.12 24.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.94 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.96 162.7 43.99 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.614 0.721 . . . . 99.99 110.852 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 0.51 5.48 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.743 2.295 . . . . 99.99 112.335 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -119.34 89.23 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.899 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.79 4.69 50.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.475 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 101.59 0.22 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 99.99 112.52 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.49 -70.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 99.99 112.453 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.89 4.98 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.733 2.289 . . . . 99.99 112.316 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -50.77 -35.94 34.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.898 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -66.41 -26.08 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.921 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -41.77 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.881 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -124.09 -98.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.096 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -166.58 177.09 6.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.101 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -112.01 161.04 16.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.932 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.36 128.16 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.139 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 26.3 mt -69.05 157.32 89.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.596 0.712 . . . . 99.99 110.925 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.3 Cg_endo -69.63 -22.96 31.95 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.638 2.225 . . . . 99.99 112.363 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -83.45 1.12 43.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.86 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.13 13.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.455 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 2.0 m -109.67 177.19 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 99.99 110.79 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 7.4 tp -130.28 129.34 43.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.908 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -124.16 129.43 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.859 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -117.29 131.22 24.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 99.99 110.892 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -32.22 18.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 99.99 112.274 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 100.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.16 119.88 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.143 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.6 166.92 30.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 99.99 112.508 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -30.83 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 99.99 111.156 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -74.8 -21.25 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.858 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.32 -3.08 31.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.804 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 139.71 58.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.869 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.98 -147.23 14.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.745 . . . . 99.99 112.516 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.91 133.78 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 99.99 111.118 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -104.94 128.29 53.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.877 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.13 138.13 53.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 156.67 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.913 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -141.26 127.92 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.929 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.21 162.95 29.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 99.99 111.139 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.01 124.43 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.905 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -88.65 172.52 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.899 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -71.09 -18.39 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.823 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -73.62 -19.77 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 99.99 110.915 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.78 -16.88 33.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 99.99 112.417 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -84.96 147.61 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 99.99 110.937 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.31 143.79 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 99.99 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.46 125.6 50.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.15 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 144.76 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.888 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' A' ' 19' ' ' LYS . 1.3 m -145.55 121.27 10.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.834 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.8 OUTLIER -119.71 123.54 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 99.99 110.92 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -129.16 118.27 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.877 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.58 132.38 33.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.86 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.79 139.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.134 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 127.94 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.892 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.83 -177.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 99.99 111.138 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.943 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.1 142.52 51.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.93 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.29 159.59 49.27 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.555 0.693 . . . . 99.99 111.159 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -46.8 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.666 2.244 . . . . 99.99 112.338 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.72 -33.37 5.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 99.99 112.544 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -131.02 70.06 82.58 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.59 0.709 . . . . 99.99 110.882 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 155.59 65.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.614 2.209 . . . . 99.99 112.318 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.905 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . 0.467 ' HB3' ' C1 ' ' A' ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.471 -0.252 . . . . 99.99 112.471 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.74 111.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 99.99 110.873 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.162 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.883 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.859 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.111 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.145 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.074 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.877 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.071 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.568 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 99.99 110.919 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 99.99 112.424 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.861 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.869 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.877 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.829 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.41 -44.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.476 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 130.52 58.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 99.99 111.07 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.258 . . . . 99.99 112.306 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -48.34 -50.51 30.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.925 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 51.5 mmtt -110.07 153.47 43.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.644 0.735 . . . . 99.99 110.842 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.67 109.52 2.31 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 99.99 112.412 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.2 Cg_endo -69.66 -84.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.768 2.312 . . . . 99.99 112.386 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -98.81 -176.24 3.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.902 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -62.73 149.01 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.873 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 155.43 42.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.911 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.83 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.94 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.912 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.884 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.897 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.105 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.484 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 99.99 110.906 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.159 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.815 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.088 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.902 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.082 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.961 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 99.99 110.839 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 99.99 112.38 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -120.32 74.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.944 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 57' ' ' ARG . . . -77.46 -1.45 76.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 99.99 112.501 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.82 103.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.471 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.75 -74.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.482 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -4.15 13.44 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.598 2.198 . . . . 99.99 112.406 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -34.64 57.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.951 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.81 -24.76 62.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.826 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.18 -42.96 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.803 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.16 -97.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.097 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.63 173.65 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.073 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.858 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.103 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 99.99 110.91 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 99.99 112.336 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.886 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.487 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 99.99 110.849 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.839 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 99.99 110.959 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 99.99 112.363 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.079 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.1 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 99.99 112.497 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 99.99 111.119 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.874 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.937 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.504 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 99.99 111.112 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.843 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.889 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.872 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.847 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.886 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 99.99 110.829 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.527 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 99.99 110.919 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.913 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.133 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.879 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 99.99 110.835 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.878 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.906 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.127 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.119 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.898 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.902 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 99.99 111.184 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 156.76 62.44 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 99.99 112.339 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.72 -76.19 1.03 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 99.99 112.526 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -153.36 157.53 32.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 99.99 110.858 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.625 2.216 . . . . 99.99 112.411 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.919 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 73.11 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.32 71.67 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 43.2 111.094 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -93.11 135.6 34.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.939 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.37 120.97 27.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.859 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 14' ' ' LEU . 41.2 mm -125.95 121.94 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.45 111.15 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.83 138.62 33.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.142 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.33 166.98 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 73.22 111.118 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.06 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 65.25 110.849 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.98 121.64 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 51.53 111.117 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.27 3.96 78.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.513 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.758 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.6 mm-40 -101.43 139.76 20.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 74.32 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.38 50.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 45.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.647 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.7 tp -144.57 142.15 29.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 63.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.1 t -122.87 146.9 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 74.51 111.163 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 93' ' ' TYR . 56.1 mt -132.22 148.37 52.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.897 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -112.04 148.88 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.21 110.908 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.12 100.82 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.832 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.37 102.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 65.12 110.92 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.33 112.483 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.803 0.335 . . . . 74.41 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.31 146.77 46.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 62.32 110.873 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CH2' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.2 132.36 48.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 65.3 110.949 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -135.55 142.62 45.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 35' ' ' THR . 4.0 tp -138.42 134.41 34.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 63.44 110.933 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' N ' HD12 ' A' ' 33' ' ' LEU . 7.3 t30 -115.16 121.92 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.874 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.2 p -138.3 176.27 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 73.23 111.118 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.26 -131.15 13.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 32.22 112.51 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.66 -37.75 4.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 54.42 110.856 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.31 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 63.43 111.172 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 38' ' ' THR . 53.7 mt-10 -102.25 33.26 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.42 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.22 -6.74 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.169 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -61.92 131.32 49.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.53 110.934 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.45 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.903 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.2 t -100.62 120.66 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.33 111.151 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 31' ' ' TRP . 3.7 mm? -95.56 146.95 24.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 74.04 110.961 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.32 163.46 36.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 71.14 110.877 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.79 0.48 5.61 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.661 2.241 . . . . 74.43 112.32 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.931 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.776 0.322 . . . . 54.43 111.089 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.48 164.83 18.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.877 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 18.5 t -107.66 132.01 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.114 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 63' ' ' SER . 39.7 mt -68.63 158.76 84.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 74.2 110.896 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -25.11 28.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 74.13 112.313 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -83.57 2.06 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 72.14 110.905 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.33 32.46 8.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.12 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.717 ' HB3' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -111.78 -179.53 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 74.21 110.851 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.645 HD22 ' CH2' ' A' ' 31' ' ' TRP . 17.0 tp -130.47 129.59 43.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.965 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 15' ' ' VAL . 24.8 t80 -124.37 129.62 51.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.05 110.859 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.814 HD22 HG12 ' A' ' 69' ' ' VAL . 5.0 mp -116.57 130.74 24.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 64.05 110.934 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -32.61 18.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 72.21 112.352 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.63 101.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 71.23 111.084 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 HD22 ' A' ' 66' ' ' LEU . 13.8 m -73.69 118.59 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.11 111.169 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.07 163.99 30.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 60.23 112.473 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.855 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.36 -30.84 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 72.31 111.152 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -75.83 -23.26 55.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 63.44 110.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.93 -4.67 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.883 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.53 140.83 58.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 75.44 110.913 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.74 -138.55 5.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.482 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.64 135.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 64.2 111.132 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.8 m-85 -103.27 135.24 45.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 54.33 110.857 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -131.36 131.47 43.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.866 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 t -125.95 156.12 40.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.14 110.87 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.16 142.73 34.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 72.12 110.886 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.17 162.53 33.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 41.21 111.087 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.0 ttm -130.43 124.72 32.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.04 172.25 8.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 64.24 110.833 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -71.44 -19.35 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 65.15 110.871 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -74.08 -20.17 60.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.85 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.43 37.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 75.32 112.438 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.1 147.47 26.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 62.41 110.935 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.69 144.7 31.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 72.54 110.901 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 131.72 50.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.111 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.53 142.91 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 75.25 110.896 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.91 121.81 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 52.1 110.854 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 123.02 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.434 ' CD2' HD22 ' A' ' 16' ' ' LEU . 3.9 m-85 -125.86 120.11 29.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 75.41 110.926 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.0 130.55 34.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 73.32 110.875 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -121.12 137.32 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 62.42 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.29 131.88 45.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 70.33 110.902 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.8 m -95.81 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 51.35 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.51 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.928 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 143.6 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 62.23 110.925 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.407 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.65 159.58 50.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.652 0.739 . . . . 73.43 111.146 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 52.32 112.34 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.963 0.411 . . . . 62.12 110.797 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.61 72.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 71.25 111.087 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 133.18 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 73.22 110.931 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.37 120.44 26.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 63.54 110.939 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.69 HG21 HD11 ' A' ' 14' ' ' LEU . 46.8 mm -125.91 121.61 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.3 111.085 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.93 137.7 34.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 62.01 111.142 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.42 166.78 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 70.11 111.085 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.59 148.72 44.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.946 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -52.08 121.57 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.1 111.145 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.653 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.87 6.67 75.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 62.21 112.538 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.3 mm-40 -101.83 140.13 20.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.709 0.766 . . . . 72.41 110.846 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 143.88 52.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.745 2.297 . . . . 65.51 112.33 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 6' ' ' ILE . 33.5 tp -144.23 142.0 30.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.898 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 65' ' ' PHE . 24.3 t -122.81 147.91 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 71.11 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 64' ' ' LEU . 50.2 mt -131.58 149.05 52.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 65.24 110.951 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.48 152.53 27.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.916 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.74 101.33 10.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.3 110.826 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 113.09 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 72.42 110.918 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' HG21 ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 64.34 112.579 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.776 0.322 . . . . 72.13 110.925 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.2 147.79 44.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 63.34 110.943 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -129.41 138.93 51.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.958 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -144.11 136.04 26.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 74.44 110.933 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.749 HD12 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -138.98 139.83 38.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 71.24 110.931 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -112.07 127.97 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.895 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.773 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -137.55 178.29 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.13 111.102 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.17 -130.44 19.08 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 74.05 112.476 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -112.67 -37.39 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.903 0.382 . . . . 74.31 110.888 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.9 t -178.42 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.055 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.9 mt-10 -102.26 33.89 2.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 63.22 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.9 -5.54 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 75.41 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -59.22 132.29 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.857 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.749 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -127.44 153.59 46.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 70.3 110.91 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.87 121.7 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.109 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' A' ' 33' ' ' LEU . 2.1 mm? -89.51 145.34 25.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.929 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -125.42 163.74 36.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.639 0.733 . . . . 61.44 110.854 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.5 Cg_endo -69.84 2.36 3.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.7 2.267 . . . . 41.22 112.275 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.937 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.719 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.695 0.284 . . . . 73.13 111.152 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -132.67 160.21 37.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 73.45 110.931 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 HD12 ' A' ' 44' ' ' LEU . 38.2 t -109.5 128.82 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.102 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.63 158.25 87.49 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.528 0.68 . . . . 42.42 110.957 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -21.38 33.41 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.24 . . . . 72.4 112.338 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -82.87 0.9 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 64.21 110.914 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.01 16.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.824 -0.703 . . . . 64.22 112.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 m -112.28 179.89 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 72.24 110.938 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 16' ' ' LEU . 10.9 tp -129.73 126.25 37.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.34 110.901 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CD2' HG22 ' A' ' 15' ' ' VAL . 34.1 t80 -126.46 135.46 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.892 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.06 129.59 25.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 73.33 110.922 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -33.03 17.17 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 73.32 112.301 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.653 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.2 102.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.432 . . . . 71.55 111.134 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -72.91 117.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.423 . . . . 73.44 111.183 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.05 162.2 30.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.805 -0.712 . . . . 54.04 112.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.26 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.72 0.295 . . . . 71.24 111.084 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -75.58 -22.74 56.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.927 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.59 -4.95 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.04 110.856 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.84 141.0 58.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 60.55 110.922 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.76 -137.96 5.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 72.12 112.465 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.6 mm -124.13 127.55 73.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.4 111.161 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.4 m-85 -104.77 134.73 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.28 144.97 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.928 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 155.45 43.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.875 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.89 130.25 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.908 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.57 161.93 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.03 111.154 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -130.14 125.28 34.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 63.21 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.49 173.16 9.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 64.12 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -70.64 -19.23 62.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.824 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -74.53 -20.56 59.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.11 -8.0 38.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 72.44 112.508 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.96 147.05 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.698 0.285 . . . . 75.33 110.948 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.94 140.32 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.483 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -105.24 129.64 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.14 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.87 144.23 33.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -145.08 125.95 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 54.13 110.85 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.7 124.12 45.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 64.44 110.891 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.87 120.62 28.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.953 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 131.34 35.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.94 137.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 64.42 111.1 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.49 129.05 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.865 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 m -93.58 -176.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.058 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -63.53 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.2 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.37 144.01 54.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 72.42 110.947 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.23 159.57 49.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 73.44 111.155 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 C-N-CA 122.718 2.278 . . . . 64.12 112.376 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.813 0.339 . . . . 72.33 110.84 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.35 73.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.496 . . . . 73.44 111.126 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -91.4 139.1 31.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 71.23 110.906 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -84.11 121.02 26.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.916 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.566 ' CG2' HD11 ' A' ' 14' ' ' LEU . 44.4 mm -125.68 121.62 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 65.14 111.065 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -95.35 139.72 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 64.4 111.126 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.83 166.33 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.058 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -124.03 149.2 46.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.823 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 99' ' ' GLN . 78.6 mt -53.88 120.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.168 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.619 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.35 6.94 77.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 54.43 112.452 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 69' ' ' VAL . 32.6 mm-40 -102.37 140.7 21.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 73.31 110.902 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 145.06 56.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 61.11 112.35 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.2 tp -142.51 142.72 32.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 72.34 110.967 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.2 t -121.12 147.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 72.05 111.072 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 17.8 mt -131.18 148.21 52.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 61.35 110.96 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -113.01 153.13 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.97 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.95 100.68 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 74.32 110.905 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.18 118.39 6.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.2 110.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 44.31 112.562 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.734 0.302 . . . . 73.33 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.63 148.09 41.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.848 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -122.96 138.25 54.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.14 142.56 34.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 74.44 110.877 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' ' 77' ' ' PHE . 16.7 tp -137.94 135.79 36.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.852 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -115.23 121.94 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.94 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.6 p -138.17 176.72 8.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.03 111.199 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.83 -131.58 12.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 73.03 112.543 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -112.88 -37.89 4.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.369 . . . . 74.05 110.852 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.18 -30.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 63.22 111.142 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.9 mt-10 -102.1 33.63 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.01 110.929 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.86 -6.1 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 73.22 111.122 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -59.88 132.16 53.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 153.93 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 72.55 110.818 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.18 121.26 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 63.52 111.144 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.55 145.24 25.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 64.41 110.853 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.82 162.12 49.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.697 0.76 . . . . 71.12 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.92 11.01 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.706 2.271 . . . . 75.51 112.327 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.942 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.845 0.355 . . . . 34.31 111.061 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.23 159.41 20.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 75.41 110.83 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.51 125.06 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 73.51 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 63' ' ' SER . 88.0 mt -68.21 156.99 88.77 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.641 0.734 . . . . 64.31 110.919 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.1 Cg_endo -69.74 -20.71 34.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.673 2.249 . . . . 71.43 112.33 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -82.48 0.89 40.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.11 110.885 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.97 28.7 14.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 74.21 112.501 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 59' ' ' LEU . 15.6 m -112.53 173.67 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 44.52 110.807 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 15.9 tp -129.29 130.42 46.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 72.24 110.871 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 34.9 t80 -124.29 136.03 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.874 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.559 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.05 130.75 23.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.656 0.741 . . . . 74.12 110.93 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -37.81 8.68 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 74.12 112.332 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.73 104.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 34.2 111.093 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 12' ' ' GLU . 19.6 m -73.06 117.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 70.14 111.139 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.97 162.67 24.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 61.03 112.476 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.29 -29.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 71.43 111.107 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.94 -24.17 58.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 63.33 110.933 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.89 -4.54 56.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 61.12 110.839 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.59 141.38 58.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 62.35 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.6 -139.81 7.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 75.05 112.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.76 130.25 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 75.12 111.103 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.675 ' CG ' HD13 ' A' ' 16' ' ' LEU . 6.2 t80 -103.2 144.3 31.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 72.23 110.912 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 146.35 52.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.55 110.823 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.7 t -126.98 151.44 48.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 64.13 110.899 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.84 131.76 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.907 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.75 161.91 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 51.23 111.054 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.8 mtp -130.17 124.4 32.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.05 110.817 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.42 172.87 9.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.911 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -70.53 -19.42 62.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 74.31 110.893 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.74 -20.34 59.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.01 110.861 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.02 39.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 61.1 112.463 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.91 147.7 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 75.04 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -104.3 142.66 34.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.53 110.813 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.525 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.74 132.55 50.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 43.42 111.14 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 144.1 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.53 110.954 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -145.06 126.09 14.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 72.11 110.889 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -118.69 122.56 42.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.901 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -128.72 120.79 27.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.955 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -83.14 133.18 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.85 138.34 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 74.44 111.125 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -129.25 143.91 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.82 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.833 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -112.47 -176.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.55 111.151 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.41 -79.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 75.32 110.933 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -63.76 144.79 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.04 110.952 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.425 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.4 159.66 49.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 72.05 111.163 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.254 . . . . 72.42 112.352 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.351 . . . . 73.13 110.865 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.55 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . -60.49 94.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 61.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.22 133.08 36.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 64.24 110.949 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.8 p-10 -89.68 119.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 62.41 110.935 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.733 HG21 HD11 ' A' ' 14' ' ' LEU . 2.7 mp -126.77 122.59 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -95.79 139.95 31.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 73.14 111.176 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.54 167.65 24.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.24 148.46 43.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.818 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 26.9 mt -52.42 121.25 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.128 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.703 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.42 8.02 71.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 31.5 112.498 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.4 mm-40 -101.94 140.3 21.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 73.55 110.952 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 144.09 52.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.707 2.271 . . . . 71.13 112.341 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 6' ' ' ILE . 21.7 tp -144.08 142.23 30.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 62.11 110.936 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 65' ' ' PHE . 33.9 t -121.84 145.93 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 50.43 111.133 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.9 mt -131.43 148.56 52.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.926 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -112.82 152.77 28.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 110.893 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.0 t -105.66 99.99 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 70.11 110.851 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 120.09 7.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.899 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 73.42 112.503 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.592 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.77 0.319 . . . . 72.31 110.875 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -120.88 148.07 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.899 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.592 ' HE1' HD13 ' A' ' 29' ' ' LEU . 26.7 m95 -127.39 136.17 51.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 72.4 110.863 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.725 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -143.4 136.83 28.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.874 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' A' ' 77' ' ' PHE . 1.4 mt -137.4 138.99 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 64.54 110.929 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -112.29 126.55 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.907 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.4 p -138.14 179.22 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 65.23 111.155 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.08 -130.83 19.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.472 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 38' ' ' THR . 12.1 mmt85 -114.9 -38.07 4.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 44.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -176.28 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 75.04 111.154 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -99.09 34.02 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.848 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.15 -4.56 7.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 64.4 111.075 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CZ2' HG22 ' A' ' 38' ' ' THR . 11.0 m0 -58.12 131.13 49.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 72.23 110.961 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 154.06 47.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 55.25 110.903 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.06 118.39 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.163 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HG ' HD11 ' A' ' 33' ' ' LEU . 1.1 mm? -90.54 145.33 24.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 61.33 110.906 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.13 163.19 43.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 74.3 110.925 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.0 Cg_endo -69.84 -3.73 12.66 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.648 2.232 . . . . 65.25 112.351 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 65.11 110.837 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.833 0.349 . . . . 61.41 111.065 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.623 HH21 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -129.32 163.01 26.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 74.52 110.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 46' ' ' PRO . 4.1 t -107.76 130.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 73.42 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.623 HD23 HH21 ' A' ' 57' ' ' ARG . 61.5 mt -68.91 157.8 87.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.626 0.727 . . . . 74.54 110.886 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -21.71 33.32 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 71.22 112.338 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.29 1.12 42.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 61.14 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.1 29.91 11.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 71.05 112.569 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.457 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.6 m -113.19 179.15 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.411 . . . . 62.12 110.827 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 65' ' ' PHE . 14.7 tp -130.01 129.31 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 74.04 110.971 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CD2' HG22 ' A' ' 15' ' ' VAL . 37.8 t80 -124.6 133.94 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 72.01 110.838 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.2 mp -114.97 131.04 23.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.549 0.69 . . . . 71.42 110.95 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -33.64 15.94 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.673 2.249 . . . . 54.34 112.365 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.95 104.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 43.04 111.099 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.43 113.12 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 60.22 111.137 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.98 162.0 33.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.718 -0.753 . . . . 71.1 112.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.837 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.11 -30.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 74.42 111.206 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.9 -23.71 55.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 71.31 110.889 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -4.07 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 70.45 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.68 140.62 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.3 110.884 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.49 -137.63 5.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 54.34 112.478 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.405 HD12 ' CG ' ' A' ' 94' ' ' ARG . 43.9 mm -123.54 133.39 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 74.25 111.052 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -103.81 143.56 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.895 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -138.67 137.99 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 75.03 110.886 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.8 t -126.51 155.29 42.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.84 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.11 135.11 32.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.963 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.02 162.66 30.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 44.34 111.079 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ttm -130.11 124.81 33.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -89.94 172.4 8.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 53.25 110.874 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -71.29 -18.65 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.952 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -73.85 -20.43 60.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -15.58 33.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.734 -0.746 . . . . 65.34 112.407 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -85.16 146.17 27.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 74.23 110.881 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.15 144.61 32.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.919 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 133.32 49.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 73.14 111.14 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.47 145.25 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.934 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -144.91 126.92 15.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 62.3 110.888 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.18 122.71 42.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.22 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -124.28 119.37 29.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.891 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.55 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.76 133.86 34.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 74.2 110.895 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.36 137.25 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 64.02 111.078 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -130.33 132.7 45.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.873 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 m -95.67 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 73.2 111.128 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -65.39 -80.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.941 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -65.49 142.98 57.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 52.34 110.912 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.446 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.13 159.54 49.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 73.22 111.184 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.134 0 C-N-CA 122.695 2.263 . . . . 42.25 112.355 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.7 p-10 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.816 0.341 . . . . 74.03 110.911 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.893 0.378 . . . . 74.43 111.073 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo . . . . . 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.914 0.388 . . . . 45.23 110.857 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -52.46 100.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 71.5 111.099 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.04 133.27 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 60.12 110.944 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 6.5 m-80 -84.26 120.31 26.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 63.51 110.932 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.6 mm -126.17 121.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.41 111.162 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 p -96.89 138.31 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.31 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -148.24 165.64 30.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.11 111.142 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -124.25 149.05 46.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 51.31 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -53.98 121.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.206 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.57 2.73 84.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 63.42 112.444 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.78 ' O ' HG22 ' A' ' 69' ' ' VAL . 17.5 mm-40 -101.09 139.63 20.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 63.34 110.902 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 143.09 49.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.671 2.248 . . . . 74.0 112.358 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 66' ' ' LEU . 40.6 tp -144.72 141.79 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.896 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -122.97 148.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 64.34 111.056 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 64' ' ' LEU . 9.4 mt -131.58 149.03 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 65.02 110.95 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -106.29 148.96 27.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.895 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 t -112.26 101.83 10.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.927 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -55.88 95.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 70.52 110.903 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 51.44 112.488 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.3 pp . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.775 0.321 . . . . 65.1 110.872 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -120.37 147.4 45.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 71.54 110.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -134.49 138.8 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.931 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.7 ' O ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpt -136.46 142.01 43.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 52.22 110.923 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 32' ' ' LYS . 55.2 mt -134.98 135.06 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 61.22 110.933 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -116.64 120.62 39.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.892 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.789 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.5 p -139.17 177.59 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 74.43 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.75 -128.91 9.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.759 -0.734 . . . . 64.24 112.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.36 -36.98 5.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 72.44 110.848 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.9 -30.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.166 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -103.13 33.46 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.874 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.65 -6.69 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 43.03 111.134 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 133.24 55.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.937 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 157.99 40.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 62.24 110.872 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.98 120.46 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 64.32 111.14 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.43 145.75 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 73.12 110.889 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.62 163.06 41.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.729 . . . . 75.22 110.89 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.9 Cg_endo -69.76 0.11 6.12 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.714 2.276 . . . . 70.44 112.316 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 71.53 110.919 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.825 0.345 . . . . 61.1 111.081 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 161.73 23.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 61.41 110.896 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.73 129.88 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 40.42 111.145 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 6.5 mp -69.61 158.26 87.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.61 0.719 . . . . 53.11 110.898 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.78 -23.12 31.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 74.13 112.303 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.03 3.48 34.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 70.31 110.818 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.14 24.84 28.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.72 -0.752 . . . . 70.32 112.457 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 2.6 m -105.97 179.73 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 75.22 110.869 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 16' ' ' LEU . 6.4 tp -130.86 127.91 39.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 73.13 110.943 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.643 ' N ' HD12 ' A' ' 64' ' ' LEU . 2.3 t80 -126.1 129.41 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.55 110.896 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.3 mp -117.77 131.24 24.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.612 0.72 . . . . 73.41 110.975 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.63 -32.47 19.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.763 2.309 . . . . 73.11 112.364 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.59 101.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 41.35 111.116 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.6 m -73.55 119.41 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 111.092 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.39 161.48 28.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.705 -0.759 . . . . 51.4 112.514 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.33 -29.39 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.728 0.299 . . . . 64.41 111.124 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -74.47 -23.2 58.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 51.41 110.893 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -5.14 57.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 65.3 110.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.66 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 65.44 110.912 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.49 -139.11 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 62.4 112.483 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.28 128.14 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 74.52 111.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD1' HD22 ' A' ' 33' ' ' LEU . 22.7 m-85 -104.5 136.72 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 64.4 110.839 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.45 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 75.33 110.881 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.4 t -127.14 152.31 47.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.909 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 131.03 24.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 61.12 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.63 163.06 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.07 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ttm -130.06 124.9 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.88 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -88.42 172.36 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.913 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.53 -18.91 62.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.926 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -73.89 -20.26 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.919 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.93 -13.53 34.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 71.34 112.548 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -84.87 147.27 26.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 74.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.58 143.85 32.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 72.15 110.925 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.76 126.89 51.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 54.45 111.12 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 144.23 34.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 73.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 m -145.8 127.74 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 63.14 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.82 122.52 41.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 64.52 110.827 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.72 119.04 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 64.31 110.906 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.02 131.45 34.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 70.24 110.87 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 77' ' ' PHE . 70.3 t -120.75 139.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.55 111.143 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 128.57 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.45 110.866 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.4 m -92.48 -176.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 64.13 111.099 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -64.69 -78.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.15 110.948 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -68.2 145.89 53.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.9 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.501 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.62 0.724 . . . . 61.44 111.072 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.166 0 C-N-CA 122.751 2.301 . . . . 64.34 112.312 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.883 0.373 . . . . 62.34 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 97.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 55.41 111.111 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -93.24 133.65 36.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 60.22 110.836 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -89.83 121.43 31.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 14' ' ' LEU . 44.9 mm -125.33 121.44 60.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 71.41 111.08 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -96.01 141.19 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.24 111.115 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 167.46 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 71.1 111.051 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -122.63 148.22 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 38.5 mt -53.12 121.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 60.42 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.9 5.76 76.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 74.15 112.47 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.8 mm-40 -102.04 140.11 20.89 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.43 110.866 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 144.01 52.47 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.608 2.205 . . . . 52.12 112.286 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.671 HD11 HG21 ' A' ' 6' ' ' ILE . 36.3 tp -144.61 142.01 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.919 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.84 144.6 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.139 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.725 HD13 ' CD2' ' A' ' 77' ' ' PHE . 1.3 mt -131.03 146.26 52.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 72.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -114.5 151.2 33.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 75.03 110.952 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 m -108.05 101.83 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.57 126.71 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.31 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 54.45 112.53 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 29' ' ' LEU . 1.3 pp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.825 0.345 . . . . 65.13 110.921 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.74 129.12 53.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 70.24 110.925 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.579 ' NE1' HD13 ' A' ' 29' ' ' LEU . 43.6 m0 -111.93 144.53 41.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 73.03 110.911 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -136.96 141.23 42.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 72.11 110.982 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 77' ' ' PHE . 13.6 tp -136.05 135.29 39.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.53 110.942 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.13 121.47 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 54.11 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.803 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 p -138.35 179.27 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 62.35 111.139 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.95 -130.24 11.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 52.13 112.49 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -112.5 -37.95 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 73.41 110.933 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t -179.83 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 72.4 111.134 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 38' ' ' THR . 19.2 mt-10 -102.6 34.03 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 61.24 110.862 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.57 -6.76 8.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -61.82 131.34 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.873 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 158.46 38.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 60.41 110.854 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.91 123.1 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 61.13 111.16 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.52 143.5 26.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 70.41 110.919 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.713 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -126.74 163.02 43.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.647 0.736 . . . . 73.13 110.856 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.694 2.263 . . . . 51.43 112.403 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.94 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.605 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 62.1 111.11 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.92 163.0 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.42 110.851 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 45' ' ' SER . 48.6 t -107.45 127.5 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.063 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.6 mp -68.27 157.58 87.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.586 0.707 . . . . 61.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.81 -20.83 34.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 70.3 112.335 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.6 1.62 41.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 28.53 20.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.827 -0.702 . . . . 74.4 112.486 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -112.57 178.01 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 72.05 110.896 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 38.0 tp -128.01 127.93 44.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.912 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 59' ' ' LEU . 9.3 t80 -125.81 135.04 51.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 71.43 110.903 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 56' ' ' ALA . 7.2 mp -113.43 128.59 25.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 73.11 110.901 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -32.5 18.34 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 71.42 112.368 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.04 102.65 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.098 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -72.36 118.42 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 73.1 111.151 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.37 158.79 26.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 31.03 112.494 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.838 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.23 -31.43 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.787 0.327 . . . . 64.15 111.102 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.79 -22.8 53.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.908 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.55 -5.27 44.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.881 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -60.7 142.49 55.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 72.45 110.831 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.16 -147.16 15.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.724 . . . . 52.13 112.511 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.82 129.91 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 73.42 111.144 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' A' ' 16' ' ' LEU . 11.3 t80 -104.87 135.28 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.0 146.72 50.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 64.23 110.799 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.59 152.72 46.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.867 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.7 128.13 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.902 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.08 31.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 62.3 111.078 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 ttm -130.11 124.71 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.44 110.873 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -87.71 171.9 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 55.13 110.943 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -71.76 -18.18 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -73.28 -26.06 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 60.41 110.86 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.92 -18.22 12.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 55.54 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -84.18 147.16 27.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 61.44 110.892 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.26 144.86 31.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.873 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 128.12 50.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 64.13 111.154 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 145.31 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 65.22 110.919 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -144.67 126.96 15.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 52.11 110.85 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 122.1 40.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 61.34 110.874 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.69 120.04 28.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.953 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.91 132.12 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.886 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.89 136.37 58.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 74.0 111.115 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -130.76 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 62.14 110.879 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.8 m -108.7 -175.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 52.4 111.142 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -66.37 -78.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.927 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -66.53 146.03 54.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 44.44 110.914 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.48 49.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 45.32 111.133 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.275 . . . . 70.54 112.338 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.849 0.357 . . . . 74.23 110.913 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.49 63.64 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 64.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -92.72 137.87 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.66 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.9 p-10 -89.95 120.99 31.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 53.21 110.871 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.66 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.24 122.3 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.16 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -95.49 142.09 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 64.43 111.11 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.77 168.34 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 51.43 111.111 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.41 148.19 41.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 64.42 110.871 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.03 122.08 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.064 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.4 3.85 86.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 62.54 112.555 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.6 mm-40 -101.39 142.7 25.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.736 . . . . 62.31 110.93 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 144.03 53.35 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.703 2.269 . . . . 62.11 112.378 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 6' ' ' ILE . 52.2 tp -143.93 143.26 31.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 72.52 110.93 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.4 t -121.07 147.71 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 62.01 111.148 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 77' ' ' PHE . 14.8 mt -131.48 149.12 52.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.893 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -107.18 151.63 25.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.896 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.6 t -107.63 100.11 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.05 110.854 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -59.71 120.53 9.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.898 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.714 -0.755 . . . . 74.13 112.466 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.772 0.32 . . . . 73.33 110.902 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -120.51 148.21 44.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.867 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.607 ' HE1' HD13 ' A' ' 29' ' ' LEU . 20.2 m95 -124.79 143.28 50.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 74.01 110.879 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 143.94 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.91 134.63 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 65.12 110.863 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -116.45 121.18 41.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.54 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.785 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.8 p -139.39 179.38 6.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 72.21 111.104 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.56 -133.35 15.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 75.12 112.552 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -112.56 -37.57 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 62.22 110.817 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.616 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.7 t -179.31 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 55.12 111.158 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.616 ' HG3' HG23 ' A' ' 38' ' ' THR . 25.0 mt-10 -102.08 33.71 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 64.24 110.85 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.92 -6.81 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 63.54 111.129 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -60.38 128.95 39.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 72.3 110.918 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.34 156.34 44.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 65.43 110.938 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 t -93.49 123.35 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 71.51 111.188 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 33' ' ' LEU . 30.6 mt -88.66 143.65 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 54.21 110.915 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.73 162.52 50.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.693 0.758 . . . . 75.3 110.854 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -4.0 13.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.767 2.311 . . . . 73.11 112.34 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 72.13 110.9 -179.941 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.796 0.331 . . . . 60.33 111.088 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 161.53 17.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.01 110.849 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.43 130.24 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 75.41 111.172 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 48.8 mt -68.82 157.83 87.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.592 0.71 . . . . 71.41 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.51 33.47 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 73.32 112.344 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.44 1.65 47.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 63.21 110.894 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.58 31.11 9.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 62.05 112.53 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.3 m -113.34 -179.05 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 73.34 110.839 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 65' ' ' PHE . 6.2 tp -129.84 128.71 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.95 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.634 ' N ' HD12 ' A' ' 64' ' ' LEU . 13.3 t80 -126.36 135.85 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.91 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.56 128.86 25.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.626 0.727 . . . . 74.23 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -32.42 19.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.724 2.283 . . . . 73.2 112.4 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.86 100.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 61.52 111.073 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -72.75 113.45 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 73.43 111.093 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.54 158.76 30.1 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 54.54 112.531 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.74 -31.09 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 63.31 111.049 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -76.23 -20.96 56.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.906 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -3.08 27.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.918 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.746 ' CD ' HG22 ' A' ' 97' ' ' VAL . 23.8 mt-10 -57.57 142.81 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 64.43 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.39 -149.95 21.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 54.13 112.406 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.58 133.03 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 74.24 111.105 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' A' ' 16' ' ' LEU . 5.0 t80 -103.28 139.08 39.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 65.14 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 141.16 51.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.883 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -125.95 153.82 43.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.34 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -139.74 130.3 25.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 74.13 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 163.18 28.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 51.31 111.093 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.8 ttm -128.42 124.78 37.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.835 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -87.23 173.4 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 71.1 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -69.53 -19.07 63.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.33 110.842 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -74.42 -20.34 60.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.75 -9.06 43.79 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 61.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -85.05 148.64 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 63.55 110.916 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.21 140.31 37.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 65.23 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.35 132.77 51.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 73.04 111.179 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.32 145.0 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.881 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -144.7 126.94 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.872 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -119.22 124.23 46.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 61.21 110.877 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.8 119.25 24.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -84.47 134.45 34.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 73.03 110.858 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.8 t -122.63 135.98 60.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 70.41 111.158 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.26 148.18 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -110.74 -175.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.114 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -67.06 -78.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 72.4 110.9 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -63.17 146.45 53.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.918 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 71.01 111.151 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 55.1 112.36 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 64.3 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.85 96.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 23.24 111.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -93.03 132.84 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 60.11 110.996 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.676 ' C ' HD12 ' A' ' 6' ' ' ILE . 5.7 p-10 -86.33 119.51 26.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.34 110.881 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.9 mp -129.2 123.2 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.54 111.18 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -95.58 138.66 32.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 63.13 111.153 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.12 166.14 27.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 65.13 111.117 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.45 149.21 44.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.804 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mt -52.58 121.34 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.139 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.51 6.96 76.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 74.22 112.471 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.761 ' O ' HG22 ' A' ' 69' ' ' VAL . 38.7 mm-40 -102.09 139.65 20.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.718 0.771 . . . . 72.04 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 144.51 54.7 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.711 2.274 . . . . 74.55 112.345 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.45 HD11 ' CG2' ' A' ' 6' ' ' ILE . 16.5 tp -143.86 141.91 30.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 60.13 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.39 144.72 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 63.54 111.202 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 64' ' ' LEU . 36.3 mt -131.14 146.88 52.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.35 110.981 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -114.34 151.75 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 61.13 110.933 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.21 99.67 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.9 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -56.39 124.53 18.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.675 -0.774 . . . . 61.44 112.471 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.799 0.333 . . . . 63.24 110.926 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.15 149.56 47.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.911 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.844 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 18.0 m-90 -117.84 135.27 54.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.951 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.654 ' C ' HD23 ' A' ' 33' ' ' LEU . 3.6 ttpt -145.87 136.58 24.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 55.33 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.018 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.54 140.83 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 64.22 110.873 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -111.7 129.0 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.914 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.6 p -135.83 179.89 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.33 111.148 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.27 -129.36 17.4 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.748 -0.739 . . . . 44.14 112.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -112.7 -37.51 4.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 74.42 110.874 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 t -178.96 -30.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.29 33.95 2.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.878 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.87 -5.14 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 72.43 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.05 132.19 53.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 70.34 110.941 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 157.56 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 74.23 110.886 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 t -102.56 120.35 52.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 62.02 111.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.018 HD12 HD21 ' A' ' 33' ' ' LEU . 5.6 mt -92.38 146.05 23.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 54.23 110.908 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 163.5 39.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.636 0.732 . . . . 73.42 110.849 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -0.6 7.14 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.704 2.269 . . . . 55.02 112.321 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 71.32 110.914 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.796 0.332 . . . . 72.31 111.084 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 161.4 17.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.871 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.9 t -108.47 129.57 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.2 111.141 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.592 HD12 ' CB ' ' A' ' 63' ' ' SER . 43.9 mt -69.11 157.47 89.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 63.12 110.937 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -22.56 31.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.726 2.284 . . . . 62.2 112.364 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -83.46 0.61 45.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 70.51 110.849 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.14 29.38 11.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 71.24 112.506 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.7 -179.68 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 63.13 110.927 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 16' ' ' LEU . 13.1 tp -128.97 129.58 45.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.928 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 9.1 t80 -125.37 131.03 53.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 71.5 110.915 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mt -113.97 130.92 23.43 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.646 0.736 . . . . 70.33 110.911 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -38.3 7.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 73.54 112.334 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.74 101.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 72.03 111.072 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.9 m -73.63 116.92 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.103 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.71 164.73 31.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 53.31 112.505 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.836 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.83 -29.4 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.7 0.286 . . . . 73.51 111.096 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -75.11 -23.96 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.4 110.95 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -3.86 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.915 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.57 141.24 52.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.902 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.66 -140.5 7.59 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.697 -0.763 . . . . 51.52 112.452 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 94' ' ' ARG . 2.5 mp -130.18 132.99 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 73.45 111.108 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CE2' HD13 ' A' ' 33' ' ' LEU . 13.2 m-85 -101.34 143.91 30.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.86 147.22 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.52 110.837 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.15 150.62 49.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.02 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.93 128.47 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.884 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.31 162.69 29.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.55 111.082 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -130.12 125.09 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.85 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -89.9 172.91 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 73.53 110.9 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -71.07 -19.24 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 64.12 110.868 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -73.81 -20.25 60.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.55 110.927 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.73 -15.17 34.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 51.13 112.454 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -84.88 146.64 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 72.03 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -105.81 144.72 32.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 73.3 110.896 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.98 50.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 71.43 111.175 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.37 144.95 32.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 63.04 110.908 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.2 m -145.03 127.49 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.33 110.854 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -118.74 127.47 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 50.15 110.872 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.87 118.1 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.957 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.75 127.29 34.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 75.15 110.85 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.13 139.94 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -128.04 129.15 46.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.846 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.3 m -88.68 -175.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 65.11 111.085 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -65.28 -80.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 74.44 110.952 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -65.76 144.48 56.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.918 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.99 47.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.698 0.761 . . . . 54.13 111.116 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 71.25 112.339 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.861 0.363 . . . . 72.11 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 52.95 72.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.22 111.072 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -93.11 132.69 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.881 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.594 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.4 t30 -84.29 120.71 26.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.856 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.594 HD12 ' C ' ' A' ' 5' ' ' ASN . 2.4 mp -126.43 126.03 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.145 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -93.59 141.95 27.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.21 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.13 168.24 22.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 73.22 111.088 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.08 147.95 47.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.865 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -54.62 122.39 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 65.42 111.127 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.69 3.94 80.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.712 -0.756 . . . . 74.21 112.509 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 6.3 mm-40 -101.1 139.56 20.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 72.34 110.851 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 143.0 49.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 72.44 112.42 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 66' ' ' LEU . 17.3 tp -144.35 141.01 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 75.34 110.893 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' HD1' ' A' ' 65' ' ' PHE . 40.4 t -123.15 148.35 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 42.41 111.134 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 64' ' ' LEU . 62.4 mt -131.61 148.67 52.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 72.53 110.882 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.49 149.48 27.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 71.52 110.876 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.5 t -112.49 101.69 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 54.45 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -53.65 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.84 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 60.04 112.464 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.709 0.29 . . . . 64.24 110.963 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.38 142.36 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.891 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -126.09 143.29 51.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.919 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -141.98 142.55 32.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.32 110.915 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.69 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.2 tp -137.87 135.99 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.878 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.605 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.6 t-20 -114.99 123.33 48.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 52.35 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 27.9 p -138.87 -179.76 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.132 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.45 -126.83 8.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 33.1 112.468 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.39 -37.45 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 72.4 110.832 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 177.13 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.2 111.148 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.67 32.92 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.88 -7.79 8.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.102 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -60.14 129.6 42.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.956 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 158.57 39.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 73.5 110.874 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.63 121.02 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.077 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.33 144.46 25.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.96 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.53 45.72 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.734 0.778 . . . . 72.21 110.868 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 0.47 5.5 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.263 . . . . 74.53 112.361 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.923 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.821 0.343 . . . . 70.21 111.037 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.51 160.91 17.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.863 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.73 130.46 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 73.44 111.153 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.622 HD12 ' CB ' ' A' ' 63' ' ' SER . 45.8 mt -69.1 158.78 85.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 75.44 110.885 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.77 -22.66 31.7 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.672 2.248 . . . . 62.01 112.35 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -85.33 1.99 46.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 61.23 110.898 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.78 23.91 24.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 60.02 112.529 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.622 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.4 m -104.4 -179.0 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 64.44 110.852 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.14 130.04 44.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.906 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.2 t80 -125.45 129.68 50.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.926 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.4 mp -118.14 129.77 25.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.605 0.717 . . . . 72.3 110.884 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -32.74 18.01 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 75.03 112.421 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.27 101.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 62.05 111.088 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.0 m -73.03 119.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 73.31 111.119 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.36 160.71 32.03 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 73.23 112.501 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.32 -31.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 65.23 111.117 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -76.46 -22.07 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 65.31 110.934 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -4.75 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.908 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -59.23 142.35 52.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 71.02 110.926 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.74 -145.89 13.44 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 53.34 112.452 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.33 133.82 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 75.33 111.16 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.69 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.5 m-85 -101.37 139.24 37.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.44 110.883 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.77 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 71.44 110.872 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 149.98 50.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 71.51 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -140.22 126.5 19.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 71.55 110.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -133.07 163.12 29.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.41 111.064 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 66.7 mmm -129.41 124.64 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.86 172.52 9.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.893 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -71.23 -22.48 61.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.926 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -74.23 -20.14 60.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.863 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.92 -2.99 35.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.729 . . . . 40.31 112.568 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.7 149.07 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 73.51 110.949 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -102.87 141.77 35.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.562 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.52 123.45 47.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 60.11 111.149 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.93 141.61 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 54.33 110.877 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -147.26 125.87 12.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.935 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -119.25 125.08 48.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 73.15 110.879 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.86 119.74 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.885 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.473 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.45 131.84 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.44 110.859 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.61 137.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 75.24 111.112 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -130.35 152.93 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 72.52 110.831 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 33.0 m -113.86 -175.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 35.14 111.148 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -65.86 -78.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 53.34 110.932 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -65.83 144.78 56.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.33 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.482 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.36 159.6 49.36 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.634 0.731 . . . . 72.02 111.145 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.7 Cg_endo . . . . . 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 72.31 112.357 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.916 0.389 . . . . 51.53 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.44 80.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 75.34 111.091 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.42 138.6 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 63.14 110.918 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.43 119.92 25.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.876 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -126.26 123.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 65.14 111.159 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.1 p -93.72 140.47 29.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 72.31 111.171 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.03 165.07 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 74.22 111.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.78 149.44 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.52 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 99' ' ' GLN . 63.6 mt -59.36 120.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.41 111.114 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.17 5.48 89.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 64.02 112.516 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.69 141.5 22.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.703 0.763 . . . . 73.31 110.905 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.9 144.06 52.1 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.665 2.243 . . . . 71.32 112.343 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' ALA . 26.5 tp -144.2 143.29 30.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.25 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -121.47 147.23 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.1 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 47.3 mt -131.85 150.64 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.45 110.966 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -111.79 152.79 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 75.44 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -106.45 101.63 11.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 42.03 110.884 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -61.42 115.94 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.21 110.942 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.516 179.896 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.814 0.34 . . . . 70.53 110.877 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -120.29 148.36 43.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.868 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.576 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 3.0 m95 -127.05 134.39 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 70.14 110.965 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.585 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.16 136.41 25.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 71.44 110.912 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.775 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -141.84 140.54 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 71.14 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.87 127.95 55.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 62.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.783 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.6 p -136.75 179.32 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.0 -129.98 12.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.654 -0.784 . . . . 50.45 112.517 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -112.62 -37.75 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 74.03 110.897 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.613 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.5 t -179.44 -30.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 71.44 111.19 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.613 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.6 mt-10 -102.7 33.68 3.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 71.34 110.888 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.44 -6.54 8.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.32 111.084 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -59.23 130.29 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 73.03 110.923 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.53 153.52 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 62.22 110.88 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG22 ' HD2' ' A' ' 32' ' ' LYS . 23.5 t -100.21 120.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.1 111.138 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.655 ' CG ' HD21 ' A' ' 33' ' ' LEU . 3.5 mm? -89.9 145.13 25.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.878 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.61 163.25 39.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.656 0.741 . . . . 72.21 110.82 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.8 Cg_endo -69.76 -2.37 10.06 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 73.02 112.368 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 71.43 110.903 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 73.2 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.15 160.67 24.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 63.31 110.882 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 31.2 t -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.51 111.079 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.27 157.53 89.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 54.51 110.886 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -22.08 32.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.679 2.253 . . . . 60.5 112.395 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -83.25 0.63 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 74.54 110.894 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.7 30.71 10.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.715 -0.755 . . . . 71.01 112.432 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.6 m -113.49 179.04 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 54.41 110.896 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 20.7 tp -129.2 128.37 43.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 73.41 110.926 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -126.39 133.5 51.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 65.13 110.914 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.42 130.8 24.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 64.44 110.856 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -33.06 17.01 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.68 2.253 . . . . 61.02 112.333 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.97 100.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.11 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.5 m -73.57 114.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.1 111.136 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.77 164.25 39.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 52.2 112.568 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.68 -31.56 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.749 0.309 . . . . 71.31 111.102 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -75.72 -22.71 56.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.871 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -5.0 41.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 51.42 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -66.37 140.85 58.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.91 -137.32 5.25 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.711 -0.757 . . . . 73.45 112.456 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.447 HG23 ' ND2' ' A' ' 92' ' ' ASN . 2.1 mp -124.19 132.68 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 71.02 111.133 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.775 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -104.79 133.52 49.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.2 110.938 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -128.0 137.57 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.883 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.36 153.7 42.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 42.33 110.869 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.66 131.64 27.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 75.21 110.918 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.8 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.54 111.028 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 tpp -130.02 124.77 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.13 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.17 172.61 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.24 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -71.15 -18.44 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 72.2 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.46 -20.37 60.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 62.32 110.856 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.16 -16.4 32.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 63.21 112.487 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -85.21 146.81 26.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.686 0.279 . . . . 73.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.31 143.93 32.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.44 132.54 50.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.14 111.135 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 145.73 31.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 53.13 110.934 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -143.73 125.34 14.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 42.51 110.876 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -120.12 122.66 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 65.54 110.814 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.3 125.11 40.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.938 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -83.25 134.02 34.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 72.32 110.861 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -121.16 136.08 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.099 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.542 ' NH1' HG22 ' A' ' 100' ' ' ILE . 1.7 mmt180 -131.18 127.95 39.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 70.54 110.837 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 25.1 m -93.09 -177.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 74.3 111.178 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.6 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 65.54 110.974 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.432 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -61.62 141.83 57.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 71.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.542 HG22 ' NH1' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -121.45 159.7 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.719 . . . . 74.12 111.119 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 51.02 112.31 179.916 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.907 0.384 . . . . 74.04 110.884 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.47 94.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.084 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.81 131.16 38.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.896 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.6 p-10 -89.88 121.94 32.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.866 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.66 ' HB ' HG22 ' A' ' 95' ' ' VAL . 4.5 mp -125.96 122.42 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 54.14 111.117 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.09 136.9 35.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.187 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.57 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 147.91 43.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.878 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -52.94 121.76 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 75.32 111.11 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.702 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.93 6.93 71.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.656 -0.783 . . . . 64.35 112.45 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.763 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.7 mm-40 -101.37 139.4 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.592 0.71 . . . . 74.41 110.968 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.39 50.82 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 73.43 112.381 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 6' ' ' ILE . 39.2 tp -144.65 141.74 29.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 62.12 110.957 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.537 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.0 t -122.55 143.62 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.107 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 HD23 ' A' ' 64' ' ' LEU . 16.6 mt -132.16 148.01 52.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 72.53 110.969 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -112.98 153.13 28.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.94 101.94 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 71.25 110.852 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.77 122.93 13.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 43.01 112.423 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.722 HD13 ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.738 0.304 . . . . 70.24 110.935 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.58 149.26 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.899 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.722 ' CH2' HD13 ' A' ' 29' ' ' LEU . 26.8 m-90 -111.82 140.77 46.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.884 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -137.63 142.43 41.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.865 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 34' ' ' ASN . 1.6 tt -138.8 134.62 33.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.89 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' N ' HD23 ' A' ' 33' ' ' LEU . 13.2 t-20 -116.23 126.98 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 54.11 110.861 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.5 p -139.86 178.01 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.097 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.61 -131.65 19.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 53.44 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -37.29 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 74.51 110.862 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.593 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -178.48 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.35 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.09 33.19 2.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 74.35 110.87 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.99 -4.51 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 63.11 111.124 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -62.73 132.2 51.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 70.53 111.03 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 158.75 38.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 71.31 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.19 122.42 52.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 65.32 111.065 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.606 HD13 HD13 ' A' ' 64' ' ' LEU . 13.7 mt -88.81 143.63 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 75.3 110.942 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.27 163.17 41.83 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.695 0.759 . . . . 74.43 110.805 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.4 Cg_endo -69.71 -1.01 7.7 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 64.23 112.308 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 70.55 110.922 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.749 0.309 . . . . 62.22 111.115 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 160.68 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 61.03 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 20.6 t -109.76 128.79 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 71.22 111.179 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 63' ' ' SER . 50.6 mt -69.16 157.83 88.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.562 0.696 . . . . 52.52 110.928 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -22.72 31.58 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 73.12 112.345 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -83.01 0.25 45.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.65 29.43 10.86 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.776 -0.726 . . . . 51.25 112.483 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.499 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.68 179.85 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 52.21 110.869 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.717 HD22 ' CE2' ' A' ' 77' ' ' PHE . 8.5 tp -129.93 129.72 44.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 15' ' ' VAL . 33.2 t80 -125.34 131.2 53.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 71.01 110.814 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.752 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.33 129.42 24.89 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 75.23 110.946 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -33.01 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 65.24 112.375 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.702 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.32 102.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.44 111.101 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.9 m -72.88 116.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.32 111.063 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.7 33.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.733 -0.746 . . . . 25.4 112.48 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.844 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.97 -29.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 73.41 111.087 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -75.11 -23.37 57.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 60.43 110.912 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.06 -5.41 57.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.7 140.33 58.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.906 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 -135.37 4.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 54.21 112.472 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.4 135.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 64.34 111.093 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.717 ' CE2' HD22 ' A' ' 64' ' ' LEU . 26.7 t80 -101.71 138.5 38.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.906 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -138.83 128.12 24.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.899 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.3 t -125.26 157.33 36.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 63.14 110.831 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -138.0 140.08 39.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.891 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.09 162.71 30.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.082 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ttm -129.56 124.99 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.864 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -90.88 172.81 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.894 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -71.1 -18.77 62.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.81 -20.33 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 60.34 110.946 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.58 35.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -85.06 146.04 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 61.24 110.877 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.51 143.26 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.52 110.864 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -105.72 130.4 53.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 51.03 111.173 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -107.1 145.69 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.957 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 124.55 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 71.25 110.847 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.5 128.79 52.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 73.24 110.912 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -131.19 122.23 26.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.35 110.906 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.34 124.5 30.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 70.13 110.872 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 6' ' ' ILE . 74.1 t -118.7 139.45 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.126 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 129.05 42.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 65.21 110.919 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.844 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 m -88.41 -175.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.168 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.32 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 72.22 110.92 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.31 142.35 57.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 73.03 110.9 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.35 159.75 48.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 72.21 111.161 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 72.54 112.277 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.916 0.388 . . . . 72.14 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.39 71.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 74.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.06 139.39 30.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 61.15 110.849 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.4 m-80 -82.4 121.09 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 75.22 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mm -125.11 122.05 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.201 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.64 142.13 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.3 111.11 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -146.96 166.25 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 63.3 111.116 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.96 148.57 48.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 60.24 110.866 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.29 121.25 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 72.3 111.198 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.0 5.01 90.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.532 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.96 141.87 23.5 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 61.43 110.892 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.87 52.36 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.783 2.322 . . . . 63.22 112.284 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 8' ' ' ALA . 65.2 tp -144.6 143.16 30.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 63.4 110.881 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.8 t -121.13 146.73 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 75.3 111.172 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.58 HD12 HD23 ' A' ' 64' ' ' LEU . 98.3 mt -131.48 149.94 52.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.953 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -111.91 150.55 30.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 62.23 110.872 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.9 t -108.73 101.2 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -57.1 124.99 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 51.11 110.913 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 71.32 112.497 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.03 0 CA-C-O 120.8 0.334 . . . . 71.24 110.92 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.62 148.58 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.887 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.654 ' HE1' HD13 ' A' ' 29' ' ' LEU . 28.6 m95 -122.79 137.03 55.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 73.25 110.969 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 139.79 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 72.04 110.874 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 34' ' ' ASN . 9.1 tp -137.99 136.08 36.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 75.41 110.889 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.7 m-80 -114.63 127.43 55.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.899 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -138.85 176.79 8.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.42 -130.81 16.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 73.0 112.445 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.53 -37.35 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 73.21 110.873 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -178.76 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.33 111.18 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.605 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.8 mt-10 -101.99 32.8 3.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 70.33 110.931 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.79 -5.88 6.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.503 . . . . 71.23 111.115 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -59.4 132.27 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 73.45 110.893 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.51 153.33 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.871 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.0 t -100.17 122.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.195 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD13 HD13 ' A' ' 64' ' ' LEU . 20.4 mt -89.29 143.6 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 62.51 110.884 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.33 42.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 71.11 110.9 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -1.76 9.08 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 61.32 112.294 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.931 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.782 0.325 . . . . 63.43 111.113 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -113.35 160.58 18.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 63.42 110.836 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 t -109.54 129.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 53.31 111.154 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.6 mt -68.55 158.51 85.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.678 . . . . 73.44 110.942 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.88 32.91 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.712 2.275 . . . . 72.23 112.387 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.32 1.33 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 70.44 110.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.77 9.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.726 . . . . 71.13 112.531 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.563 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.2 m -112.22 -179.66 3.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 73.51 110.901 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 26.9 tp -128.9 128.27 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 53.14 110.857 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 15' ' ' VAL . 31.1 t80 -126.22 136.93 53.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 74.31 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -114.61 132.22 22.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.646 0.736 . . . . 64.21 110.871 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.8 15.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 74.11 112.272 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.19 100.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.29 -0.414 . . . . 62.11 111.17 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -74.13 112.98 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.23 111.129 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.97 163.08 37.71 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 71.32 112.47 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.875 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.86 -30.74 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.745 0.307 . . . . 64.02 111.146 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.15 -22.72 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.972 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -5.05 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.917 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -61.95 142.08 57.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 63.41 110.905 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.95 -142.88 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 62.31 112.476 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.445 HG23 ' ND2' ' A' ' 92' ' ' ASN . 3.5 mt -123.95 133.22 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.34 111.108 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 16' ' ' LEU . 7.0 t80 -104.75 140.14 38.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 64.52 110.849 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -135.23 142.39 45.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 55.12 110.868 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 155.81 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.862 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -140.7 129.28 22.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 53.1 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 162.19 31.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.115 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 ttm -130.65 125.08 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 63.53 110.889 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -89.59 172.28 9.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.865 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -71.68 -18.52 62.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.5 110.812 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -20.01 60.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.54 31.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 71.44 112.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -84.98 146.83 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 51.02 110.936 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.09 143.87 32.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 61.3 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 126.64 51.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 42.24 111.171 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 145.11 32.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 62.23 110.83 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -144.58 124.52 13.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.852 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -118.88 121.45 40.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 43.22 110.827 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -128.89 120.42 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 63.31 110.957 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.75 134.28 34.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.914 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.29 139.36 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 75.42 111.172 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -129.14 148.44 51.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.851 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.875 HG21 ' HA ' ' A' ' 71' ' ' ILE . 34.6 m -112.67 -177.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 63.12 111.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -66.35 -81.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.933 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -59.24 146.25 39.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.907 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.41 159.7 49.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.611 0.72 . . . . 74.43 111.154 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 74.44 112.345 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.885 0.374 . . . . 74.25 110.79 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.39 96.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 73.1 111.058 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.85 133.79 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.896 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.421 ' C ' HD12 ' A' ' 6' ' ' ILE . 4.5 p30 -84.29 119.62 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 62.32 110.862 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.0 mp -126.52 123.54 63.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 62.11 111.096 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -94.78 140.83 29.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 71.0 111.116 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.72 167.27 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 73.45 111.113 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -124.25 148.32 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.22 110.909 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 71' ' ' ILE . 24.9 mt -53.83 121.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.23 111.125 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.65 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.72 3.97 79.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 53.03 112.45 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 14.9 mm-40 -101.1 140.33 21.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.11 110.867 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 142.28 47.59 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.676 2.251 . . . . 55.23 112.339 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 6' ' ' ILE . 23.0 tp -144.43 141.97 29.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 72.32 110.912 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 65' ' ' PHE . 41.8 t -123.34 147.97 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.116 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.835 HD12 HD23 ' A' ' 64' ' ' LEU . 94.4 mt -131.5 148.6 52.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 72.52 110.983 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -110.49 149.0 30.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.45 110.923 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 101.19 9.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 62.43 110.85 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.19 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 62.51 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.725 -0.75 . . . . 65.14 112.497 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.777 0.322 . . . . 73.54 110.928 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.13 148.62 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 54.05 110.861 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.647 ' HE3' HD21 ' A' ' 33' ' ' LEU . 5.0 m95 -127.67 132.76 49.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.856 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.7 mtmt -137.6 135.41 36.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 75.11 110.871 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.082 HD11 HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -139.93 138.84 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.881 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -112.95 127.63 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 74.23 110.848 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.1 p -137.22 179.77 6.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.149 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 -127.71 13.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 74.52 112.48 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 38' ' ' THR . 2.8 tpt180 -114.33 -37.49 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 74.13 110.823 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -179.09 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 61.14 111.158 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -99.98 32.91 2.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.895 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.76 -6.24 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 42.12 111.139 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -60.71 131.25 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 73.52 110.93 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 158.77 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.35 110.877 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.06 118.73 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.082 HD12 HD11 ' A' ' 33' ' ' LEU . 1.5 mt -90.25 145.78 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.954 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.03 162.74 43.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 63.44 110.881 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 0.16 6.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.237 . . . . 60.22 112.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.805 0.336 . . . . 71.22 111.112 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 162.06 23.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 72.03 110.881 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.27 130.15 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.12 111.18 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.4 mt -69.54 158.86 85.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 73.21 110.869 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -23.41 30.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 61.11 112.37 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -83.79 0.48 47.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 62.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.2 25.24 19.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 54.14 112.497 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.582 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -105.84 -179.43 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 61.13 110.911 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.835 HD23 HD12 ' A' ' 16' ' ' LEU . 13.7 tp -130.03 129.97 44.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 63.45 110.931 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 15' ' ' VAL . 36.9 t80 -125.37 128.83 48.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 73.25 110.817 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.2 mp -120.26 130.02 25.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.647 0.737 . . . . 63.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.36 18.95 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 73.33 112.343 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.65 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.24 101.71 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 63.44 111.057 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -73.09 119.33 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 72.44 111.124 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.03 161.91 33.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 62.2 112.533 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.755 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.59 -31.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.779 0.323 . . . . 74.44 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -75.05 -23.16 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.12 110.843 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.44 -5.48 45.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 70.12 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 140.48 58.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.868 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.36 -141.72 8.19 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 62.4 112.547 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.453 HG21 HD22 ' A' ' 92' ' ' ASN . 1.3 mp -123.5 133.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 51.13 111.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 10.7 m-85 -104.48 139.95 38.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 65.32 110.876 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HG2' ' ND2' ' A' ' 92' ' ' ASN . 9.8 mtt180 -135.41 142.01 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 75.3 110.882 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 41.8 t -128.91 150.43 50.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.3 126.75 21.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 71.41 110.925 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.97 163.06 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 34.32 111.124 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.7 ttm -129.35 125.02 35.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 62.04 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.25 172.55 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 62.12 110.905 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -70.96 -18.54 62.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 65.12 110.839 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -73.83 -25.83 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 75.54 110.85 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.78 -14.24 19.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 42.11 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.35 147.88 26.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.717 0.294 . . . . 72.33 110.882 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.12 142.49 34.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 65.11 110.911 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.69 126.29 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.137 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 144.2 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.901 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.1 m -146.9 126.7 13.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.04 110.91 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.453 HD22 HG21 ' A' ' 76' ' ' ILE . 16.0 t-20 -119.22 126.91 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.919 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 16' ' ' LEU . 8.3 m-85 -124.1 120.96 33.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 65.25 110.974 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NE ' ' HB1' ' A' ' 3' ' ' ALA . 20.1 mmt85 -83.53 130.07 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.12 110.799 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.02 134.2 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 74.21 111.121 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.454 ' NH1' HG21 ' A' ' 100' ' ' ILE . 0.8 OUTLIER -131.45 127.92 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.5 m -95.66 -177.67 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 60.35 111.068 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -66.76 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.898 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -62.48 143.83 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 73.11 110.882 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -121.37 159.72 48.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 63.51 111.124 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.23 112.311 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.896 0.379 . . . . 71.54 110.886 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.32 93.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.53 111.09 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.436 ' OE1' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -93.39 131.46 38.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 74.34 110.925 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.672 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.8 m120 -88.34 120.54 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 52.43 110.881 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.672 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.87 128.37 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 62.32 111.112 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -89.3 141.09 28.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 72.01 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.13 165.95 26.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 71.22 111.134 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 150.06 43.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.829 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 22.7 mt -68.76 120.61 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.75 -6.34 60.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 73.12 112.49 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 pp20? -102.09 141.09 21.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.41 110.842 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 145.69 58.03 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.43 112.347 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 tp -137.95 143.07 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 72.25 110.914 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 65' ' ' PHE . 39.1 t -122.09 145.0 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.31 111.133 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 30.4 mt -131.3 149.48 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.16 152.75 27.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 72.11 110.972 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -106.31 101.78 11.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.861 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -58.76 120.38 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 61.55 110.864 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 60.33 112.451 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.484 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.777 0.322 . . . . 64.11 110.931 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.6 144.81 47.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 52.32 110.96 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.484 ' HE1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -126.22 136.88 53.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.156 -0.474 . . . . 65.25 110.948 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -144.36 136.4 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 53.25 110.82 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.5 tp -138.95 136.81 35.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 73.44 110.887 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.627 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -113.45 127.13 56.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.868 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.793 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.6 p -137.99 179.39 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 74.45 111.108 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.39 -131.18 16.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 73.12 112.528 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.5 -37.29 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 63.43 110.89 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -179.4 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 75.21 111.133 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.09 33.32 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 74.11 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.61 -7.21 7.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 63.43 111.101 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -60.36 130.59 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 153.46 47.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 73.34 110.846 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.04 121.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 55.24 111.101 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.82 145.84 24.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 61.35 110.946 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.56 163.13 40.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.723 . . . . 74.05 110.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.77 2.82 3.19 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.675 2.25 . . . . 51.2 112.366 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 61.5 110.914 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.784 0.326 . . . . 44.41 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -132.54 160.18 37.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 74.33 110.9 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 46' ' ' PRO . 7.0 t -109.0 129.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 71.1 111.113 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 36.0 mt -70.28 158.82 86.65 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 52.45 110.934 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -21.87 33.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 63.51 112.339 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -83.16 1.83 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 72.14 110.884 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.21 29.69 14.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 64.43 112.472 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.8 m -113.9 -178.9 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 44.21 110.88 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 23.8 tp -129.47 127.62 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.901 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 15' ' ' VAL . 6.5 t80 -125.9 136.05 52.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 65.44 110.879 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.62 HD22 HG12 ' A' ' 69' ' ' VAL . 7.7 mp -119.29 130.22 24.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.636 0.732 . . . . 63.5 110.895 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.93 17.37 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.28 . . . . 61.01 112.308 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.77 102.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 74.01 111.105 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 12' ' ' GLU . 18.5 m -72.74 119.2 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.45 111.039 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.16 161.55 27.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 70.1 112.53 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.15 -32.26 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 72.55 111.079 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -76.01 -22.51 55.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 72.05 110.918 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -4.98 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 71.33 110.84 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.32 141.3 57.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 70.44 110.913 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.08 -138.95 5.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.743 . . . . 54.41 112.48 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.412 HG23 HD21 ' A' ' 92' ' ' ASN . 2.4 mp -123.95 130.35 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 61.15 111.132 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.552 ' CG ' HD13 ' A' ' 16' ' ' LEU . 10.8 t80 -105.49 134.17 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.84 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.56 139.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 74.53 110.817 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.5 t -125.5 156.3 39.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 53.43 110.896 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -140.75 134.67 30.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.14 110.908 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 162.36 32.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.143 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.8 mtp -130.16 125.24 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.908 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -91.51 172.43 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.827 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -18.87 62.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.51 110.864 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -73.94 -20.43 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.907 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.99 -15.33 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 55.43 112.414 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 146.18 27.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 70.32 110.88 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -106.16 143.63 34.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.87 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 129.46 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 70.12 111.16 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 145.11 35.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.858 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.21 121.53 10.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 53.13 110.9 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.412 HD21 HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -118.37 124.37 47.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 73.14 110.832 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -129.82 117.93 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 73.42 110.827 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -84.24 130.6 34.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.873 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.08 140.32 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 73.2 111.118 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.23 127.73 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.7 m -88.69 -176.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.04 111.107 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.6 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.937 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 140.74 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.885 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.71 159.63 50.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.654 0.74 . . . . 74.44 111.074 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.68 2.254 . . . . 74.04 112.274 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.826 0.346 . . . . 40.41 110.856 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.33 66.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 62.44 111.108 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.57 133.55 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 73.05 110.934 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -84.01 121.03 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 70.31 110.888 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 14' ' ' LEU . 43.6 mm -125.4 121.78 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.44 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.98 138.77 33.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.45 . . . . 74.11 111.093 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 166.88 26.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.122 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -120.93 148.35 44.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.841 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mt -52.61 121.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 61.42 111.058 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.73 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.61 7.19 72.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 51.02 112.515 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.767 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.7 mm-40 -101.37 139.43 20.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 52.13 110.939 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 143.15 49.62 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 75.42 112.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 6' ' ' ILE . 19.1 tp -145.44 142.04 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 73.41 110.859 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.13 148.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 65.22 111.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.781 HD12 HD23 ' A' ' 64' ' ' LEU . 9.2 mt -131.14 147.21 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.906 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -113.26 154.89 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.902 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 t -104.06 100.57 10.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 74.45 110.893 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.64 116.56 4.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 61.44 110.901 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.786 -0.721 . . . . 73.25 112.504 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.788 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.767 0.318 . . . . 64.14 110.932 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -145.55 148.54 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.855 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.788 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 29.0 m-90 -120.64 132.07 54.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 72.53 110.897 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' HD23 ' A' ' 33' ' ' LEU . 2.1 ttpt -139.97 135.9 33.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.952 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -148.1 140.05 24.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 74.52 110.945 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.95 128.74 55.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 44.31 110.927 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -136.33 -179.73 5.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 72.25 111.166 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.68 -129.14 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 72.33 112.549 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.51 -37.45 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 65.44 110.906 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.4 t -179.32 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.156 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.8 mt-10 -102.26 33.93 2.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 74.15 110.841 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.63 -6.32 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.54 111.148 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.73 130.2 45.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.942 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.619 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -130.8 152.97 49.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 75.33 110.882 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.85 120.66 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.31 111.189 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 33' ' ' LEU . 3.3 mm? -89.88 146.71 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.44 46.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 64.51 110.93 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.73 -1.92 9.26 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 73.11 112.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 63.2 110.974 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.796 0.331 . . . . 55.41 111.137 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.64 161.18 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.11 110.937 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 44' ' ' LEU . 24.9 t -109.0 129.93 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.11 111.042 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.45 158.98 86.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.7 . . . . 71.33 110.899 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -20.98 33.91 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.608 2.205 . . . . 71.24 112.294 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -83.12 1.59 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 74.34 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.39 25.17 26.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 61.03 112.505 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -110.84 -178.72 3.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.22 110.823 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' CE2' ' A' ' 77' ' ' PHE . 10.7 tp -129.72 127.57 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.917 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -126.12 132.51 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.904 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 69' ' ' VAL . 4.8 mp -118.54 129.61 25.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.663 0.744 . . . . 74.2 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.74 17.86 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.739 2.293 . . . . 65.45 112.313 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.73 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.76 101.29 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 25.51 111.044 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 66' ' ' LEU . 12.2 m -73.35 116.71 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 70.21 111.1 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.4 165.35 33.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 74.23 112.512 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.85 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.78 -30.17 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 72.44 111.111 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.853 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -5.0 56.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 64.32 110.821 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.69 140.94 58.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.76 -141.56 7.87 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 31.52 112.528 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD12 ' CG ' ' A' ' 94' ' ' ARG . 47.1 mm -124.41 127.72 73.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 63.32 111.115 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.787 ' CE2' HD22 ' A' ' 64' ' ' LEU . 11.2 t80 -104.66 134.18 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.22 110.897 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -127.92 146.5 50.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 72.33 110.837 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.4 t -126.25 153.87 44.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.922 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.04 130.82 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 71.11 110.887 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.55 162.58 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 65.12 111.105 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.4 ttm -130.32 125.01 33.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.919 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -89.14 172.23 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.42 110.836 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.53 -18.61 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 72.42 110.853 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -73.57 -20.23 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.21 110.829 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.91 -17.44 29.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 64.1 112.49 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -84.81 147.9 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 71.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -104.01 149.18 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.875 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.478 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.14 133.5 48.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.131 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 143.41 33.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 53.13 110.921 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.5 m -145.23 122.74 11.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 61.3 110.831 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.66 124.36 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 73.04 110.925 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -128.37 119.83 25.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 55.23 110.89 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.576 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.9 132.15 34.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 73.11 110.823 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.88 136.26 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 73.54 111.118 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.432 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -131.12 131.58 44.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.849 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.8 m -95.87 -175.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 54.41 111.171 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -66.39 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.23 110.867 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -62.85 146.33 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 75.34 110.943 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.56 49.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.688 0.756 . . . . 63.25 111.081 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 54.33 112.329 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.949 0.404 . . . . 73.13 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.9 71.11 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.059 -0.519 . . . . 55.21 111.082 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 133.28 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.946 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.45 119.13 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 60.44 110.887 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 14' ' ' LEU . 3.8 mp -126.44 124.64 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.136 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -93.51 142.25 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 55.2 111.115 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.43 166.57 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.32 111.029 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.61 148.28 46.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 62.32 110.92 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mt -54.9 121.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 42.34 111.173 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.41 76.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 72.52 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.9 mm-40 -101.91 140.7 21.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.689 0.757 . . . . 74.13 110.899 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 144.03 52.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.664 2.242 . . . . 64.11 112.331 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 6' ' ' ILE . 22.3 tp -143.54 141.31 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 75.01 110.907 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.0 t -122.44 147.19 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 62.54 111.131 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 53.4 mt -130.97 148.28 52.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.899 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -112.07 151.82 28.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.807 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 t -107.18 100.76 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.853 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.1 120.22 8.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.892 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 62.3 112.515 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.68 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.707 0.289 . . . . 62.43 110.951 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -121.51 148.62 44.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 60.14 110.878 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.68 ' HE1' HD13 ' A' ' 29' ' ' LEU . 23.5 m95 -123.11 138.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.876 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.711 ' C ' HD13 ' A' ' 33' ' ' LEU . 89.0 mttt -150.97 135.76 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.24 110.94 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.25 145.94 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.889 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.99 129.43 56.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.943 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.842 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -138.42 -179.58 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 54.24 111.157 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.89 -132.78 16.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 71.22 112.53 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.79 -37.69 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 73.22 110.882 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -179.12 -29.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.098 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.53 34.81 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.874 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.09 -4.23 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.21 111.06 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -57.32 128.05 35.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.725 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.16 156.64 47.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 74.03 110.873 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' LYS . 94.7 t -105.5 122.24 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 73.21 111.125 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 33' ' ' LEU . 4.0 mt -89.91 147.14 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 61.31 110.864 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.77 162.21 46.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.73 0.776 . . . . 54.51 110.846 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.81 -2.62 10.52 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.687 2.258 . . . . 64.31 112.319 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.899 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.811 0.339 . . . . 72.1 111.137 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 162.8 25.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.916 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 46' ' ' PRO . 8.1 t -106.75 130.95 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 75.4 111.167 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.55 HD12 ' CB ' ' A' ' 63' ' ' SER . 31.1 mt -68.7 157.69 87.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 74.32 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -22.16 32.65 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.669 2.246 . . . . 63.34 112.365 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.7 1.2 43.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.46 29.83 11.65 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 21.12 112.438 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.55 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -112.86 -179.6 3.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 64.12 110.87 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 16.3 tp -129.51 129.24 44.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.32 110.873 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' HG22 ' A' ' 15' ' ' VAL . 44.8 t80 -124.63 136.72 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.21 110.881 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.574 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -116.41 124.79 29.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.35 110.913 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.71 19.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 73.42 112.375 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.49 103.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.076 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 12' ' ' GLU . 34.4 m -71.62 118.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 72.43 111.124 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.58 157.44 23.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 75.5 112.506 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.831 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -32.02 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 72.45 111.127 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -75.6 -23.4 56.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -5.26 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 52.43 110.823 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 142.01 56.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 52.44 110.918 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.22 -138.17 5.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.798 -0.715 . . . . 74.02 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.68 127.32 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 71.04 111.195 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 14.6 m-85 -104.78 144.49 31.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 63.25 110.853 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -138.27 143.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 71.34 110.865 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.8 t -127.21 155.66 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.31 110.891 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.14 133.8 30.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.926 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.5 162.71 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 51.54 111.089 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 mtp -129.94 125.12 34.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.11 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -91.39 172.51 8.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 41.42 110.876 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.45 -18.81 62.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 74.14 110.852 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.06 -20.57 60.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.872 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.02 -15.21 33.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.83 -0.7 . . . . 45.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -85.02 146.35 27.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.742 0.306 . . . . 74.43 110.893 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 144.26 33.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.89 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 132.15 50.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 65.31 111.189 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 145.14 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.937 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -145.34 127.9 16.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.01 110.825 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -116.97 124.93 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 74.23 110.849 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -125.41 121.6 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 72.2 110.944 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -83.07 133.03 35.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.31 110.874 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -120.95 134.82 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 71.11 111.219 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 128.79 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.872 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.8 m -98.33 -177.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 73.4 111.198 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.55 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.954 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.89 144.53 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 72.3 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.4 159.61 49.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 74.15 111.125 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.9 Cg_endo . . . . . 0 C--N 1.34 0.117 0 C-N-CA 122.686 2.258 . . . . 64.03 112.319 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.81 0.338 . . . . 70.13 110.894 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.69 66.91 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 43.22 111.084 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -93.23 131.94 37.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.41 110.916 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.3 p-10 -90.83 121.85 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.887 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.58 127.42 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.137 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -94.52 142.52 27.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 61.42 111.179 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.35 168.44 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 64.3 111.061 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.43 148.06 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.596 HD11 HG13 ' A' ' 71' ' ' ILE . 33.8 mt -67.28 121.99 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.06 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.17 -9.96 54.58 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.675 -0.774 . . . . 74.41 112.429 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.71 142.66 25.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.723 . . . . 72.45 110.862 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 145.07 56.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 63.24 112.334 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.0 tp -139.71 144.44 37.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 74.4 110.909 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.608 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.9 t -120.46 145.03 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 63.44 111.104 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.3 mt -131.28 147.78 52.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.41 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -113.62 150.87 32.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 61.14 110.924 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.11 100.26 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 72.14 110.894 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -54.27 128.41 31.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.02 110.939 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.727 . . . . 74.35 112.472 179.905 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.526 0.041 0 CA-C-O 120.81 0.338 . . . . 60.52 110.888 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.71 148.44 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 63.34 110.895 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.782 ' CZ3' HG11 ' A' ' 58' ' ' VAL . 3.3 m-90 -134.47 144.11 47.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 64.14 110.982 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.452 ' C ' HD23 ' A' ' 33' ' ' LEU . 4.4 mtmt -136.21 142.05 44.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.24 110.924 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.003 HD21 HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.4 139.03 42.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 73.1 110.936 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -112.12 127.29 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.33 110.901 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 43.7 p -138.16 -179.8 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 71.21 111.141 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.44 -129.97 23.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.852 -0.689 . . . . 74.33 112.435 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -112.61 -37.4 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 73.42 110.897 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.1 t -178.69 -29.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 65.31 111.174 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -101.73 34.07 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 74.5 110.887 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -5.54 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.123 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.544 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 44.0 t90 -59.62 131.82 52.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 70.01 110.929 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.768 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.03 155.07 45.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.935 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.544 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 23.1 t -104.48 121.75 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 70.55 111.137 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.003 HD13 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -88.86 143.13 27.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.41 110.911 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -127.93 164.09 39.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 65.35 110.808 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 0.85 5.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.707 2.271 . . . . 63.1 112.277 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 74.04 110.899 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.819 0.342 . . . . 71.25 111.116 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.52 160.2 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.85 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG11 ' CZ3' ' A' ' 31' ' ' TRP . 65.7 t -111.9 129.25 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.158 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 63' ' ' SER . 86.4 mt -69.29 157.19 90.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 74.02 110.929 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.41 34.81 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.75 2.3 . . . . 73.42 112.278 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -82.41 0.57 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 63.42 110.863 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 27.39 17.37 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 54.34 112.443 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 59' ' ' LEU . 30.4 m -111.77 175.73 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.852 0.358 . . . . 50.44 110.896 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.843 HD13 HD21 ' A' ' 44' ' ' LEU . 16.5 tp -129.34 130.11 45.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.865 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.608 ' CD2' HG22 ' A' ' 15' ' ' VAL . 27.7 t80 -124.42 135.39 53.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 62.41 110.852 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.504 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.56 129.51 24.87 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 72.05 110.917 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.62 -31.68 20.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.285 . . . . 73.23 112.414 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.55 104.36 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 61.1 111.145 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.4 m -71.83 119.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 40.23 111.163 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.93 153.49 20.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 31.05 112.447 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.02 -31.18 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 54.45 111.151 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.28 -22.01 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 61.14 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.35 -3.53 34.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.839 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.785 ' CD ' HG22 ' A' ' 97' ' ' VAL . 16.8 mt-10 -58.43 142.17 49.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.1 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.46 -151.74 22.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 73.52 112.561 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.29 133.98 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 64.3 111.107 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.75 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.3 m-85 -103.04 139.38 38.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.87 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.52 141.04 51.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 m -126.82 150.24 49.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 73.13 110.891 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.07 125.51 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.881 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.43 163.97 28.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 64.15 111.091 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.8 ttm -128.34 124.88 37.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.907 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -86.91 173.15 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 73.22 110.871 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -70.22 -17.97 63.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.87 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -73.23 -19.74 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 63.25 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.36 -18.78 32.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 71.15 112.43 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -85.16 148.2 26.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 75.31 110.916 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.5 143.61 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 64.05 110.895 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.55 131.6 51.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 54.04 111.127 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 145.34 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.43 110.93 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -146.32 124.41 12.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 72.11 110.846 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -118.82 124.6 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.24 117.02 20.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.927 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -90.9 136.11 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.928 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.18 138.57 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 54.2 111.134 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.21 128.14 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 70.05 110.855 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -92.2 -175.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.24 111.11 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -65.98 -80.62 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -58.67 146.67 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 61.04 110.847 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.31 159.49 49.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.693 0.759 . . . . 74.14 111.132 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 72.2 112.368 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.835 0.35 . . . . 52.32 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.47 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 72.02 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -93.44 132.42 37.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.863 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.668 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.0 p30 -87.13 119.96 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.898 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.668 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -127.78 127.47 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.117 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -92.11 141.88 28.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 71.42 111.102 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.54 167.58 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.45 111.073 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.78 149.68 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.5 110.885 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 71' ' ' ILE . 22.5 mt -67.47 120.7 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.122 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.69 -8.29 59.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.691 -0.766 . . . . 61.22 112.468 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.08 140.81 21.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.701 . . . . 64.42 110.911 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 145.11 55.98 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.704 2.269 . . . . 74.54 112.33 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 66' ' ' LEU . 20.2 tp -142.35 143.4 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 71.44 110.917 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 64' ' ' LEU . 13.7 t -122.49 148.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 74.24 111.146 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 64' ' ' LEU . 29.6 mt -129.85 149.1 51.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 74.4 110.934 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -108.8 149.56 28.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 61.33 110.878 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.3 t -112.12 100.69 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 72.32 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.12 100.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 52.32 110.842 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.799 -0.715 . . . . 63.3 112.51 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.805 0.336 . . . . 72.52 110.937 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 148.33 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 72.55 110.912 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -127.59 137.92 52.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.923 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -135.72 138.57 42.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 73.25 110.957 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 35' ' ' THR . 1.2 tm? -137.3 131.53 32.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.948 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.738 ' N ' HD22 ' A' ' 33' ' ' LEU . 10.4 t-20 -116.53 120.68 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 45.25 110.939 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.81 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 54.8 p -138.36 179.39 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 71.55 111.191 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.61 -132.16 12.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 43.13 112.462 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 75.04 110.83 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.67 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 63.2 111.141 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.19 33.73 2.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.917 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.35 -6.01 7.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 74.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -69.24 130.59 43.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 63.31 110.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 159.32 42.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 74.41 110.875 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.73 121.48 43.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.071 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -89.63 146.12 24.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.05 110.94 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.96 162.7 43.99 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.614 0.721 . . . . 72.11 110.852 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 0.51 5.48 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.743 2.295 . . . . 75.33 112.335 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.899 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.829 0.347 . . . . 64.21 111.101 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -112.01 161.04 16.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.11 110.932 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.36 128.16 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 55.12 111.139 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 63' ' ' SER . 26.3 mt -69.05 157.32 89.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.596 0.712 . . . . 72.11 110.925 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.3 Cg_endo -69.63 -22.96 31.95 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.638 2.225 . . . . 51.43 112.363 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -83.45 1.12 43.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 71.24 110.86 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.13 13.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 65.34 112.455 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.534 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m -109.67 177.19 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 53.32 110.79 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.4 tp -130.28 129.34 43.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 73.11 110.908 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 t80 -124.16 129.43 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.859 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 14' ' ' LEU . 1.9 mp -117.29 131.22 24.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 72.24 110.892 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -32.22 18.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 75.52 112.274 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 100.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.31 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.9 m -76.16 119.88 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.04 111.143 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -91.6 166.92 30.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.508 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.851 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.6 -30.83 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 74.44 111.156 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -74.8 -21.25 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 65.31 110.858 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.32 -3.08 31.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 65.2 110.804 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 139.71 58.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 61.24 110.869 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.98 -147.23 14.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.745 . . . . 52.54 112.516 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.91 133.78 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 63.23 111.118 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.583 ' CG ' HD23 ' A' ' 33' ' ' LEU . 36.9 m-85 -104.94 128.29 53.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 62.01 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.13 138.13 53.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 156.67 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 72.11 110.913 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -141.26 127.92 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 71.42 110.929 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.21 162.95 29.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.139 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.01 124.43 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 73.11 110.905 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -88.65 172.52 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.899 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -71.09 -18.39 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.05 110.823 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -73.62 -19.77 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 73.14 110.915 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.78 -16.88 33.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 35.02 112.417 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -84.96 147.61 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 63.43 110.937 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.31 143.79 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.46 125.6 50.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 54.24 111.15 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 144.76 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.21 110.888 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -145.55 121.27 10.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.834 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 123.54 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 72.32 110.92 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -129.16 118.27 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 64.21 110.877 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.58 132.38 33.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.15 110.86 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.79 139.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 71.34 111.134 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 127.94 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.892 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.0 m -91.83 -177.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 70.34 111.138 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.51 110.943 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.1 142.52 51.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.93 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.29 159.59 49.27 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.555 0.693 . . . . 73.13 111.159 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.188 0 C-N-CA 122.666 2.244 . . . . 73.24 112.338 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.7 p-10 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.816 0.341 . . . . 74.03 110.911 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.893 0.378 . . . . 74.43 111.073 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo . . . . . 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.501 -0.24 . . . . 45.03 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.69 107.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.388 . . . . 73.11 110.898 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.32 71.67 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 43.2 111.094 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -93.11 135.6 34.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.939 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.37 120.97 27.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.859 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 14' ' ' LEU . 41.2 mm -125.95 121.94 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.45 111.15 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.83 138.62 33.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.142 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.33 166.98 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 73.22 111.118 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.06 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 65.25 110.849 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.98 121.64 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 51.53 111.117 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.27 3.96 78.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.513 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.758 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.6 mm-40 -101.43 139.76 20.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 74.32 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.38 50.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 45.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.647 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.7 tp -144.57 142.15 29.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 63.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.1 t -122.87 146.9 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 74.51 111.163 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 93' ' ' TYR . 56.1 mt -132.22 148.37 52.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.897 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -112.04 148.88 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.21 110.908 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.12 100.82 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.832 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.37 102.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 65.12 110.92 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 149.48 -46.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.33 112.483 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -96.15 102.24 10.38 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.541 0.686 . . . . 64.21 111.099 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.2 Cg_endo -69.75 -162.96 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.689 2.259 . . . . 71.24 112.363 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.46 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.54 110.911 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -45.92 168.68 0.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.627 0.727 . . . . 62.25 110.91 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.7 Cg_endo -69.73 172.93 11.7 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 73.02 112.351 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.9 Cg_endo -69.75 97.25 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.688 2.259 . . . . 53.03 112.354 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.28 -174.29 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 61.33 110.934 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 ttm-85 -63.15 132.77 52.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.04 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp -177.47 162.16 1.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.903 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.31 146.77 46.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 62.32 110.873 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CH2' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.2 132.36 48.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 65.3 110.949 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -135.55 142.62 45.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 35' ' ' THR . 4.0 tp -138.42 134.41 34.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 63.44 110.933 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' N ' HD12 ' A' ' 33' ' ' LEU . 7.3 t30 -115.16 121.92 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.874 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.2 p -138.3 176.27 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 73.23 111.118 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.26 -131.15 13.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 32.22 112.51 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.66 -37.75 4.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 54.42 110.856 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.31 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 63.43 111.172 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 38' ' ' THR . 53.7 mt-10 -102.25 33.26 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.42 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.22 -6.74 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.169 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -61.92 131.32 49.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.53 110.934 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.45 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.903 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.2 t -100.62 120.66 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.33 111.151 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 31' ' ' TRP . 3.7 mm? -95.56 146.95 24.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 74.04 110.961 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.32 163.46 36.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 71.14 110.877 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.79 0.48 5.61 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.661 2.241 . . . . 74.43 112.32 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -118.8 71.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.931 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.24 3.11 79.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 61.11 112.479 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 106.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 64.1 112.494 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.07 -72.76 0.46 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.729 -0.748 . . . . 50.2 112.504 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -0.14 6.46 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 70.24 112.359 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.456 ' HB2' ' HG3' ' A' ' 57' ' ' ARG . 17.8 p-90 -51.65 -35.1 40.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.945 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -69.59 -25.16 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 62.12 110.913 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -42.96 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.883 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.27 -97.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.21 111.118 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . -158.63 173.63 16.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 54.43 111.089 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -124.48 164.83 18.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.877 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 18.5 t -107.66 132.01 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.114 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 63' ' ' SER . 39.7 mt -68.63 158.76 84.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 74.2 110.896 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -25.11 28.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 74.13 112.313 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -83.57 2.06 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 72.14 110.905 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.33 32.46 8.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.12 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.717 ' HB3' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -111.78 -179.53 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 74.21 110.851 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.645 HD22 ' CH2' ' A' ' 31' ' ' TRP . 17.0 tp -130.47 129.59 43.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.965 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 15' ' ' VAL . 24.8 t80 -124.37 129.62 51.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.05 110.859 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.814 HD22 HG12 ' A' ' 69' ' ' VAL . 5.0 mp -116.57 130.74 24.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 64.05 110.934 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -32.61 18.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 72.21 112.352 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.63 101.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 71.23 111.084 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 HD22 ' A' ' 66' ' ' LEU . 13.8 m -73.69 118.59 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.11 111.169 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.07 163.99 30.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 60.23 112.473 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.855 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.36 -30.84 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 72.31 111.152 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -75.83 -23.26 55.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 63.44 110.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.93 -4.67 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.883 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.53 140.83 58.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 75.44 110.913 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.74 -138.55 5.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.482 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.64 135.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 64.2 111.132 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.8 m-85 -103.27 135.24 45.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 54.33 110.857 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -131.36 131.47 43.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.866 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 t -125.95 156.12 40.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.14 110.87 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.427 ' HB3' ' C6 ' ' A' ' 201' ' ' IOR . 13.8 pt20 -141.16 142.73 34.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 72.12 110.886 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.17 162.53 33.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 41.21 111.087 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.0 ttm -130.43 124.72 32.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.04 172.25 8.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 64.24 110.833 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -71.44 -19.35 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 65.15 110.871 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -74.08 -20.17 60.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.85 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.43 37.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 75.32 112.438 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.1 147.47 26.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 62.41 110.935 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.69 144.7 31.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 72.54 110.901 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 131.72 50.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.111 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.53 142.91 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 75.25 110.896 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.91 121.81 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 52.1 110.854 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 123.02 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.434 ' CD2' HD22 ' A' ' 16' ' ' LEU . 3.9 m-85 -125.86 120.11 29.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 75.41 110.926 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.0 130.55 34.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 73.32 110.875 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -121.12 137.32 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 62.42 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.29 131.88 45.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 70.33 110.902 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.8 m -95.81 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 51.35 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.51 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.928 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 143.6 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 62.23 110.925 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.407 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.65 159.58 50.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.652 0.739 . . . . 73.43 111.146 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.2 Cg_endo -69.71 -31.64 20.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 52.32 112.34 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.21 -77.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.738 . . . . 53.14 112.461 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -86.66 137.71 33.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 73.43 110.901 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 166.16 28.53 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 72.1 112.305 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.05 110.9 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.427 ' C6 ' ' HB3' ' A' ' 80' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.445 -0.262 . . . . 73.5 112.445 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m 58.73 96.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 62.12 110.797 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.61 72.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 71.25 111.087 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 133.18 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 73.22 110.931 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.37 120.44 26.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 63.54 110.939 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.69 HG21 HD11 ' A' ' 14' ' ' LEU . 46.8 mm -125.91 121.61 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.3 111.085 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.93 137.7 34.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 62.01 111.142 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.42 166.78 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 70.11 111.085 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.59 148.72 44.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.946 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -52.08 121.57 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.1 111.145 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.653 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.87 6.67 75.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 62.21 112.538 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.3 mm-40 -101.83 140.13 20.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.709 0.766 . . . . 72.41 110.846 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 143.88 52.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.745 2.297 . . . . 65.51 112.33 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 6' ' ' ILE . 33.5 tp -144.23 142.0 30.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.898 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 65' ' ' PHE . 24.3 t -122.81 147.91 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 71.11 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 64' ' ' LEU . 50.2 mt -131.58 149.05 52.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 65.24 110.951 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.48 152.53 27.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.916 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.74 101.33 10.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.3 110.826 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 113.09 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 72.42 110.918 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' HG21 ' A' ' 89' ' ' THR . . . 129.19 -39.15 1.89 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 64.34 112.579 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.19 129.17 44.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.605 0.717 . . . . 75.52 111.05 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -167.28 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 71.23 112.33 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.02 -51.52 41.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 75.01 110.8 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -111.45 133.97 21.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.508 0.671 . . . . 74.03 110.927 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.689 2.259 . . . . 74.51 112.361 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.5 Cg_endo -69.79 -58.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 63.22 112.344 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -107.16 -179.2 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.11 110.922 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.64 152.68 44.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 30.42 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -146.71 153.11 39.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 72.13 110.925 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.2 147.79 44.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 63.34 110.943 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -129.41 138.93 51.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.958 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -144.11 136.04 26.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 74.44 110.933 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.749 HD12 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -138.98 139.83 38.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 71.24 110.931 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -112.07 127.97 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.895 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.773 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -137.55 178.29 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.13 111.102 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.17 -130.44 19.08 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 74.05 112.476 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -112.67 -37.39 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.903 0.382 . . . . 74.31 110.888 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.9 t -178.42 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.055 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.9 mt-10 -102.26 33.89 2.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 63.22 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.9 -5.54 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 75.41 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -59.22 132.29 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.857 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.749 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -127.44 153.59 46.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 70.3 110.91 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.87 121.7 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.109 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' A' ' 33' ' ' LEU . 2.1 mm? -89.51 145.34 25.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.929 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -125.42 163.74 36.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.639 0.733 . . . . 61.44 110.854 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.5 Cg_endo -69.84 2.36 3.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.7 2.267 . . . . 41.22 112.275 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -116.64 101.68 8.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.937 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.33 72.44 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 73.31 112.528 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.18 133.53 5.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 62.44 112.552 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.22 -113.46 4.68 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 71.33 112.476 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.21 34.39 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.747 2.298 . . . . 61.0 112.338 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.458 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 7.7 m-90 -64.75 -33.81 76.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.908 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -65.78 -24.17 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 75.33 110.842 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.48 -33.95 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 63.31 110.828 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.82 -73.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 63.14 111.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.719 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -150.57 156.5 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.152 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -132.67 160.21 37.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 73.45 110.931 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 HD12 ' A' ' 44' ' ' LEU . 38.2 t -109.5 128.82 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.102 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.63 158.25 87.49 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.528 0.68 . . . . 42.42 110.957 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -21.38 33.41 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.24 . . . . 72.4 112.338 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -82.87 0.9 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 64.21 110.914 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.01 16.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.824 -0.703 . . . . 64.22 112.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 m -112.28 179.89 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 72.24 110.938 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 16' ' ' LEU . 10.9 tp -129.73 126.25 37.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.34 110.901 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CD2' HG22 ' A' ' 15' ' ' VAL . 34.1 t80 -126.46 135.46 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.892 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.06 129.59 25.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 73.33 110.922 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -33.03 17.17 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 73.32 112.301 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.653 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.2 102.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.432 . . . . 71.55 111.134 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -72.91 117.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.423 . . . . 73.44 111.183 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.05 162.2 30.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.805 -0.712 . . . . 54.04 112.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.26 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.72 0.295 . . . . 71.24 111.084 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -75.58 -22.74 56.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.927 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.59 -4.95 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.04 110.856 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.84 141.0 58.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 60.55 110.922 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.76 -137.96 5.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 72.12 112.465 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.6 mm -124.13 127.55 73.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.4 111.161 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.4 m-85 -104.77 134.73 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.28 144.97 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.928 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 155.45 43.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.875 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.89 130.25 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.908 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.57 161.93 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.03 111.154 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -130.14 125.28 34.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 63.21 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.49 173.16 9.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 64.12 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -70.64 -19.23 62.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.824 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -74.53 -20.56 59.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.11 -8.0 38.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 72.44 112.508 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.96 147.05 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.698 0.285 . . . . 75.33 110.948 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.94 140.32 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.483 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -105.24 129.64 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.14 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.87 144.23 33.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -145.08 125.95 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 54.13 110.85 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.7 124.12 45.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 64.44 110.891 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.87 120.62 28.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.953 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 131.34 35.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.94 137.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 64.42 111.1 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.49 129.05 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.865 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 m -93.58 -176.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.058 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -63.53 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.2 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -68.37 144.01 54.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 72.42 110.947 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.23 159.57 49.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 73.44 111.155 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo -69.73 176.4 6.79 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.718 2.278 . . . . 64.12 112.376 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.94 82.41 0.14 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 74.24 112.469 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -155.67 137.77 9.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.603 0.716 . . . . 71.33 110.888 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.64 147.88 64.6 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.701 2.267 . . . . 61.45 112.346 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.51 110.862 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.497 -0.241 . . . . 54.11 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t -179.33 97.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 72.33 110.84 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.35 73.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.496 . . . . 73.44 111.126 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -91.4 139.1 31.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 71.23 110.906 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -84.11 121.02 26.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.916 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.566 ' CG2' HD11 ' A' ' 14' ' ' LEU . 44.4 mm -125.68 121.62 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 65.14 111.065 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -95.35 139.72 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 64.4 111.126 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.83 166.33 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.058 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -124.03 149.2 46.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.823 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 99' ' ' GLN . 78.6 mt -53.88 120.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.168 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.619 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.35 6.94 77.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 54.43 112.452 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 69' ' ' VAL . 32.6 mm-40 -102.37 140.7 21.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 73.31 110.902 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 145.06 56.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 61.11 112.35 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.2 tp -142.51 142.72 32.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 72.34 110.967 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.2 t -121.12 147.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 72.05 111.072 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 17.8 mt -131.18 148.21 52.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 61.35 110.96 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -113.01 153.13 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.97 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.95 100.68 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 74.32 110.905 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.18 118.39 6.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.2 110.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.39 -40.71 1.81 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 44.31 112.562 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.51 129.43 42.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.551 0.691 . . . . 31.51 111.098 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -165.62 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.766 2.31 . . . . 72.12 112.341 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.36 -52.14 30.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 62.04 110.908 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -112.21 128.59 25.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.52 0.676 . . . . 71.45 110.965 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.1 Cg_endo -69.7 110.22 2.49 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.693 2.262 . . . . 63.34 112.362 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.0 Cg_endo -69.79 -53.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 51.22 112.373 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -106.05 -178.86 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.915 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -70.27 159.24 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 64.44 110.891 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.27 174.48 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 73.33 110.88 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.63 148.09 41.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.848 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -122.96 138.25 54.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.14 142.56 34.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 74.44 110.877 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' ' 77' ' ' PHE . 16.7 tp -137.94 135.79 36.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.852 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -115.23 121.94 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.94 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.6 p -138.17 176.72 8.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.03 111.199 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.83 -131.58 12.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 73.03 112.543 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -112.88 -37.89 4.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.369 . . . . 74.05 110.852 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.18 -30.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 63.22 111.142 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.9 mt-10 -102.1 33.63 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.01 110.929 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.86 -6.1 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 73.22 111.122 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -59.88 132.16 53.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HE3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.9 153.93 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 72.55 110.818 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.18 121.26 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 63.52 111.144 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.55 145.24 25.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 64.41 110.853 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.82 162.12 49.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.697 0.76 . . . . 71.12 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.92 11.01 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.706 2.271 . . . . 75.51 112.327 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -122.33 81.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.942 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.34 13.43 64.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.708 -0.758 . . . . 74.2 112.503 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 92.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.681 -0.771 . . . . 65.42 112.478 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.59 -64.8 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.736 -0.745 . . . . 51.44 112.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.81 3.32 2.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.645 2.23 . . . . 73.34 112.361 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -49.69 -34.59 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.912 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.82 -24.94 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 74.1 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 -43.91 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 71.44 110.833 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -126.68 -99.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 73.41 111.114 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -162.98 176.28 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 34.31 111.061 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.23 159.41 20.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 75.41 110.83 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.51 125.06 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 73.51 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 63' ' ' SER . 88.0 mt -68.21 156.99 88.77 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.641 0.734 . . . . 64.31 110.919 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.1 Cg_endo -69.74 -20.71 34.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.673 2.249 . . . . 71.43 112.33 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -82.48 0.89 40.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.11 110.885 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.97 28.7 14.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 74.21 112.501 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 59' ' ' LEU . 15.6 m -112.53 173.67 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 44.52 110.807 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 15.9 tp -129.29 130.42 46.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 72.24 110.871 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 34.9 t80 -124.29 136.03 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.874 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.559 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.05 130.75 23.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.656 0.741 . . . . 74.12 110.93 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -37.81 8.68 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 74.12 112.332 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.73 104.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 34.2 111.093 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 12' ' ' GLU . 19.6 m -73.06 117.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 70.14 111.139 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.97 162.67 24.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 61.03 112.476 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.29 -29.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 71.43 111.107 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.94 -24.17 58.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 63.33 110.933 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.89 -4.54 56.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 61.12 110.839 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.59 141.38 58.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 62.35 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.6 -139.81 7.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 75.05 112.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.76 130.25 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 75.12 111.103 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.675 ' CG ' HD13 ' A' ' 16' ' ' LEU . 6.2 t80 -103.2 144.3 31.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 72.23 110.912 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 146.35 52.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.55 110.823 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.7 t -126.98 151.44 48.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 64.13 110.899 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.84 131.76 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.907 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.75 161.91 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 51.23 111.054 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.8 mtp -130.17 124.4 32.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.05 110.817 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.42 172.87 9.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.911 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -70.53 -19.42 62.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 74.31 110.893 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.74 -20.34 59.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.01 110.861 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.02 39.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 61.1 112.463 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.91 147.7 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 75.04 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -104.3 142.66 34.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.53 110.813 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.525 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.74 132.55 50.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 43.42 111.14 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 144.1 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.53 110.954 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -145.06 126.09 14.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 72.11 110.889 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' C ' ' A' ' 201' ' ' IOR . 39.8 t30 -118.69 122.56 42.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.901 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -128.72 120.79 27.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.955 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -83.14 133.18 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.85 138.34 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 74.44 111.125 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -129.25 143.91 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.82 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.833 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -112.47 -176.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.55 111.151 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.41 -79.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 75.32 110.933 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -63.76 144.79 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.04 110.952 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.425 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.4 159.66 49.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 72.05 111.163 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo -69.77 161.85 44.35 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.254 . . . . 72.42 112.352 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.58 -56.09 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.404 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -113.99 72.72 2.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.515 0.674 . . . . 70.2 110.886 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 -177.65 2.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 74.42 112.287 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.04 110.886 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.432 ' C ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.51 -0.236 . . . . 63.23 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.53 154.17 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 73.13 110.865 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.55 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . -60.49 94.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 61.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.22 133.08 36.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 64.24 110.949 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.8 p-10 -89.68 119.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 62.41 110.935 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.733 HG21 HD11 ' A' ' 14' ' ' LEU . 2.7 mp -126.77 122.59 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -95.79 139.95 31.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 73.14 111.176 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.54 167.65 24.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.24 148.46 43.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.818 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 26.9 mt -52.42 121.25 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.128 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.703 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.42 8.02 71.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 31.5 112.498 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.4 mm-40 -101.94 140.3 21.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 73.55 110.952 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 144.09 52.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.707 2.271 . . . . 71.13 112.341 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 6' ' ' ILE . 21.7 tp -144.08 142.23 30.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 62.11 110.936 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 65' ' ' PHE . 33.9 t -121.84 145.93 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 50.43 111.133 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.9 mt -131.43 148.56 52.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.926 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -112.82 152.77 28.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 110.893 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.0 t -105.66 99.99 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 70.11 110.851 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 120.09 7.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.899 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -42.19 1.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 73.42 112.503 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.5 129.31 51.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 73.51 111.077 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.263 . . . . 73.14 112.338 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.56 -51.59 35.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.883 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.51 134.18 21.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.609 0.719 . . . . 73.32 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 109.98 2.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.638 2.225 . . . . 73.24 112.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -58.42 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.693 2.262 . . . . 73.41 112.408 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -107.22 -179.21 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.948 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -67.98 155.79 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 51.51 110.898 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.592 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -146.84 154.64 41.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 72.31 110.875 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -120.88 148.07 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.899 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.592 ' HE1' HD13 ' A' ' 29' ' ' LEU . 26.7 m95 -127.39 136.17 51.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 72.4 110.863 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.725 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -143.4 136.83 28.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.874 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' A' ' 77' ' ' PHE . 1.4 mt -137.4 138.99 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 64.54 110.929 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -112.29 126.55 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.907 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.4 p -138.14 179.22 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 65.23 111.155 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.08 -130.83 19.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.472 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 38' ' ' THR . 12.1 mmt85 -114.9 -38.07 4.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 44.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -176.28 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 75.04 111.154 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -99.09 34.02 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.848 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.15 -4.56 7.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 64.4 111.075 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CZ2' HG22 ' A' ' 38' ' ' THR . 11.0 m0 -58.12 131.13 49.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 72.23 110.961 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 154.06 47.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 55.25 110.903 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.06 118.39 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.163 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HG ' HD11 ' A' ' 33' ' ' LEU . 1.1 mm? -90.54 145.33 24.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 61.33 110.906 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.13 163.19 43.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 74.3 110.925 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.0 Cg_endo -69.84 -3.73 12.66 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.648 2.232 . . . . 65.25 112.351 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.91 86.41 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 65.11 110.837 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.12 2.15 63.4 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.752 -0.737 . . . . 65.43 112.497 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.44 105.4 0.41 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.696 -0.764 . . . . 55.2 112.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.74 -73.6 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 33.54 112.511 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -2.07 9.53 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.661 2.241 . . . . 61.21 112.351 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -35.29 48.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 61.22 110.917 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.07 -24.41 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 72.3 110.858 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.98 -43.81 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 63.33 110.9 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.53 -97.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 63.35 111.142 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -151.35 173.73 14.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 61.41 111.065 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.623 HH21 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -129.32 163.01 26.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 74.52 110.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 46' ' ' PRO . 4.1 t -107.76 130.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 73.42 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.623 HD23 HH21 ' A' ' 57' ' ' ARG . 61.5 mt -68.91 157.8 87.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.626 0.727 . . . . 74.54 110.886 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -21.71 33.32 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 71.22 112.338 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.29 1.12 42.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 61.14 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.1 29.91 11.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 71.05 112.569 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.457 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.6 m -113.19 179.15 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.411 . . . . 62.12 110.827 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 65' ' ' PHE . 14.7 tp -130.01 129.31 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 74.04 110.971 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CD2' HG22 ' A' ' 15' ' ' VAL . 37.8 t80 -124.6 133.94 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 72.01 110.838 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.2 mp -114.97 131.04 23.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.549 0.69 . . . . 71.42 110.95 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -33.64 15.94 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.673 2.249 . . . . 54.34 112.365 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.95 104.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 43.04 111.099 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.43 113.12 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 60.22 111.137 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.98 162.0 33.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.718 -0.753 . . . . 71.1 112.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.837 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.11 -30.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 74.42 111.206 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.9 -23.71 55.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 71.31 110.889 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -4.07 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 70.45 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.68 140.62 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.3 110.884 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.49 -137.63 5.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 54.34 112.478 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.405 HD12 ' CG ' ' A' ' 94' ' ' ARG . 43.9 mm -123.54 133.39 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 74.25 111.052 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -103.81 143.56 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.895 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -138.67 137.99 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 75.03 110.886 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.8 t -126.51 155.29 42.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.84 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.11 135.11 32.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.963 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.02 162.66 30.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 44.34 111.079 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ttm -130.11 124.81 33.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -89.94 172.4 8.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 53.25 110.874 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -71.29 -18.65 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.952 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -73.85 -20.43 60.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -15.58 33.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.734 -0.746 . . . . 65.34 112.407 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -85.16 146.17 27.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 74.23 110.881 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.15 144.61 32.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.919 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 133.32 49.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 73.14 111.14 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.47 145.25 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.934 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -144.91 126.92 15.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 62.3 110.888 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.18 122.71 42.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.22 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -124.28 119.37 29.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.891 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.55 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.76 133.86 34.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 74.2 110.895 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.36 137.25 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 64.02 111.078 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -130.33 132.7 45.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.873 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 m -95.67 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 73.2 111.128 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -65.39 -80.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.941 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -65.49 142.98 57.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 52.34 110.912 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.446 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.13 159.54 49.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 73.22 111.184 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo -69.74 -47.08 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.695 2.263 . . . . 42.25 112.355 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.66 96.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 44.2 112.565 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -51.7 156.88 2.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 73.12 110.863 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 100.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 73.5 112.327 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 71.44 110.879 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.471 -0.252 . . . . 62.32 112.471 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.74 111.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.7 p-10 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.41 -44.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 130.52 58.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 72.23 111.07 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.258 . . . . 54.44 112.306 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -48.34 -50.51 30.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.925 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 51.5 mmtt -110.07 153.47 43.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.644 0.735 . . . . 74.24 110.842 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 55.2 Cg_endo -69.67 109.52 2.31 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 55.4 112.412 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.66 -84.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.768 2.312 . . . . 73.45 112.386 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -176.24 3.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.53 110.902 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -62.73 149.01 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.873 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -145.7 155.43 42.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.911 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -120.32 74.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 57' ' ' ARG . . . -77.46 -1.45 76.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 34.15 112.501 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.82 103.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.696 -0.764 . . . . 74.55 112.471 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.75 -74.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 71.03 112.482 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -4.15 13.44 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.598 2.198 . . . . 72.41 112.406 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -34.64 57.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 70.31 110.951 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.81 -24.76 62.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 72.1 110.826 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.18 -42.96 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.803 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.16 -97.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 54.33 111.097 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -151.63 173.65 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.43 111.073 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo -69.78 156.76 62.44 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.72 -76.19 1.03 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 55.44 112.526 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -153.36 157.53 32.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 72.14 110.858 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.625 2.216 . . . . 72.43 112.411 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.919 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.538 -0.225 . . . . 53.12 112.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.58 153.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.914 0.388 . . . . 45.23 110.857 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -52.46 100.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 71.5 111.099 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.04 133.27 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 60.12 110.944 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 6.5 m-80 -84.26 120.31 26.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 63.51 110.932 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.6 mm -126.17 121.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.41 111.162 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 p -96.89 138.31 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.31 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -148.24 165.64 30.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.11 111.142 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -124.25 149.05 46.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 51.31 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -53.98 121.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.206 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.57 2.73 84.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 63.42 112.444 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.78 ' O ' HG22 ' A' ' 69' ' ' VAL . 17.5 mm-40 -101.09 139.63 20.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 63.34 110.902 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 143.09 49.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.671 2.248 . . . . 74.0 112.358 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 66' ' ' LEU . 40.6 tp -144.72 141.79 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.896 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -122.97 148.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 64.34 111.056 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 64' ' ' LEU . 9.4 mt -131.58 149.03 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 65.02 110.95 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -106.29 148.96 27.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.895 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 t -112.26 101.83 10.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.927 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -55.88 95.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 70.52 110.903 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.61 -46.25 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 51.44 112.488 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.08 103.89 13.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.65 0.738 . . . . 70.34 111.107 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.0 Cg_endo -69.68 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 53.04 112.354 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -62.72 -8.95 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 63.11 110.915 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -44.86 168.07 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 62.23 110.903 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 54.5 Cg_endo -69.74 172.08 13.27 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.726 2.284 . . . . 73.04 112.402 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.79 97.26 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 74.32 112.352 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.61 -175.64 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.52 110.85 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -64.87 133.17 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.44 110.839 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.3 pp -176.16 162.34 2.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 65.1 110.872 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -120.37 147.4 45.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 71.54 110.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -134.49 138.8 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.931 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.7 ' O ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpt -136.46 142.01 43.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 52.22 110.923 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 32' ' ' LYS . 55.2 mt -134.98 135.06 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 61.22 110.933 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -116.64 120.62 39.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.892 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.789 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.5 p -139.17 177.59 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 74.43 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.75 -128.91 9.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.759 -0.734 . . . . 64.24 112.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.36 -36.98 5.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 72.44 110.848 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.9 -30.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.166 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -103.13 33.46 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.874 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.65 -6.69 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 43.03 111.134 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 133.24 55.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.937 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 157.99 40.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 62.24 110.872 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.98 120.46 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 64.32 111.14 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.43 145.75 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 73.12 110.889 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.62 163.06 41.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.729 . . . . 75.22 110.89 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.9 Cg_endo -69.76 0.11 6.12 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.714 2.276 . . . . 70.44 112.316 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 -119.78 71.9 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 71.53 110.919 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 11.19 70.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 61.33 112.522 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.22 102.35 0.65 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.812 -0.709 . . . . 72.35 112.495 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 132.55 -67.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 41.15 112.495 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.64 8.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.639 2.226 . . . . 62.15 112.359 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -34.13 38.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.917 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.63 -27.72 67.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.849 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -42.39 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 60.25 110.805 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.1 -95.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 74.52 111.145 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -159.96 174.44 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 61.1 111.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 161.73 23.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 61.41 110.896 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.73 129.88 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 40.42 111.145 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 6.5 mp -69.61 158.26 87.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.61 0.719 . . . . 53.11 110.898 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.78 -23.12 31.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 74.13 112.303 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.03 3.48 34.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 70.31 110.818 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.14 24.84 28.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.72 -0.752 . . . . 70.32 112.457 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 2.6 m -105.97 179.73 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 75.22 110.869 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 16' ' ' LEU . 6.4 tp -130.86 127.91 39.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 73.13 110.943 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.643 ' N ' HD12 ' A' ' 64' ' ' LEU . 2.3 t80 -126.1 129.41 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.55 110.896 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.3 mp -117.77 131.24 24.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.612 0.72 . . . . 73.41 110.975 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.63 -32.47 19.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.763 2.309 . . . . 73.11 112.364 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.59 101.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 41.35 111.116 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.6 m -73.55 119.41 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 111.092 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.39 161.48 28.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.705 -0.759 . . . . 51.4 112.514 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.33 -29.39 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.728 0.299 . . . . 64.41 111.124 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -74.47 -23.2 58.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 51.41 110.893 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -5.14 57.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 65.3 110.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.66 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 65.44 110.912 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.49 -139.11 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 62.4 112.483 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.28 128.14 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 74.52 111.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD1' HD22 ' A' ' 33' ' ' LEU . 22.7 m-85 -104.5 136.72 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 64.4 110.839 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.45 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 75.33 110.881 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.4 t -127.14 152.31 47.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.909 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 131.03 24.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 61.12 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.63 163.06 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.07 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ttm -130.06 124.9 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.88 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -88.42 172.36 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.913 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.53 -18.91 62.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.926 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -73.89 -20.26 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.919 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.93 -13.53 34.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 71.34 112.548 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -84.87 147.27 26.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 74.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.58 143.85 32.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 72.15 110.925 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.76 126.89 51.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 54.45 111.12 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 144.23 34.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 73.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 m -145.8 127.74 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 63.14 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.82 122.52 41.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 64.52 110.827 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.72 119.04 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 64.31 110.906 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.02 131.45 34.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 70.24 110.87 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 77' ' ' PHE . 70.3 t -120.75 139.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.55 111.143 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 128.57 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.45 110.866 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.4 m -92.48 -176.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 64.13 111.099 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -64.69 -78.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.15 110.948 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -68.2 145.89 53.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.9 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.501 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.62 0.724 . . . . 61.44 111.072 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.81 -38.12 8.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.751 2.301 . . . . 64.34 112.312 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.3 93.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 63.22 112.456 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -142.94 159.34 56.82 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.531 0.681 . . . . 74.43 110.924 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -175.51 1.2 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.713 2.275 . . . . 64.11 112.266 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.884 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 112.479 -0.249 . . . . 71.22 112.479 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -173.55 148.07 1.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 62.34 110.806 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 97.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 55.41 111.111 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -93.24 133.65 36.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 60.22 110.836 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -89.83 121.43 31.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 14' ' ' LEU . 44.9 mm -125.33 121.44 60.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 71.41 111.08 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -96.01 141.19 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.24 111.115 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 167.46 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 71.1 111.051 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -122.63 148.22 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 38.5 mt -53.12 121.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 60.42 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.9 5.76 76.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 74.15 112.47 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.8 mm-40 -102.04 140.11 20.89 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.43 110.866 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 144.01 52.47 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.608 2.205 . . . . 52.12 112.286 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.671 HD11 HG21 ' A' ' 6' ' ' ILE . 36.3 tp -144.61 142.01 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.919 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.84 144.6 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.139 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.725 HD13 ' CD2' ' A' ' 77' ' ' PHE . 1.3 mt -131.03 146.26 52.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 72.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -114.5 151.2 33.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 75.03 110.952 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 m -108.05 101.83 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.57 126.71 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.31 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.89 -38.8 2.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 54.45 112.53 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.19 131.6 36.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.576 0.703 . . . . 43.31 111.09 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -164.84 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 53.24 112.379 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -48.16 -50.52 28.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 70.12 110.874 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 17.7 mmtp -109.48 152.23 42.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.59 0.71 . . . . 70.43 110.889 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.81 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.595 2.197 . . . . 72.34 112.402 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.9 Cg_endo -69.73 -83.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.693 2.262 . . . . 64.52 112.334 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 73.2 mt-30 -103.46 -176.86 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.941 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -63.01 147.59 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 70.34 110.842 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 29' ' ' LEU . 1.3 pp -145.79 151.62 38.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 65.13 110.921 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.74 129.12 53.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 70.24 110.925 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.579 ' NE1' HD13 ' A' ' 29' ' ' LEU . 43.6 m0 -111.93 144.53 41.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 73.03 110.911 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -136.96 141.23 42.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 72.11 110.982 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 77' ' ' PHE . 13.6 tp -136.05 135.29 39.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.53 110.942 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.13 121.47 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 54.11 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.803 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 p -138.35 179.27 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 62.35 111.139 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.95 -130.24 11.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 52.13 112.49 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -112.5 -37.95 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 73.41 110.933 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t -179.83 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 72.4 111.134 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 38' ' ' THR . 19.2 mt-10 -102.6 34.03 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 61.24 110.862 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.57 -6.76 8.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -61.82 131.34 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.873 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 158.46 38.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 60.41 110.854 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.91 123.1 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 61.13 111.16 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.52 143.5 26.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 70.41 110.919 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.713 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -126.74 163.02 43.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.647 0.736 . . . . 73.13 110.856 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.694 2.263 . . . . 51.43 112.403 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -125.66 73.36 1.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.94 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.73 7.72 79.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 74.25 112.459 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 112.02 4.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 71.42 112.446 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.44 -70.6 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 61.53 112.484 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -0.05 6.3 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.682 2.255 . . . . 75.53 112.398 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.442 ' HB2' ' HG3' ' A' ' 57' ' ' ARG . 21.0 p-90 -51.7 -34.69 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 60.13 110.925 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.56 -25.2 62.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 72.21 110.83 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -44.56 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 70.03 110.863 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.41 -95.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 52.35 111.066 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.605 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -148.52 174.15 12.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.45 . . . . 62.1 111.11 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HG3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -126.92 163.0 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.42 110.851 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 45' ' ' SER . 48.6 t -107.45 127.5 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.063 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.6 mp -68.27 157.58 87.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.586 0.707 . . . . 61.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.81 -20.83 34.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 70.3 112.335 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.6 1.62 41.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 28.53 20.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.827 -0.702 . . . . 74.4 112.486 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -112.57 178.01 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 72.05 110.896 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 38.0 tp -128.01 127.93 44.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.912 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 59' ' ' LEU . 9.3 t80 -125.81 135.04 51.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 71.43 110.903 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 56' ' ' ALA . 7.2 mp -113.43 128.59 25.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 73.11 110.901 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -32.5 18.34 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 71.42 112.368 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.04 102.65 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.098 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -72.36 118.42 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 73.1 111.151 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.37 158.79 26.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 31.03 112.494 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.838 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.23 -31.43 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.787 0.327 . . . . 64.15 111.102 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.79 -22.8 53.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.908 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.55 -5.27 44.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.881 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -60.7 142.49 55.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 72.45 110.831 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.16 -147.16 15.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.724 . . . . 52.13 112.511 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.82 129.91 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 73.42 111.144 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' A' ' 16' ' ' LEU . 11.3 t80 -104.87 135.28 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.0 146.72 50.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 64.23 110.799 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.59 152.72 46.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.867 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.7 128.13 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.902 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.08 31.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 62.3 111.078 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 ttm -130.11 124.71 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.44 110.873 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -87.71 171.9 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 55.13 110.943 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -71.76 -18.18 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -73.28 -26.06 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 60.41 110.86 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.92 -18.22 12.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 55.54 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -84.18 147.16 27.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 61.44 110.892 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.26 144.86 31.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.873 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 128.12 50.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 64.13 111.154 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 145.31 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 65.22 110.919 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -144.67 126.96 15.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 52.11 110.85 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 122.1 40.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 61.34 110.874 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.69 120.04 28.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.953 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.91 132.12 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.886 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.89 136.37 58.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 74.0 111.115 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -130.76 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 62.14 110.879 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.8 m -108.7 -175.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 52.4 111.142 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -66.37 -78.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.927 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -66.53 146.03 54.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 44.44 110.914 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.48 49.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 45.32 111.133 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo -69.77 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.275 . . . . 70.54 112.338 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.03 -37.54 1.51 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.772 -0.727 . . . . 72.32 112.488 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -119.55 73.89 16.53 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 73.35 110.872 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -171.08 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 74.54 112.377 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.927 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.481 -0.248 . . . . 71.31 112.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -178.93 128.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 74.23 110.913 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.49 63.64 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 64.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -92.72 137.87 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.66 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.9 p-10 -89.95 120.99 31.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 53.21 110.871 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.66 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.24 122.3 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.16 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -95.49 142.09 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 64.43 111.11 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.77 168.34 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 51.43 111.111 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.41 148.19 41.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 64.42 110.871 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.03 122.08 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.064 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.4 3.85 86.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 62.54 112.555 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.6 mm-40 -101.39 142.7 25.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.736 . . . . 62.31 110.93 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 144.03 53.35 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.703 2.269 . . . . 62.11 112.378 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 6' ' ' ILE . 52.2 tp -143.93 143.26 31.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 72.52 110.93 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.4 t -121.07 147.71 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 62.01 111.148 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 77' ' ' PHE . 14.8 mt -131.48 149.12 52.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.893 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -107.18 151.63 25.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.896 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.6 t -107.63 100.11 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.05 110.854 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -59.71 120.53 9.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.898 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.11 -39.95 1.98 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.714 -0.755 . . . . 74.13 112.466 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.57 132.27 33.83 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.563 0.697 . . . . 43.33 111.056 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.248 . . . . 72.22 112.385 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -48.38 -52.2 22.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 63.14 110.963 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 144.45 30.64 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.605 0.716 . . . . 55.03 110.898 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.0 Cg_endo -69.69 110.58 2.57 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.619 2.213 . . . . 72.12 112.364 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.3 Cg_endo -69.76 -83.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.681 2.254 . . . . 75.41 112.319 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 3.3 mp0 -91.15 -177.27 4.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.926 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -63.46 148.28 49.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.53 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.97 154.62 42.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.902 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -120.51 148.21 44.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.867 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.607 ' HE1' HD13 ' A' ' 29' ' ' LEU . 20.2 m95 -124.79 143.28 50.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 74.01 110.879 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 143.94 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.91 134.63 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 65.12 110.863 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -116.45 121.18 41.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.54 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.785 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.8 p -139.39 179.38 6.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 72.21 111.104 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.56 -133.35 15.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 75.12 112.552 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -112.56 -37.57 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 62.22 110.817 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.616 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.7 t -179.31 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 55.12 111.158 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.616 ' HG3' HG23 ' A' ' 38' ' ' THR . 25.0 mt-10 -102.08 33.71 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 64.24 110.85 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.92 -6.81 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 63.54 111.129 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -60.38 128.95 39.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 72.3 110.918 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.591 ' HG3' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -130.34 156.34 44.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 65.43 110.938 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 t -93.49 123.35 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 71.51 111.188 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 33' ' ' LEU . 30.6 mt -88.66 143.65 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 54.21 110.915 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.73 162.52 50.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.693 0.758 . . . . 75.3 110.854 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -4.0 13.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.767 2.311 . . . . 73.11 112.34 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -124.48 83.16 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 72.13 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.63 0.43 81.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 24.44 112.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -52.06 101.05 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 24.33 112.424 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.65 -73.97 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.696 -0.764 . . . . 60.25 112.464 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.67 0.81 5.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.693 2.262 . . . . 60.04 112.341 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -51.43 -35.73 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 74.42 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.55 -23.8 61.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 62.33 110.833 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.43 -43.01 11.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 35.42 110.845 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG11 ' HG3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -126.1 -98.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 75.31 111.109 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -161.09 175.76 12.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 60.33 111.088 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 161.53 17.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.01 110.849 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.43 130.24 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 75.41 111.172 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 48.8 mt -68.82 157.83 87.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.592 0.71 . . . . 71.41 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.51 33.47 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 73.32 112.344 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.44 1.65 47.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 63.21 110.894 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.58 31.11 9.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 62.05 112.53 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.3 m -113.34 -179.05 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 73.34 110.839 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 65' ' ' PHE . 6.2 tp -129.84 128.71 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.95 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.634 ' N ' HD12 ' A' ' 64' ' ' LEU . 13.3 t80 -126.36 135.85 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.91 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.56 128.86 25.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.626 0.727 . . . . 74.23 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -32.42 19.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.724 2.283 . . . . 73.2 112.4 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.86 100.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 61.52 111.073 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -72.75 113.45 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 73.43 111.093 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.54 158.76 30.1 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 54.54 112.531 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.74 -31.09 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 63.31 111.049 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -76.23 -20.96 56.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.906 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -3.08 27.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.918 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.746 ' CD ' HG22 ' A' ' 97' ' ' VAL . 23.8 mt-10 -57.57 142.81 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 64.43 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.39 -149.95 21.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 54.13 112.406 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.58 133.03 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 74.24 111.105 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' A' ' 16' ' ' LEU . 5.0 t80 -103.28 139.08 39.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 65.14 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 141.16 51.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.883 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -125.95 153.82 43.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.34 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -139.74 130.3 25.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 74.13 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 163.18 28.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 51.31 111.093 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.8 ttm -128.42 124.78 37.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.835 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -87.23 173.4 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 71.1 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -69.53 -19.07 63.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.33 110.842 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -74.42 -20.34 60.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.75 -9.06 43.79 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 61.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -85.05 148.64 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 63.55 110.916 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.21 140.31 37.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 65.23 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.35 132.77 51.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 73.04 111.179 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.32 145.0 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.881 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -144.7 126.94 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.872 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 7.7 t-20 -119.22 124.23 46.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 61.21 110.877 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.8 119.25 24.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -84.47 134.45 34.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 73.03 110.858 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.8 t -122.63 135.98 60.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 70.41 111.158 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.26 148.18 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -110.74 -175.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.114 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -67.06 -78.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 72.4 110.9 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -63.17 146.45 53.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.918 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 71.01 111.151 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo -69.75 -26.17 27.89 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 55.1 112.36 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.23 -102.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.804 -0.712 . . . . 71.51 112.52 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp 57.91 73.38 0.76 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 64.42 110.856 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 137.46 35.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.268 . . . . 53.11 112.376 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 73.55 110.881 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.409 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.469 -0.252 . . . . 74.23 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.05 155.82 6.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 64.3 110.856 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.85 96.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 23.24 111.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -93.03 132.84 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 60.11 110.996 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.676 ' C ' HD12 ' A' ' 6' ' ' ILE . 5.7 p-10 -86.33 119.51 26.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.34 110.881 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.9 mp -129.2 123.2 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.54 111.18 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -95.58 138.66 32.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 63.13 111.153 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.12 166.14 27.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 65.13 111.117 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.45 149.21 44.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.804 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mt -52.58 121.34 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.139 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.51 6.96 76.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 74.22 112.471 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.761 ' O ' HG22 ' A' ' 69' ' ' VAL . 38.7 mm-40 -102.09 139.65 20.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.718 0.771 . . . . 72.04 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 144.51 54.7 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.711 2.274 . . . . 74.55 112.345 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.45 HD11 ' CG2' ' A' ' 6' ' ' ILE . 16.5 tp -143.86 141.91 30.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 60.13 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.39 144.72 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 63.54 111.202 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 64' ' ' LEU . 36.3 mt -131.14 146.88 52.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.35 110.981 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -114.34 151.75 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 61.13 110.933 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.21 99.67 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.9 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -56.39 124.53 18.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.94 -40.28 1.92 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.675 -0.774 . . . . 61.44 112.471 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 128.99 45.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 72.23 111.134 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -164.68 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 73.25 112.34 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -48.17 -51.44 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.914 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -113.35 141.33 25.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 74.13 110.885 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HB3' HD21 ' A' ' 29' ' ' LEU . 54.2 Cg_endo -69.71 108.71 2.13 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 61.42 112.321 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.2 Cg_endo -69.79 -57.27 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.697 2.265 . . . . 75.41 112.314 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -107.21 -177.33 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 61.54 110.848 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.9 mtm-85 -64.54 151.4 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 73.2 110.927 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -146.31 160.5 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 63.24 110.926 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.15 149.56 47.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.911 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.844 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 18.0 m-90 -117.84 135.27 54.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.951 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.654 ' C ' HD23 ' A' ' 33' ' ' LEU . 3.6 ttpt -145.87 136.58 24.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 55.33 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.018 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.54 140.83 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 64.22 110.873 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -111.7 129.0 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.914 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.6 p -135.83 179.89 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.33 111.148 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.27 -129.36 17.4 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.748 -0.739 . . . . 44.14 112.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -112.7 -37.51 4.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 74.42 110.874 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 t -178.96 -30.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.29 33.95 2.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.878 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.87 -5.14 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 72.43 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.05 132.19 53.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 70.34 110.941 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 157.56 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 74.23 110.886 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 t -102.56 120.35 52.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 62.02 111.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.018 HD12 HD21 ' A' ' 33' ' ' LEU . 5.6 mt -92.38 146.05 23.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 54.23 110.908 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 163.5 39.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.636 0.732 . . . . 73.42 110.849 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -0.6 7.14 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.704 2.269 . . . . 55.02 112.321 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -122.67 71.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 71.32 110.914 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.13 12.39 64.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 73.3 112.431 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 92.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 22.12 112.521 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.46 -65.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 64.01 112.457 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 2.88 3.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.228 . . . . 62.55 112.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -34.13 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 75.3 110.924 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.98 -24.82 62.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 55.41 110.9 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -44.7 9.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 44.34 110.893 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -127.33 -98.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.518 . . . . 52.25 111.153 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -161.97 176.01 11.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.31 111.084 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 161.4 17.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.871 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.9 t -108.47 129.57 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.2 111.141 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.592 HD12 ' CB ' ' A' ' 63' ' ' SER . 43.9 mt -69.11 157.47 89.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 63.12 110.937 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -22.56 31.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.726 2.284 . . . . 62.2 112.364 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -83.46 0.61 45.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 70.51 110.849 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.14 29.38 11.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 71.24 112.506 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.7 -179.68 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 63.13 110.927 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 16' ' ' LEU . 13.1 tp -128.97 129.58 45.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.928 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 9.1 t80 -125.37 131.03 53.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 71.5 110.915 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mt -113.97 130.92 23.43 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.646 0.736 . . . . 70.33 110.911 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -38.3 7.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 73.54 112.334 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.74 101.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 72.03 111.072 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.9 m -73.63 116.92 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.103 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.71 164.73 31.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 53.31 112.505 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.836 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.83 -29.4 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.7 0.286 . . . . 73.51 111.096 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -75.11 -23.96 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.4 110.95 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -3.86 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.915 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.57 141.24 52.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.902 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.66 -140.5 7.59 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.697 -0.763 . . . . 51.52 112.452 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 94' ' ' ARG . 2.5 mp -130.18 132.99 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 73.45 111.108 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CE2' HD13 ' A' ' 33' ' ' LEU . 13.2 m-85 -101.34 143.91 30.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.86 147.22 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.52 110.837 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.15 150.62 49.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.02 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.93 128.47 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.884 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.31 162.69 29.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.55 111.082 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -130.12 125.09 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.85 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -89.9 172.91 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 73.53 110.9 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -71.07 -19.24 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 64.12 110.868 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -73.81 -20.25 60.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.55 110.927 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.73 -15.17 34.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 51.13 112.454 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -84.88 146.64 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 72.03 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -105.81 144.72 32.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 73.3 110.896 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.98 50.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 71.43 111.175 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.37 144.95 32.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 63.04 110.908 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.2 m -145.03 127.49 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.33 110.854 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 17.0 t-20 -118.74 127.47 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 50.15 110.872 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.87 118.1 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.957 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.75 127.29 34.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 75.15 110.85 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.13 139.94 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -128.04 129.15 46.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.846 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.3 m -88.68 -175.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 65.11 111.085 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -65.28 -80.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 74.44 110.952 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -65.76 144.48 56.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.918 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.99 47.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.698 0.761 . . . . 54.13 111.116 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.8 160.62 49.0 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 71.25 112.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -89.18 -120.96 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 42.51 112.469 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -169.37 73.35 0.71 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.658 0.742 . . . . 73.35 110.922 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 170.06 17.48 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.675 2.25 . . . . 71.5 112.274 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.874 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.45 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.435 -0.266 . . . . 54.43 112.435 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t 61.85 87.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 72.11 110.867 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 52.95 72.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.22 111.072 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -93.11 132.69 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.881 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.594 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.4 t30 -84.29 120.71 26.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.856 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.594 HD12 ' C ' ' A' ' 5' ' ' ASN . 2.4 mp -126.43 126.03 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.145 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -93.59 141.95 27.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.21 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.13 168.24 22.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 73.22 111.088 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.08 147.95 47.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.865 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -54.62 122.39 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 65.42 111.127 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.69 3.94 80.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.712 -0.756 . . . . 74.21 112.509 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 6.3 mm-40 -101.1 139.56 20.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 72.34 110.851 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 143.0 49.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 72.44 112.42 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 66' ' ' LEU . 17.3 tp -144.35 141.01 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 75.34 110.893 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' HD1' ' A' ' 65' ' ' PHE . 40.4 t -123.15 148.35 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 42.41 111.134 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 64' ' ' LEU . 62.4 mt -131.61 148.67 52.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 72.53 110.882 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.49 149.48 27.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 71.52 110.876 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.5 t -112.49 101.69 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 54.45 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -53.65 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.84 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.52 -46.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 60.04 112.464 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.42 103.05 11.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.585 0.707 . . . . 74.31 111.156 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 52.9 Cg_endo -69.75 -163.33 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.704 2.269 . . . . 75.41 112.269 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -10.21 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 64.22 110.857 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.454 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.1 mptt -45.72 167.82 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 74.54 110.916 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.4 Cg_endo -69.77 172.4 12.73 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 65.02 112.363 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.8 Cg_endo -69.85 96.05 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.243 . . . . 73.13 112.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.5 -174.94 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 52.11 110.927 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -62.99 132.35 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.831 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -178.22 159.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 64.24 110.963 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.38 142.36 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.891 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -126.09 143.29 51.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.919 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -141.98 142.55 32.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.32 110.915 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.69 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.2 tp -137.87 135.99 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.878 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.605 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.6 t-20 -114.99 123.33 48.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 52.35 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 27.9 p -138.87 -179.76 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.132 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.45 -126.83 8.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 33.1 112.468 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.39 -37.45 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 72.4 110.832 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 177.13 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.2 111.148 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.67 32.92 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.88 -7.79 8.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.102 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -60.14 129.6 42.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.956 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 158.57 39.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 73.5 110.874 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.63 121.02 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.077 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.33 144.46 25.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.96 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.53 45.72 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.734 0.778 . . . . 72.21 110.868 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 0.47 5.5 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.263 . . . . 74.53 112.361 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -118.93 92.72 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.923 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.67 -5.0 56.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.645 -0.788 . . . . 75.32 112.506 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.46 105.32 0.2 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 61.02 112.486 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 123.48 -75.74 0.37 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.489 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 1.09 4.68 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.716 2.277 . . . . 73.43 112.37 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -51.26 -35.37 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 72.01 110.952 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -24.94 63.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 71.32 110.894 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.16 -42.24 11.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 74.14 110.852 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -122.91 -97.91 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.131 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.03 176.61 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 70.21 111.037 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.51 160.91 17.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.863 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.73 130.46 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 73.44 111.153 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.622 HD12 ' CB ' ' A' ' 63' ' ' SER . 45.8 mt -69.1 158.78 85.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 75.44 110.885 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.77 -22.66 31.7 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.672 2.248 . . . . 62.01 112.35 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -85.33 1.99 46.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 61.23 110.898 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.78 23.91 24.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 60.02 112.529 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.622 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.4 m -104.4 -179.0 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 64.44 110.852 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.14 130.04 44.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.906 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.2 t80 -125.45 129.68 50.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.926 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.4 mp -118.14 129.77 25.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.605 0.717 . . . . 72.3 110.884 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -32.74 18.01 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 75.03 112.421 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.27 101.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 62.05 111.088 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.0 m -73.03 119.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 73.31 111.119 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.36 160.71 32.03 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 73.23 112.501 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.32 -31.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 65.23 111.117 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -76.46 -22.07 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 65.31 110.934 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -4.75 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.908 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -59.23 142.35 52.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 71.02 110.926 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.74 -145.89 13.44 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 53.34 112.452 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.33 133.82 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 75.33 111.16 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.69 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.5 m-85 -101.37 139.24 37.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.44 110.883 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.77 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 71.44 110.872 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 149.98 50.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 71.51 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.437 ' HB2' ' C6 ' ' A' ' 201' ' ' IOR . 7.4 tt0 -140.22 126.5 19.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 71.55 110.89 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -133.07 163.12 29.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.41 111.064 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 66.7 mmm -129.41 124.64 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.86 172.52 9.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.893 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -71.23 -22.48 61.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.926 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -74.23 -20.14 60.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.863 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.92 -2.99 35.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.729 . . . . 40.31 112.568 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.7 149.07 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 73.51 110.949 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -102.87 141.77 35.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.562 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.52 123.45 47.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 60.11 111.149 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.93 141.61 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 54.33 110.877 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -147.26 125.87 12.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.935 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HB2' ' C ' ' A' ' 201' ' ' IOR . 6.8 t-20 -119.25 125.08 48.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 73.15 110.879 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.86 119.74 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.885 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.473 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.45 131.84 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.44 110.859 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.61 137.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 75.24 111.112 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -130.35 152.93 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 72.52 110.831 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 33.0 m -113.86 -175.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 35.14 111.148 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -65.86 -78.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 53.34 110.932 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -65.83 144.78 56.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.33 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.482 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.36 159.6 49.36 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.634 0.731 . . . . 72.02 111.145 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.7 Cg_endo -69.72 168.56 21.16 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 72.31 112.357 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.8 108.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 32.42 112.479 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? 51.92 71.21 1.56 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 71.21 110.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -171.68 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 51.44 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 60.43 110.931 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.437 ' C6 ' ' HB2' ' A' ' 80' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.52 -0.232 . . . . 62.42 112.52 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -77.93 65.69 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 51.53 110.87 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.44 80.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 75.34 111.091 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.42 138.6 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 63.14 110.918 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.43 119.92 25.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.876 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -126.26 123.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 65.14 111.159 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.1 p -93.72 140.47 29.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 72.31 111.171 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.03 165.07 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 74.22 111.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.78 149.44 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.52 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 99' ' ' GLN . 63.6 mt -59.36 120.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.41 111.114 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.17 5.48 89.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 64.02 112.516 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.69 141.5 22.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.703 0.763 . . . . 73.31 110.905 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.9 144.06 52.1 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.665 2.243 . . . . 71.32 112.343 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' ALA . 26.5 tp -144.2 143.29 30.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.25 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -121.47 147.23 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.1 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 47.3 mt -131.85 150.64 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.45 110.966 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -111.79 152.79 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 75.44 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -106.45 101.63 11.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 42.03 110.884 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -61.42 115.94 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.21 110.942 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.61 -40.28 1.88 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.516 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.75 128.37 54.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 73.01 111.065 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -166.52 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 75.43 112.334 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -49.94 -51.78 38.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.862 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.82 135.41 21.19 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.573 0.702 . . . . 65.25 110.865 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.4 Cg_endo -69.73 109.84 2.4 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.722 2.281 . . . . 53.3 112.36 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.8 -58.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.641 2.227 . . . . 71.21 112.354 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -107.27 -179.08 3.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 73.04 110.898 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -67.85 154.01 42.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.14 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -146.7 152.37 38.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 70.53 110.877 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -120.29 148.36 43.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.868 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.576 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 3.0 m95 -127.05 134.39 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 70.14 110.965 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.585 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.16 136.41 25.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 71.44 110.912 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.775 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -141.84 140.54 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 71.14 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.87 127.95 55.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 62.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.783 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.6 p -136.75 179.32 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.0 -129.98 12.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.654 -0.784 . . . . 50.45 112.517 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -112.62 -37.75 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 74.03 110.897 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.613 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.5 t -179.44 -30.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 71.44 111.19 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.613 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.6 mt-10 -102.7 33.68 3.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 71.34 110.888 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.44 -6.54 8.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.32 111.084 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -59.23 130.29 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 73.03 110.923 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.53 153.52 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 62.22 110.88 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG22 ' HD2' ' A' ' 32' ' ' LYS . 23.5 t -100.21 120.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.1 111.138 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.655 ' CG ' HD21 ' A' ' 33' ' ' LEU . 3.5 mm? -89.9 145.13 25.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.878 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.61 163.25 39.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.656 0.741 . . . . 72.21 110.82 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.8 Cg_endo -69.76 -2.37 10.06 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 73.02 112.368 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -123.36 71.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 71.43 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.45 10.17 67.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 73.54 112.485 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.22 95.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 75.04 112.506 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.8 -67.89 0.56 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 60.33 112.433 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.55 10.37 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.599 2.199 . . . . 73.45 112.379 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -34.59 43.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 61.24 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -66.64 -26.57 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 65.45 110.907 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 -42.13 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 73.23 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -125.18 -96.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 71.43 111.116 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -160.55 174.79 13.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 73.2 111.048 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.15 160.67 24.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 63.31 110.882 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 31.2 t -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.51 111.079 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.27 157.53 89.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 54.51 110.886 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -22.08 32.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.679 2.253 . . . . 60.5 112.395 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -83.25 0.63 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 74.54 110.894 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.7 30.71 10.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.715 -0.755 . . . . 71.01 112.432 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.6 m -113.49 179.04 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 54.41 110.896 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 20.7 tp -129.2 128.37 43.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 73.41 110.926 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -126.39 133.5 51.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 65.13 110.914 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.42 130.8 24.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 64.44 110.856 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -33.06 17.01 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.68 2.253 . . . . 61.02 112.333 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.97 100.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.11 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.5 m -73.57 114.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.1 111.136 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.77 164.25 39.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 52.2 112.568 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.68 -31.56 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.749 0.309 . . . . 71.31 111.102 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -75.72 -22.71 56.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.871 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -5.0 41.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 51.42 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -66.37 140.85 58.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.91 -137.32 5.25 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.711 -0.757 . . . . 73.45 112.456 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.447 HG23 ' ND2' ' A' ' 92' ' ' ASN . 2.1 mp -124.19 132.68 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 71.02 111.133 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.775 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -104.79 133.52 49.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.2 110.938 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -128.0 137.57 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.883 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.36 153.7 42.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 42.33 110.869 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.66 131.64 27.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 75.21 110.918 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.8 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.54 111.028 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 tpp -130.02 124.77 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.13 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.17 172.61 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.24 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -71.15 -18.44 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 72.2 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.46 -20.37 60.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 62.32 110.856 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.16 -16.4 32.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 63.21 112.487 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -85.21 146.81 26.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.686 0.279 . . . . 73.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.31 143.93 32.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.44 132.54 50.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.14 111.135 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 145.73 31.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 53.13 110.934 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -143.73 125.34 14.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 42.51 110.876 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -120.12 122.66 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 65.54 110.814 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.3 125.11 40.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.938 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -83.25 134.02 34.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 72.32 110.861 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -121.16 136.08 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.099 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.542 ' NH1' HG22 ' A' ' 100' ' ' ILE . 1.7 mmt180 -131.18 127.95 39.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 70.54 110.837 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 25.1 m -93.09 -177.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 74.3 111.178 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.6 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 65.54 110.974 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.432 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -61.62 141.83 57.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 71.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.542 HG22 ' NH1' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -121.45 159.7 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.719 . . . . 74.12 111.119 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -34.31 14.8 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 51.02 112.31 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.63 114.71 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.751 -0.738 . . . . 74.54 112.471 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.36 137.61 81.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.551 0.691 . . . . 64.21 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 167.16 25.16 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.631 2.221 . . . . 63.51 112.357 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.923 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.466 -0.254 . . . . 73.13 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t -154.32 -169.02 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 74.04 110.884 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.47 94.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.084 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.81 131.16 38.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.896 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.6 p-10 -89.88 121.94 32.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.866 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.66 ' HB ' HG22 ' A' ' 95' ' ' VAL . 4.5 mp -125.96 122.42 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 54.14 111.117 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.09 136.9 35.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.187 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.57 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 147.91 43.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.878 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -52.94 121.76 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 75.32 111.11 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.702 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.93 6.93 71.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.656 -0.783 . . . . 64.35 112.45 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.763 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.7 mm-40 -101.37 139.4 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.592 0.71 . . . . 74.41 110.968 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.39 50.82 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 73.43 112.381 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 6' ' ' ILE . 39.2 tp -144.65 141.74 29.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 62.12 110.957 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.0 t -122.55 143.62 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.107 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 HD23 ' A' ' 64' ' ' LEU . 16.6 mt -132.16 148.01 52.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 72.53 110.969 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -112.98 153.13 28.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.94 101.94 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 71.25 110.852 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.77 122.93 13.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.29 -39.0 2.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 43.01 112.423 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.33 128.71 45.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.636 0.731 . . . . 74.32 111.056 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.85 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.636 2.224 . . . . 73.02 112.315 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -48.7 -48.82 40.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.13 110.896 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.14 150.88 40.44 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 72.43 110.879 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.9 Cg_endo -69.79 108.93 2.19 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.757 2.305 . . . . 62.32 112.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.6 Cg_endo -69.84 -85.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.256 . . . . 63.42 112.342 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.401 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -96.83 -176.02 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.0 110.967 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -63.07 142.85 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 60.42 110.802 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.722 HD13 ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -146.21 160.89 41.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 70.24 110.935 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.58 149.26 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.899 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.722 ' CH2' HD13 ' A' ' 29' ' ' LEU . 26.8 m-90 -111.82 140.77 46.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.884 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -137.63 142.43 41.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.865 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 34' ' ' ASN . 1.6 tt -138.8 134.62 33.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.89 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' N ' HD23 ' A' ' 33' ' ' LEU . 13.2 t-20 -116.23 126.98 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 54.11 110.861 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.5 p -139.86 178.01 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.097 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.61 -131.65 19.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 53.44 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -37.29 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 74.51 110.862 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.593 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -178.48 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.35 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.09 33.19 2.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 74.35 110.87 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.99 -4.51 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 63.11 111.124 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -62.73 132.2 51.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 70.53 111.03 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 158.75 38.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 71.31 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.19 122.42 52.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 65.32 111.065 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.606 HD13 HD13 ' A' ' 64' ' ' LEU . 13.7 mt -88.81 143.63 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 75.3 110.942 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.27 163.17 41.83 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.695 0.759 . . . . 74.43 110.805 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.4 Cg_endo -69.71 -1.01 7.7 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 64.23 112.308 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -122.27 88.54 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 70.55 110.922 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.18 67.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 74.41 112.484 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.3 101.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 73.1 112.46 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 123.89 -74.76 0.39 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 72.15 112.488 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 1.12 4.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.726 2.284 . . . . 72.01 112.348 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -51.1 -35.35 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 64.43 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.75 -24.79 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 53.11 110.806 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.98 -42.3 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 60.22 110.851 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -122.96 -98.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 71.24 111.145 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -165.76 176.15 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 62.22 111.115 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 160.68 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 61.03 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 20.6 t -109.76 128.79 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 71.22 111.179 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 63' ' ' SER . 50.6 mt -69.16 157.83 88.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.562 0.696 . . . . 52.52 110.928 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -22.72 31.58 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 73.12 112.345 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -83.01 0.25 45.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.65 29.43 10.86 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.776 -0.726 . . . . 51.25 112.483 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.499 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.68 179.85 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 52.21 110.869 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.717 HD22 ' CE2' ' A' ' 77' ' ' PHE . 8.5 tp -129.93 129.72 44.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 15' ' ' VAL . 33.2 t80 -125.34 131.2 53.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 71.01 110.814 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.752 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.33 129.42 24.89 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 75.23 110.946 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -33.01 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 65.24 112.375 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.702 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.32 102.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.44 111.101 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.9 m -72.88 116.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.32 111.063 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.7 33.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.733 -0.746 . . . . 25.4 112.48 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.844 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.97 -29.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 73.41 111.087 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -75.11 -23.37 57.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 60.43 110.912 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.06 -5.41 57.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.7 140.33 58.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.906 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 -135.37 4.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 54.21 112.472 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.4 135.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 64.34 111.093 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.717 ' CE2' HD22 ' A' ' 64' ' ' LEU . 26.7 t80 -101.71 138.5 38.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.906 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -138.83 128.12 24.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.899 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.3 t -125.26 157.33 36.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 63.14 110.831 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.423 ' HB3' ' C6 ' ' A' ' 201' ' ' IOR . 10.8 pt20 -138.0 140.08 39.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.891 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.09 162.71 30.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.082 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ttm -129.56 124.99 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.864 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -90.88 172.81 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.894 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -71.1 -18.77 62.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.81 -20.33 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 60.34 110.946 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.58 35.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -85.06 146.04 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 61.24 110.877 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.51 143.26 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.52 110.864 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -105.72 130.4 53.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 51.03 111.173 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -107.1 145.69 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.957 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 124.55 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 71.25 110.847 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.5 128.79 52.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 73.24 110.912 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -131.19 122.23 26.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.35 110.906 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.34 124.5 30.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 70.13 110.872 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 6' ' ' ILE . 74.1 t -118.7 139.45 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.126 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 129.05 42.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 65.21 110.919 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.844 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 m -88.41 -175.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.168 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.32 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 72.22 110.92 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.31 142.35 57.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 73.03 110.9 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.35 159.75 48.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 72.21 111.161 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.82 162.02 43.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 72.54 112.277 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.24 82.49 0.1 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 34.04 112.419 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.4 tttt 52.19 73.46 0.95 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 73.11 110.955 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -179.17 2.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.691 2.261 . . . . 65.01 112.347 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.842 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.423 ' C6 ' ' HB3' ' A' ' 80' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.511 -0.236 . . . . 71.21 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 t 63.01 105.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.388 . . . . 72.14 110.866 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.39 71.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 74.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.06 139.39 30.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 61.15 110.849 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.4 m-80 -82.4 121.09 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 75.22 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mm -125.11 122.05 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.201 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.64 142.13 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.3 111.11 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -146.96 166.25 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 63.3 111.116 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.96 148.57 48.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 60.24 110.866 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.29 121.25 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 72.3 111.198 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.0 5.01 90.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.532 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.96 141.87 23.5 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 61.43 110.892 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.87 52.36 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.783 2.322 . . . . 63.22 112.284 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 8' ' ' ALA . 65.2 tp -144.6 143.16 30.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 63.4 110.881 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.8 t -121.13 146.73 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 75.3 111.172 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.58 HD12 HD23 ' A' ' 64' ' ' LEU . 98.3 mt -131.48 149.94 52.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.953 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -111.91 150.55 30.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 62.23 110.872 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.9 t -108.73 101.2 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -57.1 124.99 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 51.11 110.913 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.74 -39.33 2.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 71.32 112.497 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.18 132.03 35.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.571 0.7 . . . . 70.34 111.089 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -164.96 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.649 2.232 . . . . 64.41 112.309 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -47.83 -51.84 21.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.41 110.882 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 1.4 tptt -111.22 147.48 36.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 63.45 110.961 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 109.7 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.704 2.269 . . . . 64.32 112.364 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.5 Cg_endo -69.74 -73.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.622 2.214 . . . . 63.34 112.389 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.47 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 3.2 mp0 -102.36 -177.24 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 70.13 110.864 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 mtm-85 -63.63 148.07 49.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.925 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -146.27 151.15 37.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.92 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.62 148.58 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.887 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.654 ' HE1' HD13 ' A' ' 29' ' ' LEU . 28.6 m95 -122.79 137.03 55.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 73.25 110.969 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 139.79 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 72.04 110.874 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 34' ' ' ASN . 9.1 tp -137.99 136.08 36.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 75.41 110.889 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.7 m-80 -114.63 127.43 55.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.899 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -138.85 176.79 8.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.42 -130.81 16.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 73.0 112.445 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.53 -37.35 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 73.21 110.873 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -178.76 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.33 111.18 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.605 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.8 mt-10 -101.99 32.8 3.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 70.33 110.931 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.79 -5.88 6.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.503 . . . . 71.23 111.115 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -59.4 132.27 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 73.45 110.893 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.671 ' HE3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.51 153.33 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.871 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.0 t -100.17 122.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.195 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD13 HD13 ' A' ' 64' ' ' LEU . 20.4 mt -89.29 143.6 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 62.51 110.884 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.33 42.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 71.11 110.9 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -1.76 9.08 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 61.32 112.294 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -127.34 81.11 2.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.931 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -0.7 85.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.654 -0.784 . . . . 73.44 112.457 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.78 100.13 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 52.44 112.48 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.36 -75.05 0.36 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 75.11 112.547 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.55 4.32 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.642 2.228 . . . . 75.14 112.374 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 23.9 p-90 -50.65 -35.48 30.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.8 -24.18 62.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 72.31 110.834 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.76 -42.71 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.879 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.671 HG12 ' HE3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -121.71 -98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 62.33 111.117 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -164.82 176.17 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 63.43 111.113 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -113.35 160.58 18.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 63.42 110.836 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 t -109.54 129.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 53.31 111.154 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.6 mt -68.55 158.51 85.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.678 . . . . 73.44 110.942 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.88 32.91 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.712 2.275 . . . . 72.23 112.387 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.32 1.33 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 70.44 110.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.77 9.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.726 . . . . 71.13 112.531 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.563 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.2 m -112.22 -179.66 3.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 73.51 110.901 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 26.9 tp -128.9 128.27 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 53.14 110.857 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 15' ' ' VAL . 31.1 t80 -126.22 136.93 53.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 74.31 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -114.61 132.22 22.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.646 0.736 . . . . 64.21 110.871 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.8 15.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 74.11 112.272 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.19 100.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.29 -0.414 . . . . 62.11 111.17 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -74.13 112.98 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.23 111.129 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.97 163.08 37.71 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 71.32 112.47 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.875 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.86 -30.74 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.745 0.307 . . . . 64.02 111.146 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.15 -22.72 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.972 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -5.05 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.917 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -61.95 142.08 57.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 63.41 110.905 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.95 -142.88 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 62.31 112.476 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.445 HG23 ' ND2' ' A' ' 92' ' ' ASN . 3.5 mt -123.95 133.22 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.34 111.108 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 16' ' ' LEU . 7.0 t80 -104.75 140.14 38.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 64.52 110.849 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -135.23 142.39 45.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 55.12 110.868 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 155.81 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.862 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -140.7 129.28 22.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 53.1 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 162.19 31.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.115 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 ttm -130.65 125.08 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 63.53 110.889 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -89.59 172.28 9.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.865 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -71.68 -18.52 62.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.5 110.812 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -20.01 60.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.54 31.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 71.44 112.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -84.98 146.83 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 51.02 110.936 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.09 143.87 32.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 61.3 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 126.64 51.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 42.24 111.171 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 145.11 32.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 62.23 110.83 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -144.58 124.52 13.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.852 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -118.88 121.45 40.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 43.22 110.827 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -128.89 120.42 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 63.31 110.957 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.75 134.28 34.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.914 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.29 139.36 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 75.42 111.172 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -129.14 148.44 51.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.851 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.875 HG21 ' HA ' ' A' ' 71' ' ' ILE . 34.6 m -112.67 -177.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 63.12 111.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -66.35 -81.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.933 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -59.24 146.25 39.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.907 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.41 159.7 49.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.611 0.72 . . . . 74.43 111.154 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo -69.8 -38.76 7.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 74.44 112.345 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.72 54.53 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 74.25 112.543 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -142.93 160.58 52.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 71.55 110.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 177.82 5.23 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.233 . . . . 61.1 112.357 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.34 110.947 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.423 -0.271 . . . . 73.21 112.423 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.9 p -166.9 147.42 5.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 74.25 110.79 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.39 96.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 73.1 111.058 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.85 133.79 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.896 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.421 ' C ' HD12 ' A' ' 6' ' ' ILE . 4.5 p30 -84.29 119.62 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 62.32 110.862 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.0 mp -126.52 123.54 63.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 62.11 111.096 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -94.78 140.83 29.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 71.0 111.116 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.72 167.27 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 73.45 111.113 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -124.25 148.32 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.22 110.909 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 71' ' ' ILE . 24.9 mt -53.83 121.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.23 111.125 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.65 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.72 3.97 79.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 53.03 112.45 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 14.9 mm-40 -101.1 140.33 21.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.11 110.867 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 142.28 47.59 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.676 2.251 . . . . 55.23 112.339 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 6' ' ' ILE . 23.0 tp -144.43 141.97 29.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 72.32 110.912 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 65' ' ' PHE . 41.8 t -123.34 147.97 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.116 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.835 HD12 HD23 ' A' ' 64' ' ' LEU . 94.4 mt -131.5 148.6 52.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 72.52 110.983 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -110.49 149.0 30.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.45 110.923 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 101.19 9.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 62.43 110.85 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.19 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 62.51 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.45 -46.62 0.68 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.725 -0.75 . . . . 65.14 112.497 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.0 103.7 12.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.603 0.716 . . . . 75.42 111.148 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.6 Cg_endo -69.68 -163.25 0.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 65.5 112.366 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.6 -9.48 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.914 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -45.47 168.34 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.583 0.706 . . . . 70.43 110.878 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.5 Cg_endo -69.69 172.85 11.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.756 2.304 . . . . 63.43 112.305 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.76 95.1 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 74.12 112.327 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.92 -174.3 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.902 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -63.62 131.77 49.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 72.41 110.855 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp -179.41 157.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.54 110.928 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.13 148.62 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 54.05 110.861 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.647 ' HE3' HD21 ' A' ' 33' ' ' LEU . 5.0 m95 -127.67 132.76 49.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.856 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.7 mtmt -137.6 135.41 36.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 75.11 110.871 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.082 HD11 HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -139.93 138.84 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.881 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -112.95 127.63 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 74.23 110.848 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.1 p -137.22 179.77 6.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.149 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 -127.71 13.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 74.52 112.48 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 38' ' ' THR . 2.8 tpt180 -114.33 -37.49 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 74.13 110.823 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -179.09 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 61.14 111.158 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -99.98 32.91 2.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.895 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.76 -6.24 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 42.12 111.139 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -60.71 131.25 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 73.52 110.93 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 158.77 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.35 110.877 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.06 118.73 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.082 HD12 HD11 ' A' ' 33' ' ' LEU . 1.5 mt -90.25 145.78 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.954 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.03 162.74 43.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 63.44 110.881 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 0.16 6.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.237 . . . . 60.22 112.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -119.46 72.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.74 10.0 62.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 34.21 112.388 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.93 102.26 0.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.787 -0.721 . . . . 70.05 112.487 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 132.33 -67.46 0.56 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.73 -0.748 . . . . 52.34 112.434 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -1.28 8.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.609 2.206 . . . . 74.01 112.371 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -34.08 34.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 71.33 110.856 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.45 -28.05 68.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 75.05 110.855 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.31 -42.29 10.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 62.15 110.83 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -125.71 -96.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 61.2 111.028 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -162.52 174.44 12.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 71.22 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 162.06 23.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 72.03 110.881 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.27 130.15 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.12 111.18 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.4 mt -69.54 158.86 85.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 73.21 110.869 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -23.41 30.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 61.11 112.37 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -83.79 0.48 47.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 62.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.2 25.24 19.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 54.14 112.497 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.582 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -105.84 -179.43 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 61.13 110.911 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.835 HD23 HD12 ' A' ' 16' ' ' LEU . 13.7 tp -130.03 129.97 44.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 63.45 110.931 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 15' ' ' VAL . 36.9 t80 -125.37 128.83 48.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 73.25 110.817 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.2 mp -120.26 130.02 25.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.647 0.737 . . . . 63.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.36 18.95 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 73.33 112.343 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.65 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.24 101.71 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 63.44 111.057 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -73.09 119.33 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 72.44 111.124 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.03 161.91 33.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 62.2 112.533 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.755 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.59 -31.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.779 0.323 . . . . 74.44 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -75.05 -23.16 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.12 110.843 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.44 -5.48 45.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 70.12 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 140.48 58.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.868 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.36 -141.72 8.19 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 62.4 112.547 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.453 HG21 HD22 ' A' ' 92' ' ' ASN . 1.3 mp -123.5 133.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 51.13 111.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 10.7 m-85 -104.48 139.95 38.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 65.32 110.876 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HG2' ' ND2' ' A' ' 92' ' ' ASN . 9.8 mtt180 -135.41 142.01 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 75.3 110.882 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 41.8 t -128.91 150.43 50.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.3 126.75 21.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 71.41 110.925 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.97 163.06 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 34.32 111.124 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.7 ttm -129.35 125.02 35.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 62.04 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.25 172.55 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 62.12 110.905 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -70.96 -18.54 62.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 65.12 110.839 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -73.83 -25.83 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 75.54 110.85 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.78 -14.24 19.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 42.11 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.35 147.88 26.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.717 0.294 . . . . 72.33 110.882 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.12 142.49 34.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 65.11 110.911 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.69 126.29 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.137 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 144.2 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.901 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.1 m -146.9 126.7 13.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.04 110.91 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 16.0 t-20 -119.22 126.91 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.919 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 16' ' ' LEU . 8.3 m-85 -124.1 120.96 33.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 65.25 110.974 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NE ' ' HB1' ' A' ' 3' ' ' ALA . 20.1 mmt85 -83.53 130.07 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.12 110.799 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.02 134.2 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 74.21 111.121 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.454 ' NH1' HG21 ' A' ' 100' ' ' ILE . 0.8 OUTLIER -131.45 127.92 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.5 m -95.66 -177.67 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 60.35 111.068 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -66.76 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.898 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -62.48 143.83 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 73.11 110.882 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -121.37 159.72 48.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 63.51 111.124 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.73 123.92 10.59 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.23 112.311 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.33 -115.94 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 51.02 112.486 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 160.59 1.16 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 72.24 110.864 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 172.88 11.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.644 2.229 . . . . 75.1 112.321 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 65.22 110.889 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.459 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.528 -0.229 . . . . 62.45 112.528 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -178.25 158.99 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 71.54 110.886 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.32 93.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.53 111.09 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.436 ' OE1' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -93.39 131.46 38.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 74.34 110.925 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.672 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.8 m120 -88.34 120.54 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 52.43 110.881 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.672 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.87 128.37 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 62.32 111.112 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -89.3 141.09 28.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 72.01 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.13 165.95 26.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 71.22 111.134 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 150.06 43.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.829 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 22.7 mt -68.76 120.61 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.75 -6.34 60.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 73.12 112.49 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 pp20? -102.09 141.09 21.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.41 110.842 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 145.69 58.03 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.43 112.347 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 tp -137.95 143.07 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 72.25 110.914 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 65' ' ' PHE . 39.1 t -122.09 145.0 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.31 111.133 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 30.4 mt -131.3 149.48 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.16 152.75 27.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 72.11 110.972 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -106.31 101.78 11.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.861 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -58.76 120.38 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 61.55 110.864 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.22 -42.79 1.46 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 60.33 112.451 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.32 128.6 46.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 71.41 111.083 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -165.14 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 64.33 112.36 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.12 -52.22 27.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 62.03 110.88 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 11.1 tptt -112.44 129.27 24.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 75.34 110.879 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.3 Cg_endo -69.77 109.72 2.38 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.254 . . . . 72.54 112.309 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.3 Cg_endo -69.76 -54.83 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.67 2.247 . . . . 71.22 112.351 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -105.91 -179.32 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 61.31 110.921 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -71.38 162.47 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 74.02 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.484 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -155.24 157.85 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 64.11 110.931 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.6 144.81 47.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 52.32 110.96 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' HE1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -126.22 136.88 53.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.156 -0.474 . . . . 65.25 110.948 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -144.36 136.4 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 53.25 110.82 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.5 tp -138.95 136.81 35.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 73.44 110.887 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.627 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -113.45 127.13 56.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.868 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.793 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.6 p -137.99 179.39 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 74.45 111.108 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.39 -131.18 16.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 73.12 112.528 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.5 -37.29 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 63.43 110.89 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -179.4 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 75.21 111.133 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.09 33.32 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 74.11 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.61 -7.21 7.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 63.43 111.101 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -60.36 130.59 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 153.46 47.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 73.34 110.846 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.04 121.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 55.24 111.101 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.82 145.84 24.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 61.35 110.946 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.56 163.13 40.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.723 . . . . 74.05 110.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.77 2.82 3.19 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.675 2.25 . . . . 51.2 112.366 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -115.46 101.63 9.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 61.5 110.914 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 69.4 0.53 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.77 . . . . 62.52 112.479 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.77 138.56 9.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 71.25 112.423 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.31 -115.43 5.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 70.12 112.469 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -14.26 35.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.717 2.278 . . . . 72.55 112.374 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.477 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 4.8 m-90 -62.95 -34.56 77.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 70.43 110.914 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.39 -24.27 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 34.31 110.825 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -33.76 68.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 71.31 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.26 -73.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 53.24 111.091 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.85 154.7 37.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 44.41 111.135 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -132.54 160.18 37.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 74.33 110.9 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 46' ' ' PRO . 7.0 t -109.0 129.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 71.1 111.113 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 36.0 mt -70.28 158.82 86.65 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 52.45 110.934 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -21.87 33.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 63.51 112.339 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -83.16 1.83 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 72.14 110.884 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.21 29.69 14.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 64.43 112.472 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.8 m -113.9 -178.9 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 44.21 110.88 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 23.8 tp -129.47 127.62 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.901 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 15' ' ' VAL . 6.5 t80 -125.9 136.05 52.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 65.44 110.879 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.62 HD22 HG12 ' A' ' 69' ' ' VAL . 7.7 mp -119.29 130.22 24.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.636 0.732 . . . . 63.5 110.895 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.93 17.37 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.28 . . . . 61.01 112.308 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.77 102.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 74.01 111.105 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 12' ' ' GLU . 18.5 m -72.74 119.2 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.45 111.039 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.16 161.55 27.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 70.1 112.53 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.15 -32.26 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 72.55 111.079 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -76.01 -22.51 55.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 72.05 110.918 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -4.98 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 71.33 110.84 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.32 141.3 57.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 70.44 110.913 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.08 -138.95 5.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.743 . . . . 54.41 112.48 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.412 HG23 HD21 ' A' ' 92' ' ' ASN . 2.4 mp -123.95 130.35 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 61.15 111.132 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.552 ' CG ' HD13 ' A' ' 16' ' ' LEU . 10.8 t80 -105.49 134.17 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.84 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.56 139.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 74.53 110.817 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.5 t -125.5 156.3 39.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 53.43 110.896 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -140.75 134.67 30.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.14 110.908 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 162.36 32.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.143 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.8 mtp -130.16 125.24 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.908 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -91.51 172.43 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.827 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -18.87 62.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.51 110.864 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -73.94 -20.43 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.907 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.99 -15.33 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 55.43 112.414 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 146.18 27.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 70.32 110.88 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -106.16 143.63 34.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.87 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 129.46 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 70.12 111.16 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 145.11 35.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.858 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.21 121.53 10.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 53.13 110.9 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.8 OUTLIER -118.37 124.37 47.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 73.14 110.832 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -129.82 117.93 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 73.42 110.827 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -84.24 130.6 34.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.873 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.08 140.32 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 73.2 111.118 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.23 127.73 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.7 m -88.69 -176.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.04 111.107 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.6 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.937 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 140.74 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.885 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.71 159.63 50.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.654 0.74 . . . . 74.44 111.074 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 100.04 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.68 2.254 . . . . 74.04 112.274 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.08 -37.64 2.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 74.04 112.488 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -51.83 137.51 34.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.532 0.682 . . . . 74.33 110.946 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.64 0.49 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.647 2.231 . . . . 42.02 112.342 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.893 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.428 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.516 -0.234 . . . . 72.21 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -179.71 112.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 40.41 110.856 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.33 66.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 62.44 111.108 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.57 133.55 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 73.05 110.934 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -84.01 121.03 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 70.31 110.888 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 14' ' ' LEU . 43.6 mm -125.4 121.78 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.44 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.98 138.77 33.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.45 . . . . 74.11 111.093 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 166.88 26.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.122 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -120.93 148.35 44.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.841 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mt -52.61 121.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 61.42 111.058 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.73 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.61 7.19 72.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 51.02 112.515 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.767 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.7 mm-40 -101.37 139.43 20.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 52.13 110.939 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 143.15 49.62 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 75.42 112.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 6' ' ' ILE . 19.1 tp -145.44 142.04 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 73.41 110.859 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.13 148.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 65.22 111.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.781 HD12 HD23 ' A' ' 64' ' ' LEU . 9.2 mt -131.14 147.21 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.906 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -113.26 154.89 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.902 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 t -104.06 100.57 10.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 74.45 110.893 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.64 116.56 4.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 61.44 110.901 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 89' ' ' THR . . . 124.76 -42.81 1.47 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.786 -0.721 . . . . 73.25 112.504 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.02 40.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.545 0.688 . . . . 74.02 111.14 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.9 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 72.12 112.25 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -48.98 -52.58 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -111.95 129.7 23.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 74.44 110.863 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.8 Cg_endo -69.73 110.13 2.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.594 2.196 . . . . 71.03 112.346 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.8 Cg_endo -69.77 -51.16 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.696 2.264 . . . . 73.43 112.406 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -104.36 -178.74 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 71.32 110.897 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.0 mmm-85 -65.55 158.89 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 72.3 110.81 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.788 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -154.49 166.85 32.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 64.14 110.932 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -145.55 148.54 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.855 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.788 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 29.0 m-90 -120.64 132.07 54.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 72.53 110.897 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' HD23 ' A' ' 33' ' ' LEU . 2.1 ttpt -139.97 135.9 33.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.952 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -148.1 140.05 24.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 74.52 110.945 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.95 128.74 55.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 44.31 110.927 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -136.33 -179.73 5.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 72.25 111.166 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.68 -129.14 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 72.33 112.549 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.51 -37.45 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 65.44 110.906 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.4 t -179.32 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.156 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.8 mt-10 -102.26 33.93 2.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 74.15 110.841 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.63 -6.32 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.54 111.148 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.73 130.2 45.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.942 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.619 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -130.8 152.97 49.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 75.33 110.882 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.85 120.66 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.31 111.189 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 33' ' ' LEU . 3.3 mm? -89.88 146.71 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.44 46.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 64.51 110.93 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.73 -1.92 9.26 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 73.11 112.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -128.17 71.77 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 63.2 110.974 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -91.85 -33.59 7.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 73.21 112.453 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . -21.67 120.92 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.804 -0.712 . . . . 73.31 112.527 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.11 -124.32 4.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 52.14 112.512 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HG2' ' CE3' ' A' ' 52' ' ' TRP . 54.2 Cg_endo -69.82 -6.0 17.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.734 2.289 . . . . 75.1 112.343 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.56 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 1.2 m-90 -62.88 -14.18 43.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 65.21 110.915 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 6.3 p-10 -68.44 -23.13 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 63.24 110.832 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -33.79 76.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 43.21 110.937 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -123.1 -71.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 72.42 111.133 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -155.86 156.4 34.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 55.41 111.137 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.56 ' HG3' ' HB3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -131.64 161.18 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.11 110.937 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 44' ' ' LEU . 24.9 t -109.0 129.93 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.11 111.042 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.45 158.98 86.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.7 . . . . 71.33 110.899 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -20.98 33.91 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.608 2.205 . . . . 71.24 112.294 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -83.12 1.59 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 74.34 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.39 25.17 26.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 61.03 112.505 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -110.84 -178.72 3.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.22 110.823 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' CE2' ' A' ' 77' ' ' PHE . 10.7 tp -129.72 127.57 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.917 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -126.12 132.51 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.904 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 69' ' ' VAL . 4.8 mp -118.54 129.61 25.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.663 0.744 . . . . 74.2 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.74 17.86 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.739 2.293 . . . . 65.45 112.313 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.73 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.76 101.29 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 25.51 111.044 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 66' ' ' LEU . 12.2 m -73.35 116.71 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 70.21 111.1 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.4 165.35 33.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 74.23 112.512 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.85 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.78 -30.17 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 72.44 111.111 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.853 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -5.0 56.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 64.32 110.821 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.69 140.94 58.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.76 -141.56 7.87 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 31.52 112.528 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD12 ' CG ' ' A' ' 94' ' ' ARG . 47.1 mm -124.41 127.72 73.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 63.32 111.115 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.787 ' CE2' HD22 ' A' ' 64' ' ' LEU . 11.2 t80 -104.66 134.18 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.22 110.897 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -127.92 146.5 50.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 72.33 110.837 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.4 t -126.25 153.87 44.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.922 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.04 130.82 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 71.11 110.887 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.55 162.58 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 65.12 111.105 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.4 ttm -130.32 125.01 33.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.919 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -89.14 172.23 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.42 110.836 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.53 -18.61 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 72.42 110.853 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -73.57 -20.23 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.21 110.829 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.91 -17.44 29.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 64.1 112.49 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -84.81 147.9 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 71.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -104.01 149.18 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.875 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.478 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.14 133.5 48.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.131 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 143.41 33.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 53.13 110.921 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.5 m -145.23 122.74 11.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 61.3 110.831 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.7 OUTLIER -119.66 124.36 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 73.04 110.925 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -128.37 119.83 25.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 55.23 110.89 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.576 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.9 132.15 34.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 73.11 110.823 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.88 136.26 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 73.54 111.118 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.432 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -131.12 131.58 44.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.849 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.8 m -95.87 -175.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 54.41 111.171 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -66.39 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.23 110.867 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -62.85 146.33 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 75.34 110.943 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.56 49.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.688 0.756 . . . . 63.25 111.081 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo -69.72 -177.19 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 54.33 112.329 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.3 66.43 3.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.761 . . . . 71.3 112.463 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -142.92 137.66 15.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 71.15 110.918 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.48 48.19 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.723 2.282 . . . . 74.42 112.345 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.33 110.81 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.459 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.502 -0.239 . . . . 43.43 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 57.53 83.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.949 0.404 . . . . 73.13 110.903 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.9 71.11 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.059 -0.519 . . . . 55.21 111.082 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 133.28 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.946 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.45 119.13 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 60.44 110.887 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 14' ' ' LEU . 3.8 mp -126.44 124.64 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.136 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -93.51 142.25 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 55.2 111.115 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.43 166.57 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.32 111.029 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.61 148.28 46.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 62.32 110.92 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mt -54.9 121.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 42.34 111.173 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.41 76.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 72.52 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.9 mm-40 -101.91 140.7 21.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.689 0.757 . . . . 74.13 110.899 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 144.03 52.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.664 2.242 . . . . 64.11 112.331 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 6' ' ' ILE . 22.3 tp -143.54 141.31 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 75.01 110.907 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.0 t -122.44 147.19 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 62.54 111.131 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 53.4 mt -130.97 148.28 52.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.899 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -112.07 151.82 28.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.807 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 t -107.18 100.76 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.853 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.1 120.22 8.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.892 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.49 -39.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 62.3 112.515 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 128.64 54.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.709 . . . . 61.54 111.077 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -165.13 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.686 2.257 . . . . 51.44 112.352 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -48.2 46.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.915 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -109.69 150.35 41.15 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.596 0.713 . . . . 61.23 110.891 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.87 109.59 2.37 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 70.13 112.359 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.8 Cg_endo -69.73 -80.68 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.743 2.295 . . . . 73.14 112.353 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.438 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 21.6 mm100 -103.24 -176.46 3.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 65.51 110.837 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -62.9 148.26 47.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 61.44 110.887 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.68 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.58 150.79 37.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 62.43 110.951 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -121.51 148.62 44.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 60.14 110.878 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.68 ' HE1' HD13 ' A' ' 29' ' ' LEU . 23.5 m95 -123.11 138.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.876 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.711 ' C ' HD13 ' A' ' 33' ' ' LEU . 89.0 mttt -150.97 135.76 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.24 110.94 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.25 145.94 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.889 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.99 129.43 56.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.943 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.842 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -138.42 -179.58 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 54.24 111.157 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.89 -132.78 16.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 71.22 112.53 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.79 -37.69 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 73.22 110.882 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -179.12 -29.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.098 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.53 34.81 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.874 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.09 -4.23 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.21 111.06 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -57.32 128.05 35.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.725 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.16 156.64 47.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 74.03 110.873 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' LYS . 94.7 t -105.5 122.24 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 73.21 111.125 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 33' ' ' LEU . 4.0 mt -89.91 147.14 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 61.31 110.864 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.77 162.21 46.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.73 0.776 . . . . 54.51 110.846 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.81 -2.62 10.52 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.687 2.258 . . . . 64.31 112.319 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -119.96 72.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.899 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.64 -2.53 85.47 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 53.54 112.389 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.42 109.84 0.89 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.76 . . . . 61.24 112.488 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.76 -76.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.43 112.504 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -0.65 7.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.725 2.283 . . . . 75.11 112.332 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 57' ' ' ARG . 13.1 p-90 -52.38 -35.74 52.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.835 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -24.27 61.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.866 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -43.37 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 54.01 110.869 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.24 -97.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.45 111.174 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -151.28 173.49 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 72.1 111.137 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -127.06 162.8 25.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.916 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 46' ' ' PRO . 8.1 t -106.75 130.95 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 75.4 111.167 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD12 ' CB ' ' A' ' 63' ' ' SER . 31.1 mt -68.7 157.69 87.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 74.32 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -22.16 32.65 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.669 2.246 . . . . 63.34 112.365 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.7 1.2 43.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.46 29.83 11.65 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 21.12 112.438 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.55 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -112.86 -179.6 3.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 64.12 110.87 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 16.3 tp -129.51 129.24 44.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.32 110.873 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' HG22 ' A' ' 15' ' ' VAL . 44.8 t80 -124.63 136.72 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.21 110.881 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.574 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -116.41 124.79 29.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.35 110.913 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.71 19.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 73.42 112.375 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.49 103.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.076 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 12' ' ' GLU . 34.4 m -71.62 118.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 72.43 111.124 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.58 157.44 23.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 75.5 112.506 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.831 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -32.02 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 72.45 111.127 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -75.6 -23.4 56.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -5.26 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 52.43 110.823 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 142.01 56.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 52.44 110.918 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.22 -138.17 5.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.798 -0.715 . . . . 74.02 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.68 127.32 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 71.04 111.195 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 14.6 m-85 -104.78 144.49 31.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 63.25 110.853 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -138.27 143.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 71.34 110.865 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.8 t -127.21 155.66 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.31 110.891 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.14 133.8 30.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.926 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.5 162.71 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 51.54 111.089 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 mtp -129.94 125.12 34.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.11 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -91.39 172.51 8.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 41.42 110.876 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.45 -18.81 62.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 74.14 110.852 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.06 -20.57 60.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.872 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.02 -15.21 33.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.83 -0.7 . . . . 45.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -85.02 146.35 27.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.742 0.306 . . . . 74.43 110.893 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 144.26 33.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.89 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 132.15 50.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 65.31 111.189 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 145.14 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.937 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -145.34 127.9 16.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.01 110.825 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 16.6 t-20 -116.97 124.93 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 74.23 110.849 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -125.41 121.6 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 72.2 110.944 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -83.07 133.03 35.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.31 110.874 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -120.95 134.82 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 71.11 111.219 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 128.79 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.872 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.8 m -98.33 -177.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 73.4 111.198 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.55 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.954 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.89 144.53 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 72.3 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.4 159.61 49.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 74.15 111.125 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.9 Cg_endo -69.82 -38.59 7.46 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.686 2.258 . . . . 64.03 112.319 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.99 97.8 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 54.01 112.451 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -178.96 157.75 0.94 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 73.53 110.802 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 168.13 22.53 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.681 2.254 . . . . 62.32 112.294 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.87 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.459 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.465 -0.254 . . . . 72.14 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 179.84 109.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 70.13 110.894 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.69 66.91 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 43.22 111.084 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -93.23 131.94 37.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.41 110.916 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.3 p-10 -90.83 121.85 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.887 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.58 127.42 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.137 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -94.52 142.52 27.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 61.42 111.179 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.35 168.44 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 64.3 111.061 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.43 148.06 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.596 HD11 HG13 ' A' ' 71' ' ' ILE . 33.8 mt -67.28 121.99 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.06 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.17 -9.96 54.58 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.675 -0.774 . . . . 74.41 112.429 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.71 142.66 25.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.723 . . . . 72.45 110.862 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 145.07 56.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 63.24 112.334 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.0 tp -139.71 144.44 37.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 74.4 110.909 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.608 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.9 t -120.46 145.03 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 63.44 111.104 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.3 mt -131.28 147.78 52.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.41 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -113.62 150.87 32.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 61.14 110.924 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.11 100.26 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 72.14 110.894 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -54.27 128.41 31.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.02 110.939 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.81 -42.1 1.59 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.727 . . . . 74.35 112.472 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.99 130.87 36.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.522 0.677 . . . . 60.1 111.13 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -168.47 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.703 2.268 . . . . 72.33 112.358 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -49.99 -54.57 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.905 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 tptt -113.91 128.12 26.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 73.35 110.876 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.542 ' HB3' HD21 ' A' ' 29' ' ' LEU . 52.9 Cg_endo -69.88 109.77 2.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 74.33 112.271 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.5 Cg_endo -69.82 -54.32 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.628 2.218 . . . . 30.21 112.312 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -178.4 3.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 75.15 110.893 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -65.49 162.28 18.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.823 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -163.13 147.04 10.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 60.52 110.888 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.71 148.44 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 63.34 110.895 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.782 ' CZ3' HG11 ' A' ' 58' ' ' VAL . 3.3 m-90 -134.47 144.11 47.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 64.14 110.982 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.452 ' C ' HD23 ' A' ' 33' ' ' LEU . 4.4 mtmt -136.21 142.05 44.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.24 110.924 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.003 HD21 HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.4 139.03 42.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 73.1 110.936 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -112.12 127.29 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.33 110.901 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 43.7 p -138.16 -179.8 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 71.21 111.141 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.44 -129.97 23.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.852 -0.689 . . . . 74.33 112.435 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -112.61 -37.4 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 73.42 110.897 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.1 t -178.69 -29.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 65.31 111.174 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -101.73 34.07 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 74.5 110.887 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -5.54 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.123 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.544 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 44.0 t90 -59.62 131.82 52.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 70.01 110.929 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.768 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.03 155.07 45.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.935 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.544 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 23.1 t -104.48 121.75 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 70.55 111.137 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.003 HD13 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -88.86 143.13 27.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.41 110.911 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -127.93 164.09 39.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 65.35 110.808 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 0.85 5.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.707 2.271 . . . . 63.1 112.277 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -131.07 75.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 74.04 110.899 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -0.81 86.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 43.15 112.494 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.86 112.03 4.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 71.44 112.523 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.67 -72.65 0.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 73.22 112.462 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -3.21 11.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.693 2.262 . . . . 71.52 112.327 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -34.63 49.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 73.52 110.949 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.61 -25.55 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.39 -43.67 10.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 71.52 110.829 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.58 -96.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 53.41 111.134 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -149.18 174.56 12.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.25 111.116 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.52 160.2 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.85 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG11 ' CZ3' ' A' ' 31' ' ' TRP . 65.7 t -111.9 129.25 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.158 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 63' ' ' SER . 86.4 mt -69.29 157.19 90.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 74.02 110.929 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.41 34.81 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.75 2.3 . . . . 73.42 112.278 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -82.41 0.57 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 63.42 110.863 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 27.39 17.37 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 54.34 112.443 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 59' ' ' LEU . 30.4 m -111.77 175.73 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.852 0.358 . . . . 50.44 110.896 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.843 HD13 HD21 ' A' ' 44' ' ' LEU . 16.5 tp -129.34 130.11 45.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.865 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.608 ' CD2' HG22 ' A' ' 15' ' ' VAL . 27.7 t80 -124.42 135.39 53.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 62.41 110.852 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.56 129.51 24.87 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 72.05 110.917 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.62 -31.68 20.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.285 . . . . 73.23 112.414 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.55 104.36 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 61.1 111.145 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.4 m -71.83 119.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 40.23 111.163 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.93 153.49 20.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 31.05 112.447 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.02 -31.18 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 54.45 111.151 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.28 -22.01 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 61.14 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.35 -3.53 34.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.839 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.785 ' CD ' HG22 ' A' ' 97' ' ' VAL . 16.8 mt-10 -58.43 142.17 49.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.1 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.46 -151.74 22.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 73.52 112.561 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.29 133.98 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 64.3 111.107 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.75 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.3 m-85 -103.04 139.38 38.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.87 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.52 141.04 51.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 m -126.82 150.24 49.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 73.13 110.891 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.07 125.51 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.881 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.43 163.97 28.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 64.15 111.091 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.8 ttm -128.34 124.88 37.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.907 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -86.91 173.15 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 73.22 110.871 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -70.22 -17.97 63.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.87 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -73.23 -19.74 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 63.25 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.36 -18.78 32.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 71.15 112.43 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -85.16 148.2 26.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 75.31 110.916 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.5 143.61 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 64.05 110.895 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.55 131.6 51.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 54.04 111.127 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 145.34 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.43 110.93 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -146.32 124.41 12.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 72.11 110.846 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 14.4 t-20 -118.82 124.6 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.857 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.24 117.02 20.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.927 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -90.9 136.11 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.928 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.18 138.57 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 54.2 111.134 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.21 128.14 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 70.05 110.855 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -92.2 -175.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.24 111.11 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -65.98 -80.62 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -58.67 146.67 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 61.04 110.847 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.31 159.49 49.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.693 0.759 . . . . 74.14 111.132 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo -69.78 -33.6 16.19 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 72.2 112.368 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.4 75.37 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 71.11 112.458 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 tttp 57.29 72.72 0.88 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 64.35 110.898 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 128.63 16.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.25 . . . . 72.42 112.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 73.14 110.895 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.47 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.426 -0.27 . . . . 71.2 112.426 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -168.11 171.34 9.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 52.32 110.87 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.47 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 72.02 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -93.44 132.42 37.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.863 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.668 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.0 p30 -87.13 119.96 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.898 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.668 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -127.78 127.47 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.117 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -92.11 141.88 28.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 71.42 111.102 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.54 167.58 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.45 111.073 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.78 149.68 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.5 110.885 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 71' ' ' ILE . 22.5 mt -67.47 120.7 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.122 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.69 -8.29 59.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.691 -0.766 . . . . 61.22 112.468 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.08 140.81 21.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.701 . . . . 64.42 110.911 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 145.11 55.98 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.704 2.269 . . . . 74.54 112.33 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 66' ' ' LEU . 20.2 tp -142.35 143.4 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 71.44 110.917 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 64' ' ' LEU . 13.7 t -122.49 148.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 74.24 111.146 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 64' ' ' LEU . 29.6 mt -129.85 149.1 51.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 74.4 110.934 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -108.8 149.56 28.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 61.33 110.878 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.3 t -112.12 100.69 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 72.32 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.12 100.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 52.32 110.842 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 147.08 -46.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.799 -0.715 . . . . 63.3 112.51 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.6 102.75 10.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.538 0.685 . . . . 45.5 111.075 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.9 Cg_endo -69.73 -163.21 0.1 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.705 2.27 . . . . 71.1 112.341 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -61.58 -9.4 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 65.21 110.932 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -45.37 168.04 0.1 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.704 . . . . 73.44 110.891 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.1 Cg_endo -69.79 172.57 12.42 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.655 2.237 . . . . 73.44 112.377 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.4 Cg_endo -69.77 97.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 71.34 112.355 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -100.29 -175.01 2.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 75.1 110.893 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -63.55 132.06 50.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 64.33 110.819 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -179.43 158.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 72.52 110.937 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 148.33 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 72.55 110.912 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -127.59 137.92 52.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.923 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -135.72 138.57 42.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 73.25 110.957 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 35' ' ' THR . 1.2 tm? -137.3 131.53 32.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.948 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.738 ' N ' HD22 ' A' ' 33' ' ' LEU . 10.4 t-20 -116.53 120.68 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 45.25 110.939 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.81 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 54.8 p -138.36 179.39 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 71.55 111.191 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.61 -132.16 12.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 43.13 112.462 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 75.04 110.83 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.67 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 63.2 111.141 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.19 33.73 2.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.917 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.35 -6.01 7.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 74.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -69.24 130.59 43.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 63.31 110.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 159.32 42.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 74.41 110.875 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.73 121.48 43.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.071 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -89.63 146.12 24.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.05 110.94 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.96 162.7 43.99 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.614 0.721 . . . . 72.11 110.852 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 0.51 5.48 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.743 2.295 . . . . 75.33 112.335 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -119.34 89.23 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.899 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.79 4.69 50.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 54.2 112.475 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 101.59 0.22 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 73.42 112.52 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.49 -70.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 64.31 112.453 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.89 4.98 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.733 2.289 . . . . 74.11 112.316 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -50.77 -35.94 34.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 71.35 110.898 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -66.41 -26.08 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 74.42 110.921 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -41.77 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 62.41 110.881 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -124.09 -98.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 73.01 111.096 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . -166.58 177.09 6.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 64.21 111.101 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -112.01 161.04 16.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.11 110.932 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.36 128.16 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 55.12 111.139 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 63' ' ' SER . 26.3 mt -69.05 157.32 89.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.596 0.712 . . . . 72.11 110.925 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.3 Cg_endo -69.63 -22.96 31.95 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.638 2.225 . . . . 51.43 112.363 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -83.45 1.12 43.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 71.24 110.86 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.13 13.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 65.34 112.455 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.534 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m -109.67 177.19 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 53.32 110.79 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.4 tp -130.28 129.34 43.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 73.11 110.908 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 t80 -124.16 129.43 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.859 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 14' ' ' LEU . 1.9 mp -117.29 131.22 24.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 72.24 110.892 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -32.22 18.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 75.52 112.274 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 100.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.31 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.9 m -76.16 119.88 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.04 111.143 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -91.6 166.92 30.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.508 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.851 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.6 -30.83 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 74.44 111.156 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -74.8 -21.25 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 65.31 110.858 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.32 -3.08 31.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 65.2 110.804 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 139.71 58.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 61.24 110.869 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.98 -147.23 14.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.745 . . . . 52.54 112.516 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.91 133.78 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 63.23 111.118 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.583 ' CG ' HD23 ' A' ' 33' ' ' LEU . 36.9 m-85 -104.94 128.29 53.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 62.01 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.13 138.13 53.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 156.67 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 72.11 110.913 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -141.26 127.92 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 71.42 110.929 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.21 162.95 29.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.139 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.01 124.43 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 73.11 110.905 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -88.65 172.52 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.899 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -71.09 -18.39 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.05 110.823 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -73.62 -19.77 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 73.14 110.915 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.78 -16.88 33.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 35.02 112.417 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -84.96 147.61 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 63.43 110.937 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.31 143.79 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.46 125.6 50.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 54.24 111.15 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 144.76 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.21 110.888 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -145.55 121.27 10.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.834 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.8 OUTLIER -119.71 123.54 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 72.32 110.92 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -129.16 118.27 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 64.21 110.877 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.58 132.38 33.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.15 110.86 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.79 139.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 71.34 111.134 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 127.94 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.892 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.0 m -91.83 -177.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 70.34 111.138 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.51 110.943 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.1 142.52 51.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.93 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.29 159.59 49.27 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.555 0.693 . . . . 73.13 111.159 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -46.8 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.666 2.244 . . . . 73.24 112.338 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.72 -33.37 5.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 73.03 112.544 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -131.02 70.06 82.58 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.59 0.709 . . . . 74.3 110.882 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 155.59 65.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.614 2.209 . . . . 73.23 112.318 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 65.21 110.905 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' IOR . . . . . 0.419 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.471 -0.252 . . . . 62.32 112.471 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.74 111.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.7 p-10 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.41 -44.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 130.52 58.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 72.23 111.07 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.258 . . . . 54.44 112.306 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -48.34 -50.51 30.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.925 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 51.5 mmtt -110.07 153.47 43.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.644 0.735 . . . . 74.24 110.842 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 55.2 Cg_endo -69.67 109.52 2.31 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 55.4 112.412 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.66 -84.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.768 2.312 . . . . 73.45 112.386 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -176.24 3.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.53 110.902 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -62.73 149.01 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.873 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -145.7 155.43 42.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.911 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -120.32 74.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 57' ' ' ARG . . . -77.46 -1.45 76.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 34.15 112.501 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.82 103.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.696 -0.764 . . . . 74.55 112.471 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.75 -74.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 71.03 112.482 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -4.15 13.44 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.598 2.198 . . . . 72.41 112.406 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -34.64 57.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 70.31 110.951 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.81 -24.76 62.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 72.1 110.826 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.18 -42.96 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.803 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.16 -97.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 54.33 111.097 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -151.63 173.65 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.43 111.073 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo -69.78 156.76 62.44 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.72 -76.19 1.03 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 55.44 112.526 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -153.36 157.53 32.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 72.14 110.858 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.625 2.216 . . . . 72.43 112.411 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.919 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 73.11 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.32 71.67 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 43.2 111.094 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -93.11 135.6 34.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.939 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.37 120.97 27.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.859 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 14' ' ' LEU . 41.2 mm -125.95 121.94 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.45 111.15 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.83 138.62 33.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.142 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.33 166.98 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 73.22 111.118 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.06 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 65.25 110.849 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.98 121.64 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 51.53 111.117 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.27 3.96 78.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.513 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.758 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.6 mm-40 -101.43 139.76 20.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 74.32 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.38 50.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 45.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.647 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.7 tp -144.57 142.15 29.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 63.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.1 t -122.87 146.9 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 74.51 111.163 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 93' ' ' TYR . 56.1 mt -132.22 148.37 52.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.897 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -112.04 148.88 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.21 110.908 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.12 100.82 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.832 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.37 102.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 65.12 110.92 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.33 112.483 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.803 0.335 . . . . 74.41 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.31 146.77 46.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 62.32 110.873 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CH2' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.2 132.36 48.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 65.3 110.949 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -135.55 142.62 45.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 35' ' ' THR . 4.0 tp -138.42 134.41 34.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 63.44 110.933 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.1 t-20 -115.16 121.92 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.874 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.2 p -138.3 176.27 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 73.23 111.118 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.26 -131.15 13.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 32.22 112.51 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.66 -37.75 4.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 54.42 110.856 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.31 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 63.43 111.172 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 38' ' ' THR . 53.7 mt-10 -102.25 33.26 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.42 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.22 -6.74 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.169 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -61.92 131.32 49.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.53 110.934 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.45 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.903 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.2 t -100.62 120.66 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.33 111.151 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 31' ' ' TRP . 3.7 mm? -95.56 146.95 24.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 74.04 110.961 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.32 163.46 36.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 71.14 110.877 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.79 0.48 5.61 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.661 2.241 . . . . 74.43 112.32 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.931 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.776 0.322 . . . . 54.43 111.089 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.48 164.83 18.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.877 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 18.5 t -107.66 132.01 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.114 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 63' ' ' SER . 39.7 mt -68.63 158.76 84.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 74.2 110.896 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -25.11 28.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 74.13 112.313 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -83.57 2.06 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 72.14 110.905 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.33 32.46 8.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.12 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.717 ' HB3' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -111.78 -179.53 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 74.21 110.851 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.645 HD22 ' CH2' ' A' ' 31' ' ' TRP . 17.0 tp -130.47 129.59 43.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.965 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 15' ' ' VAL . 24.8 t80 -124.37 129.62 51.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.05 110.859 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.814 HD22 HG12 ' A' ' 69' ' ' VAL . 5.0 mp -116.57 130.74 24.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 64.05 110.934 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -32.61 18.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 72.21 112.352 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.63 101.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 71.23 111.084 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 HD22 ' A' ' 66' ' ' LEU . 13.8 m -73.69 118.59 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.11 111.169 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.07 163.99 30.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 60.23 112.473 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.855 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.36 -30.84 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 72.31 111.152 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -75.83 -23.26 55.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 63.44 110.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.93 -4.67 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.883 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.53 140.83 58.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 75.44 110.913 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.74 -138.55 5.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.482 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.64 135.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 64.2 111.132 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.8 m-85 -103.27 135.24 45.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 54.33 110.857 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -131.36 131.47 43.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.866 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 t -125.95 156.12 40.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.14 110.87 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.16 142.73 34.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 72.12 110.886 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.17 162.53 33.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 41.21 111.087 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.0 ttm -130.43 124.72 32.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.04 172.25 8.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 64.24 110.833 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -71.44 -19.35 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 65.15 110.871 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -74.08 -20.17 60.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.85 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.43 37.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 75.32 112.438 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.1 147.47 26.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 62.41 110.935 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.69 144.7 31.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 72.54 110.901 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 131.72 50.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.111 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.53 142.91 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 75.25 110.896 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.91 121.81 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 52.1 110.854 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 123.02 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.434 ' CD2' HD22 ' A' ' 16' ' ' LEU . 3.9 m-85 -125.86 120.11 29.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 75.41 110.926 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.0 130.55 34.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 73.32 110.875 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -121.12 137.32 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 62.42 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.29 131.88 45.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 70.33 110.902 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.8 m -95.81 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 51.35 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.51 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.928 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 143.6 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 62.23 110.925 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.407 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.65 159.58 50.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.652 0.739 . . . . 73.43 111.146 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 52.32 112.34 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.963 0.411 . . . . 62.12 110.797 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.61 72.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 71.25 111.087 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 133.18 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 73.22 110.931 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.37 120.44 26.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 63.54 110.939 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.69 HG21 HD11 ' A' ' 14' ' ' LEU . 46.8 mm -125.91 121.61 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.3 111.085 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.93 137.7 34.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 62.01 111.142 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.42 166.78 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 70.11 111.085 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.59 148.72 44.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.946 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -52.08 121.57 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.1 111.145 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.653 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.87 6.67 75.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 62.21 112.538 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.3 mm-40 -101.83 140.13 20.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.709 0.766 . . . . 72.41 110.846 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 143.88 52.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.745 2.297 . . . . 65.51 112.33 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 6' ' ' ILE . 33.5 tp -144.23 142.0 30.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.898 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 65' ' ' PHE . 24.3 t -122.81 147.91 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 71.11 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 64' ' ' LEU . 50.2 mt -131.58 149.05 52.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 65.24 110.951 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.48 152.53 27.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.916 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.74 101.33 10.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.3 110.826 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 113.09 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 72.42 110.918 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' HG21 ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 64.34 112.579 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.776 0.322 . . . . 72.13 110.925 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.2 147.79 44.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 63.34 110.943 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -129.41 138.93 51.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.958 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -144.11 136.04 26.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 74.44 110.933 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.749 HD12 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -138.98 139.83 38.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 71.24 110.931 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -112.07 127.97 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.895 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.773 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -137.55 178.29 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.13 111.102 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.17 -130.44 19.08 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 74.05 112.476 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -112.67 -37.39 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.903 0.382 . . . . 74.31 110.888 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.9 t -178.42 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.055 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.9 mt-10 -102.26 33.89 2.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 63.22 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.9 -5.54 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 75.41 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -59.22 132.29 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.857 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.749 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -127.44 153.59 46.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 70.3 110.91 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.87 121.7 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.109 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' A' ' 33' ' ' LEU . 2.1 mm? -89.51 145.34 25.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.929 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -125.42 163.74 36.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.639 0.733 . . . . 61.44 110.854 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.5 Cg_endo -69.84 2.36 3.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.7 2.267 . . . . 41.22 112.275 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.937 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.719 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.695 0.284 . . . . 73.13 111.152 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -132.67 160.21 37.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 73.45 110.931 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 HD12 ' A' ' 44' ' ' LEU . 38.2 t -109.5 128.82 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.102 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.63 158.25 87.49 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.528 0.68 . . . . 42.42 110.957 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -21.38 33.41 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.24 . . . . 72.4 112.338 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -82.87 0.9 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 64.21 110.914 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.01 16.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.824 -0.703 . . . . 64.22 112.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 m -112.28 179.89 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 72.24 110.938 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 16' ' ' LEU . 10.9 tp -129.73 126.25 37.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.34 110.901 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CD2' HG22 ' A' ' 15' ' ' VAL . 34.1 t80 -126.46 135.46 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.892 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.06 129.59 25.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 73.33 110.922 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -33.03 17.17 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 73.32 112.301 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.653 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.2 102.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.432 . . . . 71.55 111.134 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -72.91 117.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.423 . . . . 73.44 111.183 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.05 162.2 30.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.805 -0.712 . . . . 54.04 112.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.26 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.72 0.295 . . . . 71.24 111.084 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -75.58 -22.74 56.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.927 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.59 -4.95 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.04 110.856 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.84 141.0 58.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 60.55 110.922 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.76 -137.96 5.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 72.12 112.465 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.6 mm -124.13 127.55 73.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.4 111.161 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.4 m-85 -104.77 134.73 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.28 144.97 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.928 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 155.45 43.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.875 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.89 130.25 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.908 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.57 161.93 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.03 111.154 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -130.14 125.28 34.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 63.21 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.49 173.16 9.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 64.12 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -70.64 -19.23 62.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.824 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -74.53 -20.56 59.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.11 -8.0 38.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 72.44 112.508 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.96 147.05 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.698 0.285 . . . . 75.33 110.948 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.94 140.32 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.483 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -105.24 129.64 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.14 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.87 144.23 33.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -145.08 125.95 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 54.13 110.85 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.7 124.12 45.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 64.44 110.891 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.87 120.62 28.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.953 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 131.34 35.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.94 137.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 64.42 111.1 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.49 129.05 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.865 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 m -93.58 -176.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.058 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -63.53 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.2 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.37 144.01 54.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 72.42 110.947 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.23 159.57 49.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 73.44 111.155 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 C-N-CA 122.718 2.278 . . . . 64.12 112.376 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.813 0.339 . . . . 72.33 110.84 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.35 73.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.496 . . . . 73.44 111.126 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -91.4 139.1 31.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 71.23 110.906 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -84.11 121.02 26.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.916 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.566 ' CG2' HD11 ' A' ' 14' ' ' LEU . 44.4 mm -125.68 121.62 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 65.14 111.065 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -95.35 139.72 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 64.4 111.126 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.83 166.33 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.058 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -124.03 149.2 46.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.823 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 99' ' ' GLN . 78.6 mt -53.88 120.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.168 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.619 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.35 6.94 77.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 54.43 112.452 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 69' ' ' VAL . 32.6 mm-40 -102.37 140.7 21.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 73.31 110.902 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 145.06 56.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 61.11 112.35 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.2 tp -142.51 142.72 32.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 72.34 110.967 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.2 t -121.12 147.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 72.05 111.072 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 17.8 mt -131.18 148.21 52.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 61.35 110.96 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -113.01 153.13 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.97 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.95 100.68 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 74.32 110.905 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.18 118.39 6.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.2 110.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 44.31 112.562 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.734 0.302 . . . . 73.33 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.63 148.09 41.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.848 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -122.96 138.25 54.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.14 142.56 34.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 74.44 110.877 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' ' 77' ' ' PHE . 16.7 tp -137.94 135.79 36.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.852 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -115.23 121.94 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.94 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.6 p -138.17 176.72 8.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.03 111.199 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.83 -131.58 12.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 73.03 112.543 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -112.88 -37.89 4.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.369 . . . . 74.05 110.852 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.18 -30.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 63.22 111.142 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.9 mt-10 -102.1 33.63 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.01 110.929 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.86 -6.1 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 73.22 111.122 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -59.88 132.16 53.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 153.93 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 72.55 110.818 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.18 121.26 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 63.52 111.144 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.55 145.24 25.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 64.41 110.853 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.82 162.12 49.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.697 0.76 . . . . 71.12 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.92 11.01 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.706 2.271 . . . . 75.51 112.327 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.942 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.845 0.355 . . . . 34.31 111.061 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.23 159.41 20.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 75.41 110.83 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.51 125.06 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 73.51 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 63' ' ' SER . 88.0 mt -68.21 156.99 88.77 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.641 0.734 . . . . 64.31 110.919 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.1 Cg_endo -69.74 -20.71 34.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.673 2.249 . . . . 71.43 112.33 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -82.48 0.89 40.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.11 110.885 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.97 28.7 14.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 74.21 112.501 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 59' ' ' LEU . 15.6 m -112.53 173.67 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 44.52 110.807 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 15.9 tp -129.29 130.42 46.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 72.24 110.871 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 34.9 t80 -124.29 136.03 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.874 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.559 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.05 130.75 23.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.656 0.741 . . . . 74.12 110.93 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -37.81 8.68 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 74.12 112.332 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.73 104.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 34.2 111.093 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 12' ' ' GLU . 19.6 m -73.06 117.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 70.14 111.139 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.97 162.67 24.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 61.03 112.476 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.29 -29.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 71.43 111.107 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.94 -24.17 58.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 63.33 110.933 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.89 -4.54 56.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 61.12 110.839 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.59 141.38 58.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 62.35 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.6 -139.81 7.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 75.05 112.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.76 130.25 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 75.12 111.103 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.675 ' CG ' HD13 ' A' ' 16' ' ' LEU . 6.2 t80 -103.2 144.3 31.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 72.23 110.912 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 146.35 52.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.55 110.823 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.7 t -126.98 151.44 48.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 64.13 110.899 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.84 131.76 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.907 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.75 161.91 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 51.23 111.054 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.8 mtp -130.17 124.4 32.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.05 110.817 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.42 172.87 9.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.911 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -70.53 -19.42 62.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 74.31 110.893 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.74 -20.34 59.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.01 110.861 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.02 39.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 61.1 112.463 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.91 147.7 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 75.04 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -104.3 142.66 34.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.53 110.813 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.525 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.74 132.55 50.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 43.42 111.14 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 144.1 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.53 110.954 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -145.06 126.09 14.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 72.11 110.889 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -118.69 122.56 42.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.901 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -128.72 120.79 27.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.955 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -83.14 133.18 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.85 138.34 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 74.44 111.125 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -129.25 143.91 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.82 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.833 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -112.47 -176.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.55 111.151 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.41 -79.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 75.32 110.933 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -63.76 144.79 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.04 110.952 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.425 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.4 159.66 49.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 72.05 111.163 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.254 . . . . 72.42 112.352 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.351 . . . . 73.13 110.865 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.55 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . -60.49 94.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 61.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.22 133.08 36.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 64.24 110.949 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.1 p30 -89.68 119.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 62.41 110.935 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.733 HG21 HD11 ' A' ' 14' ' ' LEU . 2.7 mp -126.77 122.59 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -95.79 139.95 31.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 73.14 111.176 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.54 167.65 24.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.24 148.46 43.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.818 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 26.9 mt -52.42 121.25 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.128 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.703 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.42 8.02 71.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 31.5 112.498 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.4 mm-40 -101.94 140.3 21.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 73.55 110.952 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 144.09 52.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.707 2.271 . . . . 71.13 112.341 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 6' ' ' ILE . 21.7 tp -144.08 142.23 30.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 62.11 110.936 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 65' ' ' PHE . 33.9 t -121.84 145.93 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 50.43 111.133 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.9 mt -131.43 148.56 52.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.926 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -112.82 152.77 28.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 110.893 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.0 t -105.66 99.99 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 70.11 110.851 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 120.09 7.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.899 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 73.42 112.503 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.592 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.77 0.319 . . . . 72.31 110.875 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -120.88 148.07 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.899 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.592 ' HE1' HD13 ' A' ' 29' ' ' LEU . 26.7 m95 -127.39 136.17 51.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 72.4 110.863 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.725 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -143.4 136.83 28.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.874 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' A' ' 77' ' ' PHE . 1.4 mt -137.4 138.99 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 64.54 110.929 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -112.29 126.55 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.907 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.4 p -138.14 179.22 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 65.23 111.155 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.08 -130.83 19.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.472 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 38' ' ' THR . 12.1 mmt85 -114.9 -38.07 4.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 44.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -176.28 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 75.04 111.154 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -99.09 34.02 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.848 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.15 -4.56 7.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 64.4 111.075 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CZ2' HG22 ' A' ' 38' ' ' THR . 11.0 m0 -58.12 131.13 49.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 72.23 110.961 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 154.06 47.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 55.25 110.903 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.06 118.39 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.163 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HG ' HD11 ' A' ' 33' ' ' LEU . 1.1 mm? -90.54 145.33 24.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 61.33 110.906 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.13 163.19 43.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 74.3 110.925 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.0 Cg_endo -69.84 -3.73 12.66 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.648 2.232 . . . . 65.25 112.351 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 65.11 110.837 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.833 0.349 . . . . 61.41 111.065 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.623 HH21 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -129.32 163.01 26.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 74.52 110.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 46' ' ' PRO . 4.1 t -107.76 130.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 73.42 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.623 HD23 HH21 ' A' ' 57' ' ' ARG . 61.5 mt -68.91 157.8 87.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.626 0.727 . . . . 74.54 110.886 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -21.71 33.32 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 71.22 112.338 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.29 1.12 42.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 61.14 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.1 29.91 11.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 71.05 112.569 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.457 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.6 m -113.19 179.15 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.411 . . . . 62.12 110.827 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 65' ' ' PHE . 14.7 tp -130.01 129.31 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 74.04 110.971 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CD2' HG22 ' A' ' 15' ' ' VAL . 37.8 t80 -124.6 133.94 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 72.01 110.838 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.2 mp -114.97 131.04 23.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.549 0.69 . . . . 71.42 110.95 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -33.64 15.94 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.673 2.249 . . . . 54.34 112.365 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.95 104.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 43.04 111.099 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.43 113.12 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 60.22 111.137 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.98 162.0 33.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.718 -0.753 . . . . 71.1 112.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.837 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.11 -30.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 74.42 111.206 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.9 -23.71 55.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 71.31 110.889 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -4.07 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 70.45 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.68 140.62 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.3 110.884 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.49 -137.63 5.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 54.34 112.478 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.405 HD12 ' CG ' ' A' ' 94' ' ' ARG . 43.9 mm -123.54 133.39 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 74.25 111.052 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -103.81 143.56 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.895 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -138.67 137.99 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 75.03 110.886 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.8 t -126.51 155.29 42.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.84 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.11 135.11 32.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.963 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.02 162.66 30.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 44.34 111.079 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ttm -130.11 124.81 33.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -89.94 172.4 8.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 53.25 110.874 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -71.29 -18.65 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.952 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -73.85 -20.43 60.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -15.58 33.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.734 -0.746 . . . . 65.34 112.407 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -85.16 146.17 27.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 74.23 110.881 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.15 144.61 32.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.919 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 133.32 49.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 73.14 111.14 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.47 145.25 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.934 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -144.91 126.92 15.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 62.3 110.888 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.18 122.71 42.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.22 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -124.28 119.37 29.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.891 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.55 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.76 133.86 34.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 74.2 110.895 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.36 137.25 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 64.02 111.078 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -130.33 132.7 45.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.873 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 m -95.67 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 73.2 111.128 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -65.39 -80.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.941 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -65.49 142.98 57.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 52.34 110.912 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.446 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.13 159.54 49.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 73.22 111.184 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.134 0 C-N-CA 122.695 2.263 . . . . 42.25 112.355 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.816 0.341 . . . . 74.03 110.911 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.893 0.378 . . . . 74.43 111.073 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo . . . . . 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.914 0.388 . . . . 45.23 110.857 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -52.46 100.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 71.5 111.099 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.04 133.27 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 60.12 110.944 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 6.5 m-80 -84.26 120.31 26.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 63.51 110.932 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.6 mm -126.17 121.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.41 111.162 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 p -96.89 138.31 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.31 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -148.24 165.64 30.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.11 111.142 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -124.25 149.05 46.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 51.31 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -53.98 121.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.206 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.57 2.73 84.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 63.42 112.444 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.78 ' O ' HG22 ' A' ' 69' ' ' VAL . 17.5 mm-40 -101.09 139.63 20.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 63.34 110.902 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 143.09 49.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.671 2.248 . . . . 74.0 112.358 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 66' ' ' LEU . 40.6 tp -144.72 141.79 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.896 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -122.97 148.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 64.34 111.056 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 64' ' ' LEU . 9.4 mt -131.58 149.03 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 65.02 110.95 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -106.29 148.96 27.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.895 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 t -112.26 101.83 10.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.927 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -55.88 95.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 70.52 110.903 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 51.44 112.488 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.3 pp . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.775 0.321 . . . . 65.1 110.872 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -120.37 147.4 45.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 71.54 110.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -134.49 138.8 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.931 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.7 ' O ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpt -136.46 142.01 43.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 52.22 110.923 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 32' ' ' LYS . 55.2 mt -134.98 135.06 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 61.22 110.933 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -116.64 120.62 39.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.892 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.789 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.5 p -139.17 177.59 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 74.43 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.75 -128.91 9.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.759 -0.734 . . . . 64.24 112.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.36 -36.98 5.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 72.44 110.848 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.9 -30.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.166 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -103.13 33.46 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.874 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.65 -6.69 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 43.03 111.134 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 133.24 55.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.937 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 157.99 40.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 62.24 110.872 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.98 120.46 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 64.32 111.14 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.43 145.75 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 73.12 110.889 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.62 163.06 41.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.729 . . . . 75.22 110.89 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.9 Cg_endo -69.76 0.11 6.12 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.714 2.276 . . . . 70.44 112.316 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 71.53 110.919 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.825 0.345 . . . . 61.1 111.081 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 161.73 23.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 61.41 110.896 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.73 129.88 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 40.42 111.145 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 6.5 mp -69.61 158.26 87.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.61 0.719 . . . . 53.11 110.898 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.78 -23.12 31.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 74.13 112.303 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.03 3.48 34.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 70.31 110.818 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.14 24.84 28.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.72 -0.752 . . . . 70.32 112.457 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 2.6 m -105.97 179.73 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 75.22 110.869 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 16' ' ' LEU . 6.4 tp -130.86 127.91 39.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 73.13 110.943 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.643 ' N ' HD12 ' A' ' 64' ' ' LEU . 2.3 t80 -126.1 129.41 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.55 110.896 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.3 mp -117.77 131.24 24.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.612 0.72 . . . . 73.41 110.975 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.63 -32.47 19.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.763 2.309 . . . . 73.11 112.364 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.59 101.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 41.35 111.116 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.6 m -73.55 119.41 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 111.092 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.39 161.48 28.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.705 -0.759 . . . . 51.4 112.514 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.33 -29.39 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.728 0.299 . . . . 64.41 111.124 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -74.47 -23.2 58.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 51.41 110.893 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -5.14 57.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 65.3 110.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.66 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 65.44 110.912 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.49 -139.11 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 62.4 112.483 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.28 128.14 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 74.52 111.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD1' HD22 ' A' ' 33' ' ' LEU . 22.7 m-85 -104.5 136.72 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 64.4 110.839 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.45 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 75.33 110.881 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.4 t -127.14 152.31 47.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.909 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 131.03 24.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 61.12 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.63 163.06 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.07 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ttm -130.06 124.9 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.88 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -88.42 172.36 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.913 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.53 -18.91 62.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.926 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -73.89 -20.26 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.919 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.93 -13.53 34.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 71.34 112.548 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -84.87 147.27 26.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 74.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.58 143.85 32.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 72.15 110.925 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.76 126.89 51.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 54.45 111.12 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 144.23 34.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 73.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 m -145.8 127.74 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 63.14 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.82 122.52 41.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 64.52 110.827 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.72 119.04 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 64.31 110.906 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.02 131.45 34.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 70.24 110.87 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 77' ' ' PHE . 70.3 t -120.75 139.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.55 111.143 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 128.57 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.45 110.866 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.4 m -92.48 -176.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 64.13 111.099 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -64.69 -78.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.15 110.948 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -68.2 145.89 53.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.9 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.501 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.62 0.724 . . . . 61.44 111.072 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.166 0 C-N-CA 122.751 2.301 . . . . 64.34 112.312 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.883 0.373 . . . . 62.34 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 97.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 55.41 111.111 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -93.24 133.65 36.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 60.22 110.836 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -89.83 121.43 31.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 14' ' ' LEU . 44.9 mm -125.33 121.44 60.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 71.41 111.08 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -96.01 141.19 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.24 111.115 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 167.46 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 71.1 111.051 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -122.63 148.22 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 38.5 mt -53.12 121.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 60.42 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.9 5.76 76.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 74.15 112.47 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.8 mm-40 -102.04 140.11 20.89 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.43 110.866 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 144.01 52.47 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.608 2.205 . . . . 52.12 112.286 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.671 HD11 HG21 ' A' ' 6' ' ' ILE . 36.3 tp -144.61 142.01 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.919 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.84 144.6 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.139 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.725 HD13 ' CD2' ' A' ' 77' ' ' PHE . 1.3 mt -131.03 146.26 52.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 72.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -114.5 151.2 33.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 75.03 110.952 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 m -108.05 101.83 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.57 126.71 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.31 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 54.45 112.53 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 29' ' ' LEU . 1.3 pp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.825 0.345 . . . . 65.13 110.921 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.74 129.12 53.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 70.24 110.925 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.579 ' NE1' HD13 ' A' ' 29' ' ' LEU . 43.6 m0 -111.93 144.53 41.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 73.03 110.911 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -136.96 141.23 42.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 72.11 110.982 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 77' ' ' PHE . 13.6 tp -136.05 135.29 39.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.53 110.942 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -116.13 121.47 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 54.11 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.803 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 p -138.35 179.27 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 62.35 111.139 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.95 -130.24 11.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 52.13 112.49 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -112.5 -37.95 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 73.41 110.933 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t -179.83 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 72.4 111.134 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 38' ' ' THR . 19.2 mt-10 -102.6 34.03 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 61.24 110.862 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.57 -6.76 8.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -61.82 131.34 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.873 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 158.46 38.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 60.41 110.854 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.91 123.1 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 61.13 111.16 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.52 143.5 26.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 70.41 110.919 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.713 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -126.74 163.02 43.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.647 0.736 . . . . 73.13 110.856 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.694 2.263 . . . . 51.43 112.403 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.94 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.605 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 62.1 111.11 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.92 163.0 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.42 110.851 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 45' ' ' SER . 48.6 t -107.45 127.5 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.063 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.6 mp -68.27 157.58 87.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.586 0.707 . . . . 61.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.81 -20.83 34.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 70.3 112.335 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.6 1.62 41.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 28.53 20.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.827 -0.702 . . . . 74.4 112.486 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -112.57 178.01 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 72.05 110.896 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 38.0 tp -128.01 127.93 44.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.912 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 59' ' ' LEU . 9.3 t80 -125.81 135.04 51.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 71.43 110.903 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 56' ' ' ALA . 7.2 mp -113.43 128.59 25.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 73.11 110.901 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -32.5 18.34 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 71.42 112.368 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.04 102.65 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.098 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -72.36 118.42 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 73.1 111.151 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.37 158.79 26.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 31.03 112.494 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.838 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.23 -31.43 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.787 0.327 . . . . 64.15 111.102 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.79 -22.8 53.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.908 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.55 -5.27 44.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.881 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -60.7 142.49 55.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 72.45 110.831 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.16 -147.16 15.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.724 . . . . 52.13 112.511 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.82 129.91 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 73.42 111.144 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' A' ' 16' ' ' LEU . 11.3 t80 -104.87 135.28 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.0 146.72 50.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 64.23 110.799 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.59 152.72 46.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.867 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.7 128.13 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.902 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.08 31.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 62.3 111.078 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 ttm -130.11 124.71 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.44 110.873 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -87.71 171.9 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 55.13 110.943 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -71.76 -18.18 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -73.28 -26.06 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 60.41 110.86 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.92 -18.22 12.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 55.54 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -84.18 147.16 27.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 61.44 110.892 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.26 144.86 31.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.873 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 128.12 50.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 64.13 111.154 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 145.31 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 65.22 110.919 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -144.67 126.96 15.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 52.11 110.85 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 122.1 40.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 61.34 110.874 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.69 120.04 28.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.953 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.91 132.12 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.886 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.89 136.37 58.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 74.0 111.115 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -130.76 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 62.14 110.879 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.8 m -108.7 -175.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 52.4 111.142 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -66.37 -78.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.927 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -66.53 146.03 54.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 44.44 110.914 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.48 49.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 45.32 111.133 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.275 . . . . 70.54 112.338 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.849 0.357 . . . . 74.23 110.913 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.49 63.64 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 64.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -92.72 137.87 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.66 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.9 p-10 -89.95 120.99 31.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 53.21 110.871 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.66 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.24 122.3 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.16 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -95.49 142.09 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 64.43 111.11 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.77 168.34 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 51.43 111.111 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.41 148.19 41.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 64.42 110.871 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.03 122.08 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.064 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.4 3.85 86.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 62.54 112.555 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.6 mm-40 -101.39 142.7 25.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.736 . . . . 62.31 110.93 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 144.03 53.35 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.703 2.269 . . . . 62.11 112.378 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 6' ' ' ILE . 52.2 tp -143.93 143.26 31.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 72.52 110.93 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.4 t -121.07 147.71 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 62.01 111.148 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 77' ' ' PHE . 14.8 mt -131.48 149.12 52.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.893 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -107.18 151.63 25.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.896 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.6 t -107.63 100.11 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.05 110.854 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -59.71 120.53 9.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.898 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.714 -0.755 . . . . 74.13 112.466 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.772 0.32 . . . . 73.33 110.902 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -120.51 148.21 44.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.867 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.607 ' HE1' HD13 ' A' ' 29' ' ' LEU . 20.2 m95 -124.79 143.28 50.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 74.01 110.879 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 143.94 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.91 134.63 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 65.12 110.863 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -116.45 121.18 41.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.54 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.785 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.8 p -139.39 179.38 6.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 72.21 111.104 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.56 -133.35 15.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 75.12 112.552 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -112.56 -37.57 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 62.22 110.817 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.616 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.7 t -179.31 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 55.12 111.158 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.616 ' HG3' HG23 ' A' ' 38' ' ' THR . 25.0 mt-10 -102.08 33.71 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 64.24 110.85 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.92 -6.81 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 63.54 111.129 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -60.38 128.95 39.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 72.3 110.918 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.34 156.34 44.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 65.43 110.938 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 t -93.49 123.35 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 71.51 111.188 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 33' ' ' LEU . 30.6 mt -88.66 143.65 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 54.21 110.915 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.73 162.52 50.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.693 0.758 . . . . 75.3 110.854 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -4.0 13.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.767 2.311 . . . . 73.11 112.34 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 72.13 110.9 -179.941 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.796 0.331 . . . . 60.33 111.088 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 161.53 17.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.01 110.849 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.43 130.24 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 75.41 111.172 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 48.8 mt -68.82 157.83 87.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.592 0.71 . . . . 71.41 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.51 33.47 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 73.32 112.344 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.44 1.65 47.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 63.21 110.894 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.58 31.11 9.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 62.05 112.53 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.3 m -113.34 -179.05 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 73.34 110.839 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 65' ' ' PHE . 6.2 tp -129.84 128.71 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.95 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.634 ' N ' HD12 ' A' ' 64' ' ' LEU . 13.3 t80 -126.36 135.85 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.91 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.56 128.86 25.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.626 0.727 . . . . 74.23 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -32.42 19.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.724 2.283 . . . . 73.2 112.4 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.86 100.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 61.52 111.073 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -72.75 113.45 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 73.43 111.093 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.54 158.76 30.1 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 54.54 112.531 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.74 -31.09 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 63.31 111.049 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -76.23 -20.96 56.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.906 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -3.08 27.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.918 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.746 ' CD ' HG22 ' A' ' 97' ' ' VAL . 23.8 mt-10 -57.57 142.81 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 64.43 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.39 -149.95 21.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 54.13 112.406 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.58 133.03 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 74.24 111.105 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' A' ' 16' ' ' LEU . 5.0 t80 -103.28 139.08 39.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 65.14 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 141.16 51.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.883 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -125.95 153.82 43.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.34 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -139.74 130.3 25.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 74.13 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 163.18 28.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 51.31 111.093 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.8 ttm -128.42 124.78 37.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.835 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -87.23 173.4 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 71.1 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -69.53 -19.07 63.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.33 110.842 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -74.42 -20.34 60.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.75 -9.06 43.79 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 61.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -85.05 148.64 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 63.55 110.916 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.21 140.31 37.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 65.23 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.35 132.77 51.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 73.04 111.179 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.32 145.0 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.881 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -144.7 126.94 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.872 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -119.22 124.23 46.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 61.21 110.877 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.8 119.25 24.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -84.47 134.45 34.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 73.03 110.858 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.8 t -122.63 135.98 60.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 70.41 111.158 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.26 148.18 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -110.74 -175.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.114 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -67.06 -78.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 72.4 110.9 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -63.17 146.45 53.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.918 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 71.01 111.151 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 55.1 112.36 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 64.3 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.85 96.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 23.24 111.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -93.03 132.84 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 60.11 110.996 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.676 ' C ' HD12 ' A' ' 6' ' ' ILE . 5.7 p-10 -86.33 119.51 26.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.34 110.881 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.9 mp -129.2 123.2 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.54 111.18 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -95.58 138.66 32.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 63.13 111.153 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.12 166.14 27.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 65.13 111.117 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.45 149.21 44.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.804 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mt -52.58 121.34 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.139 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.51 6.96 76.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 74.22 112.471 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.761 ' O ' HG22 ' A' ' 69' ' ' VAL . 38.7 mm-40 -102.09 139.65 20.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.718 0.771 . . . . 72.04 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 144.51 54.7 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.711 2.274 . . . . 74.55 112.345 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.45 HD11 ' CG2' ' A' ' 6' ' ' ILE . 16.5 tp -143.86 141.91 30.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 60.13 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.39 144.72 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 63.54 111.202 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 64' ' ' LEU . 36.3 mt -131.14 146.88 52.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.35 110.981 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -114.34 151.75 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 61.13 110.933 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.21 99.67 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.9 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -56.39 124.53 18.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.675 -0.774 . . . . 61.44 112.471 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.799 0.333 . . . . 63.24 110.926 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.15 149.56 47.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.911 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.844 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 18.0 m-90 -117.84 135.27 54.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.951 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.654 ' C ' HD23 ' A' ' 33' ' ' LEU . 3.6 ttpt -145.87 136.58 24.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 55.33 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.018 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.54 140.83 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 64.22 110.873 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -111.7 129.0 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.914 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.6 p -135.83 179.89 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.33 111.148 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.27 -129.36 17.4 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.748 -0.739 . . . . 44.14 112.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -112.7 -37.51 4.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 74.42 110.874 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 t -178.96 -30.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.29 33.95 2.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.878 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.87 -5.14 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 72.43 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.05 132.19 53.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 70.34 110.941 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 157.56 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 74.23 110.886 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 t -102.56 120.35 52.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 62.02 111.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.018 HD12 HD21 ' A' ' 33' ' ' LEU . 5.6 mt -92.38 146.05 23.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 54.23 110.908 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 163.5 39.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.636 0.732 . . . . 73.42 110.849 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -0.6 7.14 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.704 2.269 . . . . 55.02 112.321 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 71.32 110.914 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.796 0.332 . . . . 72.31 111.084 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 161.4 17.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.871 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.9 t -108.47 129.57 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.2 111.141 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.592 HD12 ' CB ' ' A' ' 63' ' ' SER . 43.9 mt -69.11 157.47 89.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 63.12 110.937 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -22.56 31.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.726 2.284 . . . . 62.2 112.364 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -83.46 0.61 45.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 70.51 110.849 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.14 29.38 11.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 71.24 112.506 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.7 -179.68 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 63.13 110.927 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 16' ' ' LEU . 13.1 tp -128.97 129.58 45.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.928 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 9.1 t80 -125.37 131.03 53.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 71.5 110.915 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mt -113.97 130.92 23.43 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.646 0.736 . . . . 70.33 110.911 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -38.3 7.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 73.54 112.334 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.74 101.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 72.03 111.072 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.9 m -73.63 116.92 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.103 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.71 164.73 31.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 53.31 112.505 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.836 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.83 -29.4 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.7 0.286 . . . . 73.51 111.096 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -75.11 -23.96 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.4 110.95 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -3.86 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.915 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.57 141.24 52.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.902 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.66 -140.5 7.59 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.697 -0.763 . . . . 51.52 112.452 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 94' ' ' ARG . 2.5 mp -130.18 132.99 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 73.45 111.108 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CE2' HD13 ' A' ' 33' ' ' LEU . 13.2 m-85 -101.34 143.91 30.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.86 147.22 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.52 110.837 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.15 150.62 49.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.02 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.93 128.47 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.884 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.31 162.69 29.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.55 111.082 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -130.12 125.09 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.85 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -89.9 172.91 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 73.53 110.9 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -71.07 -19.24 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 64.12 110.868 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -73.81 -20.25 60.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.55 110.927 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.73 -15.17 34.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 51.13 112.454 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -84.88 146.64 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 72.03 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -105.81 144.72 32.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 73.3 110.896 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.98 50.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 71.43 111.175 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.37 144.95 32.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 63.04 110.908 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.2 m -145.03 127.49 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.33 110.854 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -118.74 127.47 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 50.15 110.872 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.87 118.1 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.957 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.75 127.29 34.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 75.15 110.85 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.13 139.94 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -128.04 129.15 46.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.846 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.3 m -88.68 -175.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 65.11 111.085 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -65.28 -80.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 74.44 110.952 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -65.76 144.48 56.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.918 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.99 47.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.698 0.761 . . . . 54.13 111.116 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 71.25 112.339 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.861 0.363 . . . . 72.11 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 52.95 72.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.22 111.072 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -93.11 132.69 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.881 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.594 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.4 t30 -84.29 120.71 26.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.856 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.594 HD12 ' C ' ' A' ' 5' ' ' ASN . 2.4 mp -126.43 126.03 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.145 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -93.59 141.95 27.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.21 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.13 168.24 22.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 73.22 111.088 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.08 147.95 47.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.865 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -54.62 122.39 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 65.42 111.127 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.69 3.94 80.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.712 -0.756 . . . . 74.21 112.509 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 6.3 mm-40 -101.1 139.56 20.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 72.34 110.851 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 143.0 49.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 72.44 112.42 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 66' ' ' LEU . 17.3 tp -144.35 141.01 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 75.34 110.893 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' HD1' ' A' ' 65' ' ' PHE . 40.4 t -123.15 148.35 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 42.41 111.134 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 64' ' ' LEU . 62.4 mt -131.61 148.67 52.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 72.53 110.882 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.49 149.48 27.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 71.52 110.876 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.5 t -112.49 101.69 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 54.45 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -53.65 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.84 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 60.04 112.464 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.709 0.29 . . . . 64.24 110.963 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.38 142.36 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.891 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -126.09 143.29 51.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.919 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -141.98 142.55 32.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.32 110.915 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.69 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.2 tp -137.87 135.99 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.878 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.605 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.6 t-20 -114.99 123.33 48.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 52.35 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 27.9 p -138.87 -179.76 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.132 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.45 -126.83 8.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 33.1 112.468 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.39 -37.45 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 72.4 110.832 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 177.13 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.2 111.148 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.67 32.92 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.88 -7.79 8.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.102 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -60.14 129.6 42.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.956 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 158.57 39.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 73.5 110.874 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.63 121.02 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.077 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.33 144.46 25.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.96 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.53 45.72 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.734 0.778 . . . . 72.21 110.868 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 0.47 5.5 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.263 . . . . 74.53 112.361 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.923 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.821 0.343 . . . . 70.21 111.037 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.51 160.91 17.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.863 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.73 130.46 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 73.44 111.153 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.622 HD12 ' CB ' ' A' ' 63' ' ' SER . 45.8 mt -69.1 158.78 85.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 75.44 110.885 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.77 -22.66 31.7 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.672 2.248 . . . . 62.01 112.35 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -85.33 1.99 46.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 61.23 110.898 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.78 23.91 24.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 60.02 112.529 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.622 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.4 m -104.4 -179.0 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 64.44 110.852 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.14 130.04 44.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.906 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.2 t80 -125.45 129.68 50.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.926 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.4 mp -118.14 129.77 25.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.605 0.717 . . . . 72.3 110.884 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -32.74 18.01 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 75.03 112.421 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.27 101.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 62.05 111.088 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.0 m -73.03 119.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 73.31 111.119 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.36 160.71 32.03 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 73.23 112.501 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.32 -31.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 65.23 111.117 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -76.46 -22.07 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 65.31 110.934 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -4.75 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.908 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -59.23 142.35 52.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 71.02 110.926 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.74 -145.89 13.44 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 53.34 112.452 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.33 133.82 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 75.33 111.16 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.69 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.5 m-85 -101.37 139.24 37.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.44 110.883 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.77 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 71.44 110.872 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 149.98 50.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 71.51 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -140.22 126.5 19.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 71.55 110.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -133.07 163.12 29.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.41 111.064 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 66.7 mmm -129.41 124.64 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.86 172.52 9.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.893 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -71.23 -22.48 61.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.926 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -74.23 -20.14 60.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.863 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.92 -2.99 35.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.729 . . . . 40.31 112.568 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.7 149.07 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 73.51 110.949 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -102.87 141.77 35.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.562 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.52 123.45 47.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 60.11 111.149 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.93 141.61 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 54.33 110.877 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -147.26 125.87 12.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.935 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -119.25 125.08 48.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 73.15 110.879 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.86 119.74 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.885 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.473 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.45 131.84 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.44 110.859 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.61 137.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 75.24 111.112 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -130.35 152.93 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 72.52 110.831 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 33.0 m -113.86 -175.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 35.14 111.148 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -65.86 -78.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 53.34 110.932 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.83 144.78 56.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.33 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.482 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.36 159.6 49.36 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.634 0.731 . . . . 72.02 111.145 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.7 Cg_endo . . . . . 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 72.31 112.357 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.916 0.389 . . . . 51.53 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.44 80.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 75.34 111.091 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.42 138.6 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 63.14 110.918 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.43 119.92 25.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.876 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -126.26 123.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 65.14 111.159 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.1 p -93.72 140.47 29.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 72.31 111.171 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.03 165.07 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 74.22 111.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.78 149.44 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.52 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 99' ' ' GLN . 63.6 mt -59.36 120.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.41 111.114 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.17 5.48 89.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 64.02 112.516 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.69 141.5 22.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.703 0.763 . . . . 73.31 110.905 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.9 144.06 52.1 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.665 2.243 . . . . 71.32 112.343 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' ALA . 26.5 tp -144.2 143.29 30.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.25 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -121.47 147.23 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.1 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 47.3 mt -131.85 150.64 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.45 110.966 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -111.79 152.79 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 75.44 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -106.45 101.63 11.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 42.03 110.884 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -61.42 115.94 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.21 110.942 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.516 179.896 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.814 0.34 . . . . 70.53 110.877 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -120.29 148.36 43.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.868 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.576 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 3.0 m95 -127.05 134.39 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 70.14 110.965 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.585 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.16 136.41 25.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 71.44 110.912 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.775 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -141.84 140.54 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 71.14 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.87 127.95 55.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 62.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.783 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.6 p -136.75 179.32 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.0 -129.98 12.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.654 -0.784 . . . . 50.45 112.517 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -112.62 -37.75 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 74.03 110.897 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.613 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.5 t -179.44 -30.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 71.44 111.19 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.613 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.6 mt-10 -102.7 33.68 3.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 71.34 110.888 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.44 -6.54 8.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.32 111.084 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -59.23 130.29 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 73.03 110.923 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.53 153.52 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 62.22 110.88 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG22 ' HD2' ' A' ' 32' ' ' LYS . 23.5 t -100.21 120.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.1 111.138 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.655 ' CG ' HD21 ' A' ' 33' ' ' LEU . 3.5 mm? -89.9 145.13 25.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.878 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.61 163.25 39.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.656 0.741 . . . . 72.21 110.82 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.8 Cg_endo -69.76 -2.37 10.06 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 73.02 112.368 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 71.43 110.903 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 73.2 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.15 160.67 24.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 63.31 110.882 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 31.2 t -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.51 111.079 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.27 157.53 89.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 54.51 110.886 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -22.08 32.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.679 2.253 . . . . 60.5 112.395 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -83.25 0.63 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 74.54 110.894 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.7 30.71 10.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.715 -0.755 . . . . 71.01 112.432 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.6 m -113.49 179.04 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 54.41 110.896 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 20.7 tp -129.2 128.37 43.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 73.41 110.926 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -126.39 133.5 51.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 65.13 110.914 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.42 130.8 24.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 64.44 110.856 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -33.06 17.01 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.68 2.253 . . . . 61.02 112.333 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.97 100.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.11 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.5 m -73.57 114.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.1 111.136 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.77 164.25 39.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 52.2 112.568 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.68 -31.56 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.749 0.309 . . . . 71.31 111.102 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -75.72 -22.71 56.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.871 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -5.0 41.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 51.42 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -66.37 140.85 58.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.91 -137.32 5.25 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.711 -0.757 . . . . 73.45 112.456 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.447 HG23 ' ND2' ' A' ' 92' ' ' ASN . 2.1 mp -124.19 132.68 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 71.02 111.133 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.775 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -104.79 133.52 49.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.2 110.938 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -128.0 137.57 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.883 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.36 153.7 42.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 42.33 110.869 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.66 131.64 27.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 75.21 110.918 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.8 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.54 111.028 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 tpp -130.02 124.77 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.13 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.17 172.61 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.24 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -71.15 -18.44 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 72.2 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.46 -20.37 60.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 62.32 110.856 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.16 -16.4 32.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 63.21 112.487 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -85.21 146.81 26.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.686 0.279 . . . . 73.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.31 143.93 32.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.44 132.54 50.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.14 111.135 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 145.73 31.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 53.13 110.934 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -143.73 125.34 14.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 42.51 110.876 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -120.12 122.66 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 65.54 110.814 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.3 125.11 40.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.938 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -83.25 134.02 34.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 72.32 110.861 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -121.16 136.08 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.099 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.542 ' NH1' HG22 ' A' ' 100' ' ' ILE . 1.7 mmt180 -131.18 127.95 39.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 70.54 110.837 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 25.1 m -93.09 -177.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 74.3 111.178 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.6 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 65.54 110.974 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.466 ' NE2' ' H ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -61.62 141.83 57.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 71.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.542 HG22 ' NH1' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -121.45 159.7 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.719 . . . . 74.12 111.119 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 51.02 112.31 179.916 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.907 0.384 . . . . 74.04 110.884 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.47 94.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.084 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.81 131.16 38.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.896 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.6 p-10 -89.88 121.94 32.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.866 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.66 ' HB ' HG22 ' A' ' 95' ' ' VAL . 4.5 mp -125.96 122.42 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 54.14 111.117 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.09 136.9 35.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.187 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.57 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 147.91 43.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.878 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -52.94 121.76 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 75.32 111.11 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.702 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.93 6.93 71.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.656 -0.783 . . . . 64.35 112.45 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.763 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.7 mm-40 -101.37 139.4 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.592 0.71 . . . . 74.41 110.968 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.39 50.82 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 73.43 112.381 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 6' ' ' ILE . 39.2 tp -144.65 141.74 29.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 62.12 110.957 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.537 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.0 t -122.55 143.62 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.107 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 HD23 ' A' ' 64' ' ' LEU . 16.6 mt -132.16 148.01 52.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 72.53 110.969 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -112.98 153.13 28.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.94 101.94 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 71.25 110.852 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.77 122.93 13.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 43.01 112.423 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.722 HD13 ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.738 0.304 . . . . 70.24 110.935 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.58 149.26 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.899 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.722 ' CH2' HD13 ' A' ' 29' ' ' LEU . 26.8 m-90 -111.82 140.77 46.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.884 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -137.63 142.43 41.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.865 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 34' ' ' ASN . 1.6 tt -138.8 134.62 33.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.89 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' N ' HD23 ' A' ' 33' ' ' LEU . 13.2 t-20 -116.23 126.98 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 54.11 110.861 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.5 p -139.86 178.01 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.097 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.61 -131.65 19.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 53.44 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -37.29 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 74.51 110.862 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.593 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -178.48 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.35 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.09 33.19 2.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 74.35 110.87 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.99 -4.51 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 63.11 111.124 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -62.73 132.2 51.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 70.53 111.03 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 158.75 38.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 71.31 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.19 122.42 52.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 65.32 111.065 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.606 HD13 HD13 ' A' ' 64' ' ' LEU . 13.7 mt -88.81 143.63 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 75.3 110.942 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.27 163.17 41.83 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.695 0.759 . . . . 74.43 110.805 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.4 Cg_endo -69.71 -1.01 7.7 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 64.23 112.308 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 70.55 110.922 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.749 0.309 . . . . 62.22 111.115 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 160.68 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 61.03 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 20.6 t -109.76 128.79 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 71.22 111.179 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 63' ' ' SER . 50.6 mt -69.16 157.83 88.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.562 0.696 . . . . 52.52 110.928 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -22.72 31.58 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 73.12 112.345 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -83.01 0.25 45.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.65 29.43 10.86 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.776 -0.726 . . . . 51.25 112.483 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.499 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.68 179.85 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 52.21 110.869 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.717 HD22 ' CE2' ' A' ' 77' ' ' PHE . 8.5 tp -129.93 129.72 44.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 15' ' ' VAL . 33.2 t80 -125.34 131.2 53.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 71.01 110.814 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.752 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.33 129.42 24.89 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 75.23 110.946 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -33.01 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 65.24 112.375 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.702 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.32 102.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.44 111.101 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.9 m -72.88 116.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.32 111.063 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.7 33.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.733 -0.746 . . . . 25.4 112.48 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.844 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.97 -29.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 73.41 111.087 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -75.11 -23.37 57.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 60.43 110.912 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.06 -5.41 57.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.7 140.33 58.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.906 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 -135.37 4.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 54.21 112.472 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.486 HG23 ' ND2' ' A' ' 92' ' ' ASN . 4.9 mt -126.4 135.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 64.34 111.093 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.717 ' CE2' HD22 ' A' ' 64' ' ' LEU . 26.7 t80 -101.71 138.5 38.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.906 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -138.83 128.12 24.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.899 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.3 t -125.26 157.33 36.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 63.14 110.831 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -138.0 140.08 39.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.891 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.09 162.71 30.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.082 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ttm -129.56 124.99 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.864 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -90.88 172.81 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.894 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -71.1 -18.77 62.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.81 -20.33 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 60.34 110.946 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.58 35.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -85.06 146.04 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 61.24 110.877 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.51 143.26 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.52 110.864 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -105.72 130.4 53.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 51.03 111.173 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -107.1 145.69 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.957 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 124.55 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 71.25 110.847 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -121.5 128.79 52.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 73.24 110.912 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -131.19 122.23 26.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.35 110.906 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.34 124.5 30.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 70.13 110.872 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 6' ' ' ILE . 74.1 t -118.7 139.45 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.126 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 129.05 42.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 65.21 110.919 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.844 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 m -88.41 -175.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.168 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.32 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 72.22 110.92 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -66.31 142.35 57.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 73.03 110.9 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.35 159.75 48.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 72.21 111.161 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 72.54 112.277 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.916 0.388 . . . . 72.14 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.39 71.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 74.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.06 139.39 30.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 61.15 110.849 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.4 m-80 -82.4 121.09 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 75.22 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mm -125.11 122.05 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.201 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.64 142.13 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.3 111.11 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -146.96 166.25 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 63.3 111.116 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.96 148.57 48.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 60.24 110.866 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.29 121.25 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 72.3 111.198 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.0 5.01 90.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.532 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.96 141.87 23.5 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 61.43 110.892 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.87 52.36 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.783 2.322 . . . . 63.22 112.284 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 8' ' ' ALA . 65.2 tp -144.6 143.16 30.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 63.4 110.881 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.8 t -121.13 146.73 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 75.3 111.172 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.58 HD12 HD23 ' A' ' 64' ' ' LEU . 98.3 mt -131.48 149.94 52.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.953 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -111.91 150.55 30.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 62.23 110.872 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.9 t -108.73 101.2 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -57.1 124.99 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 51.11 110.913 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 71.32 112.497 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.03 0 CA-C-O 120.8 0.334 . . . . 71.24 110.92 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.62 148.58 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.887 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.654 ' HE1' HD13 ' A' ' 29' ' ' LEU . 28.6 m95 -122.79 137.03 55.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 73.25 110.969 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 139.79 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 72.04 110.874 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 34' ' ' ASN . 9.1 tp -137.99 136.08 36.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 75.41 110.889 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.0 m120 -114.63 127.43 55.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.899 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -138.85 176.79 8.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.42 -130.81 16.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 73.0 112.445 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.53 -37.35 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 73.21 110.873 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -178.76 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.33 111.18 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.605 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.8 mt-10 -101.99 32.8 3.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 70.33 110.931 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.79 -5.88 6.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.503 . . . . 71.23 111.115 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -59.4 132.27 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 73.45 110.893 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.51 153.33 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.871 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.0 t -100.17 122.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.195 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD13 HD13 ' A' ' 64' ' ' LEU . 20.4 mt -89.29 143.6 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 62.51 110.884 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.33 42.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 71.11 110.9 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -1.76 9.08 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 61.32 112.294 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.931 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.782 0.325 . . . . 63.43 111.113 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -113.35 160.58 18.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 63.42 110.836 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 t -109.54 129.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 53.31 111.154 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.6 mt -68.55 158.51 85.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.678 . . . . 73.44 110.942 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.88 32.91 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.712 2.275 . . . . 72.23 112.387 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.32 1.33 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 70.44 110.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.77 9.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.726 . . . . 71.13 112.531 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.563 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.2 m -112.22 -179.66 3.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 73.51 110.901 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 26.9 tp -128.9 128.27 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 53.14 110.857 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 15' ' ' VAL . 31.1 t80 -126.22 136.93 53.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 74.31 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -114.61 132.22 22.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.646 0.736 . . . . 64.21 110.871 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.8 15.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 74.11 112.272 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.19 100.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.29 -0.414 . . . . 62.11 111.17 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -74.13 112.98 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.23 111.129 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.97 163.08 37.71 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 71.32 112.47 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.875 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.86 -30.74 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.745 0.307 . . . . 64.02 111.146 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.15 -22.72 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.972 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -5.05 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.917 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -61.95 142.08 57.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 63.41 110.905 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.95 -142.88 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 62.31 112.476 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.445 HG23 ' ND2' ' A' ' 92' ' ' ASN . 3.5 mt -123.95 133.22 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.34 111.108 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 16' ' ' LEU . 7.0 t80 -104.75 140.14 38.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 64.52 110.849 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -135.23 142.39 45.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 55.12 110.868 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 155.81 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.862 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -140.7 129.28 22.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 53.1 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 162.19 31.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.115 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 ttm -130.65 125.08 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 63.53 110.889 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -89.59 172.28 9.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.865 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -71.68 -18.52 62.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.5 110.812 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -73.45 -20.01 60.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.922 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.54 31.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 71.44 112.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -84.98 146.83 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 51.02 110.936 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.09 143.87 32.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 61.3 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 126.64 51.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 42.24 111.171 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 145.11 32.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 62.23 110.83 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -144.58 124.52 13.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.852 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -118.88 121.45 40.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 43.22 110.827 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -128.89 120.42 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 63.31 110.957 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.75 134.28 34.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.914 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.29 139.36 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 75.42 111.172 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -129.14 148.44 51.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.851 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.875 HG21 ' HA ' ' A' ' 71' ' ' ILE . 34.6 m -112.67 -177.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 63.12 111.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -66.35 -81.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.933 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -59.24 146.25 39.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.907 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.41 159.7 49.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.611 0.72 . . . . 74.43 111.154 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 74.44 112.345 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.885 0.374 . . . . 74.25 110.79 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.39 96.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 73.1 111.058 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.85 133.79 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.896 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.421 ' C ' HD12 ' A' ' 6' ' ' ILE . 4.5 p30 -84.29 119.62 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 62.32 110.862 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.0 mp -126.52 123.54 63.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 62.11 111.096 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -94.78 140.83 29.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 71.0 111.116 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.72 167.27 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 73.45 111.113 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -124.25 148.32 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.22 110.909 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 71' ' ' ILE . 24.9 mt -53.83 121.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.23 111.125 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.65 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.72 3.97 79.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 53.03 112.45 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 14.9 mm-40 -101.1 140.33 21.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.11 110.867 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 142.28 47.59 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.676 2.251 . . . . 55.23 112.339 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 6' ' ' ILE . 23.0 tp -144.43 141.97 29.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 72.32 110.912 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 65' ' ' PHE . 41.8 t -123.34 147.97 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.116 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.835 HD12 HD23 ' A' ' 64' ' ' LEU . 94.4 mt -131.5 148.6 52.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 72.52 110.983 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -110.49 149.0 30.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.45 110.923 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 101.19 9.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 62.43 110.85 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.19 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 62.51 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.725 -0.75 . . . . 65.14 112.497 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.777 0.322 . . . . 73.54 110.928 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.13 148.62 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 54.05 110.861 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.647 ' HE3' HD21 ' A' ' 33' ' ' LEU . 5.0 m95 -127.67 132.76 49.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.856 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.7 mtmt -137.6 135.41 36.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 75.11 110.871 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.082 HD11 HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -139.93 138.84 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.881 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -112.95 127.63 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 74.23 110.848 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.1 p -137.22 179.77 6.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.149 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 -127.71 13.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 74.52 112.48 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 38' ' ' THR . 2.8 tpt180 -114.33 -37.49 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 74.13 110.823 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -179.09 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 61.14 111.158 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -99.98 32.91 2.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.895 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.76 -6.24 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 42.12 111.139 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -60.71 131.25 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 73.52 110.93 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 158.77 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.35 110.877 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.06 118.73 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.082 HD12 HD11 ' A' ' 33' ' ' LEU . 1.5 mt -90.25 145.78 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.954 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.03 162.74 43.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 63.44 110.881 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 0.16 6.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.237 . . . . 60.22 112.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.805 0.336 . . . . 71.22 111.112 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 162.06 23.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 72.03 110.881 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.27 130.15 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.12 111.18 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.4 mt -69.54 158.86 85.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 73.21 110.869 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -23.41 30.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 61.11 112.37 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -83.79 0.48 47.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 62.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.2 25.24 19.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 54.14 112.497 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.582 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -105.84 -179.43 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 61.13 110.911 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.835 HD23 HD12 ' A' ' 16' ' ' LEU . 13.7 tp -130.03 129.97 44.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 63.45 110.931 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 15' ' ' VAL . 36.9 t80 -125.37 128.83 48.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 73.25 110.817 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.2 mp -120.26 130.02 25.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.647 0.737 . . . . 63.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.36 18.95 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 73.33 112.343 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.65 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.24 101.71 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 63.44 111.057 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -73.09 119.33 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 72.44 111.124 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.03 161.91 33.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 62.2 112.533 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.755 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.59 -31.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.779 0.323 . . . . 74.44 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -75.05 -23.16 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.12 110.843 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.44 -5.48 45.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 70.12 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 140.48 58.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.868 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.36 -141.72 8.19 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 62.4 112.547 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG23 HD21 ' A' ' 92' ' ' ASN . 1.3 mp -123.5 133.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 51.13 111.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 10.7 m-85 -104.48 139.95 38.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 65.32 110.876 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -135.41 142.01 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 75.3 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 41.8 t -128.91 150.43 50.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.3 126.75 21.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 71.41 110.925 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.97 163.06 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 34.32 111.124 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.7 ttm -129.35 125.02 35.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 62.04 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.25 172.55 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 62.12 110.905 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -70.96 -18.54 62.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 65.12 110.839 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -73.83 -25.83 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 75.54 110.85 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.78 -14.24 19.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 42.11 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.35 147.88 26.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.717 0.294 . . . . 72.33 110.882 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.12 142.49 34.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 65.11 110.911 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.69 126.29 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.137 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 144.2 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.901 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.1 m -146.9 126.7 13.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.04 110.91 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.22 126.91 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.919 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 16' ' ' LEU . 8.3 m-85 -124.1 120.96 33.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 65.25 110.974 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NE ' ' HB1' ' A' ' 3' ' ' ALA . 20.1 mmt85 -83.53 130.07 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.12 110.799 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.02 134.2 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 74.21 111.121 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.454 ' NH1' HG21 ' A' ' 100' ' ' ILE . 0.8 OUTLIER -131.45 127.92 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.5 m -95.66 -177.67 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 60.35 111.068 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -66.76 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.898 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -62.48 143.83 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 73.11 110.882 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -121.37 159.72 48.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 63.51 111.124 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.23 112.311 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.896 0.379 . . . . 71.54 110.886 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.32 93.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.53 111.09 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.577 ' NE2' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -93.39 131.46 38.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 74.34 110.925 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.672 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.8 m120 -88.34 120.54 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 52.43 110.881 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.672 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.87 128.37 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 62.32 111.112 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -89.3 141.09 28.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 72.01 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.13 165.95 26.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 71.22 111.134 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 150.06 43.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.829 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 22.7 mt -68.76 120.61 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.75 -6.34 60.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 73.12 112.49 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 pp20? -102.09 141.09 21.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.41 110.842 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 145.69 58.03 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.43 112.347 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 tp -137.95 143.07 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 72.25 110.914 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 65' ' ' PHE . 39.1 t -122.09 145.0 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.31 111.133 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 30.4 mt -131.3 149.48 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.16 152.75 27.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 72.11 110.972 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -106.31 101.78 11.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.861 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -58.76 120.38 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 61.55 110.864 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 60.33 112.451 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.484 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.777 0.322 . . . . 64.11 110.931 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.6 144.81 47.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 52.32 110.96 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.484 ' HE1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -126.22 136.88 53.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.156 -0.474 . . . . 65.25 110.948 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -144.36 136.4 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 53.25 110.82 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.5 tp -138.95 136.81 35.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 73.44 110.887 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.627 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -113.45 127.13 56.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.868 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.793 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.6 p -137.99 179.39 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 74.45 111.108 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.39 -131.18 16.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 73.12 112.528 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.5 -37.29 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 63.43 110.89 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -179.4 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 75.21 111.133 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.09 33.32 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 74.11 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.61 -7.21 7.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 63.43 111.101 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -60.36 130.59 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 153.46 47.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 73.34 110.846 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.04 121.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 55.24 111.101 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.82 145.84 24.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 61.35 110.946 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.56 163.13 40.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.723 . . . . 74.05 110.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.77 2.82 3.19 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.675 2.25 . . . . 51.2 112.366 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 61.5 110.914 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.784 0.326 . . . . 44.41 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -132.54 160.18 37.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 74.33 110.9 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 46' ' ' PRO . 7.0 t -109.0 129.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 71.1 111.113 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 36.0 mt -70.28 158.82 86.65 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 52.45 110.934 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -21.87 33.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 63.51 112.339 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -83.16 1.83 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 72.14 110.884 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.21 29.69 14.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 64.43 112.472 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.8 m -113.9 -178.9 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 44.21 110.88 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 23.8 tp -129.47 127.62 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.901 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 15' ' ' VAL . 6.5 t80 -125.9 136.05 52.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 65.44 110.879 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.62 HD22 HG12 ' A' ' 69' ' ' VAL . 7.7 mp -119.29 130.22 24.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.636 0.732 . . . . 63.5 110.895 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.93 17.37 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.28 . . . . 61.01 112.308 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.77 102.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 74.01 111.105 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 12' ' ' GLU . 18.5 m -72.74 119.2 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.45 111.039 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.16 161.55 27.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 70.1 112.53 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.15 -32.26 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 72.55 111.079 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -76.01 -22.51 55.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 72.05 110.918 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -4.98 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 71.33 110.84 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.32 141.3 57.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 70.44 110.913 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.08 -138.95 5.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.743 . . . . 54.41 112.48 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.412 HG23 HD21 ' A' ' 92' ' ' ASN . 2.4 mp -123.95 130.35 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 61.15 111.132 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.552 ' CG ' HD13 ' A' ' 16' ' ' LEU . 10.8 t80 -105.49 134.17 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.84 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.56 139.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 74.53 110.817 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.5 t -125.5 156.3 39.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 53.43 110.896 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -140.75 134.67 30.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.14 110.908 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 162.36 32.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.143 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.8 mtp -130.16 125.24 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.908 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -91.51 172.43 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.827 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -18.87 62.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.51 110.864 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -73.94 -20.43 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.907 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.99 -15.33 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 55.43 112.414 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 146.18 27.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 70.32 110.88 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -106.16 143.63 34.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.87 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 129.46 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 70.12 111.16 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 145.11 35.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.858 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.21 121.53 10.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 53.13 110.9 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.412 HD21 HG23 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -118.37 124.37 47.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 73.14 110.832 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -129.82 117.93 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 73.42 110.827 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -84.24 130.6 34.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.873 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.08 140.32 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 73.2 111.118 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.23 127.73 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.7 m -88.69 -176.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.04 111.107 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.6 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.937 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 140.74 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.885 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.71 159.63 50.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.654 0.74 . . . . 74.44 111.074 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.68 2.254 . . . . 74.04 112.274 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.826 0.346 . . . . 40.41 110.856 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.33 66.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 62.44 111.108 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.57 133.55 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 73.05 110.934 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 2.2 p30 -84.01 121.03 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 70.31 110.888 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 14' ' ' LEU . 43.6 mm -125.4 121.78 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.44 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.98 138.77 33.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.45 . . . . 74.11 111.093 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 166.88 26.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.122 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -120.93 148.35 44.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.841 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mt -52.61 121.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 61.42 111.058 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.73 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.61 7.19 72.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 51.02 112.515 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.767 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.7 mm-40 -101.37 139.43 20.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 52.13 110.939 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 143.15 49.62 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 75.42 112.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 6' ' ' ILE . 19.1 tp -145.44 142.04 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 73.41 110.859 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.13 148.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 65.22 111.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.781 HD12 HD23 ' A' ' 64' ' ' LEU . 9.2 mt -131.14 147.21 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.906 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -113.26 154.89 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.902 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 t -104.06 100.57 10.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 74.45 110.893 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.64 116.56 4.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 61.44 110.901 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.786 -0.721 . . . . 73.25 112.504 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.788 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.767 0.318 . . . . 64.14 110.932 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -145.55 148.54 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.855 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.788 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 29.0 m-90 -120.64 132.07 54.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 72.53 110.897 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' HD23 ' A' ' 33' ' ' LEU . 2.1 ttpt -139.97 135.9 33.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.952 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -148.1 140.05 24.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 74.52 110.945 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.95 128.74 55.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 44.31 110.927 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -136.33 -179.73 5.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 72.25 111.166 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.68 -129.14 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 72.33 112.549 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.51 -37.45 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 65.44 110.906 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.4 t -179.32 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.156 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.8 mt-10 -102.26 33.93 2.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 74.15 110.841 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.63 -6.32 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.54 111.148 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.73 130.2 45.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.942 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.619 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -130.8 152.97 49.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 75.33 110.882 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.85 120.66 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.31 111.189 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 33' ' ' LEU . 3.3 mm? -89.88 146.71 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.44 46.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 64.51 110.93 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.73 -1.92 9.26 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 73.11 112.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 63.2 110.974 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.796 0.331 . . . . 55.41 111.137 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.64 161.18 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.11 110.937 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 44' ' ' LEU . 24.9 t -109.0 129.93 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.11 111.042 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.45 158.98 86.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.7 . . . . 71.33 110.899 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -20.98 33.91 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.608 2.205 . . . . 71.24 112.294 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -83.12 1.59 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 74.34 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.39 25.17 26.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 61.03 112.505 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -110.84 -178.72 3.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.22 110.823 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' CE2' ' A' ' 77' ' ' PHE . 10.7 tp -129.72 127.57 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.917 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -126.12 132.51 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.904 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 69' ' ' VAL . 4.8 mp -118.54 129.61 25.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.663 0.744 . . . . 74.2 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.74 17.86 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.739 2.293 . . . . 65.45 112.313 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.73 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.76 101.29 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 25.51 111.044 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 66' ' ' LEU . 12.2 m -73.35 116.71 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 70.21 111.1 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.4 165.35 33.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 74.23 112.512 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.85 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.78 -30.17 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 72.44 111.111 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.853 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -5.0 56.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 64.32 110.821 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.69 140.94 58.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.76 -141.56 7.87 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 31.52 112.528 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD12 ' CG ' ' A' ' 94' ' ' ARG . 47.1 mm -124.41 127.72 73.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 63.32 111.115 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.787 ' CE2' HD22 ' A' ' 64' ' ' LEU . 11.2 t80 -104.66 134.18 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.22 110.897 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -127.92 146.5 50.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 72.33 110.837 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.4 t -126.25 153.87 44.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.922 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.04 130.82 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 71.11 110.887 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.55 162.58 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 65.12 111.105 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.4 ttm -130.32 125.01 33.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.919 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -89.14 172.23 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.42 110.836 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.53 -18.61 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 72.42 110.853 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -73.57 -20.23 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.21 110.829 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.91 -17.44 29.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 64.1 112.49 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -84.81 147.9 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 71.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -104.01 149.18 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.875 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.478 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.14 133.5 48.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.131 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 143.41 33.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 53.13 110.921 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.5 m -145.23 122.74 11.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 61.3 110.831 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.66 124.36 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 73.04 110.925 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -128.37 119.83 25.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 55.23 110.89 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.576 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.9 132.15 34.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 73.11 110.823 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.88 136.26 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 73.54 111.118 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.432 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -131.12 131.58 44.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.849 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.8 m -95.87 -175.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 54.41 111.171 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -66.39 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.23 110.867 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -62.85 146.33 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 75.34 110.943 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.56 49.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.688 0.756 . . . . 63.25 111.081 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 54.33 112.329 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.949 0.404 . . . . 73.13 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.9 71.11 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.059 -0.519 . . . . 55.21 111.082 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 133.28 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.946 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.45 119.13 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 60.44 110.887 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 14' ' ' LEU . 3.8 mp -126.44 124.64 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.136 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -93.51 142.25 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 55.2 111.115 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.43 166.57 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.32 111.029 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.61 148.28 46.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 62.32 110.92 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mt -54.9 121.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 42.34 111.173 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.41 76.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 72.52 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.9 mm-40 -101.91 140.7 21.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.689 0.757 . . . . 74.13 110.899 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 144.03 52.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.664 2.242 . . . . 64.11 112.331 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 6' ' ' ILE . 22.3 tp -143.54 141.31 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 75.01 110.907 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.0 t -122.44 147.19 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 62.54 111.131 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 53.4 mt -130.97 148.28 52.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.899 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -112.07 151.82 28.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.807 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 t -107.18 100.76 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.853 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.1 120.22 8.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.892 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 62.3 112.515 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.68 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.707 0.289 . . . . 62.43 110.951 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -121.51 148.62 44.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 60.14 110.878 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.68 ' HE1' HD13 ' A' ' 29' ' ' LEU . 23.5 m95 -123.11 138.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.876 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.711 ' C ' HD13 ' A' ' 33' ' ' LEU . 89.0 mttt -150.97 135.76 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.24 110.94 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.25 145.94 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.889 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.99 129.43 56.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.943 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.842 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -138.42 -179.58 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 54.24 111.157 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.89 -132.78 16.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 71.22 112.53 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.79 -37.69 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 73.22 110.882 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -179.12 -29.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.098 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.53 34.81 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.874 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.09 -4.23 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.21 111.06 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -57.32 128.05 35.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.725 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.16 156.64 47.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 74.03 110.873 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' LYS . 94.7 t -105.5 122.24 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 73.21 111.125 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 33' ' ' LEU . 4.0 mt -89.91 147.14 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 61.31 110.864 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.77 162.21 46.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.73 0.776 . . . . 54.51 110.846 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.81 -2.62 10.52 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.687 2.258 . . . . 64.31 112.319 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.899 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.811 0.339 . . . . 72.1 111.137 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 162.8 25.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.916 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 46' ' ' PRO . 8.1 t -106.75 130.95 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 75.4 111.167 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.55 HD12 ' CB ' ' A' ' 63' ' ' SER . 31.1 mt -68.7 157.69 87.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 74.32 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -22.16 32.65 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.669 2.246 . . . . 63.34 112.365 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.7 1.2 43.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.46 29.83 11.65 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 21.12 112.438 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.55 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -112.86 -179.6 3.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 64.12 110.87 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 16.3 tp -129.51 129.24 44.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.32 110.873 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' HG22 ' A' ' 15' ' ' VAL . 44.8 t80 -124.63 136.72 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.21 110.881 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.574 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -116.41 124.79 29.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.35 110.913 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.71 19.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 73.42 112.375 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.49 103.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.076 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 12' ' ' GLU . 34.4 m -71.62 118.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 72.43 111.124 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.58 157.44 23.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 75.5 112.506 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.831 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -32.02 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 72.45 111.127 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -75.6 -23.4 56.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -5.26 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 52.43 110.823 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 142.01 56.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 52.44 110.918 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.22 -138.17 5.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.798 -0.715 . . . . 74.02 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 92' ' ' ASN . 3.6 mp -122.68 127.32 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 71.04 111.195 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 14.6 m-85 -104.78 144.49 31.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 63.25 110.853 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -138.27 143.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 71.34 110.865 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.8 t -127.21 155.66 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.31 110.891 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.14 133.8 30.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.926 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.5 162.71 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 51.54 111.089 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 mtp -129.94 125.12 34.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.11 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -91.39 172.51 8.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 41.42 110.876 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.45 -18.81 62.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 74.14 110.852 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.06 -20.57 60.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.872 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.02 -15.21 33.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.83 -0.7 . . . . 45.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -85.02 146.35 27.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.742 0.306 . . . . 74.43 110.893 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 144.26 33.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.89 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 132.15 50.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 65.31 111.189 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 145.14 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.937 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -145.34 127.9 16.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.01 110.825 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.519 HD21 HG23 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -116.97 124.93 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 74.23 110.849 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -125.41 121.6 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 72.2 110.944 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HE ' ' ND2' ' A' ' 92' ' ' ASN . 16.9 mmt85 -83.07 133.03 35.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.31 110.874 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -120.95 134.82 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 71.11 111.219 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 128.79 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.872 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.8 m -98.33 -177.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 73.4 111.198 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.55 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.954 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.89 144.53 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 72.3 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.4 159.61 49.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 74.15 111.125 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.9 Cg_endo . . . . . 0 C--N 1.34 0.117 0 C-N-CA 122.686 2.258 . . . . 64.03 112.319 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.81 0.338 . . . . 70.13 110.894 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.69 66.91 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 43.22 111.084 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -93.23 131.94 37.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.41 110.916 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.3 p-10 -90.83 121.85 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.887 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.58 127.42 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.137 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -94.52 142.52 27.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 61.42 111.179 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.35 168.44 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 64.3 111.061 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.43 148.06 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.596 HD11 HG13 ' A' ' 71' ' ' ILE . 33.8 mt -67.28 121.99 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.06 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.17 -9.96 54.58 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.675 -0.774 . . . . 74.41 112.429 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.71 142.66 25.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.723 . . . . 72.45 110.862 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 145.07 56.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 63.24 112.334 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.0 tp -139.71 144.44 37.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 74.4 110.909 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.608 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.9 t -120.46 145.03 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 63.44 111.104 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.3 mt -131.28 147.78 52.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.41 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -113.62 150.87 32.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 61.14 110.924 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.11 100.26 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 72.14 110.894 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -54.27 128.41 31.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.02 110.939 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.727 . . . . 74.35 112.472 179.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.526 0.041 0 CA-C-O 120.81 0.338 . . . . 60.52 110.888 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.71 148.44 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 63.34 110.895 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.782 ' CZ3' HG11 ' A' ' 58' ' ' VAL . 3.3 m-90 -134.47 144.11 47.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 64.14 110.982 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.452 ' C ' HD23 ' A' ' 33' ' ' LEU . 4.4 mtmt -136.21 142.05 44.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.24 110.924 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.003 HD21 HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.4 139.03 42.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 73.1 110.936 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -112.12 127.29 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.33 110.901 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 43.7 p -138.16 -179.8 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 71.21 111.141 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.44 -129.97 23.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.852 -0.689 . . . . 74.33 112.435 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -112.61 -37.4 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 73.42 110.897 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.1 t -178.69 -29.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 65.31 111.174 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -101.73 34.07 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 74.5 110.887 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -5.54 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.123 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.544 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 44.0 t90 -59.62 131.82 52.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 70.01 110.929 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.768 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.03 155.07 45.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.935 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.544 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 23.1 t -104.48 121.75 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 70.55 111.137 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.003 HD13 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -88.86 143.13 27.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.41 110.911 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -127.93 164.09 39.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 65.35 110.808 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 0.85 5.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.707 2.271 . . . . 63.1 112.277 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 74.04 110.899 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.819 0.342 . . . . 71.25 111.116 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.52 160.2 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.85 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG11 ' CZ3' ' A' ' 31' ' ' TRP . 65.7 t -111.9 129.25 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.158 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 63' ' ' SER . 86.4 mt -69.29 157.19 90.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 74.02 110.929 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.41 34.81 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.75 2.3 . . . . 73.42 112.278 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -82.41 0.57 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 63.42 110.863 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 27.39 17.37 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 54.34 112.443 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 59' ' ' LEU . 30.4 m -111.77 175.73 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.852 0.358 . . . . 50.44 110.896 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.843 HD13 HD21 ' A' ' 44' ' ' LEU . 16.5 tp -129.34 130.11 45.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.865 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.608 ' CD2' HG22 ' A' ' 15' ' ' VAL . 27.7 t80 -124.42 135.39 53.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 62.41 110.852 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.504 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.56 129.51 24.87 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 72.05 110.917 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.62 -31.68 20.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.285 . . . . 73.23 112.414 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.55 104.36 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 61.1 111.145 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.4 m -71.83 119.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 40.23 111.163 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.93 153.49 20.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 31.05 112.447 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.02 -31.18 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 54.45 111.151 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.28 -22.01 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 61.14 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.35 -3.53 34.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.839 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.785 ' CD ' HG22 ' A' ' 97' ' ' VAL . 16.8 mt-10 -58.43 142.17 49.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.1 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.46 -151.74 22.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 73.52 112.561 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.29 133.98 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 64.3 111.107 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.75 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.3 m-85 -103.04 139.38 38.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.87 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.52 141.04 51.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 m -126.82 150.24 49.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 73.13 110.891 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.07 125.51 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.881 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.43 163.97 28.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 64.15 111.091 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.8 ttm -128.34 124.88 37.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.907 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -86.91 173.15 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 73.22 110.871 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -70.22 -17.97 63.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.87 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -73.23 -19.74 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 63.25 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.36 -18.78 32.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 71.15 112.43 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -85.16 148.2 26.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 75.31 110.916 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.5 143.61 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 64.05 110.895 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.55 131.6 51.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 54.04 111.127 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 145.34 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.43 110.93 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -146.32 124.41 12.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 72.11 110.846 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -118.82 124.6 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.24 117.02 20.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.927 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -90.9 136.11 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.928 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.18 138.57 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 54.2 111.134 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.21 128.14 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 70.05 110.855 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -92.2 -175.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.24 111.11 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -65.98 -80.62 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -58.67 146.67 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 61.04 110.847 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.31 159.49 49.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.693 0.759 . . . . 74.14 111.132 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 72.2 112.368 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.835 0.35 . . . . 52.32 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.47 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 72.02 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -93.44 132.42 37.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.863 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.668 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.0 p30 -87.13 119.96 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.898 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.668 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -127.78 127.47 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.117 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -92.11 141.88 28.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 71.42 111.102 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.54 167.58 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.45 111.073 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.78 149.68 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.5 110.885 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 71' ' ' ILE . 22.5 mt -67.47 120.7 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.122 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.69 -8.29 59.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.691 -0.766 . . . . 61.22 112.468 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.08 140.81 21.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.701 . . . . 64.42 110.911 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 145.11 55.98 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.704 2.269 . . . . 74.54 112.33 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 66' ' ' LEU . 20.2 tp -142.35 143.4 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 71.44 110.917 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 64' ' ' LEU . 13.7 t -122.49 148.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 74.24 111.146 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 64' ' ' LEU . 29.6 mt -129.85 149.1 51.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 74.4 110.934 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -108.8 149.56 28.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 61.33 110.878 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.3 t -112.12 100.69 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 72.32 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.12 100.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 52.32 110.842 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.799 -0.715 . . . . 63.3 112.51 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.805 0.336 . . . . 72.52 110.937 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 148.33 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 72.55 110.912 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -127.59 137.92 52.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.923 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -135.72 138.57 42.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 73.25 110.957 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 35' ' ' THR . 1.2 tm? -137.3 131.53 32.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.948 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.738 ' N ' HD22 ' A' ' 33' ' ' LEU . 10.4 t-20 -116.53 120.68 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 45.25 110.939 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.81 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 54.8 p -138.36 179.39 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 71.55 111.191 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.61 -132.16 12.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 43.13 112.462 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 75.04 110.83 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.67 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 63.2 111.141 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.19 33.73 2.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.917 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.35 -6.01 7.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 74.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -69.24 130.59 43.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 63.31 110.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 159.32 42.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 74.41 110.875 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.73 121.48 43.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.071 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -89.63 146.12 24.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.05 110.94 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.96 162.7 43.99 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.614 0.721 . . . . 72.11 110.852 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 0.51 5.48 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.743 2.295 . . . . 75.33 112.335 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.899 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.829 0.347 . . . . 64.21 111.101 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -112.01 161.04 16.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.11 110.932 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.36 128.16 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 55.12 111.139 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 63' ' ' SER . 26.3 mt -69.05 157.32 89.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.596 0.712 . . . . 72.11 110.925 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.3 Cg_endo -69.63 -22.96 31.95 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.638 2.225 . . . . 51.43 112.363 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -83.45 1.12 43.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 71.24 110.86 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.13 13.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 65.34 112.455 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.534 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m -109.67 177.19 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 53.32 110.79 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.4 tp -130.28 129.34 43.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 73.11 110.908 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 t80 -124.16 129.43 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.859 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 14' ' ' LEU . 1.9 mp -117.29 131.22 24.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 72.24 110.892 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -32.22 18.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 75.52 112.274 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 100.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.31 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.9 m -76.16 119.88 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.04 111.143 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -91.6 166.92 30.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.508 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.851 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.6 -30.83 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 74.44 111.156 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -74.8 -21.25 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 65.31 110.858 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.32 -3.08 31.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 65.2 110.804 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 139.71 58.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 61.24 110.869 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.98 -147.23 14.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.745 . . . . 52.54 112.516 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.91 133.78 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 63.23 111.118 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.583 ' CG ' HD23 ' A' ' 33' ' ' LEU . 36.9 m-85 -104.94 128.29 53.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 62.01 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.13 138.13 53.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 156.67 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 72.11 110.913 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -141.26 127.92 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 71.42 110.929 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.21 162.95 29.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.139 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.01 124.43 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 73.11 110.905 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -88.65 172.52 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.899 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -71.09 -18.39 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.05 110.823 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -73.62 -19.77 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 73.14 110.915 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.78 -16.88 33.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 35.02 112.417 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -84.96 147.61 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 63.43 110.937 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.31 143.79 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.46 125.6 50.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 54.24 111.15 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 144.76 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.21 110.888 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -145.55 121.27 10.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.834 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 123.54 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 72.32 110.92 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -129.16 118.27 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 64.21 110.877 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.58 132.38 33.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.15 110.86 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.79 139.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 71.34 111.134 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 127.94 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.892 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.0 m -91.83 -177.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 70.34 111.138 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.51 110.943 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.1 142.52 51.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.93 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.29 159.59 49.27 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.555 0.693 . . . . 73.13 111.159 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.188 0 C-N-CA 122.666 2.244 . . . . 73.24 112.338 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.816 0.341 . . . . 74.03 110.911 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.893 0.378 . . . . 74.43 111.073 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo . . . . . 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.501 -0.24 . . . . 45.03 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.69 107.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.916 0.388 . . . . 73.11 110.898 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.32 71.67 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 43.2 111.094 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -93.11 135.6 34.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.939 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.37 120.97 27.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.859 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 14' ' ' LEU . 41.2 mm -125.95 121.94 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 75.45 111.15 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.83 138.62 33.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.142 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.33 166.98 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 73.22 111.118 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.06 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 65.25 110.849 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.98 121.64 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 51.53 111.117 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.27 3.96 78.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.513 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.758 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.6 mm-40 -101.43 139.76 20.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 74.32 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.38 50.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 45.04 112.335 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.647 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.7 tp -144.57 142.15 29.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 63.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.1 t -122.87 146.9 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 74.51 111.163 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 93' ' ' TYR . 56.1 mt -132.22 148.37 52.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.897 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -112.04 148.88 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.21 110.908 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.12 100.82 8.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.832 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.37 102.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 65.12 110.92 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 149.48 -46.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.33 112.483 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -96.15 102.24 10.38 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.541 0.686 . . . . 64.21 111.099 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.2 Cg_endo -69.75 -162.96 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.689 2.259 . . . . 71.24 112.363 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.46 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.54 110.911 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -45.92 168.68 0.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.627 0.727 . . . . 62.25 110.91 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.7 Cg_endo -69.73 172.93 11.7 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 73.02 112.351 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.9 Cg_endo -69.75 97.25 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.688 2.259 . . . . 53.03 112.354 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.28 -174.29 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 61.33 110.934 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 ttm-85 -63.15 132.77 52.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.04 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp -177.47 162.16 1.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.903 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.31 146.77 46.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 62.32 110.873 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CH2' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.2 132.36 48.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 65.3 110.949 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -135.55 142.62 45.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 35' ' ' THR . 4.0 tp -138.42 134.41 34.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 63.44 110.933 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.1 t-20 -115.16 121.92 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.874 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.2 p -138.3 176.27 8.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 73.23 111.118 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.26 -131.15 13.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 32.22 112.51 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.66 -37.75 4.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 54.42 110.856 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.31 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 63.43 111.172 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HG3' HG23 ' A' ' 38' ' ' THR . 53.7 mt-10 -102.25 33.26 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.42 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.22 -6.74 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.169 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -61.92 131.32 49.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.53 110.934 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.45 46.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.903 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.2 t -100.62 120.66 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 72.33 111.151 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 31' ' ' TRP . 3.7 mm? -95.56 146.95 24.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 74.04 110.961 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.32 163.46 36.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 71.14 110.877 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.79 0.48 5.61 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.661 2.241 . . . . 74.43 112.32 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -118.8 71.56 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.931 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.24 3.11 79.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 61.11 112.479 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 106.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 64.1 112.494 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.07 -72.76 0.46 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.729 -0.748 . . . . 50.2 112.504 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -0.14 6.46 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 70.24 112.359 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.456 ' HB2' ' HG3' ' A' ' 57' ' ' ARG . 17.8 p-90 -51.65 -35.1 40.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.945 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -69.59 -25.16 63.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 62.12 110.913 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -42.96 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.883 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.27 -97.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.21 111.118 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . -158.63 173.63 16.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 54.43 111.089 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -124.48 164.83 18.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.877 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 18.5 t -107.66 132.01 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.21 111.114 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 63' ' ' SER . 39.7 mt -68.63 158.76 84.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 74.2 110.896 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -25.11 28.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 74.13 112.313 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -83.57 2.06 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 72.14 110.905 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.33 32.46 8.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.12 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.717 ' HB3' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -111.78 -179.53 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 74.21 110.851 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.645 HD22 ' CH2' ' A' ' 31' ' ' TRP . 17.0 tp -130.47 129.59 43.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.965 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 15' ' ' VAL . 24.8 t80 -124.37 129.62 51.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.05 110.859 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.814 HD22 HG12 ' A' ' 69' ' ' VAL . 5.0 mp -116.57 130.74 24.3 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 64.05 110.934 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -32.61 18.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 72.21 112.352 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.63 101.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 71.23 111.084 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 HD22 ' A' ' 66' ' ' LEU . 13.8 m -73.69 118.59 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.11 111.169 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.07 163.99 30.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 60.23 112.473 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.855 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.36 -30.84 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 72.31 111.152 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -75.83 -23.26 55.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 63.44 110.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.93 -4.67 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.883 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.53 140.83 58.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 75.44 110.913 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.74 -138.55 5.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.482 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.64 135.33 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 64.2 111.132 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.8 m-85 -103.27 135.24 45.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 54.33 110.857 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -131.36 131.47 43.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.866 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 t -125.95 156.12 40.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.14 110.87 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.427 ' HB3' ' C6 ' ' A' ' 201' ' ' IOR . 13.8 pt20 -141.16 142.73 34.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 72.12 110.886 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.17 162.53 33.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 41.21 111.087 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.0 ttm -130.43 124.72 32.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.04 172.25 8.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 64.24 110.833 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -71.44 -19.35 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 65.15 110.871 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -74.08 -20.17 60.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.85 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.43 37.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 75.32 112.438 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.1 147.47 26.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 62.41 110.935 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.69 144.7 31.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 72.54 110.901 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.45 131.72 50.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.111 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.53 142.91 34.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 75.25 110.896 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.91 121.81 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 52.1 110.854 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 123.02 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.434 ' CD2' HD22 ' A' ' 16' ' ' LEU . 3.9 m-85 -125.86 120.11 29.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 75.41 110.926 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.0 130.55 34.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 73.32 110.875 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -121.12 137.32 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 62.42 111.151 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.29 131.88 45.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 70.33 110.902 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.8 m -95.81 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 51.35 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.51 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.928 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.13 143.6 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 62.23 110.925 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.407 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.65 159.58 50.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.652 0.739 . . . . 73.43 111.146 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.2 Cg_endo -69.71 -31.64 20.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 52.32 112.34 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.21 -77.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.738 . . . . 53.14 112.461 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -86.66 137.71 33.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 73.43 110.901 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 166.16 28.53 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 72.1 112.305 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.05 110.9 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.427 ' C6 ' ' HB3' ' A' ' 80' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.445 -0.262 . . . . 73.5 112.445 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m 58.73 96.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 62.12 110.797 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.61 72.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 71.25 111.087 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 133.18 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 73.22 110.931 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.37 120.44 26.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 63.54 110.939 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.69 HG21 HD11 ' A' ' 14' ' ' LEU . 46.8 mm -125.91 121.61 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 70.3 111.085 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.93 137.7 34.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 62.01 111.142 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.42 166.78 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 70.11 111.085 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.59 148.72 44.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.946 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -52.08 121.57 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.1 111.145 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.653 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.87 6.67 75.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 62.21 112.538 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.3 mm-40 -101.83 140.13 20.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.709 0.766 . . . . 72.41 110.846 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 143.88 52.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.745 2.297 . . . . 65.51 112.33 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 6' ' ' ILE . 33.5 tp -144.23 142.0 30.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.898 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 65' ' ' PHE . 24.3 t -122.81 147.91 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 71.11 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 64' ' ' LEU . 50.2 mt -131.58 149.05 52.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 65.24 110.951 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.48 152.53 27.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.916 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.74 101.33 10.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.3 110.826 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.54 113.09 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 72.42 110.918 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' HG21 ' A' ' 89' ' ' THR . . . 129.19 -39.15 1.89 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 64.34 112.579 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.19 129.17 44.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.605 0.717 . . . . 75.52 111.05 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -167.28 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 71.23 112.33 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.02 -51.52 41.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 75.01 110.8 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -111.45 133.97 21.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.508 0.671 . . . . 74.03 110.927 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.689 2.259 . . . . 74.51 112.361 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.5 Cg_endo -69.79 -58.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 63.22 112.344 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -107.16 -179.2 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.11 110.922 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.64 152.68 44.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 30.42 110.858 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -146.71 153.11 39.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 72.13 110.925 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.2 147.79 44.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 63.34 110.943 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -129.41 138.93 51.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.958 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -144.11 136.04 26.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 74.44 110.933 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.749 HD12 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -138.98 139.83 38.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 71.24 110.931 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -112.07 127.97 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.895 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.773 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -137.55 178.29 7.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.13 111.102 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.17 -130.44 19.08 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 74.05 112.476 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -112.67 -37.39 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.903 0.382 . . . . 74.31 110.888 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.9 t -178.42 -30.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.055 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.9 mt-10 -102.26 33.89 2.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 63.22 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.9 -5.54 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 75.41 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -59.22 132.29 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.857 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.749 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -127.44 153.59 46.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 70.3 110.91 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.87 121.7 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.109 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' A' ' 33' ' ' LEU . 2.1 mm? -89.51 145.34 25.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.929 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -125.42 163.74 36.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.639 0.733 . . . . 61.44 110.854 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.5 Cg_endo -69.84 2.36 3.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.7 2.267 . . . . 41.22 112.275 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -116.64 101.68 8.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.937 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.33 72.44 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 73.31 112.528 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.18 133.53 5.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 62.44 112.552 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.22 -113.46 4.68 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 71.33 112.476 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.21 34.39 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.747 2.298 . . . . 61.0 112.338 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.458 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 7.7 m-90 -64.75 -33.81 76.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.908 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -65.78 -24.17 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 75.33 110.842 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.48 -33.95 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 63.31 110.828 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.82 -73.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 63.14 111.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.719 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -150.57 156.5 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.152 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -132.67 160.21 37.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 73.45 110.931 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 HD12 ' A' ' 44' ' ' LEU . 38.2 t -109.5 128.82 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.102 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.63 158.25 87.49 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.528 0.68 . . . . 42.42 110.957 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -21.38 33.41 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.24 . . . . 72.4 112.338 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -82.87 0.9 41.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 64.21 110.914 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.01 16.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.824 -0.703 . . . . 64.22 112.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 m -112.28 179.89 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 72.24 110.938 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 16' ' ' LEU . 10.9 tp -129.73 126.25 37.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 74.34 110.901 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CD2' HG22 ' A' ' 15' ' ' VAL . 34.1 t80 -126.46 135.46 51.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.892 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.06 129.59 25.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 73.33 110.922 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -33.03 17.17 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 73.32 112.301 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.653 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.2 102.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.432 . . . . 71.55 111.134 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -72.91 117.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.423 . . . . 73.44 111.183 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.05 162.2 30.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.805 -0.712 . . . . 54.04 112.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.26 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.72 0.295 . . . . 71.24 111.084 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -75.58 -22.74 56.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.927 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.59 -4.95 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.04 110.856 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.84 141.0 58.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 60.55 110.922 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.76 -137.96 5.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 72.12 112.465 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.6 mm -124.13 127.55 73.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.4 111.161 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.4 m-85 -104.77 134.73 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.28 144.97 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.928 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 155.45 43.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.875 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.89 130.25 23.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.908 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.57 161.93 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.03 111.154 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -130.14 125.28 34.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 63.21 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.49 173.16 9.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 64.12 110.865 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -70.64 -19.23 62.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.824 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -74.53 -20.56 59.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.11 -8.0 38.22 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 72.44 112.508 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.96 147.05 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.698 0.285 . . . . 75.33 110.948 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.94 140.32 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.483 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -105.24 129.64 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.14 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.87 144.23 33.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.883 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -145.08 125.95 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 54.13 110.85 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.7 124.12 45.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 64.44 110.891 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -127.87 120.62 28.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.953 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 131.34 35.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.94 137.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 64.42 111.1 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.49 129.05 42.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.865 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 m -93.58 -176.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.058 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -63.53 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.2 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -68.37 144.01 54.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 72.42 110.947 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.23 159.57 49.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 73.44 111.155 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo -69.73 176.4 6.79 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.718 2.278 . . . . 64.12 112.376 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.94 82.41 0.14 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 74.24 112.469 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -155.67 137.77 9.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.603 0.716 . . . . 71.33 110.888 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.64 147.88 64.6 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.701 2.267 . . . . 61.45 112.346 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 73.51 110.862 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.497 -0.241 . . . . 54.11 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t -179.33 97.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 72.33 110.84 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.35 73.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.496 . . . . 73.44 111.126 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -91.4 139.1 31.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 71.23 110.906 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -84.11 121.02 26.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.916 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.566 ' CG2' HD11 ' A' ' 14' ' ' LEU . 44.4 mm -125.68 121.62 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 65.14 111.065 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -95.35 139.72 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 64.4 111.126 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.83 166.33 28.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.058 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -124.03 149.2 46.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.823 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 99' ' ' GLN . 78.6 mt -53.88 120.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.168 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.619 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.35 6.94 77.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 54.43 112.452 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 69' ' ' VAL . 32.6 mm-40 -102.37 140.7 21.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 73.31 110.902 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 145.06 56.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 61.11 112.35 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.2 tp -142.51 142.72 32.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 72.34 110.967 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.2 t -121.12 147.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 72.05 111.072 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 17.8 mt -131.18 148.21 52.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 61.35 110.96 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -113.01 153.13 28.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.97 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.95 100.68 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 74.32 110.905 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.18 118.39 6.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.2 110.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.39 -40.71 1.81 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 44.31 112.562 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.51 129.43 42.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.551 0.691 . . . . 31.51 111.098 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -165.62 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.766 2.31 . . . . 72.12 112.341 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.36 -52.14 30.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 62.04 110.908 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -112.21 128.59 25.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.52 0.676 . . . . 71.45 110.965 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.1 Cg_endo -69.7 110.22 2.49 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.693 2.262 . . . . 63.34 112.362 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.0 Cg_endo -69.79 -53.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 51.22 112.373 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -106.05 -178.86 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.915 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -70.27 159.24 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 64.44 110.891 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.27 174.48 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 73.33 110.88 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.63 148.09 41.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.848 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -122.96 138.25 54.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.14 142.56 34.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 74.44 110.877 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' ' 77' ' ' PHE . 16.7 tp -137.94 135.79 36.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.852 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -115.23 121.94 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.94 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.6 p -138.17 176.72 8.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.03 111.199 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.83 -131.58 12.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 73.03 112.543 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -112.88 -37.89 4.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.369 . . . . 74.05 110.852 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.18 -30.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 63.22 111.142 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.9 mt-10 -102.1 33.63 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.01 110.929 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.86 -6.1 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 73.22 111.122 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -59.88 132.16 53.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HE3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.9 153.93 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 72.55 110.818 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.18 121.26 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 63.52 111.144 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.55 145.24 25.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 64.41 110.853 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.82 162.12 49.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.697 0.76 . . . . 71.12 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.92 11.01 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.706 2.271 . . . . 75.51 112.327 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -122.33 81.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.942 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.34 13.43 64.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.708 -0.758 . . . . 74.2 112.503 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 92.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.681 -0.771 . . . . 65.42 112.478 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.59 -64.8 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.736 -0.745 . . . . 51.44 112.491 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.81 3.32 2.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.645 2.23 . . . . 73.34 112.361 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -49.69 -34.59 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.912 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.82 -24.94 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 74.1 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 -43.91 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 71.44 110.833 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -126.68 -99.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 73.41 111.114 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -162.98 176.28 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 34.31 111.061 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.23 159.41 20.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 75.41 110.83 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.51 125.06 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 73.51 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 63' ' ' SER . 88.0 mt -68.21 156.99 88.77 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.641 0.734 . . . . 64.31 110.919 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.1 Cg_endo -69.74 -20.71 34.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.673 2.249 . . . . 71.43 112.33 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -82.48 0.89 40.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.11 110.885 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.97 28.7 14.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 74.21 112.501 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 59' ' ' LEU . 15.6 m -112.53 173.67 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 44.52 110.807 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 15.9 tp -129.29 130.42 46.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 72.24 110.871 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 34.9 t80 -124.29 136.03 53.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.874 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.559 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.05 130.75 23.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.656 0.741 . . . . 74.12 110.93 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -37.81 8.68 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 74.12 112.332 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.73 104.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 34.2 111.093 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 12' ' ' GLU . 19.6 m -73.06 117.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 70.14 111.139 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.97 162.67 24.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 61.03 112.476 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.29 -29.94 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 71.43 111.107 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.94 -24.17 58.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 63.33 110.933 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.89 -4.54 56.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 61.12 110.839 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.59 141.38 58.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 62.35 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.6 -139.81 7.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 75.05 112.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.76 130.25 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 75.12 111.103 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.675 ' CG ' HD13 ' A' ' 16' ' ' LEU . 6.2 t80 -103.2 144.3 31.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 72.23 110.912 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 146.35 52.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.55 110.823 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.7 t -126.98 151.44 48.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 64.13 110.899 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.84 131.76 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.907 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.75 161.91 31.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 51.23 111.054 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.8 mtp -130.17 124.4 32.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.05 110.817 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.42 172.87 9.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.911 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -70.53 -19.42 62.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 74.31 110.893 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.74 -20.34 59.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.01 110.861 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.02 39.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 61.1 112.463 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.91 147.7 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 75.04 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -104.3 142.66 34.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.53 110.813 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.525 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.74 132.55 50.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 43.42 111.14 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 144.1 32.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.53 110.954 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -145.06 126.09 14.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 72.11 110.889 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' C ' ' A' ' 201' ' ' IOR . 6.2 t-20 -118.69 122.56 42.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.901 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -128.72 120.79 27.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.955 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -83.14 133.18 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.85 138.34 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 74.44 111.125 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -129.25 143.91 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.82 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.833 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -112.47 -176.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.55 111.151 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.41 -79.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 75.32 110.933 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -63.76 144.79 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.04 110.952 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.425 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.4 159.66 49.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 72.05 111.163 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo -69.77 161.85 44.35 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.254 . . . . 72.42 112.352 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.58 -56.09 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.404 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -113.99 72.72 2.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.515 0.674 . . . . 70.2 110.886 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 -177.65 2.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 74.42 112.287 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.04 110.886 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.432 ' C ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.51 -0.236 . . . . 63.23 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.53 154.17 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 73.13 110.865 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.55 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . -60.49 94.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 61.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.22 133.08 36.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 64.24 110.949 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.1 p30 -89.68 119.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 62.41 110.935 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.733 HG21 HD11 ' A' ' 14' ' ' LEU . 2.7 mp -126.77 122.59 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -95.79 139.95 31.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 73.14 111.176 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.54 167.65 24.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.24 148.46 43.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.818 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 26.9 mt -52.42 121.25 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.128 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.703 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.42 8.02 71.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 31.5 112.498 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.4 mm-40 -101.94 140.3 21.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 73.55 110.952 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 144.09 52.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.707 2.271 . . . . 71.13 112.341 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 6' ' ' ILE . 21.7 tp -144.08 142.23 30.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 62.11 110.936 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 65' ' ' PHE . 33.9 t -121.84 145.93 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 50.43 111.133 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.9 mt -131.43 148.56 52.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.926 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -112.82 152.77 28.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 110.893 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.0 t -105.66 99.99 9.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 70.11 110.851 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 120.09 7.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.899 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -42.19 1.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 73.42 112.503 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.5 129.31 51.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.599 0.714 . . . . 73.51 111.077 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.263 . . . . 73.14 112.338 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.56 -51.59 35.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.883 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.51 134.18 21.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.609 0.719 . . . . 73.32 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 109.98 2.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.638 2.225 . . . . 73.24 112.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -58.42 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.693 2.262 . . . . 73.41 112.408 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -107.22 -179.21 3.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 71.24 110.948 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -67.98 155.79 38.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 51.51 110.898 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.592 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -146.84 154.64 41.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 72.31 110.875 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -120.88 148.07 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.899 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.592 ' HE1' HD13 ' A' ' 29' ' ' LEU . 26.7 m95 -127.39 136.17 51.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 72.4 110.863 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.725 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -143.4 136.83 28.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.874 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' A' ' 77' ' ' PHE . 1.4 mt -137.4 138.99 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 64.54 110.929 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -112.29 126.55 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.907 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.4 p -138.14 179.22 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 65.23 111.155 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.08 -130.83 19.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.472 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 38' ' ' THR . 12.1 mmt85 -114.9 -38.07 4.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 44.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -176.28 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 75.04 111.154 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -99.09 34.02 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.848 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.15 -4.56 7.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 64.4 111.075 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CZ2' HG22 ' A' ' 38' ' ' THR . 11.0 m0 -58.12 131.13 49.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 72.23 110.961 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.03 154.06 47.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 55.25 110.903 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.06 118.39 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.163 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HG ' HD11 ' A' ' 33' ' ' LEU . 1.1 mm? -90.54 145.33 24.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 61.33 110.906 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.13 163.19 43.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 74.3 110.925 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.0 Cg_endo -69.84 -3.73 12.66 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.648 2.232 . . . . 65.25 112.351 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.91 86.41 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 65.11 110.837 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.12 2.15 63.4 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.752 -0.737 . . . . 65.43 112.497 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.44 105.4 0.41 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.696 -0.764 . . . . 55.2 112.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.74 -73.6 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 33.54 112.511 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -2.07 9.53 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.661 2.241 . . . . 61.21 112.351 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -35.29 48.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 61.22 110.917 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.07 -24.41 62.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 72.3 110.858 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.98 -43.81 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 63.33 110.9 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.53 -97.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 63.35 111.142 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -151.35 173.73 14.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 61.41 111.065 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.623 HH21 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -129.32 163.01 26.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 74.52 110.924 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 46' ' ' PRO . 4.1 t -107.76 130.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 73.42 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.623 HD23 HH21 ' A' ' 57' ' ' ARG . 61.5 mt -68.91 157.8 87.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.626 0.727 . . . . 74.54 110.886 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -21.71 33.32 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 71.22 112.338 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.29 1.12 42.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 61.14 110.891 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.1 29.91 11.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 71.05 112.569 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.457 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.6 m -113.19 179.15 4.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.411 . . . . 62.12 110.827 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 65' ' ' PHE . 14.7 tp -130.01 129.31 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 74.04 110.971 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CD2' HG22 ' A' ' 15' ' ' VAL . 37.8 t80 -124.6 133.94 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 72.01 110.838 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.2 mp -114.97 131.04 23.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.549 0.69 . . . . 71.42 110.95 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -33.64 15.94 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.673 2.249 . . . . 54.34 112.365 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.95 104.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 43.04 111.099 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.43 113.12 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 60.22 111.137 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.98 162.0 33.59 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.718 -0.753 . . . . 71.1 112.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.837 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.11 -30.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 74.42 111.206 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.9 -23.71 55.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 71.31 110.889 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -4.07 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 70.45 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.68 140.62 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.3 110.884 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.49 -137.63 5.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 54.34 112.478 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.405 HD12 ' CG ' ' A' ' 94' ' ' ARG . 43.9 mm -123.54 133.39 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 74.25 111.052 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -103.81 143.56 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.895 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -138.67 137.99 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 75.03 110.886 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.8 t -126.51 155.29 42.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.84 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.11 135.11 32.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.963 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.02 162.66 30.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 44.34 111.079 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ttm -130.11 124.81 33.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -89.94 172.4 8.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 53.25 110.874 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -71.29 -18.65 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.952 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -73.85 -20.43 60.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -15.58 33.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.734 -0.746 . . . . 65.34 112.407 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -85.16 146.17 27.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 74.23 110.881 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.15 144.61 32.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.919 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 133.32 49.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 73.14 111.14 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.47 145.25 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.934 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -144.91 126.92 15.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 62.3 110.888 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.18 122.71 42.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.22 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -124.28 119.37 29.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.891 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.55 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.76 133.86 34.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 74.2 110.895 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.36 137.25 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 64.02 111.078 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -130.33 132.7 45.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.873 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 m -95.67 -175.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 73.2 111.128 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -65.39 -80.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.941 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -65.49 142.98 57.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 52.34 110.912 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.446 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.13 159.54 49.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 73.22 111.184 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo -69.74 -47.08 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.695 2.263 . . . . 42.25 112.355 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.66 96.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 44.2 112.565 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -51.7 156.88 2.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 73.12 110.863 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 100.05 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 73.5 112.327 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 71.44 110.879 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.471 -0.252 . . . . 62.32 112.471 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.74 111.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.41 -44.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 130.52 58.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 72.23 111.07 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.258 . . . . 54.44 112.306 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -48.34 -50.51 30.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.925 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 51.5 mmtt -110.07 153.47 43.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.644 0.735 . . . . 74.24 110.842 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 55.2 Cg_endo -69.67 109.52 2.31 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 55.4 112.412 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.66 -84.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.768 2.312 . . . . 73.45 112.386 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -176.24 3.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.53 110.902 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -62.73 149.01 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.873 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -145.7 155.43 42.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.911 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -120.32 74.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 57' ' ' ARG . . . -77.46 -1.45 76.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 34.15 112.501 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.82 103.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.696 -0.764 . . . . 74.55 112.471 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.75 -74.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 71.03 112.482 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -4.15 13.44 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.598 2.198 . . . . 72.41 112.406 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -34.64 57.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 70.31 110.951 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.81 -24.76 62.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 72.1 110.826 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.18 -42.96 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.803 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.16 -97.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 54.33 111.097 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -151.63 173.65 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.43 111.073 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo -69.78 156.76 62.44 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.72 -76.19 1.03 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 55.44 112.526 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -153.36 157.53 32.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 72.14 110.858 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.625 2.216 . . . . 72.43 112.411 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.919 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.538 -0.225 . . . . 53.12 112.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.58 153.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.914 0.388 . . . . 45.23 110.857 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -52.46 100.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 71.5 111.099 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.04 133.27 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 60.12 110.944 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 6.5 m-80 -84.26 120.31 26.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 63.51 110.932 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.6 mm -126.17 121.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.41 111.162 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 p -96.89 138.31 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.31 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -148.24 165.64 30.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.11 111.142 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -124.25 149.05 46.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 51.31 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -53.98 121.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.206 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.57 2.73 84.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 63.42 112.444 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.78 ' O ' HG22 ' A' ' 69' ' ' VAL . 17.5 mm-40 -101.09 139.63 20.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 63.34 110.902 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 143.09 49.46 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.671 2.248 . . . . 74.0 112.358 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 66' ' ' LEU . 40.6 tp -144.72 141.79 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.896 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -122.97 148.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 64.34 111.056 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 64' ' ' LEU . 9.4 mt -131.58 149.03 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 65.02 110.95 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -106.29 148.96 27.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.895 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 t -112.26 101.83 10.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.927 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -55.88 95.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 70.52 110.903 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.61 -46.25 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 51.44 112.488 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.08 103.89 13.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.65 0.738 . . . . 70.34 111.107 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.0 Cg_endo -69.68 -163.47 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 53.04 112.354 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -62.72 -8.95 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 63.11 110.915 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -44.86 168.07 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 62.23 110.903 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 54.5 Cg_endo -69.74 172.08 13.27 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.726 2.284 . . . . 73.04 112.402 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.79 97.26 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.683 2.255 . . . . 74.32 112.352 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.61 -175.64 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.52 110.85 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -64.87 133.17 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.44 110.839 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.3 pp -176.16 162.34 2.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 65.1 110.872 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -120.37 147.4 45.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 71.54 110.924 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -134.49 138.8 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.931 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.7 ' O ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpt -136.46 142.01 43.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 52.22 110.923 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 32' ' ' LYS . 55.2 mt -134.98 135.06 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 61.22 110.933 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -116.64 120.62 39.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.892 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.789 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.5 p -139.17 177.59 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 74.43 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.75 -128.91 9.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.759 -0.734 . . . . 64.24 112.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.36 -36.98 5.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 72.44 110.848 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.9 -30.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.166 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -103.13 33.46 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.874 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.65 -6.69 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 43.03 111.134 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 133.24 55.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.937 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 157.99 40.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 62.24 110.872 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.98 120.46 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 64.32 111.14 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.43 145.75 24.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 73.12 110.889 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.62 163.06 41.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.729 . . . . 75.22 110.89 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.9 Cg_endo -69.76 0.11 6.12 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.714 2.276 . . . . 70.44 112.316 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 -119.78 71.9 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 71.53 110.919 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 11.19 70.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 61.33 112.522 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.22 102.35 0.65 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.812 -0.709 . . . . 72.35 112.495 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 132.55 -67.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 41.15 112.495 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.64 8.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.639 2.226 . . . . 62.15 112.359 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -34.13 38.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.917 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.63 -27.72 67.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.849 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -42.39 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 60.25 110.805 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.1 -95.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 74.52 111.145 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -159.96 174.44 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 61.1 111.081 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 161.73 23.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 61.41 110.896 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.73 129.88 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 40.42 111.145 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 6.5 mp -69.61 158.26 87.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.61 0.719 . . . . 53.11 110.898 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.78 -23.12 31.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 74.13 112.303 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.03 3.48 34.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 70.31 110.818 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.14 24.84 28.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.72 -0.752 . . . . 70.32 112.457 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 2.6 m -105.97 179.73 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 75.22 110.869 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 16' ' ' LEU . 6.4 tp -130.86 127.91 39.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 73.13 110.943 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.643 ' N ' HD12 ' A' ' 64' ' ' LEU . 2.3 t80 -126.1 129.41 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.55 110.896 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.3 mp -117.77 131.24 24.21 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.612 0.72 . . . . 73.41 110.975 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.63 -32.47 19.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.763 2.309 . . . . 73.11 112.364 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.59 101.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 41.35 111.116 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.6 m -73.55 119.41 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 111.092 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.39 161.48 28.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.705 -0.759 . . . . 51.4 112.514 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.33 -29.39 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.728 0.299 . . . . 64.41 111.124 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -74.47 -23.2 58.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 51.41 110.893 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -5.14 57.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 65.3 110.867 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.66 140.98 58.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 65.44 110.912 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.49 -139.11 6.65 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 62.4 112.483 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.28 128.14 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 74.52 111.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD1' HD22 ' A' ' 33' ' ' LEU . 22.7 m-85 -104.5 136.72 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 64.4 110.839 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.45 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 75.33 110.881 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.4 t -127.14 152.31 47.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.909 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 131.03 24.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 61.12 110.856 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.63 163.06 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.07 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.9 ttm -130.06 124.9 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.88 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -88.42 172.36 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 62.23 110.913 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.53 -18.91 62.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.926 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -73.89 -20.26 60.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.919 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.93 -13.53 34.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.741 . . . . 71.34 112.548 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -84.87 147.27 26.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 74.43 110.909 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -104.58 143.85 32.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 72.15 110.925 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.76 126.89 51.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 54.45 111.12 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 144.23 34.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 73.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 m -145.8 127.74 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 63.14 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.82 122.52 41.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 64.52 110.827 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.72 119.04 23.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 64.31 110.906 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.02 131.45 34.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 70.24 110.87 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 77' ' ' PHE . 70.3 t -120.75 139.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.55 111.143 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 128.57 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.45 110.866 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.4 m -92.48 -176.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 64.13 111.099 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -64.69 -78.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.15 110.948 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -68.2 145.89 53.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.9 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.501 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.62 0.724 . . . . 61.44 111.072 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.81 -38.12 8.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.751 2.301 . . . . 64.34 112.312 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.3 93.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 63.22 112.456 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -142.94 159.34 56.82 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.531 0.681 . . . . 74.43 110.924 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -175.51 1.2 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.713 2.275 . . . . 64.11 112.266 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.884 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 112.479 -0.249 . . . . 71.22 112.479 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -173.55 148.07 1.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 62.34 110.806 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.85 97.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 55.41 111.111 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -93.24 133.65 36.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 60.22 110.836 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -89.83 121.43 31.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 14' ' ' LEU . 44.9 mm -125.33 121.44 60.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 71.41 111.08 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -96.01 141.19 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.24 111.115 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 167.46 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 71.1 111.051 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -122.63 148.22 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 38.5 mt -53.12 121.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 60.42 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.9 5.76 76.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 74.15 112.47 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.8 mm-40 -102.04 140.11 20.89 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.43 110.866 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 144.01 52.47 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.608 2.205 . . . . 52.12 112.286 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.671 HD11 HG21 ' A' ' 6' ' ' ILE . 36.3 tp -144.61 142.01 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.919 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.84 144.6 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.139 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.725 HD13 ' CD2' ' A' ' 77' ' ' PHE . 1.3 mt -131.03 146.26 52.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 72.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -114.5 151.2 33.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 75.03 110.952 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 m -108.05 101.83 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.57 126.71 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.31 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.89 -38.8 2.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 54.45 112.53 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.19 131.6 36.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.576 0.703 . . . . 43.31 111.09 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -164.84 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 53.24 112.379 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -48.16 -50.52 28.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 70.12 110.874 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 17.7 mmtp -109.48 152.23 42.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.59 0.71 . . . . 70.43 110.889 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.81 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.595 2.197 . . . . 72.34 112.402 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.9 Cg_endo -69.73 -83.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.693 2.262 . . . . 64.52 112.334 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 73.2 mt-30 -103.46 -176.86 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.941 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -63.01 147.59 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 70.34 110.842 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 29' ' ' LEU . 1.3 pp -145.79 151.62 38.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 65.13 110.921 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.74 129.12 53.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 70.24 110.925 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.579 ' NE1' HD13 ' A' ' 29' ' ' LEU . 43.6 m0 -111.93 144.53 41.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 73.03 110.911 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -136.96 141.23 42.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 72.11 110.982 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 77' ' ' PHE . 13.6 tp -136.05 135.29 39.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.53 110.942 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -116.13 121.47 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 54.11 110.894 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.803 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.2 p -138.35 179.27 6.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 62.35 111.139 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.95 -130.24 11.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 52.13 112.49 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -112.5 -37.95 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 73.41 110.933 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t -179.83 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 72.4 111.134 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 38' ' ' THR . 19.2 mt-10 -102.6 34.03 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 61.24 110.862 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.57 -6.76 8.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -61.82 131.34 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.873 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 158.46 38.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 60.41 110.854 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.91 123.1 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 61.13 111.16 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.52 143.5 26.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 70.41 110.919 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.713 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -126.74 163.02 43.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.647 0.736 . . . . 73.13 110.856 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.694 2.263 . . . . 51.43 112.403 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -125.66 73.36 1.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.94 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.73 7.72 79.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 74.25 112.459 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 112.02 4.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 71.42 112.446 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.44 -70.6 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 61.53 112.484 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -0.05 6.3 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.682 2.255 . . . . 75.53 112.398 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.442 ' HB2' ' HG3' ' A' ' 57' ' ' ARG . 21.0 p-90 -51.7 -34.69 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 60.13 110.925 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -70.56 -25.2 62.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 72.21 110.83 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -44.56 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 70.03 110.863 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.41 -95.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 52.35 111.066 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.605 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -148.52 174.15 12.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.45 . . . . 62.1 111.11 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HG3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -126.92 163.0 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.42 110.851 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 45' ' ' SER . 48.6 t -107.45 127.5 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.063 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.6 mp -68.27 157.58 87.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.586 0.707 . . . . 61.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.81 -20.83 34.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 70.3 112.335 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -83.6 1.62 41.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 28.53 20.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.827 -0.702 . . . . 74.4 112.486 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -112.57 178.01 4.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 72.05 110.896 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 38.0 tp -128.01 127.93 44.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.912 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 59' ' ' LEU . 9.3 t80 -125.81 135.04 51.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 71.43 110.903 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 56' ' ' ALA . 7.2 mp -113.43 128.59 25.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.61 0.719 . . . . 73.11 110.901 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -32.5 18.34 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 71.42 112.368 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.04 102.65 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.098 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -72.36 118.42 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 73.1 111.151 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.37 158.79 26.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 31.03 112.494 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.838 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.23 -31.43 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.787 0.327 . . . . 64.15 111.102 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.79 -22.8 53.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.908 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.55 -5.27 44.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.881 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -60.7 142.49 55.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 72.45 110.831 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.16 -147.16 15.01 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.724 . . . . 52.13 112.511 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.82 129.91 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 73.42 111.144 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' A' ' 16' ' ' LEU . 11.3 t80 -104.87 135.28 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.0 146.72 50.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.472 . . . . 64.23 110.799 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.59 152.72 46.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.867 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.7 128.13 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.902 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 162.08 31.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 62.3 111.078 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.1 ttm -130.11 124.71 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.44 110.873 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -87.71 171.9 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 55.13 110.943 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -71.76 -18.18 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -73.28 -26.06 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 60.41 110.86 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.92 -18.22 12.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 55.54 112.475 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -84.18 147.16 27.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 61.44 110.892 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.26 144.86 31.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.873 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 128.12 50.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 64.13 111.154 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 145.31 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 65.22 110.919 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -144.67 126.96 15.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 52.11 110.85 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 122.1 40.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 61.34 110.874 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.69 120.04 28.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.953 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.91 132.12 34.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.886 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.89 136.37 58.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 74.0 111.115 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -130.76 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 62.14 110.879 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.8 m -108.7 -175.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 52.4 111.142 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -66.37 -78.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.927 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -66.53 146.03 54.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 44.44 110.914 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.48 49.96 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 45.32 111.133 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo -69.77 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.275 . . . . 70.54 112.338 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.03 -37.54 1.51 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.772 -0.727 . . . . 72.32 112.488 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -119.55 73.89 16.53 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 73.35 110.872 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -171.08 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 74.54 112.377 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.927 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.481 -0.248 . . . . 71.31 112.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -178.93 128.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 74.23 110.913 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.49 63.64 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 64.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -92.72 137.87 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.66 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.9 p-10 -89.95 120.99 31.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 53.21 110.871 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.66 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.24 122.3 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.16 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -95.49 142.09 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 64.43 111.11 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.77 168.34 23.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 51.43 111.111 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.41 148.19 41.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 64.42 110.871 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.03 122.08 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.064 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.4 3.85 86.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 62.54 112.555 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.6 mm-40 -101.39 142.7 25.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.736 . . . . 62.31 110.93 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 144.03 53.35 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.703 2.269 . . . . 62.11 112.378 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD11 HG21 ' A' ' 6' ' ' ILE . 52.2 tp -143.93 143.26 31.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 72.52 110.93 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.4 t -121.07 147.71 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 62.01 111.148 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 77' ' ' PHE . 14.8 mt -131.48 149.12 52.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.893 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -107.18 151.63 25.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.896 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.6 t -107.63 100.11 9.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.05 110.854 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -59.71 120.53 9.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.898 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.11 -39.95 1.98 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.714 -0.755 . . . . 74.13 112.466 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.57 132.27 33.83 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.563 0.697 . . . . 43.33 111.056 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.248 . . . . 72.22 112.385 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -48.38 -52.2 22.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 63.14 110.963 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 144.45 30.64 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.605 0.716 . . . . 55.03 110.898 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.0 Cg_endo -69.69 110.58 2.57 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.619 2.213 . . . . 72.12 112.364 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.3 Cg_endo -69.76 -83.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.681 2.254 . . . . 75.41 112.319 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 3.3 mp0 -91.15 -177.27 4.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.926 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -63.46 148.28 49.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.53 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.97 154.62 42.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.902 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -120.51 148.21 44.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.867 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.607 ' HE1' HD13 ' A' ' 29' ' ' LEU . 20.2 m95 -124.79 143.28 50.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 74.01 110.879 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.13 143.94 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.91 134.63 37.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 65.12 110.863 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -116.45 121.18 41.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.54 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.785 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.8 p -139.39 179.38 6.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 72.21 111.104 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.56 -133.35 15.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 75.12 112.552 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -112.56 -37.57 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 62.22 110.817 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.616 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.7 t -179.31 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 55.12 111.158 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.616 ' HG3' HG23 ' A' ' 38' ' ' THR . 25.0 mt-10 -102.08 33.71 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 64.24 110.85 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.92 -6.81 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 63.54 111.129 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -60.38 128.95 39.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 72.3 110.918 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.591 ' HG3' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -130.34 156.34 44.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 65.43 110.938 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 t -93.49 123.35 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 71.51 111.188 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 33' ' ' LEU . 30.6 mt -88.66 143.65 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 54.21 110.915 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.73 162.52 50.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.693 0.758 . . . . 75.3 110.854 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -4.0 13.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.767 2.311 . . . . 73.11 112.34 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -124.48 83.16 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 72.13 110.9 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.63 0.43 81.56 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 24.44 112.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -52.06 101.05 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.713 -0.756 . . . . 24.33 112.424 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.65 -73.97 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.696 -0.764 . . . . 60.25 112.464 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.67 0.81 5.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.693 2.262 . . . . 60.04 112.341 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -51.43 -35.73 40.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 74.42 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.55 -23.8 61.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 62.33 110.833 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.43 -43.01 11.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 35.42 110.845 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG11 ' HG3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -126.1 -98.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 75.31 111.109 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -161.09 175.76 12.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 60.33 111.088 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 161.53 17.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.01 110.849 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.43 130.24 61.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 75.41 111.172 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 48.8 mt -68.82 157.83 87.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.592 0.71 . . . . 71.41 110.926 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.51 33.47 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 73.32 112.344 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.44 1.65 47.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 63.21 110.894 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.58 31.11 9.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 62.05 112.53 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.3 m -113.34 -179.05 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 73.34 110.839 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 65' ' ' PHE . 6.2 tp -129.84 128.71 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.95 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.634 ' N ' HD12 ' A' ' 64' ' ' LEU . 13.3 t80 -126.36 135.85 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.91 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.56 128.86 25.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.626 0.727 . . . . 74.23 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -32.42 19.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.724 2.283 . . . . 73.2 112.4 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.86 100.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 61.52 111.073 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -72.75 113.45 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 73.43 111.093 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.54 158.76 30.1 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 54.54 112.531 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.74 -31.09 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 63.31 111.049 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -76.23 -20.96 56.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.906 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -3.08 27.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.918 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.746 ' CD ' HG22 ' A' ' 97' ' ' VAL . 23.8 mt-10 -57.57 142.81 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 64.43 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.39 -149.95 21.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 54.13 112.406 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.58 133.03 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 74.24 111.105 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' A' ' 16' ' ' LEU . 5.0 t80 -103.28 139.08 39.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 65.14 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.24 141.16 51.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.883 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -125.95 153.82 43.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.34 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -139.74 130.3 25.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.425 . . . . 74.13 110.98 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 163.18 28.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 51.31 111.093 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.8 ttm -128.42 124.78 37.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.835 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -87.23 173.4 9.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 71.1 110.904 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -69.53 -19.07 63.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 64.33 110.842 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -74.42 -20.34 60.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.75 -9.06 43.79 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 61.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -85.05 148.64 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.718 0.294 . . . . 63.55 110.916 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.21 140.31 37.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 65.23 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.35 132.77 51.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 73.04 111.179 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.32 145.0 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.881 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -144.7 126.94 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.872 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 7.7 t-20 -119.22 124.23 46.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 61.21 110.877 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.8 119.25 24.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.933 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -84.47 134.45 34.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 73.03 110.858 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.8 t -122.63 135.98 60.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 70.41 111.158 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -132.26 148.18 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -110.74 -175.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.114 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -67.06 -78.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 72.4 110.9 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -63.17 146.45 53.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.918 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.52 49.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 71.01 111.151 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo -69.75 -26.17 27.89 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 55.1 112.36 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.23 -102.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.804 -0.712 . . . . 71.51 112.52 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp 57.91 73.38 0.76 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 64.42 110.856 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 137.46 35.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.703 2.268 . . . . 53.11 112.376 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 73.55 110.881 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.409 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.469 -0.252 . . . . 74.23 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.05 155.82 6.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 64.3 110.856 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.85 96.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 23.24 111.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -93.03 132.84 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 60.11 110.996 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.676 ' C ' HD12 ' A' ' 6' ' ' ILE . 5.7 p-10 -86.33 119.51 26.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.34 110.881 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.9 mp -129.2 123.2 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.54 111.18 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -95.58 138.66 32.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 63.13 111.153 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.12 166.14 27.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 65.13 111.117 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.45 149.21 44.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.804 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mt -52.58 121.34 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.139 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.51 6.96 76.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 74.22 112.471 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.761 ' O ' HG22 ' A' ' 69' ' ' VAL . 38.7 mm-40 -102.09 139.65 20.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.718 0.771 . . . . 72.04 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 144.51 54.7 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.711 2.274 . . . . 74.55 112.345 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.45 HD11 ' CG2' ' A' ' 6' ' ' ILE . 16.5 tp -143.86 141.91 30.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 60.13 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.39 144.72 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 63.54 111.202 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 64' ' ' LEU . 36.3 mt -131.14 146.88 52.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.35 110.981 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -114.34 151.75 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 61.13 110.933 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.6 m -107.21 99.67 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.9 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -56.39 124.53 18.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.94 -40.28 1.92 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.675 -0.774 . . . . 61.44 112.471 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 128.99 45.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 72.23 111.134 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -164.68 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 73.25 112.34 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -48.17 -51.44 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.914 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -113.35 141.33 25.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 74.13 110.885 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HB3' HD21 ' A' ' 29' ' ' LEU . 54.2 Cg_endo -69.71 108.71 2.13 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.733 2.289 . . . . 61.42 112.321 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.2 Cg_endo -69.79 -57.27 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.697 2.265 . . . . 75.41 112.314 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -107.21 -177.33 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 61.54 110.848 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.9 mtm-85 -64.54 151.4 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 73.2 110.927 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.844 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -146.31 160.5 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 63.24 110.926 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.15 149.56 47.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.911 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.844 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 18.0 m-90 -117.84 135.27 54.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.951 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.654 ' C ' HD23 ' A' ' 33' ' ' LEU . 3.6 ttpt -145.87 136.58 24.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 55.33 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.018 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.54 140.83 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 64.22 110.873 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -111.7 129.0 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.914 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 16.6 p -135.83 179.89 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.33 111.148 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.27 -129.36 17.4 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.748 -0.739 . . . . 44.14 112.5 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -112.7 -37.51 4.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 74.42 110.874 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 t -178.96 -30.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.29 33.95 2.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.878 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.87 -5.14 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 72.43 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.05 132.19 53.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 70.34 110.941 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 157.56 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 74.23 110.886 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 t -102.56 120.35 52.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 62.02 111.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.018 HD12 HD21 ' A' ' 33' ' ' LEU . 5.6 mt -92.38 146.05 23.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 54.23 110.908 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 163.5 39.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.636 0.732 . . . . 73.42 110.849 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -0.6 7.14 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.704 2.269 . . . . 55.02 112.321 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -122.67 71.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 71.32 110.914 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.13 12.39 64.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 73.3 112.431 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 92.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 22.12 112.521 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.46 -65.28 0.56 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 64.01 112.457 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 2.88 3.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.228 . . . . 62.55 112.333 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -34.13 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 75.3 110.924 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.98 -24.82 62.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 55.41 110.9 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -44.7 9.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 44.34 110.893 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -127.33 -98.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.518 . . . . 52.25 111.153 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -161.97 176.01 11.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.31 111.084 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 161.4 17.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.871 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.9 t -108.47 129.57 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.2 111.141 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.592 HD12 ' CB ' ' A' ' 63' ' ' SER . 43.9 mt -69.11 157.47 89.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 63.12 110.937 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -22.56 31.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.726 2.284 . . . . 62.2 112.364 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -83.46 0.61 45.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 70.51 110.849 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.14 29.38 11.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 71.24 112.506 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.7 -179.68 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 63.13 110.927 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 16' ' ' LEU . 13.1 tp -128.97 129.58 45.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.928 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 9.1 t80 -125.37 131.03 53.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 71.5 110.915 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mt -113.97 130.92 23.43 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.646 0.736 . . . . 70.33 110.911 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -38.3 7.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 73.54 112.334 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.74 101.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 72.03 111.072 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.9 m -73.63 116.92 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.103 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.71 164.73 31.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 53.31 112.505 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.836 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.83 -29.4 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.7 0.286 . . . . 73.51 111.096 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -75.11 -23.96 58.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.4 110.95 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -3.86 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.915 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -58.57 141.24 52.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.902 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.66 -140.5 7.59 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.697 -0.763 . . . . 51.52 112.452 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 94' ' ' ARG . 2.5 mp -130.18 132.99 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 73.45 111.108 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CE2' HD13 ' A' ' 33' ' ' LEU . 13.2 m-85 -101.34 143.91 30.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.86 147.22 50.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.52 110.837 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.15 150.62 49.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.02 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.93 128.47 24.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.884 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.31 162.69 29.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.55 111.082 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.3 ttm -130.12 125.09 34.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.85 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -89.9 172.91 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 73.53 110.9 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -71.07 -19.24 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 64.12 110.868 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -73.81 -20.25 60.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.55 110.927 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.73 -15.17 34.68 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 51.13 112.454 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -84.88 146.64 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 72.03 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -105.81 144.72 32.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 73.3 110.896 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.98 50.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 71.43 111.175 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.37 144.95 32.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 63.04 110.908 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.2 m -145.03 127.49 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.33 110.854 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 17.0 t-20 -118.74 127.47 53.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 50.15 110.872 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.87 118.1 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.957 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -85.75 127.29 34.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 75.15 110.85 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.3 t -120.13 139.94 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -128.04 129.15 46.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.846 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.3 m -88.68 -175.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 65.11 111.085 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -65.28 -80.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 74.44 110.952 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -65.76 144.48 56.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.918 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.4 159.99 47.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.698 0.761 . . . . 54.13 111.116 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.8 160.62 49.0 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 71.25 112.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -89.18 -120.96 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 42.51 112.469 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -169.37 73.35 0.71 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.658 0.742 . . . . 73.35 110.922 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 170.06 17.48 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.675 2.25 . . . . 71.5 112.274 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.874 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.45 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.435 -0.266 . . . . 54.43 112.435 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 t 61.85 87.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 72.11 110.867 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 52.95 72.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 72.22 111.072 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -93.11 132.69 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.881 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.594 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.4 t30 -84.29 120.71 26.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.856 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.594 HD12 ' C ' ' A' ' 5' ' ' ASN . 2.4 mp -126.43 126.03 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.145 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -93.59 141.95 27.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.21 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.13 168.24 22.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 73.22 111.088 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.08 147.95 47.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.865 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 mt -54.62 122.39 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 65.42 111.127 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.69 3.94 80.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.712 -0.756 . . . . 74.21 112.509 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 6.3 mm-40 -101.1 139.56 20.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 72.34 110.851 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 143.0 49.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 72.44 112.42 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 66' ' ' LEU . 17.3 tp -144.35 141.01 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 75.34 110.893 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' HD1' ' A' ' 65' ' ' PHE . 40.4 t -123.15 148.35 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 42.41 111.134 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 64' ' ' LEU . 62.4 mt -131.61 148.67 52.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 72.53 110.882 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.49 149.48 27.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 71.52 110.876 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.5 t -112.49 101.69 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 54.45 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -53.65 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.84 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.52 -46.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 60.04 112.464 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.42 103.05 11.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.585 0.707 . . . . 74.31 111.156 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 52.9 Cg_endo -69.75 -163.33 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.704 2.269 . . . . 75.41 112.269 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -10.21 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 64.22 110.857 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.454 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.1 mptt -45.72 167.82 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 74.54 110.916 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.4 Cg_endo -69.77 172.4 12.73 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 65.02 112.363 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.8 Cg_endo -69.85 96.05 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.243 . . . . 73.13 112.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.5 -174.94 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 52.11 110.927 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -62.99 132.35 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.831 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -178.22 159.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 64.24 110.963 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -121.38 142.36 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.891 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -126.09 143.29 51.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.919 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -141.98 142.55 32.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.32 110.915 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.69 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.2 tp -137.87 135.99 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.878 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.605 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.6 t-20 -114.99 123.33 48.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 52.35 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 27.9 p -138.87 -179.76 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.132 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.45 -126.83 8.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 33.1 112.468 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.39 -37.45 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 72.4 110.832 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 177.13 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.2 111.148 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.67 32.92 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.88 -7.79 8.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.102 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -60.14 129.6 42.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.956 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 158.57 39.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 73.5 110.874 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.63 121.02 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.077 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.33 144.46 25.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.96 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.53 45.72 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.734 0.778 . . . . 72.21 110.868 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 0.47 5.5 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.263 . . . . 74.53 112.361 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -118.93 92.72 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.923 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.67 -5.0 56.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.645 -0.788 . . . . 75.32 112.506 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.46 105.32 0.2 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 61.02 112.486 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 123.48 -75.74 0.37 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.489 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 1.09 4.68 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.716 2.277 . . . . 73.43 112.37 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -51.26 -35.37 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 72.01 110.952 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -24.94 63.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 71.32 110.894 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.16 -42.24 11.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 74.14 110.852 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -122.91 -97.91 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.131 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.03 176.61 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 70.21 111.037 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.51 160.91 17.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.863 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.73 130.46 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 73.44 111.153 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.622 HD12 ' CB ' ' A' ' 63' ' ' SER . 45.8 mt -69.1 158.78 85.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 75.44 110.885 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.77 -22.66 31.7 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.672 2.248 . . . . 62.01 112.35 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -85.33 1.99 46.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 61.23 110.898 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.78 23.91 24.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 60.02 112.529 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.622 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.4 m -104.4 -179.0 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 64.44 110.852 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.14 130.04 44.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.906 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.2 t80 -125.45 129.68 50.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.926 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 14' ' ' LEU . 2.4 mp -118.14 129.77 25.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.605 0.717 . . . . 72.3 110.884 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -32.74 18.01 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 75.03 112.421 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.27 101.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 62.05 111.088 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.0 m -73.03 119.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 73.31 111.119 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.36 160.71 32.03 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 73.23 112.501 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.32 -31.18 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 65.23 111.117 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -76.46 -22.07 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 65.31 110.934 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -4.75 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.908 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -59.23 142.35 52.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 71.02 110.926 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.74 -145.89 13.44 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 53.34 112.452 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 mt -124.33 133.82 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 75.33 111.16 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.69 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.5 m-85 -101.37 139.24 37.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.44 110.883 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.34 147.77 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 71.44 110.872 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 149.98 50.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 71.51 110.904 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.437 ' HB2' ' C6 ' ' A' ' 201' ' ' IOR . 7.4 tt0 -140.22 126.5 19.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 71.55 110.89 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -133.07 163.12 29.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.41 111.064 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 66.7 mmm -129.41 124.64 34.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.86 172.52 9.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.893 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -71.23 -22.48 61.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.926 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -74.23 -20.14 60.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.863 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.92 -2.99 35.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.729 . . . . 40.31 112.568 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.7 149.07 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 73.51 110.949 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -102.87 141.77 35.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.891 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.562 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.52 123.45 47.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 60.11 111.149 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.93 141.61 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 54.33 110.877 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -147.26 125.87 12.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.935 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HB2' ' C ' ' A' ' 201' ' ' IOR . 6.8 t-20 -119.25 125.08 48.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 73.15 110.879 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.86 119.74 26.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.885 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.473 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.45 131.84 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.44 110.859 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.61 137.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 75.24 111.112 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -130.35 152.93 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 72.52 110.831 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 33.0 m -113.86 -175.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 35.14 111.148 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -65.86 -78.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 53.34 110.932 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.83 144.78 56.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 62.33 110.899 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.482 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.36 159.6 49.36 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.634 0.731 . . . . 72.02 111.145 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.7 Cg_endo -69.72 168.56 21.16 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 72.31 112.357 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.8 108.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 32.42 112.479 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? 51.92 71.21 1.56 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 71.21 110.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -171.68 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 51.44 112.372 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 60.43 110.931 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.437 ' C6 ' ' HB2' ' A' ' 80' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.52 -0.232 . . . . 62.42 112.52 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -77.93 65.69 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 51.53 110.87 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.44 80.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 75.34 111.091 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.42 138.6 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 63.14 110.918 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.43 119.92 25.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.876 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.8 mm -126.26 123.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 65.14 111.159 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.1 p -93.72 140.47 29.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 72.31 111.171 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.03 165.07 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 74.22 111.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.78 149.44 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.52 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 99' ' ' GLN . 63.6 mt -59.36 120.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.41 111.114 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.17 5.48 89.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 64.02 112.516 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.69 141.5 22.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.703 0.763 . . . . 73.31 110.905 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.9 144.06 52.1 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.665 2.243 . . . . 71.32 112.343 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' ALA . 26.5 tp -144.2 143.29 30.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.25 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -121.47 147.23 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.1 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 47.3 mt -131.85 150.64 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.45 110.966 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -111.79 152.79 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 75.44 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -106.45 101.63 11.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 42.03 110.884 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -61.42 115.94 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.21 110.942 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.61 -40.28 1.88 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.516 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.75 128.37 54.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.608 0.718 . . . . 73.01 111.065 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -166.52 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 75.43 112.334 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -49.94 -51.78 38.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.862 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.82 135.41 21.19 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.573 0.702 . . . . 65.25 110.865 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.4 Cg_endo -69.73 109.84 2.4 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.722 2.281 . . . . 53.3 112.36 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.8 -58.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.641 2.227 . . . . 71.21 112.354 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -107.27 -179.08 3.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 73.04 110.898 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -67.85 154.01 42.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.14 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -146.7 152.37 38.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 70.53 110.877 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -120.29 148.36 43.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.868 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.576 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 3.0 m95 -127.05 134.39 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 70.14 110.965 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.585 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.16 136.41 25.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 71.44 110.912 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.775 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -141.84 140.54 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 71.14 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.87 127.95 55.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 62.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.783 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 6.6 p -136.75 179.32 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.0 -129.98 12.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.654 -0.784 . . . . 50.45 112.517 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -112.62 -37.75 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 74.03 110.897 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.613 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.5 t -179.44 -30.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 71.44 111.19 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.613 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.6 mt-10 -102.7 33.68 3.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 71.34 110.888 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.44 -6.54 8.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.32 111.084 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -59.23 130.29 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 73.03 110.923 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.53 153.52 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 62.22 110.88 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG22 ' HD2' ' A' ' 32' ' ' LYS . 23.5 t -100.21 120.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.1 111.138 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.655 ' CG ' HD21 ' A' ' 33' ' ' LEU . 3.5 mm? -89.9 145.13 25.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.878 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.61 163.25 39.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.656 0.741 . . . . 72.21 110.82 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.8 Cg_endo -69.76 -2.37 10.06 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.651 2.234 . . . . 73.02 112.368 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -123.36 71.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 71.43 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.45 10.17 67.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 73.54 112.485 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.22 95.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 75.04 112.506 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.8 -67.89 0.56 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 60.33 112.433 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -2.55 10.37 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.599 2.199 . . . . 73.45 112.379 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -34.59 43.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 61.24 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -66.64 -26.57 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 65.45 110.907 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 -42.13 10.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 73.23 110.858 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -125.18 -96.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 71.43 111.116 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -160.55 174.79 13.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 73.2 111.048 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.15 160.67 24.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 63.31 110.882 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 31.2 t -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.51 111.079 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.27 157.53 89.11 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 54.51 110.886 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -22.08 32.6 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.679 2.253 . . . . 60.5 112.395 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -83.25 0.63 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 74.54 110.894 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.7 30.71 10.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.715 -0.755 . . . . 71.01 112.432 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.6 m -113.49 179.04 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 54.41 110.896 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 20.7 tp -129.2 128.37 43.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 73.41 110.926 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -126.39 133.5 51.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 65.13 110.914 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.42 130.8 24.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 64.44 110.856 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -33.06 17.01 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.68 2.253 . . . . 61.02 112.333 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.97 100.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.11 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.5 m -73.57 114.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.1 111.136 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.77 164.25 39.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 52.2 112.568 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.68 -31.56 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.749 0.309 . . . . 71.31 111.102 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -75.72 -22.71 56.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.871 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -5.0 41.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 51.42 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -66.37 140.85 58.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.91 -137.32 5.25 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.711 -0.757 . . . . 73.45 112.456 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.447 HG23 ' ND2' ' A' ' 92' ' ' ASN . 2.1 mp -124.19 132.68 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 71.02 111.133 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.775 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.6 m-85 -104.79 133.52 49.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.2 110.938 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -128.0 137.57 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.883 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.36 153.7 42.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 42.33 110.869 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.66 131.64 27.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 75.21 110.918 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.8 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.54 111.028 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 tpp -130.02 124.77 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.13 110.932 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.17 172.61 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 72.24 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -71.15 -18.44 62.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 72.2 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.46 -20.37 60.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 62.32 110.856 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.16 -16.4 32.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 63.21 112.487 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -85.21 146.81 26.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.686 0.279 . . . . 73.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.31 143.93 32.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.44 132.54 50.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.14 111.135 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 145.73 31.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 53.13 110.934 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -143.73 125.34 14.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 42.51 110.876 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -120.12 122.66 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 65.54 110.814 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.3 125.11 40.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.938 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -83.25 134.02 34.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 72.32 110.861 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -121.16 136.08 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.099 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.542 ' NH1' HG22 ' A' ' 100' ' ' ILE . 1.7 mmt180 -131.18 127.95 39.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 70.54 110.837 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 25.1 m -93.09 -177.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 74.3 111.178 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.6 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 65.54 110.974 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.466 ' NE2' ' H ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -61.62 141.83 57.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 71.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.542 HG22 ' NH1' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -121.45 159.7 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.719 . . . . 74.12 111.119 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -34.31 14.8 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.68 2.253 . . . . 51.02 112.31 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.63 114.71 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.751 -0.738 . . . . 74.54 112.471 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.36 137.61 81.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.551 0.691 . . . . 64.21 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 167.16 25.16 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.631 2.221 . . . . 63.51 112.357 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.923 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.466 -0.254 . . . . 73.13 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t -154.32 -169.02 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 74.04 110.884 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.47 94.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.084 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.81 131.16 38.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.896 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.6 p-10 -89.88 121.94 32.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.866 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.66 ' HB ' HG22 ' A' ' 95' ' ' VAL . 4.5 mp -125.96 122.42 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 54.14 111.117 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.09 136.9 35.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.187 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.57 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 147.91 43.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.878 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -52.94 121.76 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 75.32 111.11 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.702 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.93 6.93 71.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.656 -0.783 . . . . 64.35 112.45 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.763 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.7 mm-40 -101.37 139.4 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.592 0.71 . . . . 74.41 110.968 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.39 50.82 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 73.43 112.381 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 6' ' ' ILE . 39.2 tp -144.65 141.74 29.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 62.12 110.957 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.0 t -122.55 143.62 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.107 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 HD23 ' A' ' 64' ' ' LEU . 16.6 mt -132.16 148.01 52.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 72.53 110.969 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -112.98 153.13 28.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.94 101.94 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 71.25 110.852 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.77 122.93 13.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.29 -39.0 2.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 43.01 112.423 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.33 128.71 45.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.636 0.731 . . . . 74.32 111.056 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.85 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.636 2.224 . . . . 73.02 112.315 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -48.7 -48.82 40.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.13 110.896 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.14 150.88 40.44 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 72.43 110.879 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.9 Cg_endo -69.79 108.93 2.19 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.757 2.305 . . . . 62.32 112.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.6 Cg_endo -69.84 -85.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.683 2.256 . . . . 63.42 112.342 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.401 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -96.83 -176.02 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.0 110.967 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -63.07 142.85 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 60.42 110.802 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.722 HD13 ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -146.21 160.89 41.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 70.24 110.935 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.58 149.26 47.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.899 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.722 ' CH2' HD13 ' A' ' 29' ' ' LEU . 26.8 m-90 -111.82 140.77 46.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.884 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -137.63 142.43 41.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.865 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 34' ' ' ASN . 1.6 tt -138.8 134.62 33.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.89 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' N ' HD23 ' A' ' 33' ' ' LEU . 13.2 t-20 -116.23 126.98 54.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 54.11 110.861 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.5 p -139.86 178.01 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.097 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.61 -131.65 19.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 53.44 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -37.29 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 74.51 110.862 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.593 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -178.48 -29.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.35 111.133 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.09 33.19 2.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 74.35 110.87 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.99 -4.51 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 63.11 111.124 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -62.73 132.2 51.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 70.53 111.03 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 158.75 38.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 71.31 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.8 t -100.19 122.42 52.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 65.32 111.065 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.606 HD13 HD13 ' A' ' 64' ' ' LEU . 13.7 mt -88.81 143.63 26.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 75.3 110.942 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.27 163.17 41.83 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.695 0.759 . . . . 74.43 110.805 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 58' ' ' VAL . 53.4 Cg_endo -69.71 -1.01 7.7 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 64.23 112.308 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -122.27 88.54 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 70.55 110.922 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.18 67.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.807 -0.711 . . . . 74.41 112.484 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.3 101.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 73.1 112.46 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 123.89 -74.76 0.39 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 72.15 112.488 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 1.12 4.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.726 2.284 . . . . 72.01 112.348 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -51.1 -35.35 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 64.43 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.75 -24.79 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 53.11 110.806 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.98 -42.3 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 60.22 110.851 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -122.96 -98.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 71.24 111.145 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -165.76 176.15 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 62.22 111.115 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 160.68 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 61.03 110.91 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 46' ' ' PRO . 20.6 t -109.76 128.79 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 71.22 111.179 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 63' ' ' SER . 50.6 mt -69.16 157.83 88.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.562 0.696 . . . . 52.52 110.928 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -22.72 31.58 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 73.12 112.345 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -83.01 0.25 45.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.65 29.43 10.86 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.776 -0.726 . . . . 51.25 112.483 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.499 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.68 179.85 3.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 52.21 110.869 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.717 HD22 ' CE2' ' A' ' 77' ' ' PHE . 8.5 tp -129.93 129.72 44.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 15' ' ' VAL . 33.2 t80 -125.34 131.2 53.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 71.01 110.814 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.752 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -114.33 129.42 24.89 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 75.23 110.946 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -33.01 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 65.24 112.375 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.702 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.32 102.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.44 111.101 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 12' ' ' GLU . 14.9 m -72.88 116.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.32 111.063 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.7 33.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.733 -0.746 . . . . 25.4 112.48 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.844 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.97 -29.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 73.41 111.087 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -75.11 -23.37 57.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 60.43 110.912 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.06 -5.41 57.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.7 140.33 58.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.906 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 -135.37 4.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 54.21 112.472 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.486 HG23 ' ND2' ' A' ' 92' ' ' ASN . 4.9 mt -126.4 135.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 64.34 111.093 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.717 ' CE2' HD22 ' A' ' 64' ' ' LEU . 26.7 t80 -101.71 138.5 38.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.906 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -138.83 128.12 24.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.899 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.3 t -125.26 157.33 36.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 63.14 110.831 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.423 ' HB3' ' C6 ' ' A' ' 201' ' ' IOR . 6.6 pt20 -138.0 140.08 39.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.891 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.09 162.71 30.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.082 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ttm -129.56 124.99 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.864 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -90.88 172.81 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.894 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -71.1 -18.77 62.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.81 -20.33 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 60.34 110.946 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.34 -15.58 35.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -85.06 146.04 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 61.24 110.877 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.51 143.26 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.52 110.864 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -105.72 130.4 53.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 51.03 111.173 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -107.1 145.69 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.957 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 124.55 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 71.25 110.847 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -121.5 128.79 52.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 73.24 110.912 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -131.19 122.23 26.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.35 110.906 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.34 124.5 30.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 70.13 110.872 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 6' ' ' ILE . 74.1 t -118.7 139.45 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.126 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 129.05 42.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 65.21 110.919 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.844 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 m -88.41 -175.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.168 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.32 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 72.22 110.92 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -66.31 142.35 57.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 73.03 110.9 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.35 159.75 48.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 72.21 111.161 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.82 162.02 43.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 72.54 112.277 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.24 82.49 0.1 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 34.04 112.419 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.4 tttt 52.19 73.46 0.95 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 73.11 110.955 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -179.17 2.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.691 2.261 . . . . 65.01 112.347 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.842 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.423 ' C6 ' ' HB3' ' A' ' 80' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.511 -0.236 . . . . 71.21 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 t 63.01 105.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.388 . . . . 72.14 110.866 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.39 71.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 74.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.06 139.39 30.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 61.15 110.849 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.4 m-80 -82.4 121.09 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 75.22 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mm -125.11 122.05 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.201 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.64 142.13 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.3 111.11 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -146.96 166.25 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 63.3 111.116 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.96 148.57 48.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 60.24 110.866 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.29 121.25 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 72.3 111.198 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 82.0 5.01 90.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 53.21 112.532 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -100.96 141.87 23.5 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 61.43 110.892 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 143.87 52.36 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.783 2.322 . . . . 63.22 112.284 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 8' ' ' ALA . 65.2 tp -144.6 143.16 30.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 63.4 110.881 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.8 t -121.13 146.73 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 75.3 111.172 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.58 HD12 HD23 ' A' ' 64' ' ' LEU . 98.3 mt -131.48 149.94 52.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.953 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -111.91 150.55 30.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 62.23 110.872 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.9 t -108.73 101.2 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -57.1 124.99 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 51.11 110.913 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.74 -39.33 2.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 71.32 112.497 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.18 132.03 35.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.571 0.7 . . . . 70.34 111.089 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -164.96 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.649 2.232 . . . . 64.41 112.309 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -47.83 -51.84 21.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.41 110.882 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 1.4 tptt -111.22 147.48 36.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 63.45 110.961 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 109.7 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.704 2.269 . . . . 64.32 112.364 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.5 Cg_endo -69.74 -73.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.622 2.214 . . . . 63.34 112.389 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.47 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 3.2 mp0 -102.36 -177.24 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 70.13 110.864 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 mtm-85 -63.63 148.07 49.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.925 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -146.27 151.15 37.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.92 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.62 148.58 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.887 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.654 ' HE1' HD13 ' A' ' 29' ' ' LEU . 28.6 m95 -122.79 137.03 55.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 73.25 110.969 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 139.79 42.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 72.04 110.874 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 34' ' ' ASN . 9.1 tp -137.99 136.08 36.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 75.41 110.889 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.0 m120 -114.63 127.43 55.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.899 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.7 p -138.85 176.79 8.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.42 -130.81 16.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 73.0 112.445 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.53 -37.35 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.907 0.384 . . . . 73.21 110.873 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -178.76 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.33 111.18 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.605 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.8 mt-10 -101.99 32.8 3.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 70.33 110.931 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.79 -5.88 6.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.503 . . . . 71.23 111.115 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -59.4 132.27 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 73.45 110.893 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.671 ' HE3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.51 153.33 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.871 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.0 t -100.17 122.47 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.195 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD13 HD13 ' A' ' 64' ' ' LEU . 20.4 mt -89.29 143.6 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 62.51 110.884 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.03 163.33 42.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 71.11 110.9 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -1.76 9.08 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 61.32 112.294 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -127.34 81.11 2.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.931 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -0.7 85.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.654 -0.784 . . . . 73.44 112.457 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.78 100.13 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 52.44 112.48 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.36 -75.05 0.36 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 75.11 112.547 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 1.55 4.32 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.642 2.228 . . . . 75.14 112.374 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 23.9 p-90 -50.65 -35.48 30.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.8 -24.18 62.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 72.31 110.834 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.76 -42.71 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.879 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.671 HG12 ' HE3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -121.71 -98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 62.33 111.117 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -164.82 176.17 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 63.43 111.113 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -113.35 160.58 18.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 63.42 110.836 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 t -109.54 129.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 53.31 111.154 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.6 mt -68.55 158.51 85.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.678 . . . . 73.44 110.942 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.88 32.91 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.712 2.275 . . . . 72.23 112.387 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.32 1.33 48.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 70.44 110.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.77 9.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.726 . . . . 71.13 112.531 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.563 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.2 m -112.22 -179.66 3.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 73.51 110.901 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD23 HD12 ' A' ' 16' ' ' LEU . 26.9 tp -128.9 128.27 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 53.14 110.857 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 15' ' ' VAL . 31.1 t80 -126.22 136.93 53.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 74.31 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -114.61 132.22 22.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.646 0.736 . . . . 64.21 110.871 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.8 15.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 74.11 112.272 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.606 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.19 100.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.29 -0.414 . . . . 62.11 111.17 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -74.13 112.98 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 72.23 111.129 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.97 163.08 37.71 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 71.32 112.47 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.875 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.86 -30.74 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.745 0.307 . . . . 64.02 111.146 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -76.15 -22.72 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.972 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -5.05 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.917 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -61.95 142.08 57.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 63.41 110.905 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.95 -142.88 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 62.31 112.476 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.445 HG23 ' ND2' ' A' ' 92' ' ' ASN . 3.5 mt -123.95 133.22 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.34 111.108 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 16' ' ' LEU . 7.0 t80 -104.75 140.14 38.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 64.52 110.849 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -135.23 142.39 45.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 55.12 110.868 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 155.81 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.862 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -140.7 129.28 22.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 53.1 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 162.19 31.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.115 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 ttm -130.65 125.08 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 63.53 110.889 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -89.59 172.28 9.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.865 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -71.68 -18.52 62.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.5 110.812 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -73.45 -20.01 60.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.922 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.54 31.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 71.44 112.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -84.98 146.83 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 51.02 110.936 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.09 143.87 32.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 61.3 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 126.64 51.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 42.24 111.171 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 145.11 32.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 62.23 110.83 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -144.58 124.52 13.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.852 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -118.88 121.45 40.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 43.22 110.827 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -128.89 120.42 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 63.31 110.957 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -83.75 134.28 34.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.914 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.29 139.36 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 75.42 111.172 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -129.14 148.44 51.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.851 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.875 HG21 ' HA ' ' A' ' 71' ' ' ILE . 34.6 m -112.67 -177.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 63.12 111.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -66.35 -81.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.933 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -59.24 146.25 39.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.907 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.41 159.7 49.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.611 0.72 . . . . 74.43 111.154 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo -69.8 -38.76 7.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.241 . . . . 74.44 112.345 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.72 54.53 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 74.25 112.543 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -142.93 160.58 52.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 71.55 110.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 177.82 5.23 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.233 . . . . 61.1 112.357 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.34 110.947 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.423 -0.271 . . . . 73.21 112.423 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.9 p -166.9 147.42 5.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 74.25 110.79 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -58.39 96.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 73.1 111.058 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.85 133.79 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.896 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.421 ' C ' HD12 ' A' ' 6' ' ' ILE . 4.5 p30 -84.29 119.62 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 62.32 110.862 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.0 mp -126.52 123.54 63.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 62.11 111.096 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -94.78 140.83 29.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 71.0 111.116 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.72 167.27 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 73.45 111.113 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -124.25 148.32 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.22 110.909 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 71' ' ' ILE . 24.9 mt -53.83 121.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.23 111.125 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.65 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.72 3.97 79.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 53.03 112.45 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 14.9 mm-40 -101.1 140.33 21.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 75.11 110.867 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 142.28 47.59 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.676 2.251 . . . . 55.23 112.339 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 6' ' ' ILE . 23.0 tp -144.43 141.97 29.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 72.32 110.912 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 65' ' ' PHE . 41.8 t -123.34 147.97 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.116 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.835 HD12 HD23 ' A' ' 64' ' ' LEU . 94.4 mt -131.5 148.6 52.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 72.52 110.983 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -110.49 149.0 30.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.45 110.923 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 101.19 9.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 62.43 110.85 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -53.19 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 62.51 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.45 -46.62 0.68 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.725 -0.75 . . . . 65.14 112.497 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.0 103.7 12.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.603 0.716 . . . . 75.42 111.148 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.6 Cg_endo -69.68 -163.25 0.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 65.5 112.366 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.6 -9.48 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.914 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -45.47 168.34 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.583 0.706 . . . . 70.43 110.878 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.5 Cg_endo -69.69 172.85 11.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.756 2.304 . . . . 63.43 112.305 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.76 95.1 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 74.12 112.327 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.92 -174.3 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.902 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -63.62 131.77 49.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 72.41 110.855 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.2 pp -179.41 157.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.54 110.928 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.13 148.62 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 54.05 110.861 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.647 ' HE3' HD21 ' A' ' 33' ' ' LEU . 5.0 m95 -127.67 132.76 49.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.856 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.7 mtmt -137.6 135.41 36.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 75.11 110.871 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.082 HD11 HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -139.93 138.84 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.881 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -112.95 127.63 56.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 74.23 110.848 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.1 p -137.22 179.77 6.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.149 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.73 -127.71 13.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 74.52 112.48 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 38' ' ' THR . 2.8 tpt180 -114.33 -37.49 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 74.13 110.823 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -179.09 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 61.14 111.158 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -99.98 32.91 2.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.895 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.76 -6.24 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 42.12 111.139 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -60.71 131.25 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 73.52 110.93 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 158.77 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.35 110.877 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.06 118.73 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.082 HD12 HD11 ' A' ' 33' ' ' LEU . 1.5 mt -90.25 145.78 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.954 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.03 162.74 43.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 63.44 110.881 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 0.16 6.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.237 . . . . 60.22 112.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -119.46 72.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.74 10.0 62.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 34.21 112.388 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.93 102.26 0.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.787 -0.721 . . . . 70.05 112.487 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 132.33 -67.46 0.56 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.73 -0.748 . . . . 52.34 112.434 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -1.28 8.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.609 2.206 . . . . 74.01 112.371 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -34.08 34.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 71.33 110.856 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.45 -28.05 68.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 75.05 110.855 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.31 -42.29 10.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 62.15 110.83 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -125.71 -96.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 61.2 111.028 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -162.52 174.44 12.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 71.22 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 162.06 23.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 72.03 110.881 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.27 130.15 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.12 111.18 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.4 mt -69.54 158.86 85.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 73.21 110.869 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -23.41 30.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.661 2.241 . . . . 61.11 112.37 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -83.79 0.48 47.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 62.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.2 25.24 19.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 54.14 112.497 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.582 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -105.84 -179.43 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 61.13 110.911 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.835 HD23 HD12 ' A' ' 16' ' ' LEU . 13.7 tp -130.03 129.97 44.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 63.45 110.931 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 15' ' ' VAL . 36.9 t80 -125.37 128.83 48.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 73.25 110.817 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.2 mp -120.26 130.02 25.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.647 0.737 . . . . 63.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.36 18.95 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.702 2.268 . . . . 73.33 112.343 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.65 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.24 101.71 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 63.44 111.057 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.8 m -73.09 119.33 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 72.44 111.124 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.03 161.91 33.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 62.2 112.533 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.755 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.59 -31.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.779 0.323 . . . . 74.44 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -75.05 -23.16 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.12 110.843 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.44 -5.48 45.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 70.12 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 140.48 58.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.868 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.36 -141.72 8.19 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 62.4 112.547 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG23 HD21 ' A' ' 92' ' ' ASN . 1.3 mp -123.5 133.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 51.13 111.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' A' ' 33' ' ' LEU . 10.7 m-85 -104.48 139.95 38.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 65.32 110.876 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -135.41 142.01 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 75.3 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 41.8 t -128.91 150.43 50.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.3 126.75 21.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 71.41 110.925 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.97 163.06 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 34.32 111.124 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.7 ttm -129.35 125.02 35.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 62.04 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.25 172.55 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 62.12 110.905 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -70.96 -18.54 62.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 65.12 110.839 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -73.83 -25.83 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 75.54 110.85 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.78 -14.24 19.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 42.11 112.454 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.35 147.88 26.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.717 0.294 . . . . 72.33 110.882 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.12 142.49 34.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 65.11 110.911 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.69 126.29 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.137 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 144.2 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.901 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.1 m -146.9 126.7 13.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.04 110.91 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.22 126.91 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.919 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' A' ' 16' ' ' LEU . 8.3 m-85 -124.1 120.96 33.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 65.25 110.974 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NE ' ' HB1' ' A' ' 3' ' ' ALA . 20.1 mmt85 -83.53 130.07 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.12 110.799 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.02 134.2 65.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 74.21 111.121 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.454 ' NH1' HG21 ' A' ' 100' ' ' ILE . 0.8 OUTLIER -131.45 127.92 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.5 m -95.66 -177.67 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 60.35 111.068 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -66.76 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.898 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -62.48 143.83 56.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 73.11 110.882 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.454 HG21 ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -121.37 159.72 48.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 63.51 111.124 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.73 123.92 10.59 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.23 112.311 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.33 -115.94 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 51.02 112.486 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 160.59 1.16 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 72.24 110.864 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 172.88 11.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.644 2.229 . . . . 75.1 112.321 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 65.22 110.889 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.459 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.528 -0.229 . . . . 62.45 112.528 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -178.25 158.99 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 71.54 110.886 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.32 93.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.53 111.09 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.577 ' NE2' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -93.39 131.46 38.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 74.34 110.925 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.672 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.8 m120 -88.34 120.54 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 52.43 110.881 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.672 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -125.87 128.37 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 62.32 111.112 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -89.3 141.09 28.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 72.01 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.13 165.95 26.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 71.22 111.134 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 150.06 43.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.829 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 22.7 mt -68.76 120.61 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.75 -6.34 60.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 73.12 112.49 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 pp20? -102.09 141.09 21.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.41 110.842 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 145.69 58.03 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.676 2.251 . . . . 61.43 112.347 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 tp -137.95 143.07 40.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 72.25 110.914 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 65' ' ' PHE . 39.1 t -122.09 145.0 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.31 111.133 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.784 HD12 HD23 ' A' ' 64' ' ' LEU . 30.4 mt -131.3 149.48 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.16 152.75 27.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 72.11 110.972 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -106.31 101.78 11.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.861 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -58.76 120.38 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 61.55 110.864 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.22 -42.79 1.46 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 60.33 112.451 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.32 128.6 46.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 71.41 111.083 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -165.14 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 64.33 112.36 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.12 -52.22 27.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 62.03 110.88 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 11.1 tptt -112.44 129.27 24.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 75.34 110.879 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.3 Cg_endo -69.77 109.72 2.38 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.254 . . . . 72.54 112.309 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.3 Cg_endo -69.76 -54.83 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.67 2.247 . . . . 71.22 112.351 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -105.91 -179.32 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 61.31 110.921 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -71.38 162.47 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 74.02 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.484 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -155.24 157.85 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 64.11 110.931 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.6 144.81 47.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 52.32 110.96 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' HE1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -126.22 136.88 53.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.156 -0.474 . . . . 65.25 110.948 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -144.36 136.4 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 53.25 110.82 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.5 tp -138.95 136.81 35.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 73.44 110.887 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.627 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -113.45 127.13 56.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.868 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.793 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 3.6 p -137.99 179.39 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 74.45 111.108 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.39 -131.18 16.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 73.12 112.528 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.5 -37.29 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.923 0.392 . . . . 63.43 110.89 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -179.4 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 75.21 111.133 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.09 33.32 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 74.11 110.948 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.61 -7.21 7.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 63.43 111.101 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -60.36 130.59 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 153.46 47.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 73.34 110.846 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -99.04 121.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 55.24 111.101 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.82 145.84 24.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 61.35 110.946 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.56 163.13 40.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.723 . . . . 74.05 110.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.77 2.82 3.19 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.675 2.25 . . . . 51.2 112.366 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -115.46 101.63 9.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 61.5 110.914 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.77 69.4 0.53 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.77 . . . . 62.52 112.479 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.77 138.56 9.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 71.25 112.423 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.31 -115.43 5.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 70.12 112.469 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -14.26 35.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.717 2.278 . . . . 72.55 112.374 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.477 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 4.8 m-90 -62.95 -34.56 77.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 70.43 110.914 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.39 -24.27 67.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 34.31 110.825 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -33.76 68.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 71.31 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.26 -73.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 53.24 111.091 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.85 154.7 37.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 44.41 111.135 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -132.54 160.18 37.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 74.33 110.9 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 46' ' ' PRO . 7.0 t -109.0 129.88 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 71.1 111.113 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 36.0 mt -70.28 158.82 86.65 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 52.45 110.934 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -21.87 33.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 63.51 112.339 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -83.16 1.83 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 72.14 110.884 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.21 29.69 14.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.73 . . . . 64.43 112.472 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.8 m -113.9 -178.9 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 44.21 110.88 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 16' ' ' LEU . 23.8 tp -129.47 127.62 41.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.901 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 15' ' ' VAL . 6.5 t80 -125.9 136.05 52.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 65.44 110.879 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.62 HD22 HG12 ' A' ' 69' ' ' VAL . 7.7 mp -119.29 130.22 24.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.636 0.732 . . . . 63.5 110.895 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.93 17.37 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.28 . . . . 61.01 112.308 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.77 102.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 74.01 111.105 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 12' ' ' GLU . 18.5 m -72.74 119.2 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 75.45 111.039 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.16 161.55 27.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 70.1 112.53 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.15 -32.26 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 72.55 111.079 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -76.01 -22.51 55.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 72.05 110.918 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -4.98 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 71.33 110.84 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.32 141.3 57.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 70.44 110.913 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.08 -138.95 5.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.743 . . . . 54.41 112.48 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.412 HG23 HD21 ' A' ' 92' ' ' ASN . 2.4 mp -123.95 130.35 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 61.15 111.132 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.552 ' CG ' HD13 ' A' ' 16' ' ' LEU . 10.8 t80 -105.49 134.17 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.84 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.56 139.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 74.53 110.817 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.5 t -125.5 156.3 39.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 53.43 110.896 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -140.75 134.67 30.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.14 110.908 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 162.36 32.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.143 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.8 mtp -130.16 125.24 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.908 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -91.51 172.43 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.827 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.4 -18.87 62.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.51 110.864 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -73.94 -20.43 60.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.907 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.99 -15.33 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 55.43 112.414 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 146.18 27.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 70.32 110.88 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -106.16 143.63 34.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.87 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 129.46 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 70.12 111.16 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 145.11 35.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.858 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.21 121.53 10.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 53.13 110.9 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.8 OUTLIER -118.37 124.37 47.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.076 -0.511 . . . . 73.14 110.832 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -129.82 117.93 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 73.42 110.827 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -84.24 130.6 34.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 73.12 110.873 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.08 140.32 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 73.2 111.118 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.23 127.73 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.7 m -88.69 -176.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.04 111.107 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.6 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.937 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 140.74 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.885 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.71 159.63 50.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.654 0.74 . . . . 74.44 111.074 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 100.04 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.68 2.254 . . . . 74.04 112.274 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.08 -37.64 2.87 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 74.04 112.488 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -51.83 137.51 34.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.532 0.682 . . . . 74.33 110.946 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.64 0.49 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.647 2.231 . . . . 42.02 112.342 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.893 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.428 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.516 -0.234 . . . . 72.21 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -179.71 112.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 40.41 110.856 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB1' ' HE ' ' A' ' 94' ' ' ARG . . . 51.33 66.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 62.44 111.108 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.57 133.55 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 73.05 110.934 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 2.2 p30 -84.01 121.03 26.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 70.31 110.888 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 14' ' ' LEU . 43.6 mm -125.4 121.78 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.44 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.98 138.77 33.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.45 . . . . 74.11 111.093 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.61 166.88 26.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.122 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -120.93 148.35 44.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.841 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mt -52.61 121.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 61.42 111.058 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.73 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.61 7.19 72.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 51.02 112.515 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.767 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.7 mm-40 -101.37 139.43 20.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 52.13 110.939 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 143.15 49.62 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 75.42 112.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 6' ' ' ILE . 19.1 tp -145.44 142.04 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 73.41 110.859 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.13 148.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 65.22 111.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.781 HD12 HD23 ' A' ' 64' ' ' LEU . 9.2 mt -131.14 147.21 52.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.906 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -113.26 154.89 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.902 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 t -104.06 100.57 10.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 74.45 110.893 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.64 116.56 4.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 61.44 110.901 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 89' ' ' THR . . . 124.76 -42.81 1.47 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.786 -0.721 . . . . 73.25 112.504 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.02 40.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.545 0.688 . . . . 74.02 111.14 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.9 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 72.12 112.25 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -48.98 -52.58 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -111.95 129.7 23.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 74.44 110.863 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.8 Cg_endo -69.73 110.13 2.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.594 2.196 . . . . 71.03 112.346 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.8 Cg_endo -69.77 -51.16 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.696 2.264 . . . . 73.43 112.406 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -104.36 -178.74 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 71.32 110.897 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.0 mmm-85 -65.55 158.89 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 72.3 110.81 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.788 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -154.49 166.85 32.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 64.14 110.932 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -145.55 148.54 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.855 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.788 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 29.0 m-90 -120.64 132.07 54.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 72.53 110.897 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' HD23 ' A' ' 33' ' ' LEU . 2.1 ttpt -139.97 135.9 33.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.952 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -148.1 140.05 24.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 74.52 110.945 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.95 128.74 55.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 44.31 110.927 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -136.33 -179.73 5.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 72.25 111.166 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.68 -129.14 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.722 -0.751 . . . . 72.33 112.549 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.51 -37.45 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 65.44 110.906 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.4 t -179.32 -29.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.156 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.8 mt-10 -102.26 33.93 2.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 74.15 110.841 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.63 -6.32 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.54 111.148 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -58.73 130.2 45.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.942 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.619 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -130.8 152.97 49.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 75.33 110.882 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.85 120.66 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.31 111.189 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 33' ' ' LEU . 3.3 mm? -89.88 146.71 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.31 162.44 46.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.639 0.733 . . . . 64.51 110.93 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.73 -1.92 9.26 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 73.11 112.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -128.17 71.77 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 63.2 110.974 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.572 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -91.85 -33.59 7.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 73.21 112.453 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . -21.67 120.92 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.804 -0.712 . . . . 73.31 112.527 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.11 -124.32 4.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 52.14 112.512 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HG2' ' CE3' ' A' ' 52' ' ' TRP . 54.2 Cg_endo -69.82 -6.0 17.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.734 2.289 . . . . 75.1 112.343 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.56 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 1.2 m-90 -62.88 -14.18 43.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 65.21 110.915 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 6.3 p-10 -68.44 -23.13 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 63.24 110.832 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -33.79 76.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 43.21 110.937 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -123.1 -71.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 72.42 111.133 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -155.86 156.4 34.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 55.41 111.137 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.56 ' HG3' ' HB3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -131.64 161.18 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.11 110.937 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 44' ' ' LEU . 24.9 t -109.0 129.93 62.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.11 111.042 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.45 158.98 86.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.7 . . . . 71.33 110.899 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -20.98 33.91 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.608 2.205 . . . . 71.24 112.294 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -83.12 1.59 39.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 74.34 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.39 25.17 26.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 61.03 112.505 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -110.84 -178.72 3.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.22 110.823 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD22 ' CE2' ' A' ' 77' ' ' PHE . 10.7 tp -129.72 127.57 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.917 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -126.12 132.51 51.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.904 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 69' ' ' VAL . 4.8 mp -118.54 129.61 25.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.663 0.744 . . . . 74.2 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.74 17.86 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.739 2.293 . . . . 65.45 112.313 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.73 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.76 101.29 0.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 25.51 111.044 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 66' ' ' LEU . 12.2 m -73.35 116.71 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 70.21 111.1 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.4 165.35 33.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 74.23 112.512 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.85 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.78 -30.17 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 72.44 111.111 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.853 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.96 -5.0 56.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 64.32 110.821 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.69 140.94 58.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.76 -141.56 7.87 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 31.52 112.528 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD12 ' CG ' ' A' ' 94' ' ' ARG . 47.1 mm -124.41 127.72 73.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 63.32 111.115 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.787 ' CE2' HD22 ' A' ' 64' ' ' LEU . 11.2 t80 -104.66 134.18 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.22 110.897 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -127.92 146.5 50.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 72.33 110.837 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.4 t -126.25 153.87 44.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.922 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.04 130.82 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 71.11 110.887 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.55 162.58 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 65.12 111.105 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.4 ttm -130.32 125.01 33.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.919 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -89.14 172.23 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 73.42 110.836 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.53 -18.61 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 72.42 110.853 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -73.57 -20.23 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.21 110.829 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.91 -17.44 29.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 64.1 112.49 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -84.81 147.9 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 71.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -104.01 149.18 25.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.875 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.478 HG21 ' HA3' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.14 133.5 48.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.131 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 143.41 33.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 53.13 110.921 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.5 m -145.23 122.74 11.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 61.3 110.831 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.7 OUTLIER -119.66 124.36 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 73.04 110.925 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -128.37 119.83 25.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 55.23 110.89 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.576 ' HE ' ' HB1' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -83.9 132.15 34.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 73.11 110.823 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -121.88 136.26 59.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 73.54 111.118 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.432 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -131.12 131.58 44.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.849 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.8 m -95.87 -175.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 54.41 111.171 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -66.39 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.23 110.867 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -62.85 146.33 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 75.34 110.943 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.56 49.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.688 0.756 . . . . 63.25 111.081 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.0 Cg_endo -69.72 -177.19 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 54.33 112.329 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.3 66.43 3.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.761 . . . . 71.3 112.463 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -142.92 137.66 15.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 71.15 110.918 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.48 48.19 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.723 2.282 . . . . 74.42 112.345 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.33 110.81 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.459 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.502 -0.239 . . . . 43.43 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 57.53 83.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.949 0.404 . . . . 73.13 110.903 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.9 71.11 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.059 -0.519 . . . . 55.21 111.082 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 133.28 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.946 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.45 119.13 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 60.44 110.887 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 14' ' ' LEU . 3.8 mp -126.44 124.64 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.136 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 p -93.51 142.25 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 55.2 111.115 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.43 166.57 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.32 111.029 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.61 148.28 46.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 62.32 110.92 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mt -54.9 121.98 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 42.34 111.173 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.23 5.41 76.27 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 72.52 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 34.9 mm-40 -101.91 140.7 21.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.689 0.757 . . . . 74.13 110.899 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 144.03 52.82 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.664 2.242 . . . . 64.11 112.331 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 6' ' ' ILE . 22.3 tp -143.54 141.31 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 75.01 110.907 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.0 t -122.44 147.19 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 62.54 111.131 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD12 HD23 ' A' ' 64' ' ' LEU . 53.4 mt -130.97 148.28 52.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.899 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -112.07 151.82 28.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.807 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 t -107.18 100.76 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.853 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -58.1 120.22 8.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.892 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.49 -39.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 62.3 112.515 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.28 128.64 54.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.709 . . . . 61.54 111.077 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -165.13 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.686 2.257 . . . . 51.44 112.352 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -48.2 46.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.915 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -109.69 150.35 41.15 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.596 0.713 . . . . 61.23 110.891 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.87 109.59 2.37 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 70.13 112.359 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 54.8 Cg_endo -69.73 -80.68 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.743 2.295 . . . . 73.14 112.353 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.438 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 21.6 mm100 -103.24 -176.46 3.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 65.51 110.837 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -62.9 148.26 47.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 61.44 110.887 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.68 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.58 150.79 37.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 62.43 110.951 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -121.51 148.62 44.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 60.14 110.878 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.68 ' HE1' HD13 ' A' ' 29' ' ' LEU . 23.5 m95 -123.11 138.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.876 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.711 ' C ' HD13 ' A' ' 33' ' ' LEU . 89.0 mttt -150.97 135.76 17.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.24 110.94 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.725 HD23 ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.25 145.94 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.889 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.99 129.43 56.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.943 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.842 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.0 p -138.42 -179.58 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 54.24 111.157 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.89 -132.78 16.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.771 -0.728 . . . . 71.22 112.53 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.79 -37.69 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 73.22 110.882 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 39' ' ' GLU . 4.4 t -179.12 -29.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.098 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -101.53 34.81 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.874 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.09 -4.23 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.21 111.06 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -57.32 128.05 35.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.725 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.16 156.64 47.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 74.03 110.873 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' LYS . 94.7 t -105.5 122.24 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 73.21 111.125 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 33' ' ' LEU . 4.0 mt -89.91 147.14 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 61.31 110.864 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.77 162.21 46.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.73 0.776 . . . . 54.51 110.846 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.81 -2.62 10.52 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.687 2.258 . . . . 64.31 112.319 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -119.96 72.35 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.899 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.64 -2.53 85.47 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.809 -0.71 . . . . 53.54 112.389 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.42 109.84 0.89 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.76 . . . . 61.24 112.488 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.76 -76.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.43 112.504 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -0.65 7.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.725 2.283 . . . . 75.11 112.332 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 57' ' ' ARG . 13.1 p-90 -52.38 -35.74 52.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.835 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -24.27 61.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.866 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -43.37 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 54.01 110.869 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.24 -97.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.45 111.174 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -151.28 173.49 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 72.1 111.137 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -127.06 162.8 25.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.916 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 46' ' ' PRO . 8.1 t -106.75 130.95 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 75.4 111.167 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD12 ' CB ' ' A' ' 63' ' ' SER . 31.1 mt -68.7 157.69 87.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 74.32 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -22.16 32.65 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.669 2.246 . . . . 63.34 112.365 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.7 1.2 43.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.46 29.83 11.65 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.753 . . . . 21.12 112.438 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.55 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -112.86 -179.6 3.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 64.12 110.87 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.693 HD23 HD12 ' A' ' 16' ' ' LEU . 16.3 tp -129.51 129.24 44.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.32 110.873 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.439 ' CD2' HG22 ' A' ' 15' ' ' VAL . 44.8 t80 -124.63 136.72 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.21 110.881 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.574 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -116.41 124.79 29.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.35 110.913 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.71 19.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 73.42 112.375 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.49 103.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.076 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 12' ' ' GLU . 34.4 m -71.62 118.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 72.43 111.124 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.58 157.44 23.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 75.5 112.506 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.831 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -32.02 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 72.45 111.127 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -75.6 -23.4 56.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -5.26 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 52.43 110.823 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 142.01 56.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 52.44 110.918 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.22 -138.17 5.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.798 -0.715 . . . . 74.02 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 92' ' ' ASN . 3.6 mp -122.68 127.32 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 71.04 111.195 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 14.6 m-85 -104.78 144.49 31.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 63.25 110.853 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -138.27 143.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 71.34 110.865 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.8 t -127.21 155.66 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.31 110.891 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.14 133.8 30.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.926 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.5 162.71 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 51.54 111.089 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.7 mtp -129.94 125.12 34.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.11 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -91.39 172.51 8.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 41.42 110.876 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.45 -18.81 62.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 74.14 110.852 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.06 -20.57 60.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.872 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.02 -15.21 33.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.83 -0.7 . . . . 45.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -85.02 146.35 27.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.742 0.306 . . . . 74.43 110.893 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 144.26 33.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.89 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 132.15 50.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 65.31 111.189 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 145.14 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.937 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -145.34 127.9 16.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.01 110.825 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.519 HD21 HG23 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -116.97 124.93 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 74.23 110.849 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -125.41 121.6 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 72.2 110.944 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HE ' ' ND2' ' A' ' 92' ' ' ASN . 16.9 mmt85 -83.07 133.03 35.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.31 110.874 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -120.95 134.82 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 71.11 111.219 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 128.79 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.872 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.8 m -98.33 -177.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 73.4 111.198 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.55 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.954 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.89 144.53 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 72.3 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.4 159.61 49.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 74.15 111.125 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.9 Cg_endo -69.82 -38.59 7.46 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.686 2.258 . . . . 64.03 112.319 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.99 97.8 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 54.01 112.451 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -178.96 157.75 0.94 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 73.53 110.802 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 168.13 22.53 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.681 2.254 . . . . 62.32 112.294 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.87 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.459 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.465 -0.254 . . . . 72.14 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 179.84 109.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 70.13 110.894 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.69 66.91 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 43.22 111.084 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -93.23 131.94 37.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.41 110.916 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 5.3 p-10 -90.83 121.85 33.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.887 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.58 127.42 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.137 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -94.52 142.52 27.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 61.42 111.179 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.35 168.44 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 64.3 111.061 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.43 148.06 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.596 HD11 HG13 ' A' ' 71' ' ' ILE . 33.8 mt -67.28 121.99 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.06 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.17 -9.96 54.58 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.675 -0.774 . . . . 74.41 112.429 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.71 142.66 25.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.723 . . . . 72.45 110.862 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 145.07 56.2 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 63.24 112.334 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.0 tp -139.71 144.44 37.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 74.4 110.909 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.608 HG22 ' CD2' ' A' ' 65' ' ' PHE . 2.9 t -120.46 145.03 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 63.44 111.104 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.3 mt -131.28 147.78 52.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.41 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -113.62 150.87 32.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 61.14 110.924 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -108.11 100.26 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 72.14 110.894 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -54.27 128.41 31.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.02 110.939 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.81 -42.1 1.59 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.727 . . . . 74.35 112.472 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.99 130.87 36.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.522 0.677 . . . . 60.1 111.13 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -168.47 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.703 2.268 . . . . 72.33 112.358 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -49.99 -54.57 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.905 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 6.1 tptt -113.91 128.12 26.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 73.35 110.876 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.542 ' HB3' HD21 ' A' ' 29' ' ' LEU . 52.9 Cg_endo -69.88 109.77 2.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 74.33 112.271 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.5 Cg_endo -69.82 -54.32 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.628 2.218 . . . . 30.21 112.312 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -178.4 3.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 75.15 110.893 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -65.49 162.28 18.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.823 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -163.13 147.04 10.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 60.52 110.888 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -128.71 148.44 50.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 63.34 110.895 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.782 ' CZ3' HG11 ' A' ' 58' ' ' VAL . 3.3 m-90 -134.47 144.11 47.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 64.14 110.982 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.452 ' C ' HD23 ' A' ' 33' ' ' LEU . 4.4 mtmt -136.21 142.05 44.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 73.24 110.924 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.003 HD21 HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.4 139.03 42.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 73.1 110.936 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -112.12 127.29 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.33 110.901 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 43.7 p -138.16 -179.8 6.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 71.21 111.141 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.44 -129.97 23.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.852 -0.689 . . . . 74.33 112.435 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -112.61 -37.4 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 73.42 110.897 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.626 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.1 t -178.69 -29.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 65.31 111.174 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.626 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -101.73 34.07 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 74.5 110.887 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -5.54 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.123 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.544 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 44.0 t90 -59.62 131.82 52.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 70.01 110.929 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.768 ' HE2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.03 155.07 45.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.935 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.544 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 23.1 t -104.48 121.75 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 70.55 111.137 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.003 HD13 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -88.86 143.13 27.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.41 110.911 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.585 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -127.93 164.09 39.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 65.35 110.808 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 0.85 5.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.707 2.271 . . . . 63.1 112.277 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -131.07 75.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 74.04 110.899 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.85 -0.81 86.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 43.15 112.494 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.86 112.03 4.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 71.44 112.523 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.67 -72.65 0.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 73.22 112.462 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -3.21 11.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.693 2.262 . . . . 71.52 112.327 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -34.63 49.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 73.52 110.949 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.61 -25.55 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.39 -43.67 10.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 71.52 110.829 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.58 -96.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 53.41 111.134 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -149.18 174.56 12.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.25 111.116 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.52 160.2 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.85 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG11 ' CZ3' ' A' ' 31' ' ' TRP . 65.7 t -111.9 129.25 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.158 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 63' ' ' SER . 86.4 mt -69.29 157.19 90.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 74.02 110.929 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.41 34.81 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.75 2.3 . . . . 73.42 112.278 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -82.41 0.57 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 63.42 110.863 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 27.39 17.37 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 54.34 112.443 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 59' ' ' LEU . 30.4 m -111.77 175.73 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.852 0.358 . . . . 50.44 110.896 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.843 HD13 HD21 ' A' ' 44' ' ' LEU . 16.5 tp -129.34 130.11 45.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.865 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.608 ' CD2' HG22 ' A' ' 15' ' ' VAL . 27.7 t80 -124.42 135.39 53.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 62.41 110.852 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD22 HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.56 129.51 24.87 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 72.05 110.917 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.62 -31.68 20.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.285 . . . . 73.23 112.414 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.55 104.36 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 61.1 111.145 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.4 m -71.83 119.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 40.23 111.163 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.93 153.49 20.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 31.05 112.447 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.02 -31.18 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 54.45 111.151 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.28 -22.01 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 61.14 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.35 -3.53 34.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.839 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.785 ' CD ' HG22 ' A' ' 97' ' ' VAL . 16.8 mt-10 -58.43 142.17 49.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.1 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.46 -151.74 22.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.839 -0.696 . . . . 73.52 112.561 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.29 133.98 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.893 0.378 . . . . 64.3 111.107 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.75 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.3 m-85 -103.04 139.38 38.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.87 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.52 141.04 51.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 m -126.82 150.24 49.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 73.13 110.891 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.07 125.51 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.881 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.43 163.97 28.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 64.15 111.091 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.8 ttm -128.34 124.88 37.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.907 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -86.91 173.15 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 73.22 110.871 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -70.22 -17.97 63.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.87 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -73.23 -19.74 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 63.25 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.36 -18.78 32.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 71.15 112.43 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -85.16 148.2 26.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.716 0.294 . . . . 75.31 110.916 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.5 143.61 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 64.05 110.895 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.55 131.6 51.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 54.04 111.127 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 145.34 33.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.43 110.93 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -146.32 124.41 12.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 72.11 110.846 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 14.4 t-20 -118.82 124.6 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.857 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -129.24 117.02 20.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.927 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -90.9 136.11 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.928 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.18 138.57 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 54.2 111.134 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.21 128.14 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 70.05 110.855 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.4 m -92.2 -175.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.24 111.11 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -65.98 -80.62 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -58.67 146.67 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 61.04 110.847 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.31 159.49 49.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.693 0.759 . . . . 74.14 111.132 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo -69.78 -33.6 16.19 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 72.2 112.368 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.4 75.37 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 71.11 112.458 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 tttp 57.29 72.72 0.88 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 64.35 110.898 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 128.63 16.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.25 . . . . 72.42 112.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 73.14 110.895 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.47 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.426 -0.27 . . . . 71.2 112.426 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -168.11 171.34 9.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 52.32 110.87 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.47 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 72.02 111.088 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -93.44 132.42 37.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.863 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.668 ' C ' HD12 ' A' ' 6' ' ' ILE . 7.0 p30 -87.13 119.96 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.898 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.668 HD12 ' C ' ' A' ' 5' ' ' ASN . 1.8 mp -127.78 127.47 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.117 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -92.11 141.88 28.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 71.42 111.102 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.54 167.58 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.45 111.073 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.78 149.68 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.5 110.885 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 71' ' ' ILE . 22.5 mt -67.47 120.7 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.122 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.69 -8.29 59.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.691 -0.766 . . . . 61.22 112.468 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.08 140.81 21.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.701 . . . . 64.42 110.911 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 145.11 55.98 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.704 2.269 . . . . 74.54 112.33 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 66' ' ' LEU . 20.2 tp -142.35 143.4 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 71.44 110.917 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 64' ' ' LEU . 13.7 t -122.49 148.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 74.24 111.146 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 64' ' ' LEU . 29.6 mt -129.85 149.1 51.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 74.4 110.934 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -108.8 149.56 28.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 61.33 110.878 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.3 t -112.12 100.69 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 72.32 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.12 100.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 52.32 110.842 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 147.08 -46.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.799 -0.715 . . . . 63.3 112.51 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.6 102.75 10.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.538 0.685 . . . . 45.5 111.075 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.9 Cg_endo -69.73 -163.21 0.1 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.705 2.27 . . . . 71.1 112.341 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -61.58 -9.4 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 65.21 110.932 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -45.37 168.04 0.1 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.577 0.704 . . . . 73.44 110.891 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.1 Cg_endo -69.79 172.57 12.42 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.655 2.237 . . . . 73.44 112.377 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.4 Cg_endo -69.77 97.2 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 71.34 112.355 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -100.29 -175.01 2.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 75.1 110.893 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -63.55 132.06 50.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 64.33 110.819 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.485 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -179.43 158.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 72.52 110.937 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 148.33 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 72.55 110.912 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -127.59 137.92 52.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.923 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -135.72 138.57 42.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 73.25 110.957 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.76 HD11 HG23 ' A' ' 35' ' ' THR . 1.2 tm? -137.3 131.53 32.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.948 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.738 ' N ' HD22 ' A' ' 33' ' ' LEU . 10.4 t-20 -116.53 120.68 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 45.25 110.939 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.81 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 54.8 p -138.36 179.39 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 71.55 111.191 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.61 -132.16 12.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 43.13 112.462 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 75.04 110.83 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.5 t -179.67 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 63.2 111.141 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.19 33.73 2.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.917 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.35 -6.01 7.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 74.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -69.24 130.59 43.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 63.31 110.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 159.32 42.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 74.41 110.875 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.73 121.48 43.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.071 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -89.63 146.12 24.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.05 110.94 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.96 162.7 43.99 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.614 0.721 . . . . 72.11 110.852 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 0.51 5.48 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.743 2.295 . . . . 75.33 112.335 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -119.34 89.23 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.899 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.79 4.69 50.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 54.2 112.475 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 101.59 0.22 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 73.42 112.52 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.49 -70.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 64.31 112.453 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.89 4.98 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.733 2.289 . . . . 74.11 112.316 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -50.77 -35.94 34.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 71.35 110.898 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -66.41 -26.08 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 74.42 110.921 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -41.77 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 62.41 110.881 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -124.09 -98.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 73.01 111.096 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . -166.58 177.09 6.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 64.21 111.101 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -112.01 161.04 16.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.11 110.932 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.36 128.16 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 55.12 111.139 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 63' ' ' SER . 26.3 mt -69.05 157.32 89.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.596 0.712 . . . . 72.11 110.925 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.3 Cg_endo -69.63 -22.96 31.95 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.638 2.225 . . . . 51.43 112.363 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -83.45 1.12 43.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 71.24 110.86 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.13 13.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 65.34 112.455 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.534 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m -109.67 177.19 4.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 53.32 110.79 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.4 tp -130.28 129.34 43.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 73.11 110.908 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 t80 -124.16 129.43 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.859 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 14' ' ' LEU . 1.9 mp -117.29 131.22 24.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 72.24 110.892 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -32.22 18.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.705 2.27 . . . . 75.52 112.274 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 100.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.31 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.9 m -76.16 119.88 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.04 111.143 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -91.6 166.92 30.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.508 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.851 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.6 -30.83 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 74.44 111.156 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -74.8 -21.25 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 65.31 110.858 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.32 -3.08 31.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 65.2 110.804 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 139.71 58.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 61.24 110.869 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.98 -147.23 14.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.745 . . . . 52.54 112.516 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.91 133.78 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 63.23 111.118 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.583 ' CG ' HD23 ' A' ' 33' ' ' LEU . 36.9 m-85 -104.94 128.29 53.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 62.01 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.13 138.13 53.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.916 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 156.67 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 72.11 110.913 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -141.26 127.92 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 71.42 110.929 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.21 162.95 29.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.139 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.01 124.43 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 73.11 110.905 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -88.65 172.52 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.899 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -71.09 -18.39 62.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.05 110.823 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -73.62 -19.77 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 73.14 110.915 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.78 -16.88 33.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 35.02 112.417 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -84.96 147.61 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 63.43 110.937 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.31 143.79 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.46 125.6 50.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 54.24 111.15 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 144.76 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.21 110.888 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -145.55 121.27 10.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.834 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HB2' ' CA ' ' A' ' 201' ' ' IOR . 0.8 OUTLIER -119.71 123.54 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 72.32 110.92 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -129.16 118.27 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 64.21 110.877 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.58 132.38 33.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.15 110.86 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.79 139.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 71.34 111.134 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 127.94 43.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.892 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.0 m -91.83 -177.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 70.34 111.138 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.83 -81.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.51 110.943 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.1 142.52 51.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.93 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.29 159.59 49.27 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.555 0.693 . . . . 73.13 111.159 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -46.8 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.666 2.244 . . . . 73.24 112.338 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.72 -33.37 5.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 73.03 112.544 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -131.02 70.06 82.58 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.59 0.709 . . . . 74.3 110.882 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 155.59 65.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.614 2.209 . . . . 73.23 112.318 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 65.21 110.905 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . 0.419 ' CA ' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.471 -0.252 . . . . 62.32 112.471 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.74 111.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 33.4 110.873 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.06 70.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 72.23 111.162 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 132.73 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 64.02 110.883 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.602 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.8 p30 -89.27 120.11 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.859 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 5' ' ' ASN . 3.0 mp -129.33 127.91 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 71.32 111.111 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.23 142.24 27.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.23 111.145 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.48 167.55 21.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 42.43 111.074 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -117.82 149.65 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.32 110.877 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 71' ' ' ILE . 28.4 mt -67.93 120.72 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.071 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 -9.1 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 72.32 112.568 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -101.77 141.74 23.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.57 0.7 . . . . 72.43 110.919 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 145.84 59.05 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 74.4 112.424 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.64 144.4 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.308 -0.406 . . . . 74.05 110.861 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.6 t -120.97 143.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 70.15 111.107 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 77' ' ' PHE . 15.8 mt -131.52 148.19 52.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.869 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -113.91 152.25 31.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.877 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 m -107.95 101.94 11.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 54.24 110.829 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.18 124.94 15.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.41 -44.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.774 -0.727 . . . . 73.31 112.476 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 130.52 58.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 72.23 111.07 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.258 . . . . 54.44 112.306 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -48.34 -50.51 30.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.925 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 51.5 mmtt -110.07 153.47 43.2 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.644 0.735 . . . . 74.24 110.842 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 55.2 Cg_endo -69.67 109.52 2.31 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.663 2.242 . . . . 55.4 112.412 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.66 -84.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.768 2.312 . . . . 73.45 112.386 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -176.24 3.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.53 110.902 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -62.73 149.01 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.873 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -145.7 155.43 42.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.911 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -121.26 148.83 43.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.83 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.643 ' HE1' HD13 ' A' ' 29' ' ' LEU . 7.5 m95 -121.21 126.36 49.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.94 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' C ' HD23 ' A' ' 33' ' ' LEU . 7.0 mttt -139.24 135.46 33.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.43 110.912 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.866 HD21 HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.61 140.35 25.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 64.14 110.884 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.73 128.79 56.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 63.03 110.897 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.844 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.7 p -135.1 -179.99 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.105 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.86 -129.01 12.68 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 72.04 112.484 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -112.49 -37.78 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 71.35 110.906 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t -179.72 -29.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.2 111.159 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.624 ' HG3' HG23 ' A' ' 38' ' ' THR . 24.8 mt-10 -102.4 34.13 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 70.32 110.815 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.06 -6.3 8.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 62.21 111.088 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -58.77 130.4 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 53.1 110.902 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 156.7 44.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.86 119.09 52.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 62.23 111.082 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.866 HD12 HD21 ' A' ' 33' ' ' LEU . 10.2 mt -90.68 149.05 22.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 75.43 110.961 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.09 162.64 44.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.748 0.785 . . . . 54.34 110.839 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.74 -2.46 10.2 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.64 2.226 . . . . 73.42 112.38 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -120.32 74.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.944 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 57' ' ' ARG . . . -77.46 -1.45 76.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 34.15 112.501 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.82 103.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.696 -0.764 . . . . 74.55 112.471 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.75 -74.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 71.03 112.482 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -4.15 13.44 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.598 2.198 . . . . 72.41 112.406 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -34.64 57.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 70.31 110.951 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.81 -24.76 62.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 72.1 110.826 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.18 -42.96 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.803 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.16 -97.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 54.33 111.097 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -151.63 173.65 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.43 111.073 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -125.17 166.23 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 71.11 110.858 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 46' ' ' PRO . 12.1 t -107.79 130.84 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 65.21 111.103 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CB ' ' A' ' 63' ' ' SER . 39.8 mt -68.42 157.61 87.38 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 65.21 110.91 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -22.05 32.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 72.42 112.336 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.6 0.11 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.886 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.7 30.68 9.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.487 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.544 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.3 m -112.97 -179.98 3.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 75.42 110.849 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . 8.5 tp -127.91 127.75 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.913 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 15' ' ' VAL . 30.6 t80 -126.54 131.66 51.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.839 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.2 mp -114.56 130.02 24.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.15 110.959 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.78 18.3 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.739 2.293 . . . . 70.12 112.363 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.87 101.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.33 111.079 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 20.5 m -73.31 119.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 71.13 111.1 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.49 162.6 24.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 63.4 112.497 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.864 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.67 -30.17 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.349 . . . . 74.42 111.119 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.07 -23.1 57.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -4.96 51.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.937 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.7 139.88 56.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 -137.4 5.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 33.24 112.504 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 92' ' ' ASN . 4.2 mp -123.99 127.99 73.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 70.3 111.112 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.0 t80 -105.09 134.53 48.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 75.42 110.843 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -128.06 139.81 52.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.889 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.14 155.66 41.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.872 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -139.23 132.67 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.47 28.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 75.51 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 ttm -129.32 124.86 35.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.22 110.847 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -87.41 172.84 9.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.886 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -18.07 62.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.497 . . . . 74.31 110.829 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -72.95 -19.98 61.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.49 30.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 35.44 112.527 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -84.93 147.87 26.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.806 0.336 . . . . 74.43 110.919 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.94 143.85 32.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.13 133.82 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.05 111.133 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 144.37 32.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 t -145.05 127.4 15.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 72.42 110.835 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -119.75 126.76 51.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 74.24 110.913 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.55 119.67 26.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 71.35 110.878 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 130.88 34.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 75.02 110.906 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.36 135.93 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 51.03 111.127 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 128.15 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 51.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.3 m -94.48 -177.18 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 63.53 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -65.86 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 71.51 110.898 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.17 145.13 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.902 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.2 159.57 49.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.751 . . . . 72.03 111.184 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.2 Cg_endo -69.78 156.76 62.44 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.706 2.27 . . . . 75.23 112.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.72 -76.19 1.03 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 55.44 112.526 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -153.36 157.53 32.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 72.14 110.858 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.625 2.216 . . . . 72.43 112.411 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.919 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' IOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_